activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	119270	CHEMBL761537	Inhibition of PDK1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	8.0	CHEMBL2534	Homo sapiens	Inhibition	%	8.0
	119270	CHEMBL761537	Inhibition of PDK1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	8.0	CHEMBL2534	Homo sapiens	Inhibition	%	8.0
	133229	CHEMBL761450	Inhibition of PDK1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	59.0	CHEMBL2534	Homo sapiens	Inhibition	%	59.0
	138054	CHEMBL761537	Inhibition of PDK1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccccc3)c(Br)cc12)C1CC1		CHEMBL259270	=	Inhibition	%	20.0	CHEMBL2534	Homo sapiens	Inhibition	%	20.0
	144072	CHEMBL761450	Inhibition of PDK1 at 10 uM	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)ccc12)C1CC1		CHEMBL405145	=	Inhibition	%	31.0	CHEMBL2534	Homo sapiens	Inhibition	%	31.0
	177479	CHEMBL761538	Inhibition of PDK1	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1ncc(C(F)(F)F)cc1Cl		CHEMBL111620	=	Activity	%	79.0	CHEMBL2534	Homo sapiens	Activity	%	79.0
	178792	CHEMBL761538	Inhibition of PDK1	B	COCCCn1cc(C2=C(c3ccccc3O)C(=O)NC2=O)c2cccnc21		CHEMBL109944	=	Activity	%	78.0	CHEMBL2534	Homo sapiens	Activity	%	78.0
	182539	CHEMBL761538	Inhibition of PDK1	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	Activity	%	20.0	CHEMBL2534	Homo sapiens	Activity	%	20.0
	182569	CHEMBL762188	Inhibition of PDK1	B	COc1ccccc1C1=C(c2cn(CCCNC(=O)OC(C)(C)C)c3ncccc23)C(=O)NC1=O		CHEMBL109981	=	IC50	nM	570.0	CHEMBL2534	Homo sapiens	IC50	uM	0.57
	316961	CHEMBL769456	Inhibition of receptor kinase activity against PDK (phospho-inositide dependent kinase) at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCCn1ccnn1		CHEMBL281872	>	IC50	nM	20000.0	CHEMBL2534	Homo sapiens	IC50	uM	20.0
	328363	CHEMBL769457	Inhibition of receptor kinase activity against PDK (phospho-inositide dependent kinase) at ATP <Km	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1.Cl		CHEMBL533849	>	IC50	nM	20000.0	CHEMBL2534	Homo sapiens	IC50	uM	20.0
	554899	CHEMBL767851	Inhibition of PDK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3cccnc3)cc12		CHEMBL407002	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	Inhibition	%	0.0
	559743	CHEMBL767852	inhibition of PDK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL288143	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	Inhibition	%	0.0
	572160	CHEMBL758637	Inhibition of Phosphatidylinositol-trisphosphate-dependent kinase 1 at 10 uM	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Inhibition	%	9.0	CHEMBL2534	Homo sapiens	Inhibition	%	9.0
	572986	CHEMBL767852	inhibition of PDK1 in presence of 10 uM ATP	B	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3ccccc3)cc12		CHEMBL259744	=	Inhibition	%	8.0	CHEMBL2534	Homo sapiens	Inhibition	%	8.0
	586377	CHEMBL767851	Inhibition of PDK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3)cc12		CHEMBL258701	=	Inhibition	%	13.0	CHEMBL2534	Homo sapiens	Inhibition	%	13.0
	590215	CHEMBL767853	Inhibition of PDK1 in presence of 10 uM ATP	B	CCCC(=O)Nc1n[nH]c2ncc(-c3ccccc3F)cc12		CHEMBL407373	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	Inhibition	%	0.0
	616531	CHEMBL762190	Inhibition of PDK1 kinase at 100 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	104.0	CHEMBL2534	Homo sapiens	Control	%	104.0
	616570	CHEMBL762191	Inhibition of PDK1 kinase at 500 nM	B	Cn1ccc2ccc3c4[nH]c5c(CCCN[C@H]6CC[C@H](O)CC6)cccc5c4c4c(c3c21)C(=O)NC4=O		CHEMBL307152	=	Control	%	65.0	CHEMBL2534	Homo sapiens	Control	%	65.0
	750653	CHEMBL758786	Inhibition of PDK1 kinase activity	B	O=C(Cc1ccc2ccccc2c1)Nc1cc(C2CC2)n[nH]1		CHEMBL115220	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
	915738	CHEMBL615427	Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCn1cc2c2cccnc21		CHEMBL340776	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	931199	CHEMBL615427	Inhibition of human 3-phosphoinositide-dependent protein kinase 1 at 10 uM	B	O=C1NC(=O)C2=C1c1cn(c3ncccc13)CCOCCOCCOCCOCCn1cc2c2cccnc21		CHEMBL337642	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	1034885	CHEMBL762189	Inhibition of PDK1 at 10 uM	B	COc1ccc(C2=C(Nc3cccc(Cl)c3)C(=O)NC2=O)cc1		CHEMBL158208	=	Inhibition	%	19.0	CHEMBL2534	Homo sapiens	Inhibition	%	19.0
	1036280	CHEMBL762189	Inhibition of PDK1 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Inhibition	%	8.0	CHEMBL2534	Homo sapiens	Inhibition	%	8.0
	1048346	CHEMBL762189	Inhibition of PDK1 at 10 uM	B	COc1ccccc1C1=C(N2CCc3ccccc32)C(=O)NC1=O		CHEMBL160585	=	Inhibition	%	15.0	CHEMBL2534	Homo sapiens	Inhibition	%	15.0
	1055592	CHEMBL762189	Inhibition of PDK1 at 10 uM	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160586	=	Inhibition	%	3.0	CHEMBL2534	Homo sapiens	Inhibition	%	3.0
	1058278	CHEMBL762189	Inhibition of PDK1 at 10 uM	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156379	=	Inhibition	%	5.0	CHEMBL2534	Homo sapiens	Inhibition	%	5.0
	1173966	CHEMBL767854	Inhibition of Phospho-inositide dependent kinase 1 (PDK1)	B	CCN(CC)C/C=C/c1nc(O)c2c(ccc3nc(Nc4c(Cl)cccc4Cl)n(C)c32)c1C		CHEMBL281957	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1489879	CHEMBL828512	Inhibitory concentration against PDK 1	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F		CHEMBL1788116	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1600056	CHEMBL884484	Inhibitory activity against PDK1	F	COc1cc(Nc2c(C#N)cnc3cc(-c4ccc(CN5CCN(C)CC5)cn4)sc23)c(Cl)cc1Cl		CHEMBL373101	>	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
	1734143	CHEMBL854404	Residual activity at human PDK1 at 10 uM in presence of 10 uM ATP relative to control	B	O=C1NC(=O)/C(=C/c2ccc(-c3ccc(F)cc3O)o2)S1		CHEMBL379156	=	Activity	%	104.0	CHEMBL2534	Homo sapiens	Activity	%	104.0
	1739120	CHEMBL866207	Inhibition of PDK1	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Ki	nM	20000.0	CHEMBL2534	Homo sapiens	Ki	nM	20000.0
	1744406	CHEMBL866661	Inhibition of PDK1	B	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	>	Ki	nM	3800.0	CHEMBL2534	Homo sapiens	Ki	uM	3.8
	1751554	CHEMBL869143	Inhibition of PDK1	B	CC(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL213423	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1751555	CHEMBL869143	Inhibition of PDK1	B	CCNc1nnc2ccc(-c3ocnc3-c3ccc(F)cc3)cn12		CHEMBL213451	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1751556	CHEMBL869143	Inhibition of PDK1	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3ccc(F)cc3F)cn12		CHEMBL212382	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1751557	CHEMBL869143	Inhibition of PDK1	B	CC(C)(C)c1nnc2ccc(-c3ocnc3-c3cc(F)c(F)cc3F)cn12		CHEMBL212968	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1751558	CHEMBL869143	Inhibition of PDK1	B	CC(C)c1nnc2ccc(-c3c[nH]nc3-c3cc(F)ccc3F)cn12		CHEMBL214198	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1751652	CHEMBL869143	Inhibition of PDK1	B	CC(C)c1nnc2ccc(-c3ocnc3-c3ccccc3)cn12		CHEMBL379929	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1769415	CHEMBL910932	Inhibition of PDK1	B	C[C@@H]1C[C@H]2CN1CCn1nc3c(cccc3c1O)-c1nc3c(cccc3nc1O)O2		CHEMBL215803	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1779372	CHEMBL854982	Inhibition of PDK	B	Clc1ccc2c(c1Nc1ncnc3cc(OCCCN4CCCC4)cc(OC4CCOCC4)c13)OCO2		CHEMBL217090	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1779393	CHEMBL854982	Inhibition of PDK	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1782046	CHEMBL911853	Inhibition of PDK1	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1790010	CHEMBL854678	Percentage activity of human PDK1 in the presence of 10 uM of compound and 10 uM of ATP in comparison with control	B	O=C(NCc1ccc(S(=O)(=O)N2CCC(n3nnc4ccccc43)CC2)s1)c1ccc(Cl)cc1		CHEMBL383955	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	1790328	CHEMBL873768	Percent residual activity, relative to control, of PDK1 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H](CCCNC(=N)N)C(=O)NC(=O)CCCCCNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL413460	=	Activity	%	56.0	CHEMBL2534	Homo sapiens	Activity	%	56.0
	1790382	CHEMBL873768	Percent residual activity, relative to control, of PDK1 at 1 uM concentration of inhibitor in presence of 20 uM ATP	B	N=C(N)NCCC[C@@H](NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)[C@@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O)C(N)=O		CHEMBL279185	=	Activity	%	62.0	CHEMBL2534	Homo sapiens	Activity	%	62.0
	1800143	CHEMBL910451	Inhibitory activity against PDK1	B	COc1cc(Nc2c(C#N)cnc3cc(-c4coc(CN5CCN(C)CC5)c4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL219557	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1824652	CHEMBL915355	Inhibition of PDK1	B	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	>	Ki	nM	10000.0	CHEMBL2534	Homo sapiens	Ki	uM	10.0
	1824747	CHEMBL915355	Inhibition of PDK1	B	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	2070.0	CHEMBL2534	Homo sapiens	Ki	uM	2.07
	1824829	CHEMBL915355	Inhibition of PDK1	B	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	740.0	CHEMBL2534	Homo sapiens	Ki	uM	0.74
	1837926	CHEMBL920461	Inhibition of PDK1 at 10 uM relative to control	B	CN(C)c1nc2c(Br)c(Br)c(Br)c(Br)c2[nH]1		CHEMBL376505	=	Inhibition	%	112.0	CHEMBL2534	Homo sapiens	Inhibition	%	112.0
	1837965	CHEMBL920461	Inhibition of PDK1 at 10 uM relative to control	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Inhibition	%	97.0	CHEMBL2534	Homo sapiens	Inhibition	%	97.0
	1903867	CHEMBL889507	Stimulation of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)O)c[nH]1)C(=O)N2		CHEMBL228648	>	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	Inhibition	%	10.0
	1903868	CHEMBL889507	Stimulation of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(C(N)=O)c3)c[nH]1)C(=O)N2		CHEMBL228547	>	Inhibition	%	1.0	CHEMBL2534	Homo sapiens	Inhibition	%	1.0
	1903870	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL442229	=	IC50	nM	3000.0	CHEMBL2534	Homo sapiens	IC50	uM	3.0
	1903904	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)O)c[nH]1)C(=O)N2		CHEMBL228648	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
Not Active	1903905	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	Cc1c(C(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(NC(N)=O)cc21		CHEMBL228649		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Determined	1903906	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	Cc1c(CCC(=O)O)c[nH]c1/C=C1\C(=O)Nc2ccc(NC(N)=O)cc21		CHEMBL388183		IC50			CHEMBL2534	Homo sapiens	IC50		
	1903907	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(NC(N)=O)cc32)c(C)c1CCC(=O)O		CHEMBL228699	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1903908	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(NC(N)=O)cc32)c(C)c1CCC(=O)O		CHEMBL228699	=	Inhibition	%	26.0	CHEMBL2534	Homo sapiens	Inhibition	%	26.0
	1903909	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	CN(C)CCNC(=O)c1c[nH]c(/C=C2\C(=O)Nc3ccc(NC(N)=O)cc32)c1		CHEMBL228700	=	Inhibition	%	62.0	CHEMBL2534	Homo sapiens	Inhibition	%	62.0
	1903910	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCN3CCCCC3)c[nH]1)C(=O)N2		CHEMBL228701	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
Not Active	1903911	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCN3CCOCC3)c[nH]1)C(=O)N2		CHEMBL388184		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1903912	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	CN(C)C1CCN(C(=O)c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)C1		CHEMBL388395		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1903913	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCc3cnc[nH]3)c[nH]1)C(=O)N2		CHEMBL228749		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1903914	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCc3ccncc3)c[nH]1)C(=O)N2		CHEMBL228750		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Determined	1903915	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3ccccc3)c[nH]1)C(=O)N2		CHEMBL228751		IC50			CHEMBL2534	Homo sapiens	IC50		
Not Determined	1903916	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	Cc1cccc(-c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)c1		CHEMBL228545		IC50			CHEMBL2534	Homo sapiens	IC50		
Not Determined	1903917	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(F)c3)c[nH]1)C(=O)N2		CHEMBL437109		IC50			CHEMBL2534	Homo sapiens	IC50		
	1903918	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	COc1cccc(-c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)c1		CHEMBL442227	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	uM	0.01
	1903919	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(O)c3)c[nH]1)C(=O)N2		CHEMBL228439	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	uM	0.02
	1903920	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(C(=O)NCCN4CCCCC4)c3)c[nH]1)C(=O)N2		CHEMBL425650	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903921	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	CN(C)CCNC(=O)c1cccc(-c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)c1		CHEMBL228804	=	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	uM	0.1
	1903922	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(C(=O)O)c3)c[nH]1)C(=O)N2		CHEMBL228803	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	1903923	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccnc3)c[nH]1)C(=O)N2		CHEMBL375236	=	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	uM	0.1
	1903924	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	CC(=O)Nc1cccc(-c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)c1		CHEMBL374611	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903925	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(C(=O)O)c3)c[nH]1)C(=O)N2		CHEMBL228803	=	Inhibition	%	34.0	CHEMBL2534	Homo sapiens	Inhibition	%	34.0
	1903926	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(-c3cccc(C(N)=O)c3)c[nH]1)C(=O)N2		CHEMBL228547	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903927	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	NCc1cccc(-c2c[nH]c(/C=C3\C(=O)Nc4ccc(NC(N)=O)cc43)c2)c1		CHEMBL228652	=	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	Inhibition	%	65.0
	1903928	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL228654	=	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	uM	0.1
Not Determined	1903929	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CN)c[nH]1		CHEMBL228705		IC50			CHEMBL2534	Homo sapiens	IC50		
	1903930	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	CC(=O)NCc1c[nH]c(/C(C)=C2\C(=O)Nc3ccc(NC(N)=O)cc32)c1		CHEMBL228755	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903931	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)c2ccncc2)c[nH]1		CHEMBL228756	=	Inhibition	%	29.0	CHEMBL2534	Homo sapiens	Inhibition	%	29.0
	1903932	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)c2cccnc2)c[nH]1		CHEMBL388739	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903933	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)C2CCNCC2)c[nH]1		CHEMBL228757	=	Inhibition	%	33.0	CHEMBL2534	Homo sapiens	Inhibition	%	33.0
	1903934	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)C2CCN(C)CC2)c[nH]1		CHEMBL228810	=	Inhibition	%	28.0	CHEMBL2534	Homo sapiens	Inhibition	%	28.0
Not Active	1903935	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)C2CNCCN2)c[nH]1		CHEMBL228811		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1903936	CHEMBL889506	Inhibition of AKT phosphorylation in PC3 cells at 10 uM	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)CN)c[nH]1		CHEMBL228812		Activity			CHEMBL2534	Homo sapiens	Activity		
	1903937	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)CO)c[nH]1		CHEMBL388966	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	1903938	CHEMBL889500	Inhibition of AKT phosphorylation in PC3 cells	F	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1cc(CNC(=O)CCN2CCCCC2)c[nH]1		CHEMBL228867	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
Not Active	1903968	CHEMBL889507	Stimulation of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCc3ccncc3)c[nH]1)C(=O)N2		CHEMBL228750		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1903969	CHEMBL889507	Stimulation of AKT phosphorylation in PC3 cells at 10 uM	F	NC(=O)Nc1ccc2c(c1)/C(=C/c1cc(C(=O)NCCc3cnc[nH]3)c[nH]1)C(=O)N2		CHEMBL228749		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	1910497	CHEMBL890530	Inhibition of PDK1	B	CCOC(=O)c1ccc2[nH]c3c(OC)c4[nH]c5ccc(C(=O)OCC)cc5c4cc3c2c1		CHEMBL245030		Activity			CHEMBL2534	Homo sapiens	Activity		
	1969469	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	IC50	nM	1800.0	CHEMBL2534	Homo sapiens	IC50	nM	1800.0
	1969471	CHEMBL896555	Inhibition of PDK1	B	O=C1Nc2ccccc2/C1=C/c1ccc[nH]1		CHEMBL86755	=	IC50	nM	520.0	CHEMBL2534	Homo sapiens	IC50	uM	0.52
	1969474	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NC(=O)Nc1ccc2c(c1)/C(=C(\c1ccncc1)c1ccc[nH]1)C(=O)N2		CHEMBL232177	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
	1969475	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NC(=O)Nc1ccc2c(c1)/C(=C(\c1cccc(N)c1)c1ccc[nH]1)C(=O)N2		CHEMBL391101	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
	1969476	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CC/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL232176	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
	1969477	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL228654	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
	1969478	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CCN(CC)C(=O)/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL231979	=	IC50	nM	5400.0	CHEMBL2534	Homo sapiens	IC50	nM	5400.0
	1969479	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CCNC(=O)/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL401043	=	IC50	nM	6100.0	CHEMBL2534	Homo sapiens	IC50	nM	6100.0
	1969480	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NC(=O)/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL400838	=	IC50	nM	3900.0	CHEMBL2534	Homo sapiens	IC50	nM	3900.0
	1969481	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NS(=O)(=O)c1ccc2c(c1)/C(=C(\C(=O)O)c1ccc[nH]1)C(=O)N2		CHEMBL232365	=	IC50	nM	4200.0	CHEMBL2534	Homo sapiens	IC50	nM	4200.0
	1969482	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CCOC(=O)/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL400837	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
	1969483	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NS(=O)(=O)c1ccc2c(c1)/C(=C(\c1ccccc1)c1ccc[nH]1)C(=O)N2		CHEMBL267837	=	IC50	nM	29.0	CHEMBL2534	Homo sapiens	IC50	nM	29.0
	1969484	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CC/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL234811	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
	1969485	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	C/C(=C1/C(=O)Nc2ccc(S(N)(=O)=O)cc21)c1ccc[nH]1		CHEMBL234601	=	IC50	nM	67.0	CHEMBL2534	Homo sapiens	IC50	nM	67.0
	1969486	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL442229	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
	1969487	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CC(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL393902	=	IC50	nM	55.0	CHEMBL2534	Homo sapiens	IC50	nM	55.0
	1969488	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL232360	=	IC50	nM	530.0	CHEMBL2534	Homo sapiens	IC50	nM	530.0
	1969489	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NCc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL393841	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	1969490	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	N#Cc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL393840	=	IC50	nM	990.0	CHEMBL2534	Homo sapiens	IC50	nM	990.0
	1969491	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Nc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL232144	=	IC50	nM	580.0	CHEMBL2534	Homo sapiens	IC50	nM	580.0
	1969492	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2ccc(-n3ncnn3)cc2/C1=C/c1ccc[nH]1		CHEMBL232143	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
	1969493	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NC(=O)c1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL395163	=	IC50	nM	120.0	CHEMBL2534	Homo sapiens	IC50	nM	120.0
	1969494	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2ccc(C(=O)O)cc2/C1=C/c1ccc[nH]1		CHEMBL107225	=	IC50	nM	260.0	CHEMBL2534	Homo sapiens	IC50	nM	260.0
	1969495	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	COC(=O)c1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL231947	=	IC50	nM	670.0	CHEMBL2534	Homo sapiens	IC50	nM	670.0
	1969496	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	NS(=O)(=O)c1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL441911	=	IC50	nM	290.0	CHEMBL2534	Homo sapiens	IC50	nM	290.0
	1969497	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	COc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL232349	=	IC50	nM	580.0	CHEMBL2534	Homo sapiens	IC50	nM	580.0
	1969498	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccc(O)cc32)[nH]1		CHEMBL426078	=	IC50	nM	1100.0	CHEMBL2534	Homo sapiens	IC50	nM	1100.0
	1969499	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	CCc1ccc(/C=C2\C(=O)Nc3ccc(O)cc32)[nH]1		CHEMBL394300	=	IC50	nM	2300.0	CHEMBL2534	Homo sapiens	IC50	nM	2300.0
	1969500	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1ccc(/C=C2\C(=O)Nc3ccc(O)cc32)[nH]1		CHEMBL232136	=	IC50	nM	680.0	CHEMBL2534	Homo sapiens	IC50	nM	680.0
	1969501	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1c[nH]c(/C=C2\C(=O)Nc3ccc(O)cc32)c1		CHEMBL232135	=	IC50	nM	280.0	CHEMBL2534	Homo sapiens	IC50	nM	280.0
	1969502	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1cc[nH]c1/C=C1\C(=O)Nc2ccc(O)cc21		CHEMBL232134	=	IC50	nM	280.0	CHEMBL2534	Homo sapiens	IC50	nM	280.0
	1969503	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	C/C(=C1/C(=O)Nc2ccc(O)cc21)c1ccc[nH]1		CHEMBL231717	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	nM	80.0
	1969504	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2c(O)cccc2/C1=C/c1ccc[nH]1		CHEMBL393838	>	IC50	nM	26000.0	CHEMBL2534	Homo sapiens	IC50	nM	26000.0
	1969505	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2cc(O)ccc2/C1=C/c1ccc[nH]1		CHEMBL231716	=	IC50	nM	900.0	CHEMBL2534	Homo sapiens	IC50	nM	900.0
	1969506	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2ccc(O)cc2/C1=C/c1ccc[nH]1		CHEMBL393636	=	IC50	nM	340.0	CHEMBL2534	Homo sapiens	IC50	nM	340.0
	1969507	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	O=C1Nc2cccc(O)c2/C1=C/c1ccc[nH]1		CHEMBL231715	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	1969508	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1cccc2c1NC(=O)/C2=C\c1ccc[nH]1		CHEMBL393635	>	IC50	nM	26000.0	CHEMBL2534	Homo sapiens	IC50	nM	26000.0
	1969509	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1ccc2c(c1)/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL233373	=	IC50	nM	2700.0	CHEMBL2534	Homo sapiens	IC50	nM	2700.0
	1969510	CHEMBL896553	Inhibition of PDK1 mediated cAKT2 phosphorylation by AKT2 activation assay	B	Cc1cccc2c1/C(=C/c1ccc[nH]1)C(=O)N2		CHEMBL85403	=	IC50	nM	510.0	CHEMBL2534	Homo sapiens	IC50	nM	510.0
	1969511	CHEMBL896555	Inhibition of PDK1	B	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL228654	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	1981740	CHEMBL898216	Inhibition of PDK1 assessed as residual activity at 0.01 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	76.0	CHEMBL2534	Homo sapiens	Activity	%	76.0
	1981741	CHEMBL899256	Inhibition of PDK1 assessed as residual activity at 1 uM	B	N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CCCCCNC(=O)[C@@H]1C[C@@H](O)[C@H](n2cnc3c(N)ncnc32)C1)C(N)=O		CHEMBL397521	=	Activity	%	28.0	CHEMBL2534	Homo sapiens	Activity	%	28.0
	1996186	CHEMBL899847	Inhibition of PDK1 at 10 uM	B	CSc1nc(Nc2cccc(Cl)c2)c2cnn(CC(Cl)c3ccccc3)c2n1		CHEMBL400211	<	Inhibition	%	30.0	CHEMBL2534	Homo sapiens	Inhibition	%	30.0
	1998219	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	uM	0.06
	1998239	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1OCCC(C)C)ncc1c(N)nc3c(C)cccc3c12		CHEMBL238339	=	IC50	nM	1180.0	CHEMBL2534	Homo sapiens	IC50	uM	1.18
	1998240	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1OCCCN(C)C)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL393328	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	uM	0.2
	1998241	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1OCCN1CCOCC1)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL238337	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	uM	0.06
	1998242	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1NCCCN(C)C)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL238133	=	IC50	nM	970.0	CHEMBL2534	Homo sapiens	IC50	uM	0.97
	1998243	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1NCCN(C)C)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL235998	=	IC50	nM	2490.0	CHEMBL2534	Homo sapiens	IC50	uM	2.49
	1998244	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1NCCCN1CCOCC1)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL235783	=	IC50	nM	290.0	CHEMBL2534	Homo sapiens	IC50	uM	0.29
	1998245	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1NCCN1CCOCC1)ncc1c(N)nc3c(C)cccc3c12		CHEMBL235782	=	IC50	nM	300.0	CHEMBL2534	Homo sapiens	IC50	uM	0.3
	1998246	CHEMBL900101	Inhibition of PDK1	B	COc1cc2c(cc1F)ncc1c(N)nc3c(C)c(N)ccc3c12		CHEMBL236474	=	IC50	nM	580.0	CHEMBL2534	Homo sapiens	IC50	uM	0.58
	1998247	CHEMBL900101	Inhibition of PDK1	B	CCOc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OCC		CHEMBL235602	=	IC50	nM	270.0	CHEMBL2534	Homo sapiens	IC50	uM	0.27
	1998248	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3c(N)nc4c(C)c(Cl)ccc4c3c2cc1OC		CHEMBL235380	=	IC50	nM	2120.0	CHEMBL2534	Homo sapiens	IC50	uM	2.12
	1998249	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3c(N)nc4c(C)c(O)ccc4c3c2cc1OC		CHEMBL391550	=	IC50	nM	40.0	CHEMBL2534	Homo sapiens	IC50	uM	0.04
	1998250	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3c(N)nc4c(C)cccc4c3c2cc1OC		CHEMBL235377	=	IC50	nM	260.0	CHEMBL2534	Homo sapiens	IC50	uM	0.26
	1998251	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3c(N)nc4cc(N)ccc4c3c2cc1OC		CHEMBL235160	=	IC50	nM	670.0	CHEMBL2534	Homo sapiens	IC50	uM	0.67
	1998252	CHEMBL900101	Inhibition of PDK1	B	COc1cc2ncc3cnc4ccccc4c3c2cc1OC		CHEMBL235158	=	IC50	nM	7450.0	CHEMBL2534	Homo sapiens	IC50	uM	7.45
	2106290	CHEMBL947150	Inhibition of PDK1	B	N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1		CHEMBL272265	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
	2106291	CHEMBL947150	Inhibition of PDK1	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(C#Cc4cccnc4)ccc3ncc21		CHEMBL255592	>	IC50	nM	25000.0	CHEMBL2534	Homo sapiens	IC50	nM	25000.0
	2106292	CHEMBL947150	Inhibition of PDK1	B	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(C(C)C#N)cc1		CHEMBL270638	=	IC50	nM	245.0	CHEMBL2534	Homo sapiens	IC50	nM	245.0
	2106293	CHEMBL947150	Inhibition of PDK1	B	CC(C#N)c1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1		CHEMBL404024	=	IC50	nM	150.0	CHEMBL2534	Homo sapiens	IC50	nM	150.0
	2106294	CHEMBL947150	Inhibition of PDK1	B	CCc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1		CHEMBL270640	=	IC50	nM	327.0	CHEMBL2534	Homo sapiens	IC50	nM	327.0
	2106295	CHEMBL947150	Inhibition of PDK1	B	Cc1nc2cnc3ccc(C#Cc4cccnc4)cc3c2n1-c1ccc(CC#N)cc1		CHEMBL270639	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	nM	110.0
	2470346	CHEMBL995025	Inhibition of PDPK1 at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	2661422	CHEMBL1058628	Inhibition of PDK1	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	2705873	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	FC		4.0	CHEMBL2534	Homo sapiens	FC		4.0
	2705874	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1cccc(Cl)c1)c1ccccc1		CHEMBL557451	=	FC		2.2	CHEMBL2534	Homo sapiens	FC		2.2
Not Active	2705875	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1cccc(Cl)c1)c1ccccc1		CHEMBL560477		FC			CHEMBL2534	Homo sapiens	FC		
	2705876	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(F)cc1)c1ccccc1		CHEMBL557659	=	FC		3.3	CHEMBL2534	Homo sapiens	FC		3.3
Not Active	2705877	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(F)cc1)c1ccccc1		CHEMBL558324		FC			CHEMBL2534	Homo sapiens	FC		
	2705878	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(Br)cc1)c1ccccc1		CHEMBL541445	=	FC		3.9	CHEMBL2534	Homo sapiens	FC		3.9
Not Active	2705879	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(Br)cc1)c1ccccc1		CHEMBL560672		FC			CHEMBL2534	Homo sapiens	FC		
	2705880	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL564970	=	FC		4.4	CHEMBL2534	Homo sapiens	FC		4.4
Not Active	2705881	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL554080		FC			CHEMBL2534	Homo sapiens	FC		
	2705882	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL552947	=	FC		2.4	CHEMBL2534	Homo sapiens	FC		2.4
Not Active	2705883	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL550194		FC			CHEMBL2534	Homo sapiens	FC		
	2705884	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL550195	=	FC		2.1	CHEMBL2534	Homo sapiens	FC		2.1
Not Active	2705885	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL564599		FC			CHEMBL2534	Homo sapiens	FC		
	2705886	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	FC		3.9	CHEMBL2534	Homo sapiens	FC		3.9
Not Active	2705887	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL540467		FC			CHEMBL2534	Homo sapiens	FC		
	2705888	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	CCc1ccc(CC/C(=C/C(=O)O)c2ccccc2)cc1		CHEMBL558717	=	FC		1.4	CHEMBL2534	Homo sapiens	FC		1.4
Not Active	2705889	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	CCc1ccc(CC/C(=C\C(=O)O)c2ccccc2)cc1		CHEMBL550324		FC			CHEMBL2534	Homo sapiens	FC		
	2705890	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL563116	=	FC		3.2	CHEMBL2534	Homo sapiens	FC		3.2
Not Active	2705891	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL550325		FC			CHEMBL2534	Homo sapiens	FC		
	2705892	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560595	=	FC		3.5	CHEMBL2534	Homo sapiens	FC		3.5
Not Active	2705893	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560336		FC			CHEMBL2534	Homo sapiens	FC		
	2705894	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CCc1c[nH]c2ccccc12)c1ccccc1		CHEMBL549647	=	FC		3.1	CHEMBL2534	Homo sapiens	FC		3.1
	2705895	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCC1C=Nc2ccccc21)c1ccccc1		CHEMBL549648	=	FC		2.2	CHEMBL2534	Homo sapiens	FC		2.2
	2705896	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/COc1ccc(Cl)cc1)c1ccccc1		CHEMBL560996	=	FC		3.0	CHEMBL2534	Homo sapiens	FC		3.0
	2705897	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\COc1ccc(Cl)cc1)c1ccccc1		CHEMBL562078	=	FC		3.0	CHEMBL2534	Homo sapiens	FC		3.0
	2705898	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/CSc1ccc(Cl)cc1)c1ccccc1		CHEMBL565145	=	FC		2.6	CHEMBL2534	Homo sapiens	FC		2.6
	2705899	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL559049	=	FC		3.2	CHEMBL2534	Homo sapiens	FC		3.2
	2705900	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	Cc1ccc2oc(/C(=C/C(=O)O)c3ccccc3)cc2c1		CHEMBL564633	=	FC		3.1	CHEMBL2534	Homo sapiens	FC		3.1
	2705901	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551209	=	FC		3.1	CHEMBL2534	Homo sapiens	FC		3.1
Not Active	2705902	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(/c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551409		FC			CHEMBL2534	Homo sapiens	FC		
	2705903	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)CC(c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL550934	=	FC		2.9	CHEMBL2534	Homo sapiens	FC		2.9
	2705904	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	Cc1ccc2oc(C(CC(=O)O)c3ccccc3)cc2c1		CHEMBL571902	=	FC		2.7	CHEMBL2534	Homo sapiens	FC		2.7
	2705905	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C1\c2ccccc2CC1Cc1ccc(Cl)cc1		CHEMBL560938	=	FC		1.8	CHEMBL2534	Homo sapiens	FC		1.8
	2705906	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Activity	uM	8.0	CHEMBL2534	Homo sapiens	Activity	uM	8.0
Not Active	2705907	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL538138		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705908	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1cccc(Cl)c1)c1ccccc1		CHEMBL557451	=	Activity	uM	9.5	CHEMBL2534	Homo sapiens	Activity	uM	9.5
Not Active	2705909	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1cccc(Cl)c1)c1ccccc1		CHEMBL560477		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705910	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(F)cc1)c1ccccc1		CHEMBL557659	=	Activity	uM	41.0	CHEMBL2534	Homo sapiens	Activity	uM	41.0
Not Active	2705911	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(F)cc1)c1ccccc1		CHEMBL558324		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705912	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(Br)cc1)c1ccccc1		CHEMBL541445	=	Activity	uM	9.8	CHEMBL2534	Homo sapiens	Activity	uM	9.8
Not Active	2705913	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(Br)cc1)c1ccccc1		CHEMBL560672		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705914	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL564970	=	Activity	uM	7.1	CHEMBL2534	Homo sapiens	Activity	uM	7.1
Not Active	2705915	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL554080		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705916	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL552947	=	Activity	uM	2.8	CHEMBL2534	Homo sapiens	Activity	uM	2.8
Not Active	2705917	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL550194		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705918	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL550195	=	Activity	uM	4.7	CHEMBL2534	Homo sapiens	Activity	uM	4.7
Not Active	2705919	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL564599		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705920	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Activity	uM	4.0	CHEMBL2534	Homo sapiens	Activity	uM	4.0
Not Active	2705921	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL540467		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705922	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	CCc1ccc(CC/C(=C/C(=O)O)c2ccccc2)cc1		CHEMBL558717	>	Activity	uM	30.0	CHEMBL2534	Homo sapiens	Activity	uM	30.0
Not Active	2705923	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	CCc1ccc(CC/C(=C\C(=O)O)c2ccccc2)cc1		CHEMBL550324		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705924	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL563116	=	Activity	uM	6.0	CHEMBL2534	Homo sapiens	Activity	uM	6.0
Not Active	2705925	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL550325		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705926	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560595	=	Activity	uM	6.0	CHEMBL2534	Homo sapiens	Activity	uM	6.0
Not Active	2705927	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560336		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705928	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CCc1c[nH]c2ccccc12)c1ccccc1		CHEMBL549647	=	Activity	uM	7.6	CHEMBL2534	Homo sapiens	Activity	uM	7.6
	2705929	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\CCC1C=Nc2ccccc21)c1ccccc1		CHEMBL549648	=	Activity	uM	8.8	CHEMBL2534	Homo sapiens	Activity	uM	8.8
	2705930	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/COc1ccc(Cl)cc1)c1ccccc1		CHEMBL560996	=	Activity	uM	22.8	CHEMBL2534	Homo sapiens	Activity	uM	22.8
Not Active	2705931	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\COc1ccc(Cl)cc1)c1ccccc1		CHEMBL562078		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705932	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/CSc1ccc(Cl)cc1)c1ccccc1		CHEMBL565145	=	Activity	uM	22.8	CHEMBL2534	Homo sapiens	Activity	uM	22.8
	2705933	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL559049	=	Activity	uM	31.6	CHEMBL2534	Homo sapiens	Activity	uM	31.6
	2705934	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	Cc1ccc2oc(/C(=C/C(=O)O)c3ccccc3)cc2c1		CHEMBL564633	=	Activity	uM	41.3	CHEMBL2534	Homo sapiens	Activity	uM	41.3
	2705935	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551209	=	Activity	uM	13.2	CHEMBL2534	Homo sapiens	Activity	uM	13.2
Not Active	2705936	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C(/c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551409		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705937	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)CC(c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL550934	=	Activity	uM	190.0	CHEMBL2534	Homo sapiens	Activity	uM	190.0
	2705938	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	Cc1ccc2oc(C(CC(=O)O)c3ccccc3)cc2c1		CHEMBL571902	=	Activity	uM	29.1	CHEMBL2534	Homo sapiens	Activity	uM	29.1
	2705939	CHEMBL1054900	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as 50% enzyme activation relative to basal activity	B	O=C(O)/C=C1\c2ccccc2CC1Cc1ccc(Cl)cc1		CHEMBL560938	=	Activity	uM	30.0	CHEMBL2534	Homo sapiens	Activity	uM	30.0
	2705940	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Ka	/M	9.67	CHEMBL2534	Homo sapiens	Ka	/M	9.67
	2705941	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Br)cc1)c1ccccc1		CHEMBL541445	=	Ka	10'-4/M	4.78	CHEMBL2534	Homo sapiens	Ka	10'-4/M	4.78
	2705942	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL564970	=	Ka	10'-4/M	9.66	CHEMBL2534	Homo sapiens	Ka	10'-4/M	9.66
	2705943	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL552947	=	Ka	10'-4/M	7.18	CHEMBL2534	Homo sapiens	Ka	10'-4/M	7.18
	2705944	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL550195	=	Ka	10'-4/M	1.71	CHEMBL2534	Homo sapiens	Ka	10'-4/M	1.71
	2705945	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560595	=	Ka	/M	7.26	CHEMBL2534	Homo sapiens	Ka	/M	7.26
	2705946	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1c[nH]c2ccccc12)c1ccccc1		CHEMBL549647	=	Ka	/M	9.63	CHEMBL2534	Homo sapiens	Ka	/M	9.63
	2705947	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Kd	nM	10300.0	CHEMBL2534	Homo sapiens	Kd	uM	10.3
Not Active	2705948	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL538138		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705949	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1cccc(Cl)c1)c1ccccc1		CHEMBL557451		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705950	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1cccc(Cl)c1)c1ccccc1		CHEMBL560477		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705951	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(F)cc1)c1ccccc1		CHEMBL557659		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705952	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(F)cc1)c1ccccc1		CHEMBL558324		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705953	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Br)cc1)c1ccccc1		CHEMBL541445	=	Kd	nM	20900.0	CHEMBL2534	Homo sapiens	Kd	uM	20.9
Not Determined	2705954	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(Br)cc1)c1ccccc1		CHEMBL560672		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705955	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL564970	=	Kd	nM	10400.0	CHEMBL2534	Homo sapiens	Kd	uM	10.4
Not Determined	2705956	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL554080		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705957	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL552947	=	Kd	nM	13900.0	CHEMBL2534	Homo sapiens	Kd	uM	13.9
Not Determined	2705958	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(Cl)c(Cl)c1)c1ccccc1		CHEMBL550194		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705959	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL550195	=	Kd	nM	5900.0	CHEMBL2534	Homo sapiens	Kd	uM	5.9
Not Determined	2705960	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1Cl)c1ccccc1		CHEMBL564599		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705961	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Kd	nM	6200.0	CHEMBL2534	Homo sapiens	Kd	uM	6.2
Not Active	2705962	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL540467		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705963	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	CCc1ccc(CC/C(=C/C(=O)O)c2ccccc2)cc1		CHEMBL558717		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705964	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	CCc1ccc(CC/C(=C\C(=O)O)c2ccccc2)cc1		CHEMBL550324		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705965	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL563116		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705966	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc(-c2ccccc2)cc1)c1ccccc1		CHEMBL550325		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705967	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560595	=	Kd	nM	13800.0	CHEMBL2534	Homo sapiens	Kd	uM	13.8
Not Active	2705968	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCc1ccc2ccccc2c1)c1ccccc1		CHEMBL560336		Kd			CHEMBL2534	Homo sapiens	Kd		
	2705969	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1c[nH]c2ccccc12)c1ccccc1		CHEMBL549647	=	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
Not Active	2705970	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\CCC1C=Nc2ccccc21)c1ccccc1		CHEMBL549648		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705971	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/COc1ccc(Cl)cc1)c1ccccc1		CHEMBL560996		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705972	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\COc1ccc(Cl)cc1)c1ccccc1		CHEMBL562078		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705973	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/CSc1ccc(Cl)cc1)c1ccccc1		CHEMBL565145		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705974	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL559049		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705975	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	Cc1ccc2oc(/C(=C/C(=O)O)c3ccccc3)cc2c1		CHEMBL564633		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705976	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(\c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551209		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705977	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C(/c1ccccc1)c1cc2cc(Cl)ccc2s1		CHEMBL551409		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705978	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)CC(c1ccccc1)c1cc2cc(Cl)ccc2o1		CHEMBL550934		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705979	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	Cc1ccc2oc(C(CC(=O)O)c3ccccc3)cc2c1		CHEMBL571902		Kd			CHEMBL2534	Homo sapiens	Kd		
Not Determined	2705980	CHEMBL1054895	Binding affinity to PDK1 (50 to 359) by isothermal titration calorimetry	B	O=C(O)/C=C1\c2ccccc2CC1Cc1ccc(Cl)cc1		CHEMBL560938		Kd			CHEMBL2534	Homo sapiens	Kd		
Active	2705981	CHEMBL1054898	Binding affinity to GST-PDK1 V127T mutant expressed in HEK293 cells at 2 uM	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O		CHEMBL557007		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	2705982	CHEMBL1054902	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells at 20 uM	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	2705983	CHEMBL1054896	Binding affinity to GST-PDK1 L155S mutant expressed in HEK293 cells at 2 uM	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O		CHEMBL557007		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	2705984	CHEMBL1054897	Binding affinity to GST-PDK1 L155S mutant expressed in HEK293 cells at 20 uM	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	2705985	CHEMBL1054903	Binding affinity to GST-PDK1 V127T mutant expressed in HEK293 cells at 20 uM	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	2705986	CHEMBL1054905	Binding affinity to GST-PDK1 I119A mutant expressed in HEK293 cells at 20 uM	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	2705987	CHEMBL1054904	Binding affinity to GST-PDK1 I119A mutant expressed in HEK293 cells at 2 uM	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O		CHEMBL557007		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	2705988	CHEMBL1054905	Binding affinity to GST-PDK1 I119A mutant expressed in HEK293 cells at 20 uM	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL550259		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	2705989	CHEMBL1054901	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells at 2 uM	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CS)C(=O)O		CHEMBL557007		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	2705990	CHEMBL1054904	Binding affinity to GST-PDK1 I119A mutant expressed in HEK293 cells at 2 uM	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
	2705991	CHEMBL1054899	Binding affinity to wild type recombinant GST-PDK1 expressed in HEK293 cells assessed as maximum enzyme activation	B	O=C(O)/C=C(\CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL538138	=	FC		4.0	CHEMBL2534	Homo sapiens	FC		4.0
	2891071	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891072	CHEMBL1061922	Binding constant for full-length PDPK1	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891073	CHEMBL1061922	Binding constant for full-length PDPK1	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891074	CHEMBL1061922	Binding constant for full-length PDPK1	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891075	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891076	CHEMBL1061922	Binding constant for full-length PDPK1	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891077	CHEMBL1061922	Binding constant for full-length PDPK1	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891078	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891079	CHEMBL1061922	Binding constant for full-length PDPK1	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891080	CHEMBL1061922	Binding constant for full-length PDPK1	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891081	CHEMBL1061922	Binding constant for full-length PDPK1	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891082	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891083	CHEMBL1061922	Binding constant for full-length PDPK1	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891084	CHEMBL1061922	Binding constant for full-length PDPK1	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891085	CHEMBL1061922	Binding constant for full-length PDPK1	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891086	CHEMBL1061922	Binding constant for full-length PDPK1	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891087	CHEMBL1061922	Binding constant for full-length PDPK1	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891088	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891089	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891090	CHEMBL1061922	Binding constant for full-length PDPK1	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	3100.0	CHEMBL2534	Homo sapiens	Kd	nM	3100.0
	2891091	CHEMBL1061922	Binding constant for full-length PDPK1	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891092	CHEMBL1061922	Binding constant for full-length PDPK1	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	700.0	CHEMBL2534	Homo sapiens	Kd	nM	700.0
	2891093	CHEMBL1061922	Binding constant for full-length PDPK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891094	CHEMBL1061922	Binding constant for full-length PDPK1	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891095	CHEMBL1061922	Binding constant for full-length PDPK1	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891096	CHEMBL1061922	Binding constant for full-length PDPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	190.0	CHEMBL2534	Homo sapiens	Kd	nM	190.0
	2891097	CHEMBL1061922	Binding constant for full-length PDPK1	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891098	CHEMBL1061922	Binding constant for full-length PDPK1	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891099	CHEMBL1061922	Binding constant for full-length PDPK1	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891100	CHEMBL1061922	Binding constant for full-length PDPK1	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891101	CHEMBL1061922	Binding constant for full-length PDPK1	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891102	CHEMBL1061922	Binding constant for full-length PDPK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891103	CHEMBL1061922	Binding constant for full-length PDPK1	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.7	CHEMBL2534	Homo sapiens	Kd	nM	1.7
	2891104	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2600.0	CHEMBL2534	Homo sapiens	Kd	nM	2600.0
	2891105	CHEMBL1061922	Binding constant for full-length PDPK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3500.0	CHEMBL2534	Homo sapiens	Kd	nM	3500.0
	2891106	CHEMBL1061922	Binding constant for full-length PDPK1	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891107	CHEMBL1061922	Binding constant for full-length PDPK1	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	2891108	CHEMBL1061922	Binding constant for full-length PDPK1	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
Antagonist	2893009	CHEMBL1063720	Percentage PDK1 activity remaining in the presence of 0.01uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	30.0	CHEMBL2534	Homo sapiens	Activity	%	30.0
	2893010	CHEMBL1063720	Percentage PDK1 activity remaining in the presence of 0.01uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	88.0	CHEMBL2534	Homo sapiens	Activity	%	88.0
Antagonist	2893011	CHEMBL1063720	Percentage PDK1 activity remaining in the presence of 0.01uM inhibitor	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Activity	%	2.0	CHEMBL2534	Homo sapiens	Activity	%	2.0
	2893012	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
Antagonist	2893013	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Activity	%	5.0	CHEMBL2534	Homo sapiens	Activity	%	5.0
	2893014	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Activity	%	79.0	CHEMBL2534	Homo sapiens	Activity	%	79.0
	2893015	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Activity	%	79.0	CHEMBL2534	Homo sapiens	Activity	%	79.0
	2893016	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL6291	=	Activity	%	62.0	CHEMBL2534	Homo sapiens	Activity	%	62.0
Antagonist	2893017	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Activity	%	11.0	CHEMBL2534	Homo sapiens	Activity	%	11.0
Antagonist	2893018	CHEMBL1062851	Percentage PDK1 activity remaining in the presence of 0.1uM inhibitor	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Activity	%	25.0	CHEMBL2534	Homo sapiens	Activity	%	25.0
	2893019	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	=	Activity	%	79.0	CHEMBL2534	Homo sapiens	Activity	%	79.0
	2893020	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	2893021	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Activity	%	74.0	CHEMBL2534	Homo sapiens	Activity	%	74.0
Antagonist	2893022	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	8.0	CHEMBL2534	Homo sapiens	Activity	%	8.0
	2893023	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Activity	%	85.0	CHEMBL2534	Homo sapiens	Activity	%	85.0
	2893024	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	2893025	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	2893026	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	92.0	CHEMBL2534	Homo sapiens	Activity	%	92.0
	2893027	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c3c(c(C(=O)/C=C/c4ccccc4)c2O)OC(C)(C)C=C3)c1O		CHEMBL34241	=	Activity	%	79.0	CHEMBL2534	Homo sapiens	Activity	%	79.0
	2893028	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	C[C@H]1CNCCN1S(=O)(=O)c1cccc2cnccc12		CHEMBL1233654	=	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	2893029	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1		CHEMBL322970	=	Activity	%	62.0	CHEMBL2534	Homo sapiens	Activity	%	62.0
	2893030	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	2893031	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Activity	%	72.0	CHEMBL2534	Homo sapiens	Activity	%	72.0
	2893032	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Activity	%	75.0	CHEMBL2534	Homo sapiens	Activity	%	75.0
	2893033	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	NC(=O)c1sc(-c2ccsc2)cc1N		CHEMBL193093	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	2893034	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	2893035	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	102.0	CHEMBL2534	Homo sapiens	Activity	%	102.0
	2893036	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Activity	%	84.0	CHEMBL2534	Homo sapiens	Activity	%	84.0
	2893037	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Activity	%	82.0	CHEMBL2534	Homo sapiens	Activity	%	82.0
	2893038	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	CC(=O)O[C@H]1[C@H](C)O[C@@H](Oc2c(-c3ccc(O)cc3)oc3cc(O)cc(O)c3c2=O)[C@H](O)[C@@H]1OC(C)=O		CHEMBL240954	=	Activity	%	103.0	CHEMBL2534	Homo sapiens	Activity	%	103.0
	2893039	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=C(Nc1cc(Cl)cc2c1[nH]c1cnccc12)c1cccnc1		CHEMBL79004	=	Activity	%	87.0	CHEMBL2534	Homo sapiens	Activity	%	87.0
	2893040	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=C(NOC[C@@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl.O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL540501	=	Activity	%	84.0	CHEMBL2534	Homo sapiens	Activity	%	84.0
	2893041	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(\N)Sc1ccccc1N		CHEMBL34704	=	Activity	%	77.0	CHEMBL2534	Homo sapiens	Activity	%	77.0
	2893042	CHEMBL1061083	Percentage PDK1 activity remaining in the presence of 10uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	95.0	CHEMBL2534	Homo sapiens	Activity	%	95.0
	2893043	CHEMBL1061907	Percentage PDK1 activity remaining in the presence of 25uM inhibitor	B	COc1cc(OC)c(C=C2C(=O)Nc3ccccc32)c(OC)c1		CHEMBL576349	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	2893044	CHEMBL1061907	Percentage PDK1 activity remaining in the presence of 25uM inhibitor	B	NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12		CHEMBL489157	=	Activity	%	83.0	CHEMBL2534	Homo sapiens	Activity	%	83.0
	2893045	CHEMBL1061084	Percentage PDK1 activity remaining in the presence of 2uM inhibitor	B	Cn1cc(C2=C(c3ccc(Cl)cc3Cl)C(=O)NC2=O)c2ccccc21		CHEMBL102714	=	Activity	%	92.0	CHEMBL2534	Homo sapiens	Activity	%	92.0
	2893046	CHEMBL1061908	Percentage PDK1 activity remaining in the presence of 3uM inhibitor	B	Cc1ccc(-c2c(C(=O)CF)n(CCCO)c3ncnc(N)c23)cc1		CHEMBL515414	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	2893047	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	2893048	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	2893049	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
Antagonist	2893050	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	Activity	%	34.0	CHEMBL2534	Homo sapiens	Activity	%	34.0
	2893051	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Activity	%	91.0	CHEMBL2534	Homo sapiens	Activity	%	91.0
	2893052	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	=	Activity	%	73.0	CHEMBL2534	Homo sapiens	Activity	%	73.0
	2893053	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Activity	%	74.0	CHEMBL2534	Homo sapiens	Activity	%	74.0
	2893054	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Activity	%	81.0	CHEMBL2534	Homo sapiens	Activity	%	81.0
	2893055	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	2893056	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	COC[C@H]1OC(=O)c2coc3c2[C@@]1(C)C1=C(C3=O)[C@@H]2CCC(=O)[C@@]2(C)C[C@H]1OC(C)=O		CHEMBL428496	=	Activity	%	91.0	CHEMBL2534	Homo sapiens	Activity	%	91.0
	2893057	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	2893058	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Activity	%	71.0	CHEMBL2534	Homo sapiens	Activity	%	71.0
	2893059	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Activity	%	62.0	CHEMBL2534	Homo sapiens	Activity	%	62.0
	2893060	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC(=O)O.O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL265470	=	Activity	%	83.0	CHEMBL2534	Homo sapiens	Activity	%	83.0
	2893061	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Activity	%	56.0	CHEMBL2534	Homo sapiens	Activity	%	56.0
	2893062	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Activity	%	102.0	CHEMBL2534	Homo sapiens	Activity	%	102.0
	2893063	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c(c1)[nH]c1c(C)nccc12		CHEMBL269538	=	Activity	%	87.0	CHEMBL2534	Homo sapiens	Activity	%	87.0
	2893064	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC1=NCCc2c1[nH]c1cc(O)ccc21		CHEMBL129177	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	2893065	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1nccc2c1[nH]c1ccccc12		CHEMBL12014	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	2893066	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	COc1ccc2c3c([nH]c2c1)C(C)=NCC3		CHEMBL340807	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	2893067	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Oc1c(Br)cc(C=C2c3cc(I)ccc3NC2O)cc1Br		CHEMBL1794051	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	2893068	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CNCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL148333	=	Activity	%	91.0	CHEMBL2534	Homo sapiens	Activity	%	91.0
	2893069	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Activity	%	57.0	CHEMBL2534	Homo sapiens	Activity	%	57.0
	2893070	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	2893071	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	2893072	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Activity	%	88.0	CHEMBL2534	Homo sapiens	Activity	%	88.0
	2893073	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
	2893074	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Activity	%	85.0	CHEMBL2534	Homo sapiens	Activity	%	85.0
	2893075	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
Antagonist	2893076	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	CCCCCCOC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608532	=	Activity	%	4.0	CHEMBL2534	Homo sapiens	Activity	%	4.0
	2893077	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Activity	%	88.0	CHEMBL2534	Homo sapiens	Activity	%	88.0
	2893078	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	2893079	CHEMBL1063811	Percentage PDK1 activity remaining in the presence of 1uM inhibitor	B	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	=	Activity	%	84.0	CHEMBL2534	Homo sapiens	Activity	%	84.0
	2897174	CHEMBL1052131	Percent residual PDK1 activity in the presence of 10uM inhibitor	B	O=C(O)Cc1c2ccccc2n2c1[nH]c(=O)c1ccccc12		CHEMBL92361	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	2897175	CHEMBL1052131	Percent residual PDK1 activity in the presence of 10uM inhibitor	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	2897176	CHEMBL1052131	Percent residual PDK1 activity in the presence of 10uM inhibitor	B	Cc1cc(O)c2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL289277	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	2921223	CHEMBL1057580	Inhibition of PDPK1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	2924713	CHEMBL1056851	Inhibition of PDK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c3cc[nH]c3ccc21		CHEMBL567173	=	Activity	%	82.0	CHEMBL2534	Homo sapiens	Activity	%	82.0
	2924714	CHEMBL1056851	Inhibition of PDK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	c1ccc2c(c1)[nH]c1c2ccc2cc[nH]c21		CHEMBL584980	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	2924715	CHEMBL1056851	Inhibition of PDK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2ccc3c4ccccc4[nH]c3c12		CHEMBL575754	=	Activity	%	85.0	CHEMBL2534	Homo sapiens	Activity	%	85.0
	2924716	CHEMBL1056851	Inhibition of PDK1 assessed as residual enzyme activity at 10 uM relative to untreated control	B	O=Cc1c[nH]c2c1ccc1c3ccccc3[nH]c12		CHEMBL583972	=	Activity	%	76.0	CHEMBL2534	Homo sapiens	Activity	%	76.0
	3022338	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(N(C)C)cc3c2cc1OC		CHEMBL569345	=	IC50	nM	739.0	CHEMBL2534	Homo sapiens	IC50	nM	739.0
	3022339	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCNc1cc2c(cnc3cc(OCCOC)c(OC)cc32)c(N)n1		CHEMBL570941	=	IC50	nM	7490.0	CHEMBL2534	Homo sapiens	IC50	nM	7490.0
	3022340	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(N4CCCC4)cc3c2cc1OC		CHEMBL572218	=	IC50	nM	1864.0	CHEMBL2534	Homo sapiens	IC50	nM	1864.0
	3022341	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(N4CCC(O)CC4)cc3c2cc1OC		CHEMBL570478	=	IC50	nM	2064.0	CHEMBL2534	Homo sapiens	IC50	nM	2064.0
	3022342	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(-n4ccnc4)cc3c2cc1OC		CHEMBL571159	=	IC50	nM	70.0	CHEMBL2534	Homo sapiens	IC50	nM	70.0
	3022343	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(-n4cnc(C)c4)cc3c2cc1OC		CHEMBL585344	=	IC50	nM	108.0	CHEMBL2534	Homo sapiens	IC50	nM	108.0
	3022344	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(-n4cnc(-c5ccccc5)c4)cc3c2cc1OC		CHEMBL570952	=	IC50	nM	2033.0	CHEMBL2534	Homo sapiens	IC50	nM	2033.0
	3022345	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-n4ccnc4)cc3c2cc1OC		CHEMBL576905	=	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	nM	100.0
	3022346	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4ccoc4)cc3c2cc1OC		CHEMBL569346	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	3022347	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncn4C)cc3c2cc1OC		CHEMBL569905	=	IC50	nM	66.0	CHEMBL2534	Homo sapiens	IC50	nM	66.0
	3022348	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4ccccn4)cc3c2cc1OC		CHEMBL578388	>	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	nM	100.0
	3022349	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2c(cc1OCC1CCN(C)CC1)ncc1c(N)nc(-c3ccncc3)cc12		CHEMBL570701	=	IC50	nM	6923.0	CHEMBL2534	Homo sapiens	IC50	nM	6923.0
	3022350	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cccnc4)cc3c2cc1OC		CHEMBL572234	=	IC50	nM	35.0	CHEMBL2534	Homo sapiens	IC50	nM	35.0
	3022351	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	CCOc1cc2ncc3c(N)nc(-c4cccnc4)cc3c2cc1OCC		CHEMBL570943	=	IC50	nM	74.0	CHEMBL2534	Homo sapiens	IC50	nM	74.0
	3022352	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2c(cc1OCc1ccccc1)ncc1c(N)nc(-c3cccnc3)cc12		CHEMBL585341	=	IC50	nM	146.0	CHEMBL2534	Homo sapiens	IC50	nM	146.0
	3022353	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COCCOc1cc2ncc3c(N)nc(-c4cccnc4)cc3c2cc1OC		CHEMBL583247	=	IC50	nM	43.0	CHEMBL2534	Homo sapiens	IC50	nM	43.0
	3022354	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2c(cc1OCCCN1CCCCC1)ncc1c(N)nc(-c3cccnc3)cc12		CHEMBL583455	=	IC50	nM	144.0	CHEMBL2534	Homo sapiens	IC50	nM	144.0
	3022355	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(N)c4)cc3c2cc1OC		CHEMBL572235	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
	3022356	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(O)c4)cc3c2cc1OC		CHEMBL571806	=	IC50	nM	57.0	CHEMBL2534	Homo sapiens	IC50	nM	57.0
	3022357	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Br)c4)cc3c2cc1OC		CHEMBL570148	=	IC50	nM	65.0	CHEMBL2534	Homo sapiens	IC50	nM	65.0
	3022358	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cccnc4C)cc3c2cc1OC		CHEMBL571163	=	IC50	nM	532.0	CHEMBL2534	Homo sapiens	IC50	nM	532.0
	3022359	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4ccc(N)nc4)cc3c2cc1OC		CHEMBL576907	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	3022360	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5)c4)cc3c2cc1OC		CHEMBL570727	=	IC50	nM	283.0	CHEMBL2534	Homo sapiens	IC50	nM	283.0
	3022361	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1ccccc1Nc1cncc(-c2cc3c(cnc4cc(OC)c(OC)cc43)c(N)n2)c1		CHEMBL570281	=	IC50	nM	74.0	CHEMBL2534	Homo sapiens	IC50	nM	74.0
	3022362	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cccc(Nc2cncc(-c3cc4c(cnc5cc(OC)c(OC)cc54)c(N)n3)c2)c1		CHEMBL569153	=	IC50	nM	434.0	CHEMBL2534	Homo sapiens	IC50	nM	434.0
	3022363	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1ccc(Nc2cncc(-c3cc4c(cnc5cc(OC)c(OC)cc54)c(N)n3)c2)cc1		CHEMBL569828	=	IC50	nM	383.0	CHEMBL2534	Homo sapiens	IC50	nM	383.0
	3022364	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5CO)c4)cc3c2cc1OC		CHEMBL572219	=	IC50	nM	47.0	CHEMBL2534	Homo sapiens	IC50	nM	47.0
	3022365	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5cccc(CO)c5)c4)cc3c2cc1OC		CHEMBL570702	=	IC50	nM	67.0	CHEMBL2534	Homo sapiens	IC50	nM	67.0
	3022366	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccc(CO)cc5)c4)cc3c2cc1OC		CHEMBL570284	=	IC50	nM	142.0	CHEMBL2534	Homo sapiens	IC50	nM	142.0
	3022367	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5CCO)c4)cc3c2cc1OC		CHEMBL585339	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
	3022368	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccc(CCO)cc5)c4)cc3c2cc1OC		CHEMBL571166	=	IC50	nM	91.0	CHEMBL2534	Homo sapiens	IC50	nM	91.0
	3022369	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5N)c4)cc3c2cc1OC		CHEMBL585345	=	IC50	nM	51.0	CHEMBL2534	Homo sapiens	IC50	nM	51.0
	3022370	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5F)c4)cc3c2cc1OC		CHEMBL571168	=	IC50	nM	30.0	CHEMBL2534	Homo sapiens	IC50	nM	30.0
	3022371	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5Nc5ccccc5)c4)cc3c2cc1OC		CHEMBL585340	=	IC50	nM	505.0	CHEMBL2534	Homo sapiens	IC50	nM	505.0
	3022372	CHEMBL1041993	Inhibition of PDPK1 by ELISA assay	B	COc1cc2ncc3c(N)nc(-c4cncc(Nc5ccccc5OCc5ccccc5)c4)cc3c2cc1OC		CHEMBL570504	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	3063543	CHEMBL1037985	Binding affinity to human PDPK1 at 200 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CSSC[C@@H](C(=O)NCC(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595545	=	Activity	%	16.0	CHEMBL2534	Homo sapiens	Activity	%	16.0
	3063633	CHEMBL1043362	Binding affinity to human PDPK1 at 500 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(N)=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL595546	=	Activity	%	18.0	CHEMBL2534	Homo sapiens	Activity	%	18.0
	3063723	CHEMBL1042485	Binding affinity to human PDPK1 at 50 nM by cell-based competition binding assay relative to control in presence of DTT	B	CO[C@@H]1[C@H](N(C)C(=O)CCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)NCCC(=O)N[C@H]2CNC(=O)C[C@@H](C(N)=O)NC(=O)CNC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc3ccccc3)NC(=O)[C@H](C(C)C)NC2=O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL609010	=	Activity	%	48.0	CHEMBL2534	Homo sapiens	Activity	%	48.0
	3066878	CHEMBL1066084	Inhibition of PDPK1 at 10 uM	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Inhibition	%	3.0	CHEMBL2534	Homo sapiens	INH	%	3.0
	3066968	CHEMBL1066084	Inhibition of PDPK1 at 10 uM	B	O=C1Nc2ccccc2/C1=C1\C(=O)N(CCCc2ccccc2)c2ccccc21		CHEMBL607196	=	Inhibition	%	7.0	CHEMBL2534	Homo sapiens	INH	%	7.0
	3084377	CHEMBL1072656	Inhibition of pdk1	B	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	IC50	nM	53.0	CHEMBL2534	Homo sapiens	IC50	uM	0.053
	3260527	CHEMBL1111786	Inhibition of PDK1	B	O=C(Nc1cccc(-c2ccnc3cc(-c4ccncc4)nn23)c1)c1cccc(C(F)(F)F)c1		CHEMBL1089082	>	IC50	nM	50000.0	CHEMBL2534	Homo sapiens	IC50	uM	50.0
	3266009	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OCCN)c4)cc3c2cc1OC		CHEMBL1095278	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
	3266010	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](C)N)c4)cc3c2cc1OC		CHEMBL1095279	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	3266011	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](C)N)c4)cc3c2cc1OC		CHEMBL1097955	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
	3266012	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	CC[C@H](N)COc1cncc(-c2cc3c(cnc4cc(OC)c(OC)cc43)c(N)n2)c1		CHEMBL1097956	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	3266013	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	CC[C@@H](N)COc1cncc(-c2cc3c(cnc4cc(OC)c(OC)cc43)c(N)n2)c1		CHEMBL1094320	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
	3266014	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)CC(C)C)c4)cc3c2cc1OC		CHEMBL1094321	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
	3266015	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)CC(C)C)c4)cc3c2cc1OC		CHEMBL1094637	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
	3266016	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccccc5)c4)cc3c2cc1OC		CHEMBL1097602	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
	3266017	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5ccccc5)c4)cc3c2cc1OC		CHEMBL1095294	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
	3266018	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccc(F)cc5)c4)cc3c2cc1OC		CHEMBL1095621	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
	3266019	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5ccc(F)cc5)c4)cc3c2cc1OC		CHEMBL1095622	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
	3266020	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5cccc(C(F)(F)F)c5)c4)cc3c2cc1OC		CHEMBL1098302	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
	3266021	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5cccc(C(F)(F)F)c5)c4)cc3c2cc1OC		CHEMBL1095285	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
	3266022	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5c[nH]c6ccccc56)c4)cc3c2cc1OC		CHEMBL1095612	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	3266023	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@H](N)Cc5c[nH]c6ccccc56)c4)cc3c2cc1OC		CHEMBL1097604	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
	3266024	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccccc5Cl)c4)cc3c2cc1OC		CHEMBL1095931	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
	3266025	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5cccc(Cl)c5)c4)cc3c2cc1OC		CHEMBL1096271	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
	3266026	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccc(Cl)c(Cl)c5)c4)cc3c2cc1OC		CHEMBL1097972	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	3266027	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc(-c4cncc(OC[C@@H](N)Cc5ccncc5)c4)cc3c2cc1OC		CHEMBL1097973	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
	3266142	CHEMBL1103719	Inhibition of human GST-tagged-PDK1 expressed in HEK293 cells	B	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	nM	60.0
	3332076	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3333491	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3334896	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3336316	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3337610	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3338941	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3339195	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3340498	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3341858	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3343305	CHEMBL1166614	Inhibition of PDPK1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	3352637	CHEMBL1175615	Inhibition of PDK1	B	NC(=O)Cn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1171948	=	IC50	nM	2740.0	CHEMBL2534	Homo sapiens	IC50	nM	2740.0
	3352639	CHEMBL1175615	Inhibition of PDK1	B	NC(=O)c1nn(CC2CCNCC2)c2c1CCc1cnc(Nc3ccccc3)nc1-2		CHEMBL1171949	=	IC50	nM	374.0	CHEMBL2534	Homo sapiens	IC50	nM	374.0
	3352644	CHEMBL1175615	Inhibition of PDK1	B	NCCCn1nc(C(N)=O)c2c1-c1nc(Nc3ccccc3)ncc1CC2		CHEMBL1171950	=	IC50	nM	36.0	CHEMBL2534	Homo sapiens	IC50	nM	36.0
	3352646	CHEMBL1175615	Inhibition of PDK1	B	Cc1cc(CNC(=O)c2nn(C)c3c2CCc2cnc(Nc4ccc(N5CCN(C)CC5)cc4)nc2-3)ccn1		CHEMBL1169805	=	IC60	nM	713.0	CHEMBL2534	Homo sapiens	IC60	nM	713.0
	3352648	CHEMBL1175615	Inhibition of PDK1	B	Cc1cc(CNC(=O)c2nn(CCCN)c3c2CCc2cnc(Nc4cccc(CC(=O)N(C)C)c4)nc2-3)ccn1		CHEMBL1172241	=	IC50	nM	85.0	CHEMBL2534	Homo sapiens	IC50	nM	85.0
Not Active	3356167	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(Nc2ccccc2)CCc2ccccc21		CHEMBL1171191		EC50			CHEMBL2534	Homo sapiens	EC50		
	3356168	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Nc2ccccc2)CCc2ccccc21	Outside typical range	CHEMBL1171192	=	EC50	nM	900000.0	CHEMBL2534	Homo sapiens	EC50	uM	900.0
Not Active	3356169	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)N(Cc2ccccc2)CCc2ccccc21		CHEMBL1171602		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356170	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)N(Cc2ccccc2)CCc2ccccc21		CHEMBL1171603		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356171	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(Oc2ccccc2)CCc2ccccc21		CHEMBL1171774		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356172	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Oc2ccccc2)CCc2ccccc21		CHEMBL1170726		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356173	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(Sc2ccccc2)CCc2ccccc21		CHEMBL1171775		EC50			CHEMBL2534	Homo sapiens	EC50		
	3356174	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Sc2ccccc2)CCc2ccccc21	Outside typical range	CHEMBL1171225	=	EC50	nM	101000.0	CHEMBL2534	Homo sapiens	EC50	uM	101.0
Not Active	3356175	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(OC(=O)c2ccccc2)CCc2ccccc21		CHEMBL1170929		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356176	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(OC(=O)c2ccccc2)CCc2ccccc21		CHEMBL1171194		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356177	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(NC(=O)c2ccccc2)CCc2ccccc21		CHEMBL1171195		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356178	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(NC(=O)c2ccccc2)CCc2ccccc21		CHEMBL1171382		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356179	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COC(=O)CN1C(=O)C(NS(=O)(=O)c2ccccc2)CCc2ccccc21		CHEMBL1171383		EC50			CHEMBL2534	Homo sapiens	EC50		
Not Active	3356180	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(NS(=O)(=O)c2ccccc2)CCc2ccccc21		CHEMBL1171778		EC50			CHEMBL2534	Homo sapiens	EC50		
	3356181	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Sc2ccc(Cl)cc2)CCc2ccccc21		CHEMBL1171955	=	EC50	nM	23000.0	CHEMBL2534	Homo sapiens	EC50	uM	23.0
	3356182	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	COc1ccc(SC2CCc3ccccc3N(CC(=O)O)C2=O)cc1		CHEMBL1171125	=	EC50	nM	53000.0	CHEMBL2534	Homo sapiens	EC50	uM	53.0
	3356183	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Sc2ccc(C(=O)O)cc2)CCc2ccccc21	Outside typical range	CHEMBL1171415	=	EC50	nM	187000.0	CHEMBL2534	Homo sapiens	EC50	uM	187.0
	3356184	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Sc2ccc(Cl)cc2Cl)CCc2ccccc21		CHEMBL1171416	=	EC50	nM	75000.0	CHEMBL2534	Homo sapiens	EC50	uM	75.0
	3356185	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CN1C(=O)C(Sc2c(Cl)cccc2Cl)CCc2ccccc21		CHEMBL1171329	=	EC50	nM	45000.0	CHEMBL2534	Homo sapiens	EC50	uM	45.0
	3356186	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1	Outside typical range	CHEMBL550259	=	EC50	nM	133000.0	CHEMBL2534	Homo sapiens	EC50	uM	133.0
	3356187	CHEMBL1174636	Displacement of PIFtide from His-tagged PDK1 by HTRF assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O		CHEMBL1171330	=	EC50	nM	10000.0	CHEMBL2534	Homo sapiens	EC50	uM	10.0
	3358724	CHEMBL1175190	Inhibition of PDPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	84.0	CHEMBL2534	Homo sapiens	INH	%	84.0
	3359166	CHEMBL1175190	Inhibition of PDPK1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	60.0	CHEMBL2534	Homo sapiens	INH	%	60.0
	3397065	CHEMBL1216006	Binding affinity to human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Ka	10'4/M	9.7	CHEMBL2534	Homo sapiens	Ka	10'4/M	9.7
	3397066	CHEMBL1216006	Binding affinity to human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Ka	10'5/M	1.62	CHEMBL2534	Homo sapiens	Ka	10'5/M	1.62
	3397067	CHEMBL1216006	Binding affinity to human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Kd	nM	10300.0	CHEMBL2534	Homo sapiens	Kd	uM	10.3
	3397068	CHEMBL1216006	Binding affinity to human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by isothermal titration calorimetry	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Kd	nM	6200.0	CHEMBL2534	Homo sapiens	Kd	uM	6.2
Not Active	3397069	CHEMBL1216012	Displacement of TNP-ATP from human PDPK1 Y288G/Q292A mutant expressed in insect cell system at 83 uM by surface plasmon resonance assay	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397070	CHEMBL1216013	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as protection from deuterium incorporation into protein at 125 uM after 100 mins by LC/MS/MS analysis	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397071	CHEMBL1216013	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as protection from deuterium incorporation into protein at 125 uM after 100 mins by LC/MS/MS analysis	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
	3397072	CHEMBL1216007	Activation of human PDPK1 expressed in insect cell system assessed as substrate phosphorylation by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	AC50	nM	3700.0	CHEMBL2534	Homo sapiens	AC50	uM	3.7
	3397073	CHEMBL1216008	Activation of human PDPK1 expressed in insect cell system assessed as substrate phosphorylation at 8 uM by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Emax	%	430.0	CHEMBL2534	Homo sapiens	Emax	%	430.0
	3397074	CHEMBL1216009	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	AC50	nM	3100.0	CHEMBL2534	Homo sapiens	AC50	uM	3.1
	3397075	CHEMBL1216010	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation at 8 uM by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL552276	=	Emax	%	368.0	CHEMBL2534	Homo sapiens	Emax	%	368.0
	3397076	CHEMBL1216007	Activation of human PDPK1 expressed in insect cell system assessed as substrate phosphorylation by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	AC50	nM	7950.0	CHEMBL2534	Homo sapiens	AC50	uM	7.95
	3397077	CHEMBL1216008	Activation of human PDPK1 expressed in insect cell system assessed as substrate phosphorylation at 8 uM by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Emax	%	433.0	CHEMBL2534	Homo sapiens	Emax	%	433.0
	3397078	CHEMBL1216009	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	AC50	nM	10000.0	CHEMBL2534	Homo sapiens	AC50	uM	10.0
	3397079	CHEMBL1216010	Activation of human PDPK1 Y288G/Q292A mutant expressed in insect cell system assessed as substrate phosphorylation at 8 uM by fluorescence assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Emax	%	411.0	CHEMBL2534	Homo sapiens	Emax	%	411.0
Not Active	3397080	CHEMBL1216011	Displacement of TNP-ATP from human PDPK1 Y288G/Q292A mutant expressed in insect cell system at 167 uM by surface plasmon resonance assay	B	O=C(O)/C=C(\CCc1ccc(Br)cc1F)c1ccccc1		CHEMBL540467		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	3397081	CHEMBL1216016	Allosteric activation of human PDPK1 T226W mutant expressed in insect cell system at 500 uM by surface plasmon resonance assay	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL550259		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397082	CHEMBL1216019	Allosteric activation of wild type human PDPK1 expressed in insect cell system at 20 uM by surface plasmon resonance assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397083	CHEMBL1216014	Allosteric activation of human PDPK1 F224W mutant expressed in insect cell system at 200 uM by surface plasmon resonance assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	3397084	CHEMBL1216015	Allosteric activation of human PDPK1 T226W mutant expressed in insect cell system at 200 uM by surface plasmon resonance assay	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397085	CHEMBL1216017	Allosteric activation of human PDPK1 F224W mutant expressed in insect cell system at 20 uM by surface plasmon resonance assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	3397086	CHEMBL1216018	Allosteric activation of human PDPK1 T226W mutant expressed in insect cell system at 20 uM by surface plasmon resonance assay	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203		Activity			CHEMBL2534	Homo sapiens	Activity		
	3443480	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	3.0	CHEMBL2534	Homo sapiens	INH	%	3.0
	3443697	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	2.0	CHEMBL2534	Homo sapiens	INH	%	2.0
	3444852	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	7.0	CHEMBL2534	Homo sapiens	INH	%	7.0
	3445238	CHEMBL1244560	Binding affinity to PDPK1	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.4	CHEMBL2534	Homo sapiens	Kd	nM	3.4
	3445476	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	2.0	CHEMBL2534	Homo sapiens	INH	%	2.0
	3445693	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	8.0	CHEMBL2534	Homo sapiens	INH	%	8.0
	3445888	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	CC(C)n1nc(-c2cccc(O)c2)c2c(N)ncnc21		CHEMBL1230790	=	Inhibition	%	9.0	CHEMBL2534	Homo sapiens	INH	%	9.0
	3446078	CHEMBL1244246	Inhibition of PDK1 at 1 uM after 60 mins by FRET assay in presence of 100 uM ATP	B	Cn1nc(-c2ccc3ccccc3c2)c2c(N)ncnc21		CHEMBL1234815	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	3448037	CHEMBL1249688	Inhibition of human PDK1 activity at 10 uM by radiometric assay	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Inhibition	%	3.0	CHEMBL2534	Homo sapiens	INH	%	3.0
	3448113	CHEMBL1249688	Inhibition of human PDK1 activity at 10 uM by radiometric assay	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	3448549	CHEMBL1244560	Binding affinity to PDPK1	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	3449003	CHEMBL1244560	Binding affinity to PDPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	110.0	CHEMBL2534	Homo sapiens	Kd	nM	110.0
	3449302	CHEMBL1244560	Binding affinity to PDPK1	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	=	Kd	nM	15.0	CHEMBL2534	Homo sapiens	Kd	nM	15.0
	3449478	CHEMBL1244560	Binding affinity to PDPK1	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3500.0	CHEMBL2534	Homo sapiens	Kd	nM	3500.0
	3449780	CHEMBL1244560	Binding affinity to PDPK1	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	3450177	CHEMBL1244560	Binding affinity to PDPK1	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	uM	10.0
	3463313	CHEMBL1252615	Inhibition of PDK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	88.0	CHEMBL2534	Homo sapiens	INH	%	88.0
	3463857	CHEMBL1252615	Inhibition of PDK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	12.0	CHEMBL2534	Homo sapiens	INH	%	12.0
	3464076	CHEMBL1252615	Inhibition of PDK1 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	89.0	CHEMBL2534	Homo sapiens	INH	%	89.0
	3590248	CHEMBL1292114	Inhibition of PDK1	B	Oc1cccc(-c2cc(Nc3ccc4[nH]ncc4c3)nc(N3CCOCC3)n2)c1		CHEMBL1289975	>	IC50	nM	25000.0	CHEMBL2534	Homo sapiens	IC50	uM	25.0
	5120407	CHEMBL1648668	Inhibition of human PDK1 at 10 uM after 60 mins by TR-FRET assay	B	S=c1[nH]nc(-c2ccncc2)n1-c1ccc2ccccc2c1		CHEMBL1644616	=	Inhibition	%	108.0	CHEMBL2534	Homo sapiens	INH	%	108.0
	5120849	CHEMBL1646934	Inhibition of PDPK1 at 10 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2534	Homo sapiens	INH	%	20.0
	5140497	CHEMBL1646790	Inhibition of PDPK1 at 1 uM	B	CC(C)(C)c1cc(C(=O)O)c(NC(=O)Nc2ccc3[nH]ncc3c2)s1		CHEMBL1641799	=	Inhibition	%	20.0	CHEMBL2534	Homo sapiens	INH	%	20.0
	5293752	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	OCc1cc(O)[nH]n1		CHEMBL1688204	=	IC50	nM	344000.0	CHEMBL2534	Homo sapiens	IC50	uM	344.0
	5293753	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	NC(=O)c1n[nH]cc1N		CHEMBL1688205	=	IC50	nM	200000.0	CHEMBL2534	Homo sapiens	IC50	uM	200.0
	5293754	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	c1nnc2n1CCCC2		CHEMBL1688206	=	IC50	nM	244000.0	CHEMBL2534	Homo sapiens	IC50	uM	244.0
	5293755	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1nc(N)c2nc[nH]c2n1		CHEMBL388596	=	IC50	nM	50800.0	CHEMBL2534	Homo sapiens	IC50	uM	50.8
	5293756	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	CNc1ncnc2[nH]ncc12		CHEMBL1688207	=	IC50	nM	90800.0	CHEMBL2534	Homo sapiens	IC50	uM	90.8
	5293757	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	c1ccc(-c2nccs2)cc1		CHEMBL1688208	=	IC50	nM	95100.0	CHEMBL2534	Homo sapiens	IC50	uM	95.1
	5293758	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	O=c1cc(Cl)c2sccc2[nH]1		CHEMBL1688209	=	IC50	nM	102000.0	CHEMBL2534	Homo sapiens	IC50	uM	102.0
	5293759	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1[nH]nc2ccccc12		CHEMBL1331627	=	IC50	nM	311000.0	CHEMBL2534	Homo sapiens	IC50	uM	311.0
	5293760	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	NC(=O)c1nnc(N)nc1N		CHEMBL1688210	=	IC50	nM	145000.0	CHEMBL2534	Homo sapiens	IC50	uM	145.0
	5293761	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1nnc2ccccc2n1		CHEMBL1688211	=	IC50	nM	160000.0	CHEMBL2534	Homo sapiens	IC50	uM	160.0
	5293762	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	O=C1NCCc2ccccc21		CHEMBL1688212	=	IC50	nM	169000.0	CHEMBL2534	Homo sapiens	IC50	uM	169.0
	5293763	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	NC(=O)c1cccc2cc[nH]c12		CHEMBL1688213	=	IC50	nM	97500.0	CHEMBL2534	Homo sapiens	IC50	uM	97.5
	5293764	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1nc2c(O)cccc2s1		CHEMBL1269497	=	IC50	nM	256000.0	CHEMBL2534	Homo sapiens	IC50	uM	256.0
	5293765	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1cc(-c2ccco2)[nH]n1		CHEMBL1688214	=	IC50	nM	313000.0	CHEMBL2534	Homo sapiens	IC50	uM	313.0
	5293766	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	c1cc(-c2cc[nH]n2)ccn1		CHEMBL116211	=	IC50	nM	326000.0	CHEMBL2534	Homo sapiens	IC50	uM	326.0
	5293767	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	COc1[nH]cnc2ncnc1-2		CHEMBL305107	=	IC50	nM	340000.0	CHEMBL2534	Homo sapiens	IC50	uM	340.0
	5293768	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	O=c1[nH]cnc2ccccc12		CHEMBL266540	=	IC50	nM	345000.0	CHEMBL2534	Homo sapiens	IC50	uM	345.0
	5293769	CHEMBL1696294	Inhibition of His-tagged-truncated human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 3 hrs by Scintillation proximity assay	B	Nc1cc2ccccc2cn1		CHEMBL61743	=	IC50	nM	376000.0	CHEMBL2534	Homo sapiens	IC50	uM	376.0
	5293770	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	370.0	CHEMBL2534	Homo sapiens	IC50	uM	0.37
	5293771	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Nc1n[nH]c2cc(-c3ccncn3)ccc12.O=C(O)C(F)(F)F		CHEMBL1688216	=	IC50	nM	2670.0	CHEMBL2534	Homo sapiens	IC50	uM	2.67
	5293772	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Cl.Nc1cc(-c2ccc3c(N)n[nH]c3c2)ccn1		CHEMBL1688217	=	IC50	nM	7280.0	CHEMBL2534	Homo sapiens	IC50	uM	7.28
	5293773	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Nc1cccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688218	=	IC50	nM	13600.0	CHEMBL2534	Homo sapiens	IC50	uM	13.6
	5293774	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Nc1cccc(-c2ccc3c(N)n[nH]c3c2)c1		CHEMBL1688219	=	IC50	nM	21200.0	CHEMBL2534	Homo sapiens	IC50	uM	21.2
	5293775	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Nc1n[nH]c2cc(-c3ccccn3)ccc12		CHEMBL1688220	>	IC50	nM	25100.0	CHEMBL2534	Homo sapiens	IC50	uM	25.1
	5293776	CHEMBL1696295	Inhibition of human PDK1 preincubated with substrate biotinylated-AKT3 for 30 mins measured after 4 hrs by Scintillation proximity assay	B	Cl.Nc1n[nH]c2cc(-c3ccncc3)ccc12		CHEMBL1688221	=	IC50	nM	13200.0	CHEMBL2534	Homo sapiens	IC50	uM	13.2
	5293879	CHEMBL1697124	Inhibition of PDK1 after 60 mins by radiometric assay	B	O=C(Nc1ccc([N+](=O)[O-])cc1Cl)c1cc(Cl)ccc1O		CHEMBL1448	=	IC50	nM	83900.0	CHEMBL2534	Homo sapiens	IC50	uM	83.9
	6154886	CHEMBL1762899	Inhibition of PDK1	B	CC(=O)NC[C@H]1CC[C@H](c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn32)CC1		CHEMBL1762110	=	IC50	nM	11200.0	CHEMBL2534	Homo sapiens	IC50	uM	11.2
	6154929	CHEMBL1762899	Inhibition of PDK1	B	CN(C)C(=O)N1CCC(c2nc(-c3cc4ccccc4[nH]3)c3c(N)nccn23)CC1		CHEMBL1762114	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	6168292	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1COCCN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614773	=	IC50	nM	63.1	CHEMBL2534	Homo sapiens	pIC50		7.2
	6168293	CHEMBL1768778	Inhibition of PDK1	B	C[C@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765727	=	IC50	nM	1258.93	CHEMBL2534	Homo sapiens	pIC50		5.9
	6168294	CHEMBL1768778	Inhibition of PDK1	B	CC[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765728	=	IC50	nM	31.62	CHEMBL2534	Homo sapiens	pIC50		7.5
	6168295	CHEMBL1768778	Inhibition of PDK1	B	CC(C)[C@@H]1COCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765729	=	IC50	nM	199.53	CHEMBL2534	Homo sapiens	pIC50		6.7
	6168296	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CCCCN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765730	=	IC50	nM	125.89	CHEMBL2534	Homo sapiens	pIC50		6.9
	6168297	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCO[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1614774	=	IC50	nM	19.95	CHEMBL2534	Homo sapiens	pIC50		7.7
	6168298	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCO[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765731	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
	6168299	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765732	=	IC50	nM	31.62	CHEMBL2534	Homo sapiens	pIC50		7.5
	6168300	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@@H](C(=O)Nc3ccccc3)C2)n1		CHEMBL1765733	=	IC50	nM	125.89	CHEMBL2534	Homo sapiens	pIC50		6.9
	6168301	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCCC3)C2)n1		CHEMBL1765734	=	IC50	nM	63.1	CHEMBL2534	Homo sapiens	pIC50		7.2
	6168302	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCC[C@H](C(=O)NC3CCCC3)C2)n1		CHEMBL1765735	=	IC50	nM	125.89	CHEMBL2534	Homo sapiens	pIC50		6.9
	6168303	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	3.162	CHEMBL2534	Homo sapiens	pIC50		8.5
	6168304	CHEMBL1768778	Inhibition of PDK1	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	=	IC50	nM	1258.93	CHEMBL2534	Homo sapiens	pIC50		5.9
	6168305	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737	=	IC50	nM	794.33	CHEMBL2534	Homo sapiens	pIC50		6.1
	6168306	CHEMBL1768778	Inhibition of PDK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	=	IC50	nM	1.585	CHEMBL2534	Homo sapiens	pIC50		8.8
	6168307	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	=	IC50	nM	7.943	CHEMBL2534	Homo sapiens	pIC50		8.1
	6168308	CHEMBL1768778	Inhibition of PDK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	2.512	CHEMBL2534	Homo sapiens	pIC50		8.6
	6168309	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	=	IC50	nM	5.012	CHEMBL2534	Homo sapiens	pIC50		8.3
	6168310	CHEMBL1768778	Inhibition of PDK1	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	=	IC50	nM	3.162	CHEMBL2534	Homo sapiens	pIC50		8.5
	6168311	CHEMBL1768778	Inhibition of PDK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	=	IC50	nM	3.162	CHEMBL2534	Homo sapiens	pIC50		8.5
	6168312	CHEMBL1768778	Inhibition of PDK1	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	=	IC50	nM	6.31	CHEMBL2534	Homo sapiens	pIC50		8.2
	6168313	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC(NC(=O)c3ccccc3)C2)n1		CHEMBL1765745	=	IC50	nM	63.1	CHEMBL2534	Homo sapiens	pIC50		7.2
	6168314	CHEMBL1768778	Inhibition of PDK1	B	CC(C)(C)OC(=O)NC1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765746	=	IC50	nM	50.12	CHEMBL2534	Homo sapiens	pIC50		7.3
	6168315	CHEMBL1768778	Inhibition of PDK1	B	CC(C)(C)OC(=O)N[C@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765747	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
	6168316	CHEMBL1768778	Inhibition of PDK1	B	CC(C)(C)OC(=O)N[C@@H]1CCCN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765748	=	IC50	nM	25.12	CHEMBL2534	Homo sapiens	pIC50		7.6
	6168317	CHEMBL1768778	Inhibition of PDK1	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	15.85	CHEMBL2534	Homo sapiens	pIC50		7.8
	6168318	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1CC[C@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765749	=	IC50	nM	630.96	CHEMBL2534	Homo sapiens	pIC50		6.2
	6168319	CHEMBL1768778	Inhibition of PDK1	B	C[C@H]1CC[C@@H](NC(=O)OC(C)(C)C)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614776	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	pIC50		8.0
	6168320	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	=	IC50	nM	6.31	CHEMBL2534	Homo sapiens	pIC50		8.2
	6168321	CHEMBL1768778	Inhibition of PDK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	=	IC50	nM	0.7943	CHEMBL2534	Homo sapiens	pIC50		9.1
	6168322	CHEMBL1768778	Inhibition of PDK1	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	=	IC50	nM	0.631	CHEMBL2534	Homo sapiens	pIC50		9.2
	6168323	CHEMBL1768778	Inhibition of PDK1	B	CNc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765752	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
	6168324	CHEMBL1768778	Inhibition of PDK1	B	CN(C)c1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765753	=	IC50	nM	19952.62	CHEMBL2534	Homo sapiens	pIC50		4.7
	6168325	CHEMBL1768778	Inhibition of PDK1	B	CCNc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765754	=	IC50	nM	7943.28	CHEMBL2534	Homo sapiens	pIC50		5.1
	6168326	CHEMBL1768778	Inhibition of PDK1	B	COc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765755	=	IC50	nM	12589.25	CHEMBL2534	Homo sapiens	pIC50		4.9
	6168327	CHEMBL1768778	Inhibition of PDK1	B	Nc1nccc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1688215	=	IC50	nM	398.11	CHEMBL2534	Homo sapiens	pIC50		6.4
	6168328	CHEMBL1768778	Inhibition of PDK1	B	Cc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765756	=	IC50	nM	125.89	CHEMBL2534	Homo sapiens	pIC50		6.9
	6168329	CHEMBL1768778	Inhibition of PDK1	B	CC(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765757	=	IC50	nM	251.19	CHEMBL2534	Homo sapiens	pIC50		6.6
	6168330	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765758	=	IC50	nM	199.53	CHEMBL2534	Homo sapiens	pIC50		6.7
	6168331	CHEMBL1768778	Inhibition of PDK1	B	COc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765759	=	IC50	nM	251.19	CHEMBL2534	Homo sapiens	pIC50		6.6
	6168332	CHEMBL1768778	Inhibition of PDK1	B	CNc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765760	=	IC50	nM	79.43	CHEMBL2534	Homo sapiens	pIC50		7.1
	6168333	CHEMBL1768778	Inhibition of PDK1	B	CCNc1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614771	=	IC50	nM	158.49	CHEMBL2534	Homo sapiens	pIC50		6.8
	6168334	CHEMBL1768778	Inhibition of PDK1	B	CC(C)Nc1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765761	=	IC50	nM	125.89	CHEMBL2534	Homo sapiens	pIC50		6.9
	6168335	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(NC2CCCC2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765762	=	IC50	nM	50.12	CHEMBL2534	Homo sapiens	pIC50		7.3
	6168336	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(Nc2ccccc2)cc(-c2ccc3c(N)n[nH]c3c2)n1		CHEMBL1765876	=	IC50	nM	19.95	CHEMBL2534	Homo sapiens	pIC50		7.7
	6168337	CHEMBL1768778	Inhibition of PDK1	B	CN(C)c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765877	=	IC50	nM	501.19	CHEMBL2534	Homo sapiens	pIC50		6.3
	6168338	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)[nH]nc3c2)cc(N2CCOCC2)n1		CHEMBL1614772	=	IC50	nM	316.23	CHEMBL2534	Homo sapiens	pIC50		6.5
	6168339	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCC2)n1		CHEMBL1765878	=	IC50	nM	251.19	CHEMBL2534	Homo sapiens	pIC50		6.6
	6168340	CHEMBL1768778	Inhibition of PDK1	B	Nc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2CCCCC2)n1		CHEMBL1765879	=	IC50	nM	251.19	CHEMBL2534	Homo sapiens	pIC50		6.6
	6168521	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	327.0	CHEMBL2534	Homo sapiens	IC50	nM	327.0
	6168522	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	>	IC50	nM	29300.0	CHEMBL2534	Homo sapiens	IC50	nM	29300.0
Not Determined	6168523	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737		IC50			CHEMBL2534	Homo sapiens	IC50		
	6168524	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	=	IC50	nM	165.0	CHEMBL2534	Homo sapiens	IC50	nM	165.0
	6168525	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	=	IC50	nM	472.0	CHEMBL2534	Homo sapiens	IC50	nM	472.0
	6168526	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	113.0	CHEMBL2534	Homo sapiens	IC50	nM	113.0
	6168527	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	=	IC50	nM	264.0	CHEMBL2534	Homo sapiens	IC50	nM	264.0
	6168528	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	=	IC50	nM	57.0	CHEMBL2534	Homo sapiens	IC50	nM	57.0
	6168529	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
	6168530	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	=	IC50	nM	85.0	CHEMBL2534	Homo sapiens	IC50	nM	85.0
	6168531	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	=	IC50	nM	74.0	CHEMBL2534	Homo sapiens	IC50	nM	74.0
	6168532	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
	6168533	CHEMBL1768783	Inhibition of PDK1-mediated AKT phosphorylation at Thr308 residue in human PC3 cells by ELISA	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	=	IC50	nM	22.0	CHEMBL2534	Homo sapiens	IC50	nM	22.0
	6168534	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	=	IC50	nM	333.0	CHEMBL2534	Homo sapiens	IC50	nM	333.0
	6168535	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765736	>	IC50	nM	29300.0	CHEMBL2534	Homo sapiens	IC50	nM	29300.0
Not Determined	6168536	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765737		IC50			CHEMBL2534	Homo sapiens	IC50		
	6168537	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)Nc3ccccc3)CC[C@H]2C)n1		CHEMBL1765738	=	IC50	nM	655.0	CHEMBL2534	Homo sapiens	IC50	nM	655.0
	6168538	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1CC[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765739	=	IC50	nM	316.0	CHEMBL2534	Homo sapiens	IC50	nM	316.0
	6168539	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	293.0	CHEMBL2534	Homo sapiens	IC50	nM	293.0
	6168540	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	=	IC50	nM	594.0	CHEMBL2534	Homo sapiens	IC50	nM	594.0
	6168541	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CC[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765742	=	IC50	nM	88.0	CHEMBL2534	Homo sapiens	IC50	nM	88.0
	6168542	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)OC[C@H]2C)n1		CHEMBL1765743	=	IC50	nM	30.0	CHEMBL2534	Homo sapiens	IC50	nM	30.0
	6168543	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CC[C@@H]1CO[C@H](C(=O)NC2CCCCC2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(NC)n1		CHEMBL1765744	=	IC50	nM	102.0	CHEMBL2534	Homo sapiens	IC50	nM	102.0
	6168544	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1C[C@@H](NC(=O)OC(C)(C)C)CN(c2cc(-c3ccc4c(N)[nH]nc4c3)nc(N)n2)C1		CHEMBL1614777	=	IC50	nM	151.0	CHEMBL2534	Homo sapiens	IC50	nM	151.0
	6168545	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@H](C)C[C@@H](N(C)C(=O)OC(C)(C)C)C2)n1		CHEMBL1765750	=	IC50	nM	19.0	CHEMBL2534	Homo sapiens	IC50	nM	19.0
	6168546	CHEMBL1768784	Inhibition of PDK1-mediated RSK phosphorylation at Ser221 residue in human PC3 cells by ELISA	B	C[C@@H]1C[C@@H](N(C)C(=O)CC(C)(C)C)CN(c2cc(-c3ccc4c(N)n[nH]c4c3)nc(N)n2)C1		CHEMBL1765751	=	IC50	nM	116.0	CHEMBL2534	Homo sapiens	IC50	nM	116.0
	6168547	CHEMBL1768785	Inhibition of PDK1-mediated AKT phosphorylation at Ser473 in human PC3 cells by ELISA	B	C[C@@H]1CC[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)[nH]nc3c2)nc(N)n1		CHEMBL1614775	>	IC50	nM	29300.0	CHEMBL2534	Homo sapiens	IC50	nM	29300.0
	6168548	CHEMBL1768785	Inhibition of PDK1-mediated AKT phosphorylation at Ser473 in human PC3 cells by ELISA	B	C[C@@H]1CO[C@H](C(=O)Nc2ccccc2)CN1c1cc(-c2ccc3c(N)n[nH]c3c2)nc(N)n1		CHEMBL1765741	>	IC50	nM	29300.0	CHEMBL2534	Homo sapiens	IC50	nM	29300.0
	6169189	CHEMBL1768792	Inhibition of human PDK1 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	0.0	CHEMBL2534	Homo sapiens	Activity	%	0.0
	6169238	CHEMBL1768778	Inhibition of PDK1	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	2.5	CHEMBL2534	Homo sapiens	IC50	nM	2.5
	6173420	CHEMBL1768229	Inhibition of PDK1 at 25 uM by direct TR-FRET assay	B	NC(=O)c1ccsc1NC(=O)Cc1csc2ccccc12		CHEMBL1767254	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	6265570	CHEMBL1798279	Inhibition of PDPK1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4NS(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796254	<	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	INH	%	65.0
	6265674	CHEMBL1798279	Inhibition of PDPK1 at 1 uM	B	COCCN1CCc2cc(Nc3ncc(Cl)c(N[C@@H]4CCCC[C@H]4N(C)S(C)(=O)=O)n3)c(OC)cc2CC1		CHEMBL1796257	<	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	INH	%	65.0
	6341109	CHEMBL1826681	Activity of PDPK1 kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
Not Active	6360126	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NS(=O)(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830566		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360127	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830567		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360128	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCCC[C@H](N)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830568		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360129	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCCC[C@@H](N)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830569		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360130	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C#N)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830570		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360131	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	FC(F)(F)c1ccc(-c2ccc(-c3cc(C(F)(F)F)nn3-c3ccc(N4CCNCC4)cc3)cc2)cc1		CHEMBL1830571		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360132	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL1830572		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360133	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCCC[C@H](N)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL1830573		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360134	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(C)CC(N)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL1830574		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360135	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCC(C)C(N)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL1830575		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360136	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NC(Cc1ccccc1)C(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL1830576		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360137	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(c2)oc2ccccc23)cc1		CHEMBL1830577		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360138	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(c2)oc2ccccc23)cc1		CHEMBL1830578		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360139	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc3c(ccc4ccccc43)c2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830579		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360140	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)c1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830580		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360141	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCNC(=O)c1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830581		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360142	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(C)NC(=O)c1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830582		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360143	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830583		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360144	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830584		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360145	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(C)NC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830585		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360146	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)c1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830586		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360147	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360148	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830588		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360149	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)c1cc(-c2ccc3ccc4ccccc4c3c2)n(-c2ccc(NC(=O)CN)cc2)n1		CHEMBL1830589		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360150	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3ccc4ccccc4c3c2)cc1		CHEMBL1830590		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360151	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NCCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3ccc4ccccc4c3c2)cc1		CHEMBL1830591		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360152	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCNC(=O)c1cc(-c2ccc3ccc4ccccc4c3c2)n(-c2ccc(NC(=O)CN)cc2)n1		CHEMBL1830592		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360153	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)c1cc(-c2ccc3c(ccc4ccccc43)c2)n(-c2ccc(NC(=O)CN)cc2)n1		CHEMBL1828650		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360154	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CCNC(=O)c1cc(-c2ccc3ccc4ccccc4c3c2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830593		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360155	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)c1cc(-c2ccc3c(ccc4ccccc43)c2)n(-c2ccc(NC(=O)CCN)cc2)n1		CHEMBL1830594		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360156	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1)N1CCOCC1		CHEMBL1830595		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360157	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C1CCC(=O)N1c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830596		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360158	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NC(=O)CNc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830597		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360159	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830598		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360160	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NC(=O)CCNc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830599		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360161	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	COc1ccc(S(=O)(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830600		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360162	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)c([N+](=O)[O-])c1		CHEMBL1830601		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360163	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(c1cccc([N+](=O)[O-])c1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830602		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360164	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(=O)c1ccc(S(=O)(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830603		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360165	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(=O)Nc1ccc(S(=O)(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830604		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360166	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=[N+]([O-])c1ccc(S(=O)(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830605		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360167	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(c1ccc(OC(F)(F)F)cc1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830606		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360168	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(c1ccc(Cl)c([N+](=O)[O-])c1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830607		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360169	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(c1ccncc1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830608		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360170	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	COc1cc([N+](=O)[O-])ccc1S(=O)(=O)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830609		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360171	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NC(=O)c1ccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830610		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360172	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	O=C(c1ccc([N+](=O)[O-])cc1)N1CCN(c2ccc(-n3nc(C(F)(F)F)cc3-c3ccc4c(ccc5ccccc54)c3)cc2)CC1		CHEMBL1830611		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360173	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	N#Cc1cccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)c1		CHEMBL1830612		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360174	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CC(=O)c1cc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)ccc1Cl		CHEMBL1830613		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360175	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	NC(=O)c1cccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)c1		CHEMBL1830614		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360176	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	N#Cc1ccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830615		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360177	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	Nc1ccc(C(=O)N2CCN(c3ccc(-n4nc(C(F)(F)F)cc4-c4ccc5c(ccc6ccccc65)c4)cc3)CC2)cc1		CHEMBL1830616		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360178	CHEMBL1833068	Inhibition of PDK2 in human PC3 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCOCC3)cc2)n1		CHEMBL1830716		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	6360179	CHEMBL1833069	Inhibition of PDK2 in human MDA-MB-231 cells assessed as Akt Thr-308 dephosphorylation by Western blot analysis	F	CNC(=O)CCc1cc(-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)n(-c2ccc(N3CCNCC3)cc2)n1		CHEMBL1830587		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	7567271	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7567730	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7568201	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7568659	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	2600.0	CHEMBL2534	Homo sapiens	Kd	nM	2600.0
	7569244	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7569704	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7570197	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7570624	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	3500.0	CHEMBL2534	Homo sapiens	Kd	nM	3500.0
	7571220	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7571677	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7571711	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7572174	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7572590	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7573201	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	2800.0	CHEMBL2534	Homo sapiens	Kd	nM	2800.0
	7573692	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3900.0	CHEMBL2534	Homo sapiens	Kd	nM	3900.0
	7574161	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	190.0	CHEMBL2534	Homo sapiens	Kd	nM	190.0
	7574569	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7575198	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7575669	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7576134	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7576542	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7576711	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7577170	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7577648	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	650.0	CHEMBL2534	Homo sapiens	Kd	nM	650.0
	7578118	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7578523	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7578719	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7579093	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7579543	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7580017	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7580486	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7580889	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7581077	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7581462	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7581907	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7582378	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7583423	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7583820	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7584265	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7584736	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	700.0	CHEMBL2534	Homo sapiens	Kd	nM	700.0
	7584756	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	120.0	CHEMBL2534	Homo sapiens	Kd	nM	120.0
	7585160	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7585753	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7586161	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7586607	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7587090	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7587714	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7588133	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	3.4	CHEMBL2534	Homo sapiens	Kd	nM	3.4
	7588615	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7589066	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7589679	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7590128	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7590602	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7591053	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7591632	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7592104	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7592577	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7593030	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7593177	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7593612	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7594084	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7594557	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7595009	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7595145	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7595589	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7596063	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7596534	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7596981	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1.7	CHEMBL2534	Homo sapiens	Kd	nM	1.7
	7597117	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7597570	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7598043	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
	7598513	CHEMBL1908573	Binding constant for PDPK1 kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
Dose-dependent effect	7850749	CHEMBL1913783	Inhibition of PDK1 phosphorylation in human A549 cells after 24 hrs by Western blot analysis	B	C=C(C)[C@@]12O[C@@]3(/C=C/C=C/CCCCC)O[C@@H]1[C@@H]1[C@@H]4O[C@]4(CO)[C@@H](O)[C@]4(O)C(=O)C(C)=C[C@H]4[C@@]1(O3)[C@H](C)[C@H]2OC(C)=O		CHEMBL1911631		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	7931121	CHEMBL1919458	Inhibition of PDK1 relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	7.0	CHEMBL2534	Homo sapiens	INH	%	7.0
	7986261	CHEMBL1937383	Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting	B	Cc1cnc2nc1-c1cccc(c1)OCC/C=C/CN(C)Cc1cccc(c1)N2		CHEMBL1933343	=	IC50	nM	1400.0	CHEMBL2534	Homo sapiens	IC50	uM	1.4
	7986262	CHEMBL1937383	Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting	B	CN1C/C=C/CCOc2cccc(c2)-c2nc(nc3[nH]cnc23)Nc2cccc(c2)C1		CHEMBL1933344	=	IC50	nM	390.0	CHEMBL2534	Homo sapiens	IC50	uM	0.39
	7986263	CHEMBL1937383	Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting	B	Oc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1		CHEMBL1933345	=	IC50	nM	1600.0	CHEMBL2534	Homo sapiens	IC50	uM	1.6
	7986264	CHEMBL1937383	Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)CN)c3)nc3[nH]cnc23)cc1OC		CHEMBL1933346	=	IC50	nM	98.0	CHEMBL2534	Homo sapiens	IC50	uM	0.098
	7986265	CHEMBL1937383	Inhibition of PDK1 using [gamma33P]-ATP as substrate after 30 mins by scintillation counting	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	IC50	nM	39.0	CHEMBL2534	Homo sapiens	IC50	uM	0.039
	8001932	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	Cc1cc(CNC(=O)c2nn(CCCN)c3c2CCc2cnc(Nc4cccc(CC(=O)N(C)C)c4)nc2-3)ccn1		CHEMBL1172241	=	IC50	nM	85.0	CHEMBL2534	Homo sapiens	IC50	nM	85.0
	8001933	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
	8001934	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	O=C(N[C@@H](COc1ccc2[nH]c(=O)[nH]c2c1)c1ccccc1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL1234429	=	EC50	nM	1.0	CHEMBL2534	Homo sapiens	EC50	nM	1.0
	8001937	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CNc1cncc(C(=O)c2cn(C(C)C)c3ncnc(N)c23)n1		CHEMBL1940243	=	Ki	nM	100.0	CHEMBL2534	Homo sapiens	Ki	nM	100.0
	8001938	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(NCCc3cccnc3)n2)c2c(N)ncnc21		CHEMBL1940244	=	Ki	nM	35.0	CHEMBL2534	Homo sapiens	Ki	nM	35.0
	8001940	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCC[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940246	=	Ki	nM	0.6	CHEMBL2534	Homo sapiens	Ki	nM	0.6
	8001941	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3COC[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1938415	=	Ki	nM	0.6	CHEMBL2534	Homo sapiens	Ki	nM	0.6
	8001942	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCO[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940248	=	Ki	nM	1.3	CHEMBL2534	Homo sapiens	Ki	nM	1.3
	8001943	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CNC[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940249	=	Ki	nM	2.5	CHEMBL2534	Homo sapiens	Ki	nM	2.5
	8001944	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940250	=	Ki	nM	1.0	CHEMBL2534	Homo sapiens	Ki	nM	1.0
	8001945	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	Ki	nM	0.7	CHEMBL2534	Homo sapiens	Ki	nM	0.7
	8001946	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	Ki	nM	1.4	CHEMBL2534	Homo sapiens	Ki	nM	1.4
	8001947	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	Ki	nM	1.4	CHEMBL2534	Homo sapiens	Ki	nM	1.4
	8002037	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCC[C@@H]3c3ccccc3)n2)c2c(N)ncnc21		CHEMBL1940245	=	Ki	nM	2.0	CHEMBL2534	Homo sapiens	Ki	nM	2.0
	8002040	CHEMBL1942054	Inhibition of recombinant human His-tagged PDK1 catalytic domain using Ac-Sox-PKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIAD-NH2 as substrate by fluorescence-based spectrophotometry	B	CC(C)n1cc(C(=O)c2cncc(N(C)[C@@H]3CCC[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940247	=	Ki	nM	0.9	CHEMBL2534	Homo sapiens	Ki	nM	0.9
	8002044	CHEMBL1942164	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human SKOV3 cells after 2 hrs by ELISA	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	70.0	CHEMBL2534	Homo sapiens	IC50	nM	70.0
	8002045	CHEMBL1942164	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human SKOV3 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	70.0	CHEMBL2534	Homo sapiens	IC50	nM	70.0
	8002046	CHEMBL1942164	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human SKOV3 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
	8002047	CHEMBL1942165	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human A549 cells after 2 hrs by ELISA	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	50.0	CHEMBL2534	Homo sapiens	IC50	nM	50.0
	8002048	CHEMBL1942165	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human A549 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	nM	80.0
	8002049	CHEMBL1942165	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human A549 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	300.0	CHEMBL2534	Homo sapiens	IC50	nM	300.0
	8002053	CHEMBL1942167	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human H460 cells after 2 hrs by ELISA	B	CC(C)n1cc(C(=O)c2cncc(N[C@@H]3CCN(C=O)[C@@H]3c3ccc(F)cc3)n2)c2c(N)ncnc21		CHEMBL1940251	=	IC50	nM	120.0	CHEMBL2534	Homo sapiens	IC50	nM	120.0
	8002054	CHEMBL1942167	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human H460 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccc(F)cc1		CHEMBL1940252	=	IC50	nM	160.0	CHEMBL2534	Homo sapiens	IC50	nM	160.0
	8002055	CHEMBL1942167	Inhibition of PDK1-mediated AKT1 phosphorylation at T308 in human H460 cells after 2 hrs by ELISA	B	CC(=O)N1CC[C@@H](Nc2cncc(C(=O)c3cn(C(C)C)c4ncnc(N)c34)n2)[C@H]1c1ccccc1		CHEMBL1940253	=	IC50	nM	320.0	CHEMBL2534	Homo sapiens	IC50	nM	320.0
	8036726	CHEMBL1954512	Inhibition of recombinant PDK1 using P2925 peptide as substrate by fluorescence polarization assay	B	CCOC(=O)c1ccc(Nc2cc(C)nc(Nc3ccc(C(=O)OCC)cc3)n2)cc1		CHEMBL1951891	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
	8036740	CHEMBL1954526	Inhibition of recombinant PDK1 using RPRAATF as substrate by scintillation counting	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118	=	IC50	nM	48000.0	CHEMBL2534	Homo sapiens	IC50	uM	48.0
	8047155	CHEMBL1959380	Inhibition of PDPK1 at 1 uM	B	CN1CCN(c2ccc(Nc3nc(N)c(C(=O)c4ccc5c(c4)OCCO5)s3)cc2)CC1		CHEMBL1956070	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	8061228	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	2.25	CHEMBL2534	Homo sapiens	Inhibition	%	2.25
	8061629	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.17	CHEMBL2534	Homo sapiens	Inhibition	%	0.17
	8061927	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	0.63	CHEMBL2534	Homo sapiens	Inhibition	%	0.63
	8062267	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.21	CHEMBL2534	Homo sapiens	Inhibition	%	4.21
	8062653	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	2.38	CHEMBL2534	Homo sapiens	Inhibition	%	2.38
	8062975	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.77	CHEMBL2534	Homo sapiens	Inhibition	%	0.77
	8063606	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.65	CHEMBL2534	Homo sapiens	Inhibition	%	2.65
	8064012	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	0.71	CHEMBL2534	Homo sapiens	Inhibition	%	0.71
	8064351	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	1.22	CHEMBL2534	Homo sapiens	Inhibition	%	1.22
	8064699	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.22	CHEMBL2534	Homo sapiens	Inhibition	%	2.22
	8065089	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	-1.04	CHEMBL2534	Homo sapiens	Inhibition	%	-1.04
	8065429	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.36	CHEMBL2534	Homo sapiens	Inhibition	%	3.36
	8066153	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.73	CHEMBL2534	Homo sapiens	Inhibition	%	0.73
	8066513	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	3.22	CHEMBL2534	Homo sapiens	Inhibition	%	3.22
	8067202	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.73	CHEMBL2534	Homo sapiens	Inhibition	%	1.73
	8067547	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	0.82	CHEMBL2534	Homo sapiens	Inhibition	%	0.82
	8068280	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	0.43	CHEMBL2534	Homo sapiens	Inhibition	%	0.43
	8068629	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.85	CHEMBL2534	Homo sapiens	Inhibition	%	0.85
	8069027	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.4	CHEMBL2534	Homo sapiens	Inhibition	%	0.4
	8069447	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	2.84	CHEMBL2534	Homo sapiens	Inhibition	%	2.84
	8069832	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.95	CHEMBL2534	Homo sapiens	Inhibition	%	0.95
	8070479	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	1.17	CHEMBL2534	Homo sapiens	Inhibition	%	1.17
	8071284	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.02	CHEMBL2534	Homo sapiens	Inhibition	%	1.02
	8071681	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.0	CHEMBL2534	Homo sapiens	Inhibition	%	2.0
	8072030	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.63	CHEMBL2534	Homo sapiens	Inhibition	%	0.63
	8072111	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	0.19	CHEMBL2534	Homo sapiens	Inhibition	%	0.19
	8072120	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.08	CHEMBL2534	Homo sapiens	Inhibition	%	1.08
	8072501	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.31	CHEMBL2534	Homo sapiens	Inhibition	%	1.31
	8072850	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	1.17	CHEMBL2534	Homo sapiens	Inhibition	%	1.17
	8073942	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.46	CHEMBL2534	Homo sapiens	Inhibition	%	0.46
	8074605	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.03	CHEMBL2534	Homo sapiens	Inhibition	%	1.03
	8074956	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.4	CHEMBL2534	Homo sapiens	Inhibition	%	-0.4
	8075291	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.98	CHEMBL2534	Homo sapiens	Inhibition	%	-0.98
	8075669	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.28	CHEMBL2534	Homo sapiens	Inhibition	%	1.28
	8076035	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	0.59	CHEMBL2534	Homo sapiens	Inhibition	%	0.59
	8076407	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.29	CHEMBL2534	Homo sapiens	Inhibition	%	1.29
	8077114	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	3.51	CHEMBL2534	Homo sapiens	Inhibition	%	3.51
	8077466	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.99	CHEMBL2534	Homo sapiens	Inhibition	%	0.99
	8078123	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-2.08	CHEMBL2534	Homo sapiens	Inhibition	%	-2.08
	8078449	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.07	CHEMBL2534	Homo sapiens	Inhibition	%	-0.07
	8079197	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	0.22	CHEMBL2534	Homo sapiens	Inhibition	%	0.22
	8079563	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	2.01	CHEMBL2534	Homo sapiens	Inhibition	%	2.01
	8079926	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	0.96	CHEMBL2534	Homo sapiens	Inhibition	%	0.96
	8080255	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	0.43	CHEMBL2534	Homo sapiens	Inhibition	%	0.43
	8080283	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	19.64	CHEMBL2534	Homo sapiens	Inhibition	%	19.64
	8080622	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.04	CHEMBL2534	Homo sapiens	Inhibition	%	1.04
	8081010	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-3.23	CHEMBL2534	Homo sapiens	Inhibition	%	-3.23
	8081369	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.97	CHEMBL2534	Homo sapiens	Inhibition	%	1.97
	8082092	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	0.3	CHEMBL2534	Homo sapiens	Inhibition	%	0.3
	8082429	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.73	CHEMBL2534	Homo sapiens	Inhibition	%	3.73
	8083105	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.57	CHEMBL2534	Homo sapiens	Inhibition	%	3.57
	8083428	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	-0.34	CHEMBL2534	Homo sapiens	Inhibition	%	-0.34
	8084201	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	20.79	CHEMBL2534	Homo sapiens	Inhibition	%	20.79
	8084543	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	2.47	CHEMBL2534	Homo sapiens	Inhibition	%	2.47
	8085282	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-3.37	CHEMBL2534	Homo sapiens	Inhibition	%	-3.37
	8085614	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.8	CHEMBL2534	Homo sapiens	Inhibition	%	3.8
	8086304	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	0.58	CHEMBL2534	Homo sapiens	Inhibition	%	0.58
	8086627	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.45	CHEMBL2534	Homo sapiens	Inhibition	%	2.45
	8087220	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.1	CHEMBL2534	Homo sapiens	Inhibition	%	2.1
	8087558	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.73	CHEMBL2534	Homo sapiens	Inhibition	%	7.73
	8087920	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	0.7	CHEMBL2534	Homo sapiens	Inhibition	%	0.7
	8088562	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	0.82	CHEMBL2534	Homo sapiens	Inhibition	%	0.82
	8089379	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.42	CHEMBL2534	Homo sapiens	Inhibition	%	10.42
	8089723	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	4.14	CHEMBL2534	Homo sapiens	Inhibition	%	4.14
	8090127	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.25	CHEMBL2534	Homo sapiens	Inhibition	%	-0.25
	8090459	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.52	CHEMBL2534	Homo sapiens	Inhibition	%	2.52
	8090822	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.37	CHEMBL2534	Homo sapiens	Inhibition	%	0.37
	8091027	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.7	CHEMBL2534	Homo sapiens	Inhibition	%	1.7
	8091388	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	-0.1	CHEMBL2534	Homo sapiens	Inhibition	%	-0.1
	8091767	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	0.98	CHEMBL2534	Homo sapiens	Inhibition	%	0.98
	8092395	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.06	CHEMBL2534	Homo sapiens	Inhibition	%	2.06
	8092767	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.7	CHEMBL2534	Homo sapiens	Inhibition	%	-0.7
	8093120	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.22	CHEMBL2534	Homo sapiens	Inhibition	%	0.22
	8093208	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.27	CHEMBL2534	Homo sapiens	Inhibition	%	2.27
	8093572	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	0.47	CHEMBL2534	Homo sapiens	Inhibition	%	0.47
	8093935	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	2.53	CHEMBL2534	Homo sapiens	Inhibition	%	2.53
	8094634	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	-1.21	CHEMBL2534	Homo sapiens	Inhibition	%	-1.21
	8095014	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.29	CHEMBL2534	Homo sapiens	Inhibition	%	6.29
	8095581	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	0.01	CHEMBL2534	Homo sapiens	Inhibition	%	0.01
	8096211	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.95	CHEMBL2534	Homo sapiens	Inhibition	%	1.95
	8096574	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	0.06	CHEMBL2534	Homo sapiens	Inhibition	%	0.06
	8096954	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	1.13	CHEMBL2534	Homo sapiens	Inhibition	%	1.13
	8097632	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	6.08	CHEMBL2534	Homo sapiens	Inhibition	%	6.08
	8098259	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	12.09	CHEMBL2534	Homo sapiens	Inhibition	%	12.09
	8098663	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.07	CHEMBL2534	Homo sapiens	Inhibition	%	0.07
	8099358	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	0.15	CHEMBL2534	Homo sapiens	Inhibition	%	0.15
	8099923	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.64	CHEMBL2534	Homo sapiens	Inhibition	%	0.64
	8100293	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	2.95	CHEMBL2534	Homo sapiens	Inhibition	%	2.95
	8100633	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	8.47	CHEMBL2534	Homo sapiens	Inhibition	%	8.47
	8101299	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-0.87	CHEMBL2534	Homo sapiens	Inhibition	%	-0.87
	8102116	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	-1.42	CHEMBL2534	Homo sapiens	Inhibition	%	-1.42
	8102471	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.9	CHEMBL2534	Homo sapiens	Inhibition	%	1.9
	8102815	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.57	CHEMBL2534	Homo sapiens	Inhibition	%	-1.57
	8103189	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	0.94	CHEMBL2534	Homo sapiens	Inhibition	%	0.94
	8103551	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	-1.35	CHEMBL2534	Homo sapiens	Inhibition	%	-1.35
	8103925	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.81	CHEMBL2534	Homo sapiens	Inhibition	%	1.81
	8104110	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.86	CHEMBL2534	Homo sapiens	Inhibition	%	-0.86
	8104482	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	2.77	CHEMBL2534	Homo sapiens	Inhibition	%	2.77
	8105106	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.6	CHEMBL2534	Homo sapiens	Inhibition	%	-0.6
	8105496	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	0.63	CHEMBL2534	Homo sapiens	Inhibition	%	0.63
	8105858	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	1.45	CHEMBL2534	Homo sapiens	Inhibition	%	1.45
	8105914	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	2.17	CHEMBL2534	Homo sapiens	Inhibition	%	2.17
	8106303	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.53	CHEMBL2534	Homo sapiens	Inhibition	%	2.53
	8106683	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.2	CHEMBL2534	Homo sapiens	Inhibition	%	1.2
	8107329	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	2.62	CHEMBL2534	Homo sapiens	Inhibition	%	2.62
	8107754	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.5	CHEMBL2534	Homo sapiens	Inhibition	%	1.5
	8108959	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.28	CHEMBL2534	Homo sapiens	Inhibition	%	-0.28
	8109297	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	-0.35	CHEMBL2534	Homo sapiens	Inhibition	%	-0.35
	8109651	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.17	CHEMBL2534	Homo sapiens	Inhibition	%	-1.17
	8110457	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	3.8	CHEMBL2534	Homo sapiens	Inhibition	%	3.8
	8111128	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.37	CHEMBL2534	Homo sapiens	Inhibition	%	2.37
	8111479	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.24	CHEMBL2534	Homo sapiens	Inhibition	%	0.24
	8111869	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	13.11	CHEMBL2534	Homo sapiens	Inhibition	%	13.11
	8112211	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	2.62	CHEMBL2534	Homo sapiens	Inhibition	%	2.62
	8112603	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	1.01	CHEMBL2534	Homo sapiens	Inhibition	%	1.01
	8112775	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	1.23	CHEMBL2534	Homo sapiens	Inhibition	%	1.23
	8113151	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	1.35	CHEMBL2534	Homo sapiens	Inhibition	%	1.35
	8113511	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.51	CHEMBL2534	Homo sapiens	Inhibition	%	-0.51
	8114151	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.06	CHEMBL2534	Homo sapiens	Inhibition	%	0.06
	8114507	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	-0.87	CHEMBL2534	Homo sapiens	Inhibition	%	-0.87
	8114949	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	2.41	CHEMBL2534	Homo sapiens	Inhibition	%	2.41
	8115338	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.76	CHEMBL2534	Homo sapiens	Inhibition	%	-0.76
	8115682	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.98	CHEMBL2534	Homo sapiens	Inhibition	%	1.98
	8116401	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	2.52	CHEMBL2534	Homo sapiens	Inhibition	%	2.52
	8116759	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.82	CHEMBL2534	Homo sapiens	Inhibition	%	0.82
	8117326	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	6.76	CHEMBL2534	Homo sapiens	Inhibition	%	6.76
	8117976	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.57	CHEMBL2534	Homo sapiens	Inhibition	%	0.57
	8118316	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	1.2	CHEMBL2534	Homo sapiens	Inhibition	%	1.2
	8118712	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.28	CHEMBL2534	Homo sapiens	Inhibition	%	1.28
	8119119	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	2.96	CHEMBL2534	Homo sapiens	Inhibition	%	2.96
	8119502	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	3.92	CHEMBL2534	Homo sapiens	Inhibition	%	3.92
	8120151	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.78	CHEMBL2534	Homo sapiens	Inhibition	%	-0.78
	8120535	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.36	CHEMBL2534	Homo sapiens	Inhibition	%	-1.36
	8121260	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-1.22	CHEMBL2534	Homo sapiens	Inhibition	%	-1.22
	8121814	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	1.27	CHEMBL2534	Homo sapiens	Inhibition	%	1.27
	8122159	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-0.72	CHEMBL2534	Homo sapiens	Inhibition	%	-0.72
	8122521	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	20.79	CHEMBL2534	Homo sapiens	Inhibition	%	20.79
	8123174	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	0.58	CHEMBL2534	Homo sapiens	Inhibition	%	0.58
	8123676	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	3.74	CHEMBL2534	Homo sapiens	Inhibition	%	3.74
	8123993	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	0.77	CHEMBL2534	Homo sapiens	Inhibition	%	0.77
	8124336	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	2.46	CHEMBL2534	Homo sapiens	Inhibition	%	2.46
	8124699	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.36	CHEMBL2534	Homo sapiens	Inhibition	%	1.36
	8125065	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	1.58	CHEMBL2534	Homo sapiens	Inhibition	%	1.58
	8125419	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	-0.25	CHEMBL2534	Homo sapiens	Inhibition	%	-0.25
	8125811	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	-1.1	CHEMBL2534	Homo sapiens	Inhibition	%	-1.1
	8125975	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-0.53	CHEMBL2534	Homo sapiens	Inhibition	%	-0.53
	8126363	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.96	CHEMBL2534	Homo sapiens	Inhibition	%	0.96
	8126960	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	0.03	CHEMBL2534	Homo sapiens	Inhibition	%	0.03
	8127351	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	4.01	CHEMBL2534	Homo sapiens	Inhibition	%	4.01
	8127717	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-1.02	CHEMBL2534	Homo sapiens	Inhibition	%	-1.02
	8128157	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	4.18	CHEMBL2534	Homo sapiens	Inhibition	%	4.18
	8128548	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	-0.25	CHEMBL2534	Homo sapiens	Inhibition	%	-0.25
	8129199	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.51	CHEMBL2534	Homo sapiens	Inhibition	%	0.51
	8129612	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	1.6	CHEMBL2534	Homo sapiens	Inhibition	%	1.6
	8130808	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.38	CHEMBL2534	Homo sapiens	Inhibition	%	0.38
	8131171	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.65	CHEMBL2534	Homo sapiens	Inhibition	%	0.65
	8131515	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.43	CHEMBL2534	Homo sapiens	Inhibition	%	0.43
	8132333	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	3.26	CHEMBL2534	Homo sapiens	Inhibition	%	3.26
	8132704	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	3.64	CHEMBL2534	Homo sapiens	Inhibition	%	3.64
	8132993	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.08	CHEMBL2534	Homo sapiens	Inhibition	%	2.08
	8133355	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.89	CHEMBL2534	Homo sapiens	Inhibition	%	1.89
	8133751	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.52	CHEMBL2534	Homo sapiens	Inhibition	%	-1.52
	8134079	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.95	CHEMBL2534	Homo sapiens	Inhibition	%	-0.95
	8134463	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.18	CHEMBL2534	Homo sapiens	Inhibition	%	0.18
	8134647	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	2.23	CHEMBL2534	Homo sapiens	Inhibition	%	2.23
	8135031	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-0.5	CHEMBL2534	Homo sapiens	Inhibition	%	-0.5
	8135370	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	-0.19	CHEMBL2534	Homo sapiens	Inhibition	%	-0.19
	8136024	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.13	CHEMBL2534	Homo sapiens	Inhibition	%	1.13
	8136392	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	-1.49	CHEMBL2534	Homo sapiens	Inhibition	%	-1.49
	8137204	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	1.19	CHEMBL2534	Homo sapiens	Inhibition	%	1.19
	8137548	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	2.19	CHEMBL2534	Homo sapiens	Inhibition	%	2.19
	8138265	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.07	CHEMBL2534	Homo sapiens	Inhibition	%	0.07
	8138637	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-3.15	CHEMBL2534	Homo sapiens	Inhibition	%	-3.15
	8139204	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.34	CHEMBL2534	Homo sapiens	Inhibition	%	1.34
	8139842	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.4	CHEMBL2534	Homo sapiens	Inhibition	%	4.4
	8140189	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.16	CHEMBL2534	Homo sapiens	Inhibition	%	-0.16
	8140572	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.46	CHEMBL2534	Homo sapiens	Inhibition	%	1.46
	8140939	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.78	CHEMBL2534	Homo sapiens	Inhibition	%	0.78
	8141017	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.89	CHEMBL2534	Homo sapiens	Inhibition	%	1.89
	8141371	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	2.58	CHEMBL2534	Homo sapiens	Inhibition	%	2.58
	8142035	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	-0.83	CHEMBL2534	Homo sapiens	Inhibition	%	-0.83
	8142427	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	0.45	CHEMBL2534	Homo sapiens	Inhibition	%	0.45
	8142827	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	1.23	CHEMBL2534	Homo sapiens	Inhibition	%	1.23
	8143131	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.28	CHEMBL2534	Homo sapiens	Inhibition	%	-0.28
	8143701	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.65	CHEMBL2534	Homo sapiens	Inhibition	%	0.65
	8144039	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	2.06	CHEMBL2534	Homo sapiens	Inhibition	%	2.06
	8144402	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.76	CHEMBL2534	Homo sapiens	Inhibition	%	1.76
	8144756	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.43	CHEMBL2534	Homo sapiens	Inhibition	%	1.43
	8145583	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	3.92	CHEMBL2534	Homo sapiens	Inhibition	%	3.92
	8145868	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	9.04	CHEMBL2534	Homo sapiens	Inhibition	%	9.04
	8146212	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	1.38	CHEMBL2534	Homo sapiens	Inhibition	%	1.38
	8146596	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.7	CHEMBL2534	Homo sapiens	Inhibition	%	0.7
	8147298	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.51	CHEMBL2534	Homo sapiens	Inhibition	%	-0.51
	8147675	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	-0.15	CHEMBL2534	Homo sapiens	Inhibition	%	-0.15
	8147862	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	-0.14	CHEMBL2534	Homo sapiens	Inhibition	%	-0.14
	8148244	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.59	CHEMBL2534	Homo sapiens	Inhibition	%	4.59
	8148582	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.7	CHEMBL2534	Homo sapiens	Inhibition	%	-0.7
	8149242	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	0.12	CHEMBL2534	Homo sapiens	Inhibition	%	0.12
	8149600	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	1.56	CHEMBL2534	Homo sapiens	Inhibition	%	1.56
	8150047	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	2.37	CHEMBL2534	Homo sapiens	Inhibition	%	2.37
	8150431	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	1.0	CHEMBL2534	Homo sapiens	Inhibition	%	1.0
	8150775	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	1.81	CHEMBL2534	Homo sapiens	Inhibition	%	1.81
	8151103	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.15	CHEMBL2534	Homo sapiens	Inhibition	%	-3.15
	8151504	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.73	CHEMBL2534	Homo sapiens	Inhibition	%	1.73
	8151866	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-2.03	CHEMBL2534	Homo sapiens	Inhibition	%	-2.03
	8152432	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.01	CHEMBL2534	Homo sapiens	Inhibition	%	0.01
	8153067	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	14.78	CHEMBL2534	Homo sapiens	Inhibition	%	14.78
	8153428	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.8	CHEMBL2534	Homo sapiens	Inhibition	%	2.8
	8153809	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-0.56	CHEMBL2534	Homo sapiens	Inhibition	%	-0.56
	8154263	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	2.81	CHEMBL2534	Homo sapiens	Inhibition	%	2.81
	8154613	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.74	CHEMBL2534	Homo sapiens	Inhibition	%	1.74
	8155292	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-0.37	CHEMBL2534	Homo sapiens	Inhibition	%	-0.37
	8155677	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	-0.05	CHEMBL2534	Homo sapiens	Inhibition	%	-0.05
	8156429	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	1.92	CHEMBL2534	Homo sapiens	Inhibition	%	1.92
	8156803	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	0.31	CHEMBL2534	Homo sapiens	Inhibition	%	0.31
	8157431	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.64	CHEMBL2534	Homo sapiens	Inhibition	%	3.64
	8157785	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.16	CHEMBL2534	Homo sapiens	Inhibition	%	3.16
	8158170	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	2.91	CHEMBL2534	Homo sapiens	Inhibition	%	2.91
	8158420	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	9.36	CHEMBL2534	Homo sapiens	Inhibition	%	9.36
	8159106	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	0.08	CHEMBL2534	Homo sapiens	Inhibition	%	0.08
	8159450	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.05	CHEMBL2534	Homo sapiens	Inhibition	%	2.05
	8159805	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	2.08	CHEMBL2534	Homo sapiens	Inhibition	%	2.08
	8160457	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	0.39	CHEMBL2534	Homo sapiens	Inhibition	%	0.39
	8161268	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	4.84	CHEMBL2534	Homo sapiens	Inhibition	%	4.84
	8161617	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.81	CHEMBL2534	Homo sapiens	Inhibition	%	0.81
	8161979	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	0.96	CHEMBL2534	Homo sapiens	Inhibition	%	0.96
	8162894	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	30.12	CHEMBL2534	Homo sapiens	Inhibition	%	30.12
	8163287	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.52	CHEMBL2534	Homo sapiens	Inhibition	%	1.52
	8163645	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	-0.67	CHEMBL2534	Homo sapiens	Inhibition	%	-0.67
	8164266	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.82	CHEMBL2534	Homo sapiens	Inhibition	%	0.82
	8164645	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	2.83	CHEMBL2534	Homo sapiens	Inhibition	%	2.83
	8165013	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	2.46	CHEMBL2534	Homo sapiens	Inhibition	%	2.46
	8165083	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.18	CHEMBL2534	Homo sapiens	Inhibition	%	3.18
	8165448	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.58	CHEMBL2534	Homo sapiens	Inhibition	%	0.58
	8165815	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	1.59	CHEMBL2534	Homo sapiens	Inhibition	%	1.59
	8166433	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	4.03	CHEMBL2534	Homo sapiens	Inhibition	%	4.03
	8167070	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.08	CHEMBL2534	Homo sapiens	Inhibition	%	2.08
	8167435	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	2.56	CHEMBL2534	Homo sapiens	Inhibition	%	2.56
	8168080	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	0.63	CHEMBL2534	Homo sapiens	Inhibition	%	0.63
	8168445	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.05	CHEMBL2534	Homo sapiens	Inhibition	%	2.05
	8168805	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.98	CHEMBL2534	Homo sapiens	Inhibition	%	-1.98
	8169639	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	14.16	CHEMBL2534	Homo sapiens	Inhibition	%	14.16
	8170267	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.44	CHEMBL2534	Homo sapiens	Inhibition	%	2.44
	8170631	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.18	CHEMBL2534	Homo sapiens	Inhibition	%	2.18
	8170990	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.46	CHEMBL2534	Homo sapiens	Inhibition	%	2.46
	8171187	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.76	CHEMBL2534	Homo sapiens	Inhibition	%	2.76
	8171922	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.33	CHEMBL2534	Homo sapiens	Inhibition	%	1.33
	8172278	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.34	CHEMBL2534	Homo sapiens	Inhibition	%	9.34
	8172630	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.22	CHEMBL2534	Homo sapiens	Inhibition	%	0.22
	8173297	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	3.34	CHEMBL2534	Homo sapiens	Inhibition	%	3.34
	8173662	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.18	CHEMBL2534	Homo sapiens	Inhibition	%	3.18
	8174105	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	-0.19	CHEMBL2534	Homo sapiens	Inhibition	%	-0.19
	8174477	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.6	CHEMBL2534	Homo sapiens	Inhibition	%	0.6
	8174823	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.86	CHEMBL2534	Homo sapiens	Inhibition	%	4.86
	8175745	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	1.33	CHEMBL2534	Homo sapiens	Inhibition	%	1.33
	8176122	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	2.61	CHEMBL2534	Homo sapiens	Inhibition	%	2.61
	8176495	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	11.55	CHEMBL2534	Homo sapiens	Inhibition	%	11.55
	8177123	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.02	CHEMBL2534	Homo sapiens	Inhibition	%	2.02
	8177485	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	29.77	CHEMBL2534	Homo sapiens	Inhibition	%	29.77
	8177873	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.99	CHEMBL2534	Homo sapiens	Inhibition	%	3.99
	8178325	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.92	CHEMBL2534	Homo sapiens	Inhibition	%	1.92
	8178676	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	0.01	CHEMBL2534	Homo sapiens	Inhibition	%	0.01
	8179316	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	10.9	CHEMBL2534	Homo sapiens	Inhibition	%	10.9
	8179677	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.25	CHEMBL2534	Homo sapiens	Inhibition	%	1.25
	8179934	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.14	CHEMBL2534	Homo sapiens	Inhibition	%	0.14
	8180312	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.86	CHEMBL2534	Homo sapiens	Inhibition	%	1.86
	8180973	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.13	CHEMBL2534	Homo sapiens	Inhibition	%	1.13
	8181328	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	6.52	CHEMBL2534	Homo sapiens	Inhibition	%	6.52
	8181692	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	1.51	CHEMBL2534	Homo sapiens	Inhibition	%	1.51
	8182055	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	0.91	CHEMBL2534	Homo sapiens	Inhibition	%	0.91
	8182358	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	3.96	CHEMBL2534	Homo sapiens	Inhibition	%	3.96
	8183169	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	1.14	CHEMBL2534	Homo sapiens	Inhibition	%	1.14
	8183522	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	1.11	CHEMBL2534	Homo sapiens	Inhibition	%	1.11
	8183888	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	2.36	CHEMBL2534	Homo sapiens	Inhibition	%	2.36
	8184248	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	2.37	CHEMBL2534	Homo sapiens	Inhibition	%	2.37
	8184514	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.07	CHEMBL2534	Homo sapiens	Inhibition	%	0.07
	8184818	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	1.87	CHEMBL2534	Homo sapiens	Inhibition	%	1.87
	8185191	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.04	CHEMBL2534	Homo sapiens	Inhibition	%	0.04
	8185546	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.83	CHEMBL2534	Homo sapiens	Inhibition	%	1.83
	8185901	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.09	CHEMBL2534	Homo sapiens	Inhibition	%	2.09
	8186569	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.19	CHEMBL2534	Homo sapiens	Inhibition	%	4.19
	8186932	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	2.36	CHEMBL2534	Homo sapiens	Inhibition	%	2.36
	8187030	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.65	CHEMBL2534	Homo sapiens	Inhibition	%	1.65
	8187378	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.72	CHEMBL2534	Homo sapiens	Inhibition	%	1.72
	8187750	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.34	CHEMBL2534	Homo sapiens	Inhibition	%	0.34
	8188103	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	1.94	CHEMBL2534	Homo sapiens	Inhibition	%	1.94
	8189027	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	5.59	CHEMBL2534	Homo sapiens	Inhibition	%	5.59
	8189407	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.6	CHEMBL2534	Homo sapiens	Inhibition	%	4.6
	8190408	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.16	CHEMBL2534	Homo sapiens	Inhibition	%	2.16
	8190769	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.23	CHEMBL2534	Homo sapiens	Inhibition	%	1.23
	8191615	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	2.62	CHEMBL2534	Homo sapiens	Inhibition	%	2.62
	8191961	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.78	CHEMBL2534	Homo sapiens	Inhibition	%	0.78
	8192607	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	2.42	CHEMBL2534	Homo sapiens	Inhibition	%	2.42
	8192967	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.07	CHEMBL2534	Homo sapiens	Inhibition	%	1.07
	8193239	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	1.54	CHEMBL2534	Homo sapiens	Inhibition	%	1.54
	8193608	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.8	CHEMBL2534	Homo sapiens	Inhibition	%	7.8
	8193914	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.76	CHEMBL2534	Homo sapiens	Inhibition	%	-1.76
	8194269	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	1.3	CHEMBL2534	Homo sapiens	Inhibition	%	1.3
	8194624	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.64	CHEMBL2534	Homo sapiens	Inhibition	%	1.64
	8194991	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	4.68	CHEMBL2534	Homo sapiens	Inhibition	%	4.68
	8195288	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.22	CHEMBL2534	Homo sapiens	Inhibition	%	3.22
	8195651	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	3.18	CHEMBL2534	Homo sapiens	Inhibition	%	3.18
	8196464	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	2.18	CHEMBL2534	Homo sapiens	Inhibition	%	2.18
	8196816	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	3.07	CHEMBL2534	Homo sapiens	Inhibition	%	3.07
	8197181	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	3.11	CHEMBL2534	Homo sapiens	Inhibition	%	3.11
	8198114	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	1.88	CHEMBL2534	Homo sapiens	Inhibition	%	1.88
	8198476	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.78	CHEMBL2534	Homo sapiens	Inhibition	%	0.78
	8198830	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.52	CHEMBL2534	Homo sapiens	Inhibition	%	1.52
	8199467	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	3.09	CHEMBL2534	Homo sapiens	Inhibition	%	3.09
	8199854	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.42	CHEMBL2534	Homo sapiens	Inhibition	%	1.42
	8200216	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	3.22	CHEMBL2534	Homo sapiens	Inhibition	%	3.22
	8200320	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.53	CHEMBL2534	Homo sapiens	Inhibition	%	0.53
	8200659	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.95	CHEMBL2534	Homo sapiens	Inhibition	%	2.95
	8201033	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	4.31	CHEMBL2534	Homo sapiens	Inhibition	%	4.31
	8201655	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.48	CHEMBL2534	Homo sapiens	Inhibition	%	0.48
	8201934	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	2.02	CHEMBL2534	Homo sapiens	Inhibition	%	2.02
	8202298	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.98	CHEMBL2534	Homo sapiens	Inhibition	%	-1.98
	8203299	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	1.36	CHEMBL2534	Homo sapiens	Inhibition	%	1.36
	8203669	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	1.41	CHEMBL2534	Homo sapiens	Inhibition	%	1.41
	8204027	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	2.34	CHEMBL2534	Homo sapiens	Inhibition	%	2.34
	8204883	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	9.34	CHEMBL2534	Homo sapiens	Inhibition	%	9.34
	8205507	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.85	CHEMBL2534	Homo sapiens	Inhibition	%	1.85
	8205870	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.84	CHEMBL2534	Homo sapiens	Inhibition	%	1.84
	8206226	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.02	CHEMBL2534	Homo sapiens	Inhibition	%	-2.02
	8206502	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.14	CHEMBL2534	Homo sapiens	Inhibition	%	1.14
	8206825	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.51	CHEMBL2534	Homo sapiens	Inhibition	%	1.51
	8207175	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	0.49	CHEMBL2534	Homo sapiens	Inhibition	%	0.49
	8207529	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	5.57	CHEMBL2534	Homo sapiens	Inhibition	%	5.57
	8207885	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	0.97	CHEMBL2534	Homo sapiens	Inhibition	%	0.97
	8208552	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.2	CHEMBL2534	Homo sapiens	Inhibition	%	2.2
	8208909	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.07	CHEMBL2534	Homo sapiens	Inhibition	%	2.07
	8209354	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	1.75	CHEMBL2534	Homo sapiens	Inhibition	%	1.75
	8209728	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	2.67	CHEMBL2534	Homo sapiens	Inhibition	%	2.67
	8210088	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	2.16	CHEMBL2534	Homo sapiens	Inhibition	%	2.16
	8210992	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.42	CHEMBL2534	Homo sapiens	Inhibition	%	1.42
	8211386	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.16	CHEMBL2534	Homo sapiens	Inhibition	%	2.16
	8211733	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	-0.19	CHEMBL2534	Homo sapiens	Inhibition	%	-0.19
	8212359	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.87	CHEMBL2534	Homo sapiens	Inhibition	%	1.87
	8212716	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.18	CHEMBL2534	Homo sapiens	Inhibition	%	2.18
	8213110	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	3.8	CHEMBL2534	Homo sapiens	Inhibition	%	3.8
	8213567	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	0.12	CHEMBL2534	Homo sapiens	Inhibition	%	0.12
	8213904	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.77	CHEMBL2534	Homo sapiens	Inhibition	%	0.77
	8214546	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.89	CHEMBL2534	Homo sapiens	Inhibition	%	2.89
	8214922	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	1.56	CHEMBL2534	Homo sapiens	Inhibition	%	1.56
	8215173	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	0.38	CHEMBL2534	Homo sapiens	Inhibition	%	0.38
	8215550	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	0.68	CHEMBL2534	Homo sapiens	Inhibition	%	0.68
	8216176	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.61	CHEMBL2534	Homo sapiens	Inhibition	%	2.61
	8216536	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	15.09	CHEMBL2534	Homo sapiens	Inhibition	%	15.09
	8216898	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	2.38	CHEMBL2534	Homo sapiens	Inhibition	%	2.38
	8217561	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	5.59	CHEMBL2534	Homo sapiens	Inhibition	%	5.59
	8218352	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.52	CHEMBL2534	Homo sapiens	Inhibition	%	2.52
	8218719	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	1.13	CHEMBL2534	Homo sapiens	Inhibition	%	1.13
	8219074	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.16	CHEMBL2534	Homo sapiens	Inhibition	%	1.16
	8220038	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	3.85	CHEMBL2534	Homo sapiens	Inhibition	%	3.85
	8220391	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	-0.79	CHEMBL2534	Homo sapiens	Inhibition	%	-0.79
	8220729	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	1.84	CHEMBL2534	Homo sapiens	Inhibition	%	1.84
	8221360	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.24	CHEMBL2534	Homo sapiens	Inhibition	%	2.24
	8221749	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.39	CHEMBL2534	Homo sapiens	Inhibition	%	1.39
	8222104	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	2.4	CHEMBL2534	Homo sapiens	Inhibition	%	2.4
	8222202	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	0.17	CHEMBL2534	Homo sapiens	Inhibition	%	0.17
	8222560	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.51	CHEMBL2534	Homo sapiens	Inhibition	%	4.51
	8222902	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	1.14	CHEMBL2534	Homo sapiens	Inhibition	%	1.14
	8223560	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.69	CHEMBL2534	Homo sapiens	Inhibition	%	1.69
	8223810	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	0.71	CHEMBL2534	Homo sapiens	Inhibition	%	0.71
	8224196	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.23	CHEMBL2534	Homo sapiens	Inhibition	%	2.23
	8224590	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.95	CHEMBL2534	Homo sapiens	Inhibition	%	2.95
	8225197	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.78	CHEMBL2534	Homo sapiens	Inhibition	%	1.78
	8225559	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.98	CHEMBL2534	Homo sapiens	Inhibition	%	0.98
	8225918	CHEMBL1961894	GSK_PKIS: PDK1 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	2.07	CHEMBL2534	Homo sapiens	Inhibition	%	2.07
active	9673662	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(-c2[nH]c(-c3ccnc(N)n3)cc2C(N)=O)c1C		CHEMBL1964290	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9673663	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2onc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL213505	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673664	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673665	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#CCOc1ccc(Nc2nc(Nc3cccc(S(N)(=O)=O)c3)ncc2Br)cc1		CHEMBL1987034	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9673666	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1993941	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673667	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1Cl		CHEMBL377383	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673668	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Nc2ccnc(Nc3ccccc3)n2)cc1		CHEMBL578061	=	Ki	nM	7943.28	CHEMBL2534	Homo sapiens	pKi		5.1
active	9673669	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(N2CCOCC2)cc2[nH]c(-c3c(NCC(O)c4cccc(Cl)c4)cc[nH]c3=O)nc12		CHEMBL2005886	=	Ki	nM	501.19	CHEMBL2534	Homo sapiens	pKi		6.3
inactive	9673670	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL481491	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673671	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682345	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673672	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)Nc1c(C(N)=O)sc2ccc(Cl)c(Cl)c12		CHEMBL1973142	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673673	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4nc(N)nc(N)c34)cc2)c1		CHEMBL1973145	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673674	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982924	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673675	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL2005936	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673676	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC1CCC(Nc2nccc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1966628	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9673677	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc(C(N)=O)c3)cc2)c1		CHEMBL1971141	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673678	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC1CCCCC1Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL1995813	=	Ki	nM	316.23	CHEMBL2534	Homo sapiens	pKi		6.5
inactive	9673679	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(C)n(Cc2ccccc2)c2ccc(C(=O)Nc3nc[nH]n3)cc12		CHEMBL1979718	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673680	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COCc1ccccc1)COc1cncc(C=Cc2ccncc2)c1		CHEMBL1993781	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673681	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCn1c2cc(Cl)c(O)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL523823	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673682	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1(C)CC2=Nc3cc(Cl)ccc3SC2=C(O)C1		CHEMBL1562756	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673683	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3cn[nH]c3c2)n1		CHEMBL244378	=	Ki	nM	19.95	CHEMBL2534	Homo sapiens	pKi		7.7
active	9673684	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cc(F)cc13)CN(C(=O)N1CCCCC1)CC2		CHEMBL362558	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9673685	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(OCC(F)(F)F)nccn23)n1		CHEMBL2001957	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673686	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1969372	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673687	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnn2ccc(C(=O)Nc3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1990583	=	Ki	nM	10.0	CHEMBL2534	Homo sapiens	pKi		8.0
active	9673688	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	501.19	CHEMBL2534	Homo sapiens	pKi		6.3
inactive	9673689	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc2ccc(NS(=O)(=O)c3ccc(N)cc3)cc2nc1C		CHEMBL2006263	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673690	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1993584	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673691	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCn1c(C)c(-c2ccnc(Nc3cccc(OC)c3)n2)sc1=O		CHEMBL1986263	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673692	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1c[nH]c2ncnc(NCCCO)c12		CHEMBL2000114	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673693	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673694	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnccn1)Nc1ccnc2c(F)cccc12		CHEMBL1975647	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673695	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1968380	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673696	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccccc1)Nc1ncc([N+](=O)[O-])s1		CHEMBL1964644	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673697	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccc(Cl)c(Cl)c1)Nc1ccc2[nH]ncc2c1		CHEMBL1981782	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673698	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1cc2c(-c3ccccc3F)n[nH]c2s1		CHEMBL1977681	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9673699	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)C(C)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(C)cc5)cc4)csc23)cn1		CHEMBL1970142	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673700	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673701	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCNc1cc2cc(-c3cccnc3)ccc2cn1		CHEMBL1990912	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673702	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673703	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(-c4ccccc4)c3n2)c1		CHEMBL1988163	=	Ki	nM	398.11	CHEMBL2534	Homo sapiens	pKi		6.4
active	9673704	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(O)ccc1-n1c2cc(Cl)ccc2c(=O)c2c(N)nc(N)nc21		CHEMBL1995592	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9673705	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1CCCc2oc3cc(C(F)(F)F)ccc3c(=O)c21		CHEMBL2006493	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673706	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1cc2nn[nH]c2cc1Cl		CHEMBL1996923	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673707	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1C		CHEMBL1983449	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673708	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]cnc2c1oc1ccc(Cl)cc12		CHEMBL1992323	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673709	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(Cl)nccn23)n1		CHEMBL1969735	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673710	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCc1nc2c(c3cc(OC)c(OC)cc13)C(=O)NC2=O		CHEMBL2003524	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673711	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc2c(c1)C(=Cc1c[nH]cn1)C(=O)N2		CHEMBL2002649	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9673712	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCn1c(C2CCNCC2)nc(-c2ccc(Cl)c(Cl)c2)c1-c1ccnc(NC2CCCCC2)n1		CHEMBL437747	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673713	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Brc1ccc2c(c1)-c1[nH]ncc1C2		CHEMBL1995172	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673714	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL507936	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673715	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=S(=O)(NCCNCC=Cc1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL1987756	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673716	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCNS(C)(=O)=O)cnc(N)c34)cc2)c1		CHEMBL1994321	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
active	9673717	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCCc2[nH]c(-c3ccnc(C=Cc4ccccc4)c3)cc21		CHEMBL1997129	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9673718	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc(Cl)cc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1984788	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673719	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	FC(F)(F)c1ccc(-c2nnc3ccc(NC4CC4)nn23)cc1		CHEMBL451964	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673720	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL1964307	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673721	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1ccc(-c2nc3sccn3c2-c2ccncc2)cc1		CHEMBL2000508	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673722	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCNc1n[s+]([O-])nc1Nc1ccc(F)cc1		CHEMBL1971694	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673723	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2001547	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673724	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1Cl		CHEMBL210928	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673725	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1F		CHEMBL1994361	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673726	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(NC(=O)CCNC(=O)Nc2nc(C)c(-c3ccc(-n4cccn4)cc3)s2)no1		CHEMBL1986603	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673727	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673728	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2cc3cnccc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1972840	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9673729	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2)cc1		CHEMBL1977148	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673730	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C2SC(=O)NC2=O)ccc1O		CHEMBL2003286	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673731	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccn1		CHEMBL1992306	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673732	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(O)Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL2002165	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9673733	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2c1C(c1ccccc1I)C(C#N)=C(N)O2		CHEMBL1979318	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673734	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1989518	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673735	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1998585	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9673736	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cncc1C(OCc1c(-c2ccc(OC(F)(F)F)cc2)cc(C#N)c(=O)n1C)c1ccc(C#N)cc1		CHEMBL127898	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673737	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2C		CHEMBL519697	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673738	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(F)c2)c1		CHEMBL2004934	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673739	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3I)cc12		CHEMBL1975128	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9673740	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)C1CCCN(C(=O)c2cc(-c3ccc4[nH]ncc4c3)on2)C1		CHEMBL1970369	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673741	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C(C)C(=O)N(C)C)c5)cnc(N)c34)cc2)cc1		CHEMBL2001485	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673742	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673743	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)c2c(n1)sc1c(N)ncnc12		CHEMBL504950	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673744	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1966425	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673745	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(NC(=O)Cc2ccc(-c3cccc4[nH]nc(N)c34)cc2)ccc1F		CHEMBL1984363	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673746	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)COc1ccc(Nc2nc(Nc3ccc(C)c(S(N)(=O)=O)c3)ncc2F)cc1		CHEMBL1978099	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9673747	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COC(=O)c1c(-c2ccc(NC(=O)Nc3ccccc3)cc2)c2c(N)ncnn2c1C		CHEMBL1977041	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673748	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cccc2c1Nc1nnc(Cl)cc1C(=O)N2		CHEMBL1968070	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673749	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)Nc1cccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)c1		CHEMBL1988608	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673750	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)cc1C		CHEMBL184847	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673751	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)c1ccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)cc1		CHEMBL1984367	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673752	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NC(=O)C(c2cnc3ccccn23)=C1c1cn2c3c(cccc13)CN(C(=O)N1CCOCC1)CC2		CHEMBL178737	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673753	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2cnc(-c3cncc(OCC(N)Cc4cccc(C(F)(F)F)c4)c3)cc12		CHEMBL1998159	=	Ki	nM	199.53	CHEMBL2534	Homo sapiens	pKi		6.7
inactive	9673754	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(C)nccn23)n1		CHEMBL1982563	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673755	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1CCCN1Cc1ccc2c(c1)[nH]c(=O)c1cccn12		CHEMBL539474	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9673756	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2ccc3[nH]c(=O)oc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1987679	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673757	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5ccc(OC(F)F)cc5)cc4)csc23)cn1		CHEMBL1988387	=	Ki	nM	501.19	CHEMBL2534	Homo sapiens	pKi		6.3
inactive	9673758	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(NC(=O)c2cnn3c(-c4ccccc4)ccnc23)c1		CHEMBL1997759	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673759	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9673760	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673761	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2cc(Cl)cc(Cl)c2c(-c2cc(Cl)ccc2O)c1O		CHEMBL1974803	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673762	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL1970074	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673763	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1986970	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673764	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1cc(-c2ccncc2)nc(NC2CCCCC2)[nH]1		CHEMBL1958401	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673765	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2cc(-c3ccccc3)cnc2[nH]1		CHEMBL2003456	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673766	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(F)cccc12		CHEMBL1966816	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673767	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673768	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(N)C1CCC(C(=O)Nc2ccnc3[nH]ccc23)CC1		CHEMBL2002992	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
active	9673769	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1cnc(NC(=O)Nc2ccc3cc(C(=O)O)ccc3c2)cn1		CHEMBL560813	=	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673770	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CC(CN2CCCC2)C1		CHEMBL1968791	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673771	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1CC(c2ccc(Cl)cc2Cl)Cc2nc3cc(Cl)ccc3c(O)c21		CHEMBL326282	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673772	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1ccccc1C=NNC(=O)c1nnn(-c2nonc2N)c1N1CCCC1		CHEMBL1992732	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673773	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1ccc(-c2nc3occn3c2-c2ccnc(NC3CCNCC3)n2)cc1		CHEMBL1971186	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673774	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Cc1ccc(Cl)cc1)Nc1[nH]nc2c1CCC2		CHEMBL2003482	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673775	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCCC5)cnc(N)c34)cc2)c1		CHEMBL1973211	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9673776	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1984700	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673777	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673778	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(-c2cccc(OCc3ccccc3)c2)c2c(N)ncnc2n1C1CCC(N2CCCC2)CC1		CHEMBL2007151	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673779	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1ccccc1		CHEMBL1972125	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673780	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1ccc2[nH]ncc2c1)c1cccc(F)c1		CHEMBL1461728	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673781	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673782	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1cc2cc(-c3ccc4cn[nH]c4c3)cnc2[nH]1		CHEMBL1976134	=	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673783	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(C(=O)Nc2c(C(N)=O)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL1965131	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673784	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccccc3)cc12		CHEMBL1972158	<	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9673785	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1974457	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673786	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	<	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9673787	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Oc1ccc(Nc2ncnc3scc(Cl)c23)cc1		CHEMBL2006580	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673788	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1Cl		CHEMBL2006581	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673789	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)c1cc(NC(=O)Nc2cccc3ccccc23)n(-c2cccc(C(=O)NCC#N)c2)n1		CHEMBL1979855	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673790	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1noc2cccc(-c3cccc(O)c3)c12		CHEMBL1970340	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673791	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)NC(=O)COc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3ccccc3n2)c1		CHEMBL2005186	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673792	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCC(O)C(O)Cn1cc(I)c2c(N)ncnc21		CHEMBL1975534	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673793	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NS(=O)(=O)c1cccc(Nc2ncc3ccn(Cc4ccccc4)c3n2)c1		CHEMBL1993424	=	Ki	nM	398.11	CHEMBL2534	Homo sapiens	pKi		6.4
inactive	9673794	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2c1C(c1ccccc1F)C1=C(CC(C)(C)CC1=O)N2		CHEMBL1966703	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673795	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)N(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1969561	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673796	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673797	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)c1cc2sncc2cc1NC(=O)C(=O)O		CHEMBL1997023	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673798	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1964687	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673799	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9673800	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3ccc(Br)c(F)c3F)cncc2s1		CHEMBL1999918	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673801	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1974254	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673802	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C(=O)N2c3ccccc3Sc3c(Cl)cncc32)cc1		CHEMBL1988537	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673803	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)c(C)c2)c1		CHEMBL1969049	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673804	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)cc1		CHEMBL2005828	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673805	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1		CHEMBL363648	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673806	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673807	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1sc2c(Br)ccc(Cl)c2c1N		CHEMBL1998611	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673808	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL485556	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673809	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCc2ccc(Cl)c(Cl)c2)c(Nc2ccncc2)c1=O		CHEMBL1975900	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673810	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C2SC(=S)NC2=O)ccc1O		CHEMBL1973098	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673811	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(=O)CC)c3c2)cc1		CHEMBL1972221	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673812	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3cc(F)c4[nH]c(C)cc4c3)csc12		CHEMBL2006778	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673813	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(S(C)(=O)=O)c(OC)cc1CC(=O)Nc1cc(N)c(C#N)c(OC(C)C)n1		CHEMBL378627	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673814	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1c(F)cccc1F		CHEMBL1996979	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673815	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cccc2[nH]c(-c3ccc(C4CCCNC4)cc3F)nc12		CHEMBL1997025	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673816	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1968406	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673817	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)csc12		CHEMBL1982476	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9673818	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1998545	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673819	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1csc(NC(=O)c2sc3nc(-c4ccncc4)ccc3c2N)n1		CHEMBL1986869	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673820	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)c(Cl)ccc12		CHEMBL2006010	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673821	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1ccc(-c2ncn(CCN3CCOCC3)c2-c2ccc3[nH]ncc3c2)cc1		CHEMBL1682558	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673822	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1c(NCC(N)Cc2ccccc2)nc(-c2ccncc2)c(-c2ccc3ccccc3c2)c1=O		CHEMBL1990496	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673823	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2cc(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)ccc12		CHEMBL1997623	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673824	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccc(Cl)cc5o4)cc3)c1)CNC2=O		CHEMBL2002479	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673825	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCN(C)CCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1993166	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673826	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccc(Cl)cc1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL1967094	=	Ki	nM	316.23	CHEMBL2534	Homo sapiens	pKi		6.5
inactive	9673827	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)c1ccccc1		CHEMBL1966035	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673828	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)c1cc(Cl)cc(Cl)c1)c1ccc(-c2ccncc2)cc1		CHEMBL2003341	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673829	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(-c2n[nH]cc2-c2ccncc2)cc1		CHEMBL1992644	<	Ki	nM	10000.0	CHEMBL2534	Homo sapiens	pKi		5.0
inactive	9673830	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NS(=O)(=O)c1ccc(NCCSc2ccc(O)cc2)c([N+](=O)[O-])c1)c1ccc(-c2ccc(F)cc2)cc1		CHEMBL1992645	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673831	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Oc1cccc(Nc2ncnc3scc(Cl)c23)c1		CHEMBL1982992	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673832	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(-c2ccccc2)n(-c2cc(NN=Cc3ccco3)ncn2)n1		CHEMBL1999590	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673833	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1F		CHEMBL1981079	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673834	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)CCCNc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)n1		CHEMBL1972276	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673835	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCc2ccc(Cl)cc2)c(Nc2ccncc2)c1=O		CHEMBL1980489	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673836	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCc4cccc(F)c4)cc2NC3=O)ccc1O		CHEMBL2000832	=	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673837	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)c1		CHEMBL1967116	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673838	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nn(C)c2c1c(=O)c1cc(Cl)ccc1n2OCC(C)C		CHEMBL1977814	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673839	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc2ccccn2c1-c1csc(Nc2ccc(O)cc2)n1		CHEMBL513846	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673840	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccc(Br)cc1)Nc1ccc2[nH]ncc2c1		CHEMBL1970709	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673841	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673842	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2cc3nccn3c(Nc3ccccc3C(N)=O)n2)cc1OC		CHEMBL1998112	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673843	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)n1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)cc21		CHEMBL1969126	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673844	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2sc(Br)c(-c3ccc(NC(=O)Cc4cccc(Cl)c4)cc3)c12		CHEMBL1980896	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673845	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)NC1CCN(c2nc3[nH]cc(C(=O)O)c(=O)c3c(C)c2F)C1		CHEMBL1975208	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673846	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9673847	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1		CHEMBL1991429	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673848	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(Oc3cccc(F)c3)cncc2s1		CHEMBL1964777	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673849	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)C(=O)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1971149	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673850	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc2c(c1)NC(=O)c1ccccc1N2		CHEMBL1999714	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673851	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Cc1ccccc1Cl)Nc1ccc2cn[nH]c2c1		CHEMBL1987533	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673852	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(O)CNc1nccc(-c2c(-c3ccc(F)cc3F)nc3c(CC4CC4)nccn23)n1		CHEMBL1994040	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673853	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC1CC2OC(C)(C1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL1980995	=	Ki	nM	1.259	CHEMBL2534	Homo sapiens	pKi		8.9
active	9673854	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2ccc3c(c2)CC(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL1967302	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9673855	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCCCN4CCOCC4)cc2-3)cn1		CHEMBL398951	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673856	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2cnc3c(c2cc1OC)C(=O)NC3=O		CHEMBL1982506	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673857	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)CCNC(=O)C=Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2004716	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9673858	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1		CHEMBL1968127	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673859	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1975233	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673860	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cccc(F)c3F)cc12		CHEMBL1985406	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673861	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1nc(C(F)(F)F)c2c(=O)c3cc(Cl)ccc3n(O)c21		CHEMBL207400	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673862	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(O)ccc1-n1cc(C(=O)NN)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL2000894	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673863	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccccc1NC(=O)Nc1ccc2c(c1)CCc1sc3ncnc(N)c3c1-2		CHEMBL1982135	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673864	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1sc1ncnc(N)c12		CHEMBL1976090	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673865	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4c(c3)OCO4)csc12		CHEMBL1993243	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673866	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCC(CO)Nc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1992922	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9673867	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3o2)cc1		CHEMBL2004771	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673868	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CC(CN2CCCC2)C1		CHEMBL1988370	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673869	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1997597	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673870	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	S=c1[nH]nc2c3c4c(sc3n3c(=S)[nH]nc3n12)CCC4		CHEMBL1969537	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673871	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673872	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CC(C)(C)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1976093	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673873	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2ccc(F)cc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1996543	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673874	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1cccs1		CHEMBL1975256	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673875	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cnc4c(-c5cnn(C)c5)cnn4c3N)cc2)c1		CHEMBL508928	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673876	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(-c2cc3c(=O)[nH]c4ccccc4n3c2)c1		CHEMBL1991356	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673877	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL2004892	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673878	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Oc1ccc(-c2noc(-c3ccc(NC4CCC(C(=O)O)C4)cc3)n2)cc1Cl		CHEMBL1997503	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673879	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(Oc3ccc(Br)cc3)cncc2s1		CHEMBL116070	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673880	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)c(C)c(OCCCc2c(C(=O)O)[nH]c3c(-c4ccccc4C)cccc23)c1		CHEMBL1990821	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673881	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc(-c2cccc(N)c2)cc2cccnc12		CHEMBL1970314	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673882	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCCn1cnc(-c2ccc(F)cc2)c1-c1ccncc1		CHEMBL2004871	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673883	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncn3)cc2)c1		CHEMBL2004872	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673884	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1CCN(C(=O)CO)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL1969879	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9673885	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnccn1)Nc1ccnc2ccccc12		CHEMBL1981720	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9673886	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(N)COc1cnc(Cl)c(C=Cc2ccncc2)c1		CHEMBL1993548	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9673887	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3nsc4ncnc(N)c34)cc2)c1		CHEMBL262433	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677841	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(-c2nn(C(C)(C)C)c3ncnc(N)c23)cc1		CHEMBL306380	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677842	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NNC(=S)Nc1ccc(Cl)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1966722	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
active	9677843	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(C(=O)NCCNC(C)=O)cc2NC3=O)ccc1O		CHEMBL1975500	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9677844	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4snc(N)c34)cc2)c1		CHEMBL1976328	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677845	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ccnc(N)c34)cc2)c1		CHEMBL394619	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677846	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)cc1OC		CHEMBL1964399	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9677847	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1c2c(nc3ccccc13)C(=C1CCCC1)CC2		CHEMBL1996831	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677848	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc1)CCN2		CHEMBL411903	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
active	9677849	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN)cnc(N)c34)cc2)c1		CHEMBL1965988	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9677850	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCC(c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)C(O)C1		CHEMBL422897	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677851	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(-c2ccc3[nH]nc(N)c3c2)nnn1Cc1ccccc1		CHEMBL1989646	=	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677852	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Cc2cc(-c3ccc4[nH]ncc4c3)on2)cc1		CHEMBL1682357	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677853	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCCc2[nH]c(-c3ccncc3)cc21		CHEMBL225519	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677854	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2cccnc2)cc(N)c1C#N		CHEMBL209534	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677855	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1978200	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677856	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
active	9677857	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)S(=O)(=O)c1ccccc1-c1ccc2c(c1)Nc1ccccc1NC2=O		CHEMBL2006631	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9677858	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C2SC(=Nc3ccccc3)NC2=O)ccc1O		CHEMBL1970522	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677859	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1n[nH]c2nc3ccccc3cc12)c1ccncc1		CHEMBL1990415	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677860	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	C(=Cc1cncc(OC2CCNC2)c1)c1ccncc1		CHEMBL1966087	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677861	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1nc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)cncc21		CHEMBL1964692	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677862	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)Cc1ccc(Cl)cc1)c1ccc(-c2ccncc2)cc1		CHEMBL1996931	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677863	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	FC(F)(F)c1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C(F)(F)F)c1		CHEMBL1964413	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677864	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL1973483	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677865	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(Cn2cc(-c3ccc4[nH]ncc4c3)nn2)c(C)c1		CHEMBL1984432	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677866	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL1970735	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677867	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL219722	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677868	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(c1cc(-c2ccc3[nH]ncc3c2)on1)N1CCCC(O)C1		CHEMBL1997340	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677869	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOC(=O)C1=C(N)n2c(sc(=Cc3cccs3)c2=O)=C(C(N)=O)C1c1cccs1		CHEMBL2004365	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677870	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(Nc2ncnc3ccccc23)c1		CHEMBL117697	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677871	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	=	Ki	nM	501.19	CHEMBL2534	Homo sapiens	pKi		6.3
inactive	9677872	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(-c2ccncn2)c(-c2ccc(F)cc2)n1		CHEMBL1989474	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677873	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCOCC4)c3)n2)c1		CHEMBL1090360	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677874	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1nc2ccccc2n1CCCO)c1cccc([N+](=O)[O-])c1		CHEMBL210887	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677875	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1ccccc1Nc1nc(Nc2ccc(N3CCOCC3)cc2OC)ncc1Cl		CHEMBL458997	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9677876	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C(F)(F)F)c2)c1		CHEMBL1971021	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677877	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(OC(F)(F)F)c4)c3)cc12		CHEMBL1965836	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677878	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]cnc2c1sc1c(Cl)ccc(Cl)c12		CHEMBL583144	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677879	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3ccc(F)cc3)cncc2s1		CHEMBL1974310	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677880	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc2c(NC(=O)Nc3cccc(C(F)(F)F)n3)ccnc2c1		CHEMBL1982660	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677881	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2sc3c(c12)-c1ccc(NC(=O)Nc2ccccc2)cc1CC3		CHEMBL1994693	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677882	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cccc(-c2cnc3[nH]cc(-c4ccccc4)c3c2)c1		CHEMBL1982957	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
active	9677883	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
inactive	9677884	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NNC(=S)Nc1ccc(F)cc1)C(O)(c1ccccc1)c1ccccc1		CHEMBL1975138	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677885	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccc(S(C)(=O)=O)cc2)cc(N)c1C#N		CHEMBL424872	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677886	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1=NN(c2ccc(C(=O)O)cc2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL2006836	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677887	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#Cc5cccnc5)cnc(N)c34)cc2)c1		CHEMBL1971947	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677888	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677889	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677890	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc2nnc(SCc3cn4ccccc4n3)n2c2ccccc12		CHEMBL1980704	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677891	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1sc2ccc(Cl)c(Cl)c2c1NC(=O)c1ccc(Cl)cc1		CHEMBL2003271	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677892	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccncc4)nn12)CCCC3		CHEMBL1966808	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677893	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)c1n[nH]c2c1C(c1ccccc1F)C(C#N)=C(N)O2		CHEMBL2004447	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677894	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Ki	nM	15.85	CHEMBL2534	Homo sapiens	pKi		7.8
inactive	9677895	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCNc1cc2cc(-c3ccsc3)ccc2cn1		CHEMBL1973860	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677896	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2nnc(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL260135	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677897	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21		CHEMBL220241	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677898	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=S(=O)(O)c1ccc(NCc2ccc3c(c2)OCO3)c2c(O)cccc12		CHEMBL2004544	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677899	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]cc(I)c2nc(-c3cccc(Cl)c3)cn12		CHEMBL1982610	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677900	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(C2(c3cccc(C)c3)CC2C(=O)Nc2ccncc2)c1		CHEMBL1999496	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677901	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1cnc2c(ccc3cnccc32)c1O		CHEMBL2006933	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677902	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ccc(-c2csc3c(C=Cc4nc5ccccc5[nH]4)cnc(N)c23)cc1		CHEMBL1988300	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677903	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C(=O)Nc2n[nH]c3ccc(-c4cn(Cc5ccccc5)nn4)cc23)cc1OC		CHEMBL1991078	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
active	9677904	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9677905	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCNc1ccc2c3c(cccc13)C(=O)N(CCNCCO)C2=O		CHEMBL1987359	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677906	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=NNC(=N)N)c1cc(NC(=O)c2cccc(C(=O)Nc3cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c3)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL2000685	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677907	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9677908	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(CO)ccc4F)cc3)c12		CHEMBL1985311	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677909	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1CSc2c(C(=O)O)c(=O)c3cc(F)c(N4CCC(N)C4)cc3n21		CHEMBL1989265	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677910	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc(-c2ccnc(N)n2)[nH]c1-c1ccc(Cl)cc1Cl		CHEMBL1965660	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677911	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NN=Cc2c[nH]c3cc(NC(=O)C4CC4c4ccccc4)cc1c23		CHEMBL1969502	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9677912	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2C1CCC(N2CCCC2)CC1		CHEMBL1965910	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677913	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Nc1c(-c2ccc3[nH]ncc3c2)nc2ncccn12		CHEMBL1682553	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677914	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(-c2c(-c3ccncc3)nc(NCC(N)Cc3ccccc3)n(C)c2=O)c1		CHEMBL1971430	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677915	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C(=O)Nc2cnc3[nH]cc(-c4ccccc4)c3c2)cc1		CHEMBL1997764	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677916	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3coc4ncnc(N)c34)cc2)c1		CHEMBL1983963	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677917	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(CN)Cc4ccccc4)c3)cc12		CHEMBL2000271	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677918	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Oc1ccc(-c2n[nH]c(Nc3cccc(Cl)c3)c2-c2ccc(O)cc2)cc1		CHEMBL1985092	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677919	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2cccs2)c1-c1ccccc1		CHEMBL2004692	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677920	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL1981410	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677921	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1(O)CC(c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn23)C1		CHEMBL1996234	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677922	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C=C2C(=O)ON=C2c2ccc(Br)cc2)cc1OC		CHEMBL1991434	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677923	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)c1cccc2c(S(=O)(=O)N(CCN)c3cncc(-c4ccc5cnccc5c4)c3)cccc12		CHEMBL1967544	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677924	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCCCCCOc1cc(CCCO)c(Cl)cc1NC(=O)N2		CHEMBL223367	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
active	9677925	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Ki	nM	7943.28	CHEMBL2534	Homo sapiens	pKi		5.1
inactive	9677926	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cn(-c2ccc(O)cc2Cl)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL340384	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677927	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1996587	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677928	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)NCCOc1cncc(-c2ccc3cnccc3c2)c1		CHEMBL1964804	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677929	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2cnc3c(Br)cnn3c2)cc1		CHEMBL443962	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677930	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C=C2SC(=Nc3ccccc3)NC2=O)cc1O		CHEMBL2000354	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677931	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1965507	<	Ki	nM	398.11	CHEMBL2534	Homo sapiens	pKi		6.4
inactive	9677932	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677933	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1n[nH]c2nc3ccccc3cc12		CHEMBL1967564	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677934	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL592030	=	Ki	nM	1.585	CHEMBL2534	Homo sapiens	pKi		8.8
active	9677935	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCCNc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL2000071	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9677936	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc2c(NC(=O)Nc3cc(C(F)(F)F)ccn3)ccnc2c1		CHEMBL1979176	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677937	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1970317	=	Ki	nM	316.23	CHEMBL2534	Homo sapiens	pKi		6.5
inactive	9677938	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc2c(C)n1		CHEMBL2000408	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677939	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCCCCOc1cc(NCc3cncs3)c(Cl)cc1NC(=O)N2		CHEMBL248757	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9677940	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCC(C(=O)n2nc(N)c3cc(-c4cn(Cc5ccccc5)nn4)ccc32)CC1		CHEMBL1978014	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677941	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccc(Br)cc1)c1cnn2c(-c3ccccc3)ccnc12		CHEMBL1990179	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9677942	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnccn1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1994538	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677943	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1983195	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9677944	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCCOc1cc2c(c(-c3ccc(Nc4nc5ccccc5o4)cc3)c1)CNC2=O		CHEMBL1975490	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677945	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc2nccc(NC(=O)Nc3cccc(C(F)(F)F)n3)c2c1		CHEMBL1964444	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677946	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)Nc1cc(N)c(C#N)c(-c2ccsc2)n1		CHEMBL2006567	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677947	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1csc2ncnc(Nc3ccccc3)c12		CHEMBL1986139	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677948	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677949	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(Cl)cccc12		CHEMBL1980540	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677950	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN(C)C)cnc(N)c34)cc2)c1		CHEMBL1979883	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
active	9677951	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(C)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1984162	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
active	9677952	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1cnc(Nc2ccccc2)nc1Nc1ccccc1		CHEMBL491758	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9677953	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C(C)(C)C		CHEMBL1986186	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677954	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1cc2[nH]ncc2cc1-c1cc(CN2CCCCC2)no1		CHEMBL1682360	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677955	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2c1C(c1ccccc1Cl)C(C#N)=C(N)O2		CHEMBL1970189	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677956	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1c(I)nn2C1CCC(O)CC1		CHEMBL1996791	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677957	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3c(C)sc4ncnc(N)c34)cc2)c1		CHEMBL371206	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9677958	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(C=NNc2ncnc3c2[nH]c2ccccc23)cc1OC		CHEMBL1974664	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677959	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)c1ccc2nc(-c3n[nH]c4ccccc34)[nH]c2c1		CHEMBL1970104	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9677960	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)c1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1974288	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677961	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)c1		CHEMBL196363	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677962	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2cc3nccn3c(Nc3ncccc3C(N)=O)n2)cc1OC		CHEMBL1190711	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677963	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2cccc(-c3ccc(Br)cc3)c12		CHEMBL1990346	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677964	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1cccc(-c2nc(Nc3ccc4[nH]ncc4c3)c3cc(OCCN4CCCC4)ccc3n2)c1		CHEMBL1968705	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677965	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL404367	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677966	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Cc1cc(-c2ccc3[nH]nc(N)c3c2)on1		CHEMBL1966343	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677967	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCCN)c3)cc12		CHEMBL1967887	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677968	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL2000568	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677969	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4ncnc(N)c34)cc2)cc1C		CHEMBL2000335	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
active	9677970	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9677971	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(-c2cnn3c(N)c(-c4ccc(NC(=O)Nc5cccc(C(F)(F)F)c5)cc4)cnc23)cn1		CHEMBL1988717	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677972	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(Nc2nc(NC3CCCCC3N)cnc2C(N)=O)c1		CHEMBL1974328	=	Ki	nM	39.81	CHEMBL2534	Homo sapiens	pKi		7.4
active	9677973	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9677974	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1ccc2[nH]ncc2c1)c1ccc(Cl)cc1		CHEMBL1973808	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677975	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Oc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL2000429	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677976	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)cc1		CHEMBL1972576	=	Ki	nM	158.49	CHEMBL2534	Homo sapiens	pKi		6.8
inactive	9677977	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NN=Cc1ccc(Sc2nc3ccccc3[nH]2)o1)c1cccc([N+](=O)[O-])c1		CHEMBL1992555	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677978	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677979	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(N)c3c2)cc1		CHEMBL1992342	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677980	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(Cl)ccc1NC(=S)NNC(=O)C(O)(c1ccccc1)c1ccccc1		CHEMBL1988173	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9677981	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	C(=NNc1nc2ccccc2[nH]1)c1c[nH]c2ccccc12		CHEMBL535331	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677982	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#CC1=C(N)n2c(sc(=Cc3ccco3)c2=O)=C(C(N)=O)C1c1ccco1		CHEMBL1989805	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677983	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677984	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Cn1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL1965423	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677985	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)=C(C)c1cccc2c(CCCOc3cccc(Cl)c3Cl)c(C(=O)O)[nH]c12		CHEMBL1982980	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677986	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCC(N)(C#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12)CC		CHEMBL1983025	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677987	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(Cc1c[nH]c2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1983945	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677988	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccccc1)c1ccc(-c2ccncc2)cc1		CHEMBL1977135	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677989	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NC(=S)SC1=C1C(=O)Nc2ccc(Br)cc21		CHEMBL2001920	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677990	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cncc2s1		CHEMBL2002322	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677991	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(Nc2ncc([N+](=O)[O-])c(Nc3ccccc3C(N)=O)n2)cc(OC)c1OC		CHEMBL1241473	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
inactive	9677992	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(F)c(-c2ccc3nnc(N)n3c2)c1		CHEMBL2002323	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9677993	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)N(Cc1ccc2[nH]c(=O)c3cccn3c2c1)C1CC1		CHEMBL1978448	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9677994	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCCOc1cncc(C=Cc2ccncc2)c1		CHEMBL1972258	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677995	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)CC#Cc1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(C)c4)cc3)csc12		CHEMBL2001257	<	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9677996	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(Cl)cc4Cl)c(=O)c3=O)ccc21		CHEMBL2005548	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677997	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(CNc2c(Nc3ccc4[nH]ncc4c3)c(=O)c2=O)cc1		CHEMBL1992536	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677998	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccccc1-c1c(C(=O)O)n(CCCOc2cccc3ccccc23)c2ccccc12		CHEMBL1987793	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9677999	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN1CCN(CCCC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1		CHEMBL1992740	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678000	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCCn1cnc(-c2ccccc2)c1-c1ccncc1		CHEMBL2002373	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678001	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ccc(-c2cncc(OCC(N)Cc3c[nH]c4ccccc34)c2)cc1C(=O)c1cccc(Cl)c1		CHEMBL1973348	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678002	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2NCCCN)c1		CHEMBL2006188	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678003	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2scc(-c3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1967531	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678004	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1nn(C(=O)CC)c2nc3ccccc3cc12		CHEMBL1970913	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678005	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCS(=O)(=O)Nc1ccc(-c2ccc3[nH]nc(NC(C)=O)c3c2)cc1		CHEMBL1973893	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678006	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOC(=O)c1cccc2[nH]c(-c3ccc(N4CCC(N)C4)cc3)nc12		CHEMBL1995736	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678007	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678008	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2cc(C)c(-c3ccc4[nH]nc(C)c4c3)s2)c1		CHEMBL1997534	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678009	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)O)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1996500	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678010	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)Cn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL1985095	=	Ki	nM	7.943	CHEMBL2534	Homo sapiens	pKi		8.1
inactive	9678011	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4n3CCC4)nn12		CHEMBL1977374	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678012	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCc1nnn(-c2nonc2N)c1C(=O)NN=C(C)c1ccc(O)cc1O		CHEMBL1991180	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
active	9678013	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)O)c5)cnc(N)c34)cc2)c1		CHEMBL1989708	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9678014	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)cn2c1		CHEMBL1682540	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678015	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCc1c(-c2ccc(C(C)(C)O)cc2)[nH]c2nccnc12		CHEMBL1976420	=	Ki	nM	125.89	CHEMBL2534	Homo sapiens	pKi		6.9
inactive	9678016	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(CNc2c(Nc3ccncc3)c(=O)c2=O)cc1		CHEMBL1994864	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678017	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCO)c(Cl)cc1NC(=O)N2		CHEMBL413779	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9678018	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(Cc2ccc3c(c2)Cc2c(-c4csc(C#CCOCC5CC5)c4)n[nH]c2-3)CC1		CHEMBL2002446	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678019	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1nc(-c2cc3c(Oc4ccc(I)cc4)cncc3s2)[nH]o1		CHEMBL497151	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678020	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCC1CCC(CNc2nc(NCc3ccccc3Cl)ncc2[N+](=O)[O-])CC1		CHEMBL246970	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678021	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(O)ccc1-n1cc(C(N)=O)c(=O)c2ccc(-c3ccncc3)cc21		CHEMBL340921	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678022	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCCCO)c(Cl)cc1NC(=O)N2		CHEMBL373598	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9678023	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ccc(NC(=O)Nc2ccnc3cc(C(F)(F)F)ccc23)nc1		CHEMBL1999718	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678024	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Nc2ccc3ncsc3c2C1=CNc1ccc(S(=O)(=O)Nc2ccccn2)cc1		CHEMBL1973540	=	Ki	nM	15.85	CHEMBL2534	Homo sapiens	pKi		7.8
inactive	9678025	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Nc2ccccc2Nc2nnc(I)cc21		CHEMBL1977346	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678026	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3ccc4nccnc4c3N)cc2)c1		CHEMBL1971649	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678027	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)S(=O)(=O)n1c(N)nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2003657	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678028	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9678029	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1cc(-c2c[nH]c3ncccc23)nc(NC2CCCCC2)n1		CHEMBL2006439	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678030	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)N(C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1)C(C)C		CHEMBL2006156	=	Ki	nM	3162.28	CHEMBL2534	Homo sapiens	pKi		5.5
inactive	9678031	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2ccc(NC(=O)Nc3cc(F)cc(F)c3)cc2)c2c(N)noc12		CHEMBL1969190	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678032	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)n[nH]c12		CHEMBL1973937	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678033	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Ki	nM	7.943	CHEMBL2534	Homo sapiens	pKi		8.1
active	9678034	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OC1CCC(Nc2cc(Cl)nc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1991674	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
active	9678035	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1ccc(-c2c[nH]c3nccc(Cl)c23)cc1		CHEMBL1982711	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9678036	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1984842	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678037	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cn[nH]c5)cnc(N)c34)cc2)c1		CHEMBL1969102	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9678038	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1682346	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678039	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)CC#Cc1ccc2c(c1)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL2007044	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678040	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)N1CCN(CCCOc2ccc3c(c2)-c2[nH]nc(-c4ccc(C#N)nc4)c2C3)CC1		CHEMBL2001998	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678041	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C(C#N)c2nc3ccccc3[nH]2)c(Br)cc1O		CHEMBL1994241	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9678042	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)Nc1cc2c(cc1Cl)NC(=O)Nc1cnc(C#N)c(n1)OCCCCCO2		CHEMBL223460	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678043	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1ccc(Cl)cc1		CHEMBL1998829	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678044	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Ki	nM	125.89	CHEMBL2534	Homo sapiens	pKi		6.9
active	9678045	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cnc(Nc2cccc(S(N)(=O)=O)c2)nc1Nc1ccc(OCC(N)=O)cc1		CHEMBL1988838	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9678046	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN1CCN(c2ccc(Nc3nccc(-c4c(-c5cccc(C(=O)Nc6ccccc6F)c5)nc5ccccn45)n3)cc2)CC1		CHEMBL1981725	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678047	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]ncc34)cc2)c1		CHEMBL375284	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678048	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCn1cc(-c2ccncn2)c(-c2ccc(Cl)cc2)n1		CHEMBL1982866	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678049	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2005792	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678050	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(CSc2nc(-c3ccncc3)n[nH]2)cc1		CHEMBL1968926	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678051	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1c(-c2ccccc2)c2cc(Cl)ccc2[nH]c1=O		CHEMBL462120	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678052	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccncc2)cc(N)c1C#N		CHEMBL1984206	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678053	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Nc1c(Nc2ccncc2)c(=O)c1=O)C1CCCCC1		CHEMBL1991577	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678054	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4ccccc4F)cc3)c12		CHEMBL1965570	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678055	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2sc3c(c2c2nc(-c4ccccc4)nn12)CCCC3		CHEMBL2007592	=	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678056	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(NC(=O)Cc2cc(OC)c(S(C)(=O)=O)cc2OC)cc(N)c1C#N		CHEMBL210963	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678057	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cncc2cccc(S(=O)(=O)N3CCCNCC3C)c12		CHEMBL1082440	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9678058	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(CO)N1CCC(c2[nH]nc(-c3ccc(Cl)cc3F)c2-c2ccncn2)CC1		CHEMBL1614705	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678059	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL1972362	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678060	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2cnc(-c3ccncc3)s2)c1		CHEMBL1984633	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678061	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678062	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL2007372	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678063	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)N2CC=C(c3c[nH]c4ncccc34)CC2)c1		CHEMBL1965845	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678064	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3cccc(N4CCCC4=O)c3)n2)c1)c1c(F)cccc1F		CHEMBL2006715	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678065	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cccc2[nH]c(-c3ccc(NC(=O)c4cccc(S(=O)(=O)N5CCOCC5)c4)cc3)nc12		CHEMBL1986597	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678066	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3cccc(F)c3)cncc2s1		CHEMBL1971017	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678067	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cccc2[nH]c(-c3ccncc3)nc12		CHEMBL1990482	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678068	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1ccc(-c2nc3cnccn3c2-c2ccnc(NCC3CC3)n2)cc1		CHEMBL1990904	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678069	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1975121	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9678070	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCC1CCCCC1)c1cc2c(-c3ccccc3)n[nH]c2s1		CHEMBL2005475	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
inactive	9678071	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCS(=O)(=O)c1ccc(-c2cncc3sc(C(N)=O)cc23)cc1		CHEMBL2000104	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678072	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cncc4c3c(N)nn4C)cc2)c1		CHEMBL402846	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678073	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1=NN(c2ccc(Cl)c(Cl)c2)C(=O)C1=Cc1c(C)c(C#N)c2nc3ccccc3n2c1O		CHEMBL1997349	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9678074	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2C)c1		CHEMBL183844	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682035	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL220057	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682036	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Nc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682545	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682037	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1c[nH]c2ccccc12		CHEMBL1974935	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682038	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(OC2CCCC2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL2001224	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682039	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682040	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(O)Cc1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1976732	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682041	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)OC(=O)n1ncc2cc(Nc3c(NCc4ccc(S(N)(=O)=O)cc4)c(=O)c3=O)ccc21		CHEMBL1969506	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682042	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)c1ccccc1)N1CC=C(c2c[nH]c3ncccc23)CC1		CHEMBL1964937	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682043	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(COc2ccc(Nc3ncnc4ccccc34)cc2)cc1		CHEMBL1980163	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682044	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCn1cc(-c2cc(-c3cc4ccccc4s3)c3[nH]ncc3c2)c2nc(N)ncc21		CHEMBL590109	=	Ki	nM	19.95	CHEMBL2534	Homo sapiens	pKi		7.7
inactive	9682045	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2nn(C3CCC(N4CCN(C(C)=O)CC4)CC3)c3ncnc(N)c23)ccc1NC(=O)c1cc2ccccc2n1C		CHEMBL1970879	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682046	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(C=O)c(O)n2c(nc3ccccc32)c1C#N		CHEMBL1989856	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682047	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)N(c1ccncc1)c1c(NC(C)C(C)(C)C)c(=O)c1=O		CHEMBL2005899	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682048	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1cnc2nc(-c3ccc4[nH]ncc4c3)c(NC3CCCCC3)n2c1		CHEMBL1682552	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682049	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682050	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCC1COc1cncc(CCc2ccncc2)c1		CHEMBL1996155	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682051	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CCO)c5)cnc(N)c34)cc2F)c1		CHEMBL1986851	=	Ki	nM	316.23	CHEMBL2534	Homo sapiens	pKi		6.5
active	9682052	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4cccc(Cl)c4)c3)cc12		CHEMBL1974870	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9682053	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCc1cc(-c2ccc3[nH]ncc3c2)on1		CHEMBL1682359	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682054	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)c(C=C2C(=O)Nc3ccccc32)[nH]1		CHEMBL2002702	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
active	9682055	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL1970903	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682056	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(C=Cc2ccncc2)c1)Cc1ccccc1		CHEMBL1991846	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682057	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(Nc2nccc(Nc3c(NC(C)C(C)(C)C)c(=O)c3=O)n2)c1		CHEMBL1969523	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
inactive	9682058	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL207995	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682059	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Nc2cc(CCOc3ccc(N4CCOCC4)cc3)ccc2Nc2cc(-c3cn(Cc4cc(F)c(F)c(F)c4)c4cnccc34)ccc21		CHEMBL2001923	=	Ki	nM	100.0	CHEMBL2534	Homo sapiens	pKi		7.0
inactive	9682060	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)N1CCC(Nc2nccc(-c3c(-c4ccc(F)cc4)nc4occn34)n2)CC1		CHEMBL1986781	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682061	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1nc(-c2ccc3[nH]ncc3c2)cc(-c2ccccc2)[nH]1		CHEMBL526133	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682062	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1c(=O)c(Oc2ccc(F)cc2F)cc2cnc(NC3CCOCC3)nc21		CHEMBL1230122	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682063	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCc2c1cccc2-c1ccc(Nc2nc3ccccc3[nH]2)cc1		CHEMBL1979057	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682064	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1OCC(O)CO		CHEMBL1981045	=	Ki	nM	398.11	CHEMBL2534	Homo sapiens	pKi		6.4
inactive	9682065	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCOCC#Cc1cc(-c2n[nH]c3c2C(=O)c2cc(CN4CCN(C)CC4)ccc2-3)cs1		CHEMBL387971	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682066	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Cn2nnc(-c3ccc4[nH]ncc4c3)c2C2CC2)cc1		CHEMBL1975418	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682067	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2ccc(Cl)cc2c(-c2ccccc2)c1C1=NNC(c2ccccc2)C1		CHEMBL1992796	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682068	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1999428	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682069	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCCCCCOc1cc(OCC(O)CO)c(Cl)cc1NC(=O)N2		CHEMBL223257	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682070	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL1967560	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682071	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682072	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3noc4ncnc(N)c34)cc2)c1		CHEMBL211378	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682073	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CCN5CCOCC5)cnc(N)c34)cc2)c1		CHEMBL1982465	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682074	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2ccc3c(c2)C(=Cc2ccco2)C(=O)N3)c1)Cc1c[nH]c2ccccc12		CHEMBL2001751	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
inactive	9682075	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCCCCCCNC(=O)NCc1cccnc1)NCc1cccnc1		CHEMBL2003420	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682076	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccccc1NC(=O)Nc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL1984586	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682077	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(Cl)c(N2CCC(CN)C2)nc2[nH]cc(C(=O)O)c(=O)c12		CHEMBL1999774	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682078	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1c(O)ccc2c1CCCC2=NNC(=O)Cc1cccc2ccccc12		CHEMBL1972659	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682079	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OC1CCN(c2ncnc3[nH]cc(-c4ccccc4)c23)CC1		CHEMBL1973395	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682080	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(NC(=O)Nc2ccc(-c3cccc4onc(N)c34)cc2)cc1Cl		CHEMBL272453	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682081	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3C)cc2)c1		CHEMBL1970217	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682082	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Nc2ccccc2Nc2nnccc21		CHEMBL1971801	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682083	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Nc2ccccc2Nc2nnc(Cl)cc21		CHEMBL1968850	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682084	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOC(=O)c1ccc2[nH]c3c(c2c1)CCNC3=O		CHEMBL2005528	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682085	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)cc2)c1		CHEMBL185569	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682086	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1cc2[nH]ncc2cc1-c1cn(CC2CCOCC2)nn1		CHEMBL1969843	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682087	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3[nH]nc(C(=O)Nc4ccccc4)c3c2)ccc1O		CHEMBL2007002	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682088	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Nc1nccc(-c2c(-c3ccc(F)cc3)nc3occn23)n1)c1ccccc1		CHEMBL1990288	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682089	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCC(NC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)CC1		CHEMBL1987007	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
inactive	9682090	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1cc(-c2c[nH]c3ncccc23)cc(NCc2ccccc2)n1		CHEMBL1969588	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682091	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(Nc2nccc(Nc3cc(C4CCCCC4)no3)n2)cc(OC)c1OC		CHEMBL1984711	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682092	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(Nc2ncc(F)c(NC3C4C=CC(C4)C3C(N)=O)n2)ccc1N1CCN(C)CC1		CHEMBL1967878	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9682093	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCC(NC(=O)c1ccc(-c2ccncc2)cc1)c1ccccc1		CHEMBL1990254	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682094	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCn1c(NC(=O)c2ccc(C#N)cc2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL484390	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682095	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCc2cccc(C(F)(F)F)c2)c(Nc2ccncc2)c1=O		CHEMBL1979252	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682096	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(Cc2cn(-c3ccc4[nH]ncc4c3)nn2)cc1		CHEMBL1682341	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682097	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(CC(C)(C)O)c5)cnc(N)c34)cc2)cc1		CHEMBL2004290	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682098	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2ccc(-c3nnn(Cc4ccccc4)c3-c3ccc(F)cc3)cc12		CHEMBL1986499	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682099	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C=C2SC(=Nc3ccccc3)NC2=O)c1		CHEMBL1972937	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682100	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	C#Cc1cc2c(cc1OC)-c1[nH]nc(-c3ccc(C#N)nc3)c1C2		CHEMBL1972250	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682101	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2cnc(-n3cnc4ccc(F)cc43)nc2n1C1CCOc2c(F)cccc21		CHEMBL2000393	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
inactive	9682102	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4c3CNC4=O)c(C)c2)c1		CHEMBL2004311	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682103	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Brc1cnc2[nH]cc(-c3ccccc3)c2c1		CHEMBL1992634	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682104	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc3c(c2)CCc2sc4ncnc(N)c4c2-3)c1		CHEMBL1242373	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682105	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1988075	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682106	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Fc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL316264	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682107	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1991678	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682108	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc(Nc2cc(CNC(=O)C(F)(F)F)c(O)c(-c3ccc(Cl)cc3)c2)n1		CHEMBL2001239	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682109	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2scc(C(=O)Nc3ccc(NC(=O)Nc4ccccc4)cc3)c12		CHEMBL1988594	=	Ki	nM	100.0	CHEMBL2534	Homo sapiens	pKi		7.0
inactive	9682110	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1c(I)nn2C1OC(CO)C(O)C1O		CHEMBL2001288	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682111	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncnc2c1N=C(c1ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc1)CCN2		CHEMBL260092	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682112	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682113	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NN=Cc1ccc(O)cc1O)Nc1cccc2nsnc12		CHEMBL1999811	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682114	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ncc(C#N)c(-c3ccccc3)c12		CHEMBL1965495	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682115	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1ccc2nc3c(c(Cl)c2c1)CCNC3=O		CHEMBL1985074	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682116	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nc2ccc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc2n1CC1CC1		CHEMBL1982874	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682117	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL2000481	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682118	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CC(=O)NC(COc1cncc(-c2ccc3cnccc3c2)c1)Cc1c[nH]c2ccccc12		CHEMBL1991725	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682119	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(-c3cccc4sncc34)cc2)c1		CHEMBL1992242	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682120	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCOc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL2007296	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682121	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2ccc3[nH]ncc3c2)n1		CHEMBL396523	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9682122	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(NC(C)=O)cc(N)c1C#N		CHEMBL208637	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682123	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)cc(NC(=O)Nc2ccc(NC(=O)c3csc4ncnc(N)c34)cc2)c1		CHEMBL1970203	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682124	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(c1cc(Cc2n[nH]c(=O)c3c2CCCC3)ccc1F)N1CCN(c2ncccn2)CC1		CHEMBL1986530	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682125	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCCc2ccc(Oc3ccccc3)cc2)c(Nc2ccncc2)c1=O		CHEMBL1999321	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682126	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)C=Cc1cnc(N)c2c(-c3ccc4sc(C)nc4c3)csc12		CHEMBL1968590	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682127	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(Nc2ncnc3ccc(-c4ccc(CN5CC6C(CO)C6C5)cc4)cc23)ccc1Oc1ccccc1		CHEMBL1999749	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682128	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCC1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCCCC4)cc3OC)nc2N1C1CCCC1		CHEMBL2005375	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682129	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1ccc(-c2n[nH]cc2-c2ccncn2)cc1Cl		CHEMBL1984191	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682130	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C(=O)O)c(Cl)cc1NC(=O)Nc1cnc(C#N)cn1		CHEMBL1983006	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682131	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCCC1COc1cncc(CCc2ccccc2)c1		CHEMBL1972183	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682132	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(N3CCN(C(C)=O)CC3)ccc2OC)ncc1Br		CHEMBL1971029	=	Ki	nM	158.49	CHEMBL2534	Homo sapiens	pKi		6.8
inactive	9682133	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Nc1n[nH]c2ccc(N)cc12		CHEMBL1995391	<	Ki	nM	10000.0	CHEMBL2534	Homo sapiens	pKi		5.0
inactive	9682134	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(Cc1cccc2ccccc12)C(=O)Nc1cncc(C=Cc2ccncc2)c1		CHEMBL1985580	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682135	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)c12		CHEMBL394790	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682136	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4ccccc4F)c3)cc21		CHEMBL226471	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682137	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc2c(sc3c(Br)ccc(Cl)c32)c(=O)o1		CHEMBL1974702	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682138	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)C(=O)c1c(-c2ccc3[nH]ncc3c2)nnn1Cc1ccccc1		CHEMBL1996111	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682139	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCC4(O)CC4)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1965589	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682140	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCCCCCCNC(=O)Nc1cccnc1)Nc1cccnc1		CHEMBL1998193	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682141	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)O)s3)c2cc1OC		CHEMBL474432	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682142	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nnc(-c2cc3c(Oc4ccc(C(F)(F)F)cc4)cncc3s2)o1		CHEMBL1988153	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682143	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=O)N1CCN(C2CCC(n3nc(-c4ccc(NC(=O)c5cc6ccccc6n5C)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1972584	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682144	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ccc2[nH]c(O)c(-c3ccc(CN4CCOCC4)cn3)c2c1		CHEMBL1969664	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682145	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1999556	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682146	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1ccccc1Sc1ccc2c(C=Cc3ccccn3)n[nH]c2c1		CHEMBL1988437	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9682147	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cc(C=Cc2ccncc2)cnc1Cl)Cc1c[nH]c2ccccc12		CHEMBL1968245	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682148	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCC(C(=O)Nc1ccc2[nH]ncc2c1)c1ccc(Cl)c(Cl)c1		CHEMBL1998121	=	Ki	nM	158.49	CHEMBL2534	Homo sapiens	pKi		6.8
active	9682149	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cccc(NC(=O)Nc2ccc(-c3csc4c(C#CC(C)(C)N)cnc(N)c34)cc2)c1		CHEMBL1979577	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9682150	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CC4CC4)nccn23)n1		CHEMBL1991800	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682151	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)Nc2ccc(CCOc4ccc(N5CCOCC5)cc4)cc2NC3=O)ccc1CC#N		CHEMBL1985566	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682152	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCC(CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL52387	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682153	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nn(-c2ccccc2)c2c1c(=O)c1cc(Cl)ccc1n2O		CHEMBL379835	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682154	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1cc(C(CN)c2cncc(C=Cc3ccncc3)c2)c2ccccc21		CHEMBL1979357	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682155	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ncc2nc1OCC(O)C(O)COc1ccc(Cl)cc1NC(=O)N2		CHEMBL1980802	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682156	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCc2ccc(Cl)cc2Cl)c(Nc2ccc3[nH]ncc3c2)c1=O		CHEMBL1979554	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682157	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCOc1ncnc2[nH]cc(-c3ccccc3)c12		CHEMBL1996817	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9682158	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nonc1-n1nnc(C(=O)NN=Cc2ccncc2)c1-c1ccccc1		CHEMBL1419458	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682159	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccc(S(N)(=O)=O)cc2)cc(N)c1C#N		CHEMBL2004355	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682160	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	=	Ki	nM	100.0	CHEMBL2534	Homo sapiens	pKi		7.0
inactive	9682161	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCn1c2cc(Cl)c(F)cc2c(=O)c2c(=O)o[nH]c21		CHEMBL468280	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682162	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(C)c2oc(Nc3ccc(-c4cccc(C(N)=O)c4N)cc3F)nc2c1		CHEMBL1990884	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682163	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C		CHEMBL1990885	=	Ki	nM	1000.0	CHEMBL2534	Homo sapiens	pKi		6.0
inactive	9682164	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL256835	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682165	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(C(F)(F)F)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1980142	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682166	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL41783	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682167	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1c(-c2ccc(NC(=O)Nc3cccc(C(F)(F)F)c3)cc2)ccc2nccnc12		CHEMBL2004438	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682168	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc2c1Nc1cc(Nc3ccncc3)ccc1C(=O)N2		CHEMBL2006276	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
inactive	9682169	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2ccc(NC(=O)Nc3cccc(Br)c3)cc2)c2c(N)noc12		CHEMBL271381	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682170	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(C(=O)Nc2c(C#N)sc3ccc(Cl)c(Cl)c23)cc1		CHEMBL2006785	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682171	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(NC(=O)Nc2ccc(-c3csc4c(-c5cnn(C)c5)cnc(N)c34)cc2)cc1		CHEMBL1982466	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682172	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)Nc2ccc([N+](=O)[O-])cc2NC3=O)ccc1O		CHEMBL1995740	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9682173	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1cc2c(-c3ccccc3)cncc2s1		CHEMBL1996390	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682174	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OC1CCC(Nc2nc(Cl)cc(-c3c[nH]c4ncccc34)n2)CC1		CHEMBL1986943	=	Ki	nM	501.19	CHEMBL2534	Homo sapiens	pKi		6.3
inactive	9682175	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC1CCN(C(=O)CC#N)CC1N(C)c1ncnc2[nH]ccc12		CHEMBL234085	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682176	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3F)nc12		CHEMBL1995832	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682177	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2sc(C(=O)NCCc3ccc(Cl)cc3)cc12		CHEMBL1998414	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682178	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Oc1ccc(Nc2[nH]nc(-c3ccc(O)cc3)c2-c2ccc(O)cc2)cc1		CHEMBL1969042	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682179	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C(C#N)c2nc3cc(C)ccc3[nH]2)c(Br)cc1O		CHEMBL2000345	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682180	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1ccccc1		CHEMBL1999931	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9682181	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]sc2c1c(=O)c1cc(F)c(NCc3ccccc3)c(F)c1n2C1CC1		CHEMBL1991640	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682182	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1375418	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682183	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Ki	nM	12.59	CHEMBL2534	Homo sapiens	pKi		7.9
active	9682184	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1[nH]c(C=C2C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL2007064	=	Ki	nM	630.96	CHEMBL2534	Homo sapiens	pKi		6.2
inactive	9682185	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COC(C(=O)N1Cc2[nH]nc(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL1981047	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682186	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccc(Cl)c(Cl)c4)c3)cc12		CHEMBL1991063	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9682187	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(CN)NC(=O)c2ccc(-c3ccncc3)cc2)c1		CHEMBL1976240	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682188	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc(-c2ccc(NC(=O)Nc3ccc(F)c(C)c3)cc2)c2c(N)noc12		CHEMBL1979093	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682189	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2sccc2c2nc(-c3ccncc3)nn12		CHEMBL1968151	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682190	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1ccc(CNc2ccc3nnc(-c4ccccc4)n3n2)cc1		CHEMBL1381197	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682191	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(CNC(=O)c2cc3c(-c4ccccc4)n[nH]c3s2)c1		CHEMBL1987009	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9682192	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1n[nH]c2ccc(-c3cncc(OCC(N)Cc4ccccc4)c3)cc12		CHEMBL2002726	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682193	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnccn1)Nc1ccnc2cc(C(F)(F)F)ccc12		CHEMBL2003817	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682194	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ncccc2N1		CHEMBL336961	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682195	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nnc(-c2cc3c(Oc4ccc(Cl)cc4)cncc3s2)o1		CHEMBL1994830	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682196	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COCCOC1CCC(n2nc(-c3ccc(Nc4nc5cc(C)cc(Cl)c5o4)cc3)c3c(N)ncnc32)CC1		CHEMBL1987054	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
active	9682197	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncc(-c2ccncc2)c2scc(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL1970083	=	Ki	nM	398.11	CHEMBL2534	Homo sapiens	pKi		6.4
inactive	9682198	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1NCCc2[nH]c(-c3ccnc(-c4cnc5ccccc5c4)c3)cc21		CHEMBL226403	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682199	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cc(C)ccc4F)cc3)csc12		CHEMBL2005631	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9682200	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncc(C=CC(=O)NCCCn2ccnc2)c2scc(-c3ccc(Br)cc3)c12		CHEMBL1994938	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682201	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL1825138	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682202	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1977223	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682203	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)C(=O)Oc1ccc2c(c1)nc(NC(=O)c1cccc([N+](=O)[O-])c1)n2CCCO		CHEMBL1236126	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682204	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NCCCNS(=O)(=O)c1cccc(C(=O)Nc2ccc(-c3n[nH]c(=O)c4ccccc34)cc2)c1		CHEMBL1966279	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682205	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Clc1cc(NC2CCCCC2)nc(-c2c[nH]c3ncccc23)n1		CHEMBL1997846	=	Ki	nM	79.43	CHEMBL2534	Homo sapiens	pKi		7.1
inactive	9682206	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)Cn1c(N)nc2c(F)cc(-c3c(-c4ccc(F)cc4)nc4sccn34)cc21		CHEMBL2004419	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682207	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(=NNC(=N)N)c1cc(NC(=O)NCCCCCCNC(=O)Nc2cc(C(C)=NNC(=N)N)cc(C(C)=NNC(=N)N)c2)cc(C(C)=NNC(=N)N)c1		CHEMBL1991728	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682208	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(=O)c1cc2c(-c3ccc(F)cc3F)cncc2s1		CHEMBL1975787	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682209	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(C=C(C#N)c2n[nH]c(N)c2C#N)ccc1O		CHEMBL2002407	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682210	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1ccc2cn[nH]c2c1)c1ccc(Cl)cc1		CHEMBL1972489	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682211	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Brc1ccc2[nH]nc(-c3ccccc3)c2c1		CHEMBL1994074	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682212	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(Nc2nc3ccc([N+](=O)[O-])cc3[nH]2)nc1		CHEMBL1992937	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682213	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cccc(N2CCOCC2)n1)Nc1ccnc2c(C(F)(F)F)cccc12		CHEMBL1972119	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682214	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)C(=O)Nc1ccc2nc(-c3ccco3)c(-c3ccco3)nc2c1		CHEMBL1986328	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682215	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL95692	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682216	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Cc1ccccc1)Nc1cccc(-c2nc3sccn3c2-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)c1		CHEMBL1090356	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682217	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnccn1)Nc1ccnc2ccc(C(F)(F)F)cc12		CHEMBL1976455	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682218	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1		CHEMBL1983923	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9682219	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682220	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(CNc2nc3ccc(-c4ccncc4)cc3s2)cc1		CHEMBL1983534	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682221	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1c(NCc2ccccc2F)c(Nc2ccncc2)c1=O		CHEMBL1982361	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682222	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOC(=O)C1=c2sc(=Cc3ccco3)c(=O)n2C(N)=C(C#N)C1c1ccco1		CHEMBL1999112	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682223	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	OCCC(Nc1nc2ccc(-c3ccncc3)cc2s1)c1ccccc1		CHEMBL1982122	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682224	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1ccc(-c2cccc3sncc23)cc1)Nc1ccc(F)c(C(F)(F)F)c1		CHEMBL2000801	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682225	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc(CNc2nc(-c3ccc4[nH]ncc4c3)cs2)cc1		CHEMBL1682546	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682226	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3cnccn23)n1		CHEMBL1991395	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682227	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(c2cccc(Nc3nccc(-c4c(C(N)=O)nc5ccccn45)n3)c2)CC1		CHEMBL1971245	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682228	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nccn2c(-c3ccnc(NCC(C)(C)CO)n3)c(-c3ccc(F)cc3)nc12		CHEMBL1987648	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682229	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOC(=O)c1cn(-c2ccc(O)cc2C)c2cc(-c3ccncc3)ccc2c1=O		CHEMBL1996780	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682230	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NCc1ccccc1)c1cccc(-c2cnc3[nH]ccc3c2)c1		CHEMBL1972142	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682231	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncc(-c2ccoc2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1966514	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682232	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCCCCCCCCCOc1ccc(NC(=N)N)cc1NC(=N)N		CHEMBL1980715	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682233	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12)c1cccc(F)c1		CHEMBL2003638	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
active	9682234	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Ki	nM	1258.93	CHEMBL2534	Homo sapiens	pKi		5.9
inactive	9682235	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ccc2nc(N)n(-c3nc(-c4ccccc4)cs3)c2c1		CHEMBL1996066	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682236	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC(COc1cncc(-c2cc3ccncc3s2)c1)Cc1c[nH]c2ccccc12		CHEMBL1966524	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9682237	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1n[nH]c2cccc(-c3ccc(NC(=O)Nc4cc(C(=O)O)ccc4F)cc3)c12		CHEMBL1993722	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682238	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=c1[nH]c2sc3c(c2c2nc(-c4cccnc4)nn12)CCCC3		CHEMBL1970806	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682239	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1nc(COc2ccccc2Cl)sc1-c1ccnc(N)n1		CHEMBL1375640	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682240	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCC(=O)Nc1n[nH]c2nnc(-c3cccc(F)c3F)cc12		CHEMBL1979970	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682241	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1ccc(-c2n[nH]c3c2Cc2ccc(OCCN4CCOCC4)cc2-3)cn1		CHEMBL249282	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682242	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C)NC(=O)c1ccc2nc3[nH]c4ccccc4c3nc2c1		CHEMBL1969264	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682243	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	N#Cc1c(O)[nH]c(=O)c2c(=N)oc3ccc(Cl)cc3c12		CHEMBL1973711	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682244	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(CCCNc2cccc(-c3nc4c(C(N)=O)cccc4[nH]3)n2)CC1		CHEMBL2006237	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682245	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(C(N)=O)n1cc(-c2cnc(N)c3c(-c4ccc(NC(=O)Nc5cccc(F)c5)cc4)csc23)cn1		CHEMBL1967720	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682246	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	NC1C2CN(c3nc4c(cc3F)c(=O)c(C(=O)O)cn4-c3ccc(F)cc3F)CC12		CHEMBL1624529	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682247	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccn2c(C3CC(CN4CCCC4)C3)nc(-c3cccc(OCc4ccccc4)c3)c12		CHEMBL1991138	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682248	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(NC(CO)Cc1ccccc1)c1ccc(-c2ccncc2)cc1F		CHEMBL1969755	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682249	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCNC(=O)c1cnc(N)c2c(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)csc12		CHEMBL1979516	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682250	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(N)C1CCC(C(=O)Nc2ccncc2)CC1		CHEMBL1994526	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682251	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1ccc(N2C(=O)c3ccccc3C2=O)cc1O		CHEMBL1972820	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682252	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)OC1=NNC(=O)C1=Cc1c[nH]c2ccccc12		CHEMBL1989029	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682253	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1ccccc1CNc1ncc([N+](=O)[O-])c(NCC2CCC(CN)CC2)n1		CHEMBL392642	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682254	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682255	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN(C)CC(=O)Nc1n[nH]c2ccc(-c3cn(Cc4ccccc4)nn3)cc12		CHEMBL1965631	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682256	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccccc1NC(=O)Nc1ccc(NC(=O)c2csc3ncnc(N)c23)cc1		CHEMBL1980144	=	Ki	nM	251.19	CHEMBL2534	Homo sapiens	pKi		6.6
inactive	9682257	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cccc(C(C)NC(=O)c2ccc(-c3ccncc3F)cc2OC)c1		CHEMBL1991188	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682258	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)c1nnc2ccc(-c3c(-c4ccc(F)cc4F)nc4occn34)nn12		CHEMBL1972849	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682259	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCOc1nc(C(=O)NCc2ccccc2S(N)(=O)=O)cc(N)c1C#N		CHEMBL377408	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682260	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682261	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL231209	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682262	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4cccc(Br)c4)cc3)c12		CHEMBL1976220	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9682263	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1ccc(C(=O)Nc2ccon2)cc1Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL259922	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682264	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CN1CCN(C2CCC(n3cc(-c4ccc(Oc5ccccc5)cc4)c4c(N)ncnc43)CC2)CC1		CHEMBL1997617	=	Ki	nM	1995.26	CHEMBL2534	Homo sapiens	pKi		5.7
inactive	9682265	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CC(C)(CO)CNc1nccc(-c2c(-c3ccc(F)cc3)nc3c(CCN)nccn23)n1		CHEMBL1982383	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9682266	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CCCCn1c(NC(=O)c2cccc(C#N)c2)nc2cc(N(C)C(=O)C3CCCCC3)ccc21		CHEMBL1969301	=	Ki	nM	1584.89	CHEMBL2534	Homo sapiens	pKi		5.8
inactive	9682267	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17370	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9686228	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1nccc2scc(-c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3)c12		CHEMBL1987910	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9686229	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1ccc2c(NC(=O)Nc3cccc(Br)n3)ccnc2c1		CHEMBL1983932	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9686230	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Nc1ncc(-c2cnn(CCO)c2)c2scc(-c3ccc(NC(=O)Nc4cccc(F)c4)cc3)c12		CHEMBL1980297	=	Ki	nM	794.33	CHEMBL2534	Homo sapiens	pKi		6.1
inactive	9686231	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	c1ccc2c(c1)nnn2Cc1cn(-c2ccc3[nH]ncc3c2)nn1		CHEMBL1966069	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9686232	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9686233	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc2cc(-c3csc4c(-c5cccc(S(C)(=O)=O)c5)cnc(N)c34)ccc2[nH]1		CHEMBL1997822	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9686234	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	Cc1cc(OCC2CCC(C(=O)O)C2)c(NC(=O)Nc2cnc(C#N)cn2)cc1Cl		CHEMBL1991285	=	Ki	nM	2511.89	CHEMBL2534	Homo sapiens	pKi		5.6
active	9686235	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(O)c1ccccc1Nc1ccnc(Nc2cccc(O)c2)n1		CHEMBL243088	=	Ki	nM	158.49	CHEMBL2534	Homo sapiens	pKi		6.8
inactive	9686236	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc(-c2ccc3c(c2)NC(=O)c2ccc(-c4ccccc4NS(C)(=O)=O)cc2N3)cc(OC)c1OC		CHEMBL1984038	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9686237	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CNS(=O)(=O)c1ccccc1Nc1nc(Nc2cc(OC)c(OC)c(OC)c2)ncc1Cl		CHEMBL1993661	=	Ki	nM	7.943	CHEMBL2534	Homo sapiens	pKi		8.1
inactive	9686238	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(Nc1cnc2[nH]cc(-c3ccccc3)c2c1)c1cccc(F)c1F		CHEMBL1974416	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
inactive	9686239	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	CSc1nn(-c2ccccn2)c(N)c1C(N)=O		CHEMBL2004615	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
active	9686240	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	COc1cc2c(cc1F)C(c1ccccc1Cl)=Nc1c(n[nH]c1C)N2		CHEMBL1980391	=	Ki	nM	50.12	CHEMBL2534	Homo sapiens	pKi		7.3
inactive	9686241	CHEMBL1963821	PUBCHEM_BIOASSAY: Navigating the Kinome. (Class of assay: other) Panel member name: PDPK1	F	O=C(c1cccc(-c2cnc3[nH]ccc3c2)c1)N1CCOCC1		CHEMBL1997872	<	Ki	nM	3981.07	CHEMBL2534	Homo sapiens	pKi		5.4
	10871408	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(C(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023419	=	IC50	nM	3300.0	CHEMBL2534	Homo sapiens	IC50	uM	3.3
	10871409	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)C4CCNCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023418	=	IC50	nM	79.0	CHEMBL2534	Homo sapiens	IC50	uM	0.079
	10871410	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(C(=O)NC4CCNCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023417	=	IC50	nM	4500.0	CHEMBL2534	Homo sapiens	IC50	uM	4.5
	10871411	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCCC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023416	=	IC50	nM	220.0	CHEMBL2534	Homo sapiens	IC50	uM	0.22
	10871412	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NCCN4CCOCC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023415	=	IC50	nM	75.0	CHEMBL2534	Homo sapiens	IC50	uM	0.075
	10871413	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NCCN4CCOCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023414	=	IC50	nM	84.0	CHEMBL2534	Homo sapiens	IC50	uM	0.084
	10871414	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1		CHEMBL2023413	=	IC50	nM	46.0	CHEMBL2534	Homo sapiens	IC50	uM	0.046
	10871415	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)NC4CCNC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023201	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	uM	0.11
	10871416	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1cc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)ccc1N		CHEMBL2023200	=	IC50	nM	410.0	CHEMBL2534	Homo sapiens	IC50	uM	0.41
	10871417	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	O=C(Nc1cccc(Nc2nc(-c3ccc(F)nc3)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023199	=	IC50	nM	400.0	CHEMBL2534	Homo sapiens	IC50	uM	0.4
	10871418	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	O=C(Nc1cccc(Nc2nc(-c3ccncc3)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023198	=	IC50	nM	1200.0	CHEMBL2534	Homo sapiens	IC50	uM	1.2
	10871419	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	O=C(Nc1cccc(Nc2nc(-c3ccc4c(c3)OCO4)c3nc[nH]c3n2)c1)N1CCCC1		CHEMBL2023197	=	IC50	nM	280.0	CHEMBL2534	Homo sapiens	IC50	uM	0.28
	10871420	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023196	=	IC50	nM	170.0	CHEMBL2534	Homo sapiens	IC50	uM	0.17
	10871421	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]cnc23)cc1		CHEMBL1933347	=	IC50	nM	150.0	CHEMBL2534	Homo sapiens	IC50	uM	0.15
	10871422	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	CN1CCN(Cc2cccc(-c3nc(Nc4cccc(Cl)c4)nc4[nH]cnc34)c2)CC1		CHEMBL2023195	=	IC50	nM	260.0	CHEMBL2534	Homo sapiens	IC50	uM	0.26
	10871423	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	Oc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1		CHEMBL1933345	=	IC50	nM	1600.0	CHEMBL2534	Homo sapiens	IC50	uM	1.6
	10871424	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	COc1ccc(-c2nc(Nc3cccc(Cl)c3)nc3[nH]cnc23)cc1OC		CHEMBL2023194	=	IC50	nM	970.0	CHEMBL2534	Homo sapiens	IC50	uM	0.97
	10871444	CHEMBL2027574	Inhibition of PDK1 assessed as [gamma-33P]ATP incorporation into substrate after 1 hr by scintillation counting	B	CN1C/C=C/CCOc2cccc(c2)-c2nc(nc3[nH]cnc23)Nc2cccc(c2)C1		CHEMBL1933344	=	IC50	nM	390.0	CHEMBL2534	Homo sapiens	IC50	uM	0.39
	10889741	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	c1nc(N2CCOCC2)c2nc[nH]c2n1		CHEMBL271138	=	IC50	nM	92000.0	CHEMBL2534	Homo sapiens	IC50	uM	92.0
	10889742	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=C(O)c1cc2cc(F)ccc2[nH]1		CHEMBL23507	=	IC50	nM	297000.0	CHEMBL2534	Homo sapiens	IC50	uM	297.0
	10889743	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	Cc1sc2nc[nH]c(=O)c2c1C		CHEMBL2029510	=	IC50	nM	828000.0	CHEMBL2534	Homo sapiens	IC50	uM	828.0
	10889744	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	Oc1ncnc2ccsc12		CHEMBL1891423	=	IC50	nM	492000.0	CHEMBL2534	Homo sapiens	IC50	uM	492.0
	10889745	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	CC(C)(C)c1cc2nc[nH]c(=O)c2s1		CHEMBL2029511	=	IC50	nM	55000.0	CHEMBL2534	Homo sapiens	IC50	uM	55.0
	10889746	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	Cc1n[nH]c(=O)c2nc[nH]c12		CHEMBL2029512	=	IC50	nM	472000.0	CHEMBL2534	Homo sapiens	IC50	uM	472.0
	10889747	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	COc1ccc(Nc2ncnc3[nH]ncc23)cc1		CHEMBL2029513	=	IC50	nM	61000.0	CHEMBL2534	Homo sapiens	IC50	uM	61.0
	10889748	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	CC1=CC(=O)OC2NN=C(C)C12		CHEMBL2029514	=	IC50	nM	302000.0	CHEMBL2534	Homo sapiens	IC50	uM	302.0
	10889749	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	CC(=O)Nc1nc2ccc(F)cc2s1		CHEMBL2029515	=	IC50	nM	402000.0	CHEMBL2534	Homo sapiens	IC50	uM	402.0
	10889750	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]ccn2nc3c(c12)CCCC3		CHEMBL2029516	=	IC50	nM	273000.0	CHEMBL2534	Homo sapiens	IC50	uM	273.0
	10889751	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	COc1ccc(-c2cc3ncnc(O)c3s2)cc1		CHEMBL1612732	=	IC50	nM	86000.0	CHEMBL2534	Homo sapiens	IC50	uM	86.0
	10889752	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]cnc2cc(-c3ccc(F)cc3)sc12		CHEMBL2029517	=	IC50	nM	122000.0	CHEMBL2534	Homo sapiens	IC50	uM	122.0
	10889753	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	Cc1csc2c(O)ncnc12		CHEMBL1877245	=	IC50	nM	461000.0	CHEMBL2534	Homo sapiens	IC50	uM	461.0
	10889754	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	CNc1csc2c(=O)[nH]cnc12		CHEMBL2029518	=	IC50	nM	154000.0	CHEMBL2534	Homo sapiens	IC50	uM	154.0
	10889755	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	CN(C)c1csc2c(=O)[nH]cnc12		CHEMBL2029519	=	IC50	nM	109000.0	CHEMBL2534	Homo sapiens	IC50	uM	109.0
	10889756	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=C(Nc1csc2c(=O)[nH]cnc12)c1ccccc1		CHEMBL2029520	=	IC50	nM	95000.0	CHEMBL2534	Homo sapiens	IC50	uM	95.0
	10889757	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]cnc2c(-c3ccccc3)csc12		CHEMBL2029521	=	IC50	nM	15000.0	CHEMBL2534	Homo sapiens	IC50	uM	15.0
	10889758	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	Cc1c(-c2ccc(F)cc2)sc2c(=O)[nH]cnc12		CHEMBL2029522	=	IC50	nM	106000.0	CHEMBL2534	Homo sapiens	IC50	uM	106.0
	10889759	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]cnc2c(-c3ccccc3)c(-c3ccc(F)cc3)sc12		CHEMBL2029523	=	IC50	nM	33000.0	CHEMBL2534	Homo sapiens	IC50	uM	33.0
	10889760	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	COc1ccc(-c2c(-c3ccc(F)cc3)sc3c(=O)[nH]cnc23)cc1OC		CHEMBL2029524	=	IC50	nM	11000.0	CHEMBL2534	Homo sapiens	IC50	uM	11.0
	10889761	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]cnc2c(/C=C/c3ccccc3)c(-c3ccc(F)cc3)sc12		CHEMBL2029525	=	IC50	nM	39000.0	CHEMBL2534	Homo sapiens	IC50	uM	39.0
	10889762	CHEMBL2034299	Competitive inhibition of PDK1 using [gamma-33P]-ATP as substrate after 30 mins by scintillation counting	B	O=c1[nH]cnc2c(-c3cn[nH]c3)c(-c3ccc(F)cc3)sc12		CHEMBL2029526	=	IC50	nM	5200.0	CHEMBL2534	Homo sapiens	IC50	uM	5.2
	10898372	CHEMBL2039412	Inhibition of human PDK1 assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c2c1C(=O)CC(c1ccc(O)cc1)O2		CHEMBL492828	=	IC50	nM	58700.0	CHEMBL2534	Homo sapiens	IC50	uM	58.7
	10898373	CHEMBL2039412	Inhibition of human PDK1 assessed as inhibition of [33P] incorporation into substrate after 60 mins by scintillation counting	B	COc1cc(O)c(CC=C(C)C)c(O)c1C(=O)/C=C/c1ccc(O)cc1		CHEMBL253896	=	IC50	nM	6600.0	CHEMBL2534	Homo sapiens	IC50	uM	6.6
	10978449	CHEMBL2066258	Inhibition of human recombinant PDK1 expressed in insect cells using ulight FLGFTYVAP as substrate assessed as residual activity at 1 uM after 90 mins by Cerep assay	B	N#Cc1ccc(-c2ccc(CSc3nnc(-c4ccc5c(c4)OCO5)o3)cc2)cc1		CHEMBL2064515	>	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	12047298	CHEMBL2157323	Inhibition of PDK1 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	18.3	CHEMBL2534	Homo sapiens	INH	%	18.3
	12047411	CHEMBL2157247	Inhibition of PDK1 at 1 uM by direct inhibition assay	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	-6.9	CHEMBL2534	Homo sapiens	INH	%	-6.9
	12060788	CHEMBL2156907	Inhibition of PDK1	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3F)c2)cnc1N		CHEMBL2152252	>	IC50	nM	3600.0	CHEMBL2534	Homo sapiens	IC50	nM	3600.0
	12060789	CHEMBL2156907	Inhibition of PDK1	B	CNC(=O)c1nc(-c2ccc(Cl)c(S(=O)(=O)Nc3cccc(F)c3C)c2)cnc1N		CHEMBL2152253	>	IC50	nM	3600.0	CHEMBL2534	Homo sapiens	IC50	nM	3600.0
	12060935	CHEMBL2157414	Binding affinity to PDPK1 at 1 uM by high throughput binding assay relative to control	B	Nc1cc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc(-c2cnc3[nH]cc(-c4ccncc4)c3c2)c1		CHEMBL2152288	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	12094386	CHEMBL2166166	Inhibition of human PDK1 at 10 uM	B	CCOc1ccc(Nc2c(C)c(N[C@H]3CCCNC3)nc3ccnn23)cc1		CHEMBL1235213	=	Inhibition	%	-9.0	CHEMBL2534	Homo sapiens	INH	%	-9.0
	12145309	CHEMBL2187084	Inhibition of PDK1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CNC(=O)c2ccccc2)cc1		CHEMBL2177819	>	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	12145310	CHEMBL2187084	Inhibition of PDK1 using fluorescent labelled substrate at 5 uM by caliper method	B	Nc1ncccc1-c1nc2cccnc2n1-c1ccc(CC(=O)Nc2ccccc2)cc1		CHEMBL2177818	>	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	12146453	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Oc2ccccc2)cc1		CHEMBL2177660	=	max activation		7.0	CHEMBL2534	Homo sapiens	max activation		7.0
	12146454	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1Cl)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177664	=	max activation		5.5	CHEMBL2534	Homo sapiens	max activation		5.5
	12146455	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(C[C@H](c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177667	=	max activation		5.5	CHEMBL2534	Homo sapiens	max activation		5.5
	12146456	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	max activation		5.5	CHEMBL2534	Homo sapiens	max activation		5.5
	12146457	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	CCc1ccc(C(=O)CC(c2ccccc2)C(C(=O)O)C(=O)O)cc1		CHEMBL2177663	=	max activation		5.0	CHEMBL2534	Homo sapiens	max activation		5.0
	12146458	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc2ccccc2c1		CHEMBL2177655	=	max activation		4.8	CHEMBL2534	Homo sapiens	max activation		4.8
	12146459	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL2177679	=	max activation		4.0	CHEMBL2534	Homo sapiens	max activation		4.0
	12146460	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(I)cc1)c1ccccc1		CHEMBL2177681	=	max activation		4.0	CHEMBL2534	Homo sapiens	max activation		4.0
	12146461	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2ccccc2c1		CHEMBL2177657	=	max activation		4.0	CHEMBL2534	Homo sapiens	max activation		4.0
	12146462	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177670	=	max activation		4.0	CHEMBL2534	Homo sapiens	max activation		4.0
	12146463	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177675	=	max activation		4.0	CHEMBL2534	Homo sapiens	max activation		4.0
	12146464	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177669	=	max activation		3.8	CHEMBL2534	Homo sapiens	max activation		3.8
	12146465	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(ccc3ccccc32)c1		CHEMBL2177687	=	max activation		3.7	CHEMBL2534	Homo sapiens	max activation		3.7
	12146466	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Br)cc1		CHEMBL2177672	=	max activation		3.7	CHEMBL2534	Homo sapiens	max activation		3.7
	12146467	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(c1)[nH]c1ccccc12		CHEMBL2177686	=	max activation		3.6	CHEMBL2534	Homo sapiens	max activation		3.6
	12146468	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	COc1ccc2cc(C(=O)CC(c3ccccc3)C(C(=O)O)C(=O)O)ccc2c1		CHEMBL2177656	=	max activation		3.6	CHEMBL2534	Homo sapiens	max activation		3.6
	12146469	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177659	=	max activation		3.6	CHEMBL2534	Homo sapiens	max activation		3.6
	12146470	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177666	=	max activation		3.5	CHEMBL2534	Homo sapiens	max activation		3.5
	12146471	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	max activation		3.4	CHEMBL2534	Homo sapiens	max activation		3.4
	12146472	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1		CHEMBL2181203	=	max activation		3.4	CHEMBL2534	Homo sapiens	max activation		3.4
	12146473	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc2cc(O)ccc2c1)c1ccccc1		CHEMBL2177653	=	max activation		3.0	CHEMBL2534	Homo sapiens	max activation		3.0
	12146474	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL2177685	=	max activation		3.0	CHEMBL2534	Homo sapiens	max activation		3.0
	12146475	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1c[nH]c2ccccc12		CHEMBL2177654	=	max activation		3.0	CHEMBL2534	Homo sapiens	max activation		3.0
	12146476	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	CCc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C(=O)O)C(=O)O)cc1		CHEMBL2177662	=	max activation		3.0	CHEMBL2534	Homo sapiens	max activation		3.0
	12146477	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(Br)cc1		CHEMBL2177671	=	max activation		3.0	CHEMBL2534	Homo sapiens	max activation		3.0
	12146478	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(Oc2ccccc2)cc1)c1ccccc1		CHEMBL2177676	=	max activation		2.8	CHEMBL2534	Homo sapiens	max activation		2.8
	12146479	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1cccc(Cl)c1		CHEMBL2177674	=	max activation		2.6	CHEMBL2534	Homo sapiens	max activation		2.6
	12146480	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc2ccccc2c1)c1ccccc1		CHEMBL2177652	=	max activation		2.5	CHEMBL2534	Homo sapiens	max activation		2.5
	12146481	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(I)cc1)c1ccc(Cl)cc1		CHEMBL2177680	=	max activation		2.5	CHEMBL2534	Homo sapiens	max activation		2.5
	12146482	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1cccc(Cl)c1)c1ccccc1		CHEMBL2177684	=	max activation		2.5	CHEMBL2534	Homo sapiens	max activation		2.5
	12146483	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	CCc1ccc(C(=O)CC(CC(=O)O)c2ccccc2)cc1		CHEMBL2177677	=	max activation		2.0	CHEMBL2534	Homo sapiens	max activation		2.0
	12146484	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(Br)cc1)c1ccccc1		CHEMBL2177682	=	max activation		2.0	CHEMBL2534	Homo sapiens	max activation		2.0
	12146485	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(C[C@@H](c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177665	=	max activation		2.0	CHEMBL2534	Homo sapiens	max activation		2.0
	12146486	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177673	=	max activation		2.0	CHEMBL2534	Homo sapiens	max activation		2.0
	12146487	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc2c(ccc3ccccc32)c1)c1ccccc1		CHEMBL2177651	=	max activation		1.5	CHEMBL2534	Homo sapiens	max activation		1.5
	12146489	CHEMBL2182502	Binding affinity to PDK1	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	Kd	nM	43.0	CHEMBL2534	Homo sapiens	Kd	nM	43.0
	12146490	CHEMBL2182499	Increase in thermal stability of PDK1 by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	EC50	nM	85800.0	CHEMBL2534	Homo sapiens	EC50	uM	85.8
	12146491	CHEMBL2182499	Increase in thermal stability of PDK1 by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177670	=	EC50	nM	60000.0	CHEMBL2534	Homo sapiens	EC50	uM	60.0
	12146492	CHEMBL2182499	Increase in thermal stability of PDK1 by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(c1)[nH]c1ccccc12		CHEMBL2177686	=	EC50	nM	30200.0	CHEMBL2534	Homo sapiens	EC50	uM	30.2
	12146493	CHEMBL2182499	Increase in thermal stability of PDK1 by differential scanning fluorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	EC50	nM	14200.0	CHEMBL2534	Homo sapiens	EC50	uM	14.2
	12146494	CHEMBL2182499	Increase in thermal stability of PDK1 by differential scanning fluorimetry	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177659	=	EC50	nM	13000.0	CHEMBL2534	Homo sapiens	EC50	uM	13.0
	12146496	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177675	=	Activity	uM	2.0	CHEMBL2534	Homo sapiens	Activity	uM	2.0
	12146497	CHEMBL2182497	Increase in thermal stability of PDK1 assessed as concentration required to increase 1.5 degC thermal stability by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	Activity	uM	67.6	CHEMBL2534	Homo sapiens	Activity	uM	67.6
	12146498	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL550259	=	Activity	uM	38.0	CHEMBL2534	Homo sapiens	Activity	uM	38.0
	12146499	CHEMBL2182497	Increase in thermal stability of PDK1 assessed as concentration required to increase 1.5 degC thermal stability by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177670	=	Activity	uM	30.9	CHEMBL2534	Homo sapiens	Activity	uM	30.9
	12146500	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(I)cc1)c1ccc(Cl)cc1		CHEMBL2177680	=	Activity	uM	20.0	CHEMBL2534	Homo sapiens	Activity	uM	20.0
	12146501	CHEMBL2182497	Increase in thermal stability of PDK1 assessed as concentration required to increase 1.5 degC thermal stability by differential scanning fluorimetry	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177659	=	Activity	uM	18.9	CHEMBL2534	Homo sapiens	Activity	uM	18.9
	12146502	CHEMBL2182497	Increase in thermal stability of PDK1 assessed as concentration required to increase 1.5 degC thermal stability by differential scanning fluorimetry	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(c1)[nH]c1ccccc12		CHEMBL2177686	=	Activity	uM	18.2	CHEMBL2534	Homo sapiens	Activity	uM	18.2
	12146503	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Oc2ccccc2)cc1		CHEMBL2177660	=	Activity	uM	16.0	CHEMBL2534	Homo sapiens	Activity	uM	16.0
	12146504	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(Oc2ccccc2)cc1)c1ccccc1		CHEMBL2177676	=	Activity	uM	15.0	CHEMBL2534	Homo sapiens	Activity	uM	15.0
	12146505	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL2177679	=	Activity	uM	15.0	CHEMBL2534	Homo sapiens	Activity	uM	15.0
	12146506	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1c[nH]c2ccccc12		CHEMBL2177654	=	Activity	uM	14.0	CHEMBL2534	Homo sapiens	Activity	uM	14.0
	12146507	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(Br)cc1		CHEMBL2177671	=	Activity	uM	12.0	CHEMBL2534	Homo sapiens	Activity	uM	12.0
	12146508	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc2cc(O)ccc2c1)c1ccccc1		CHEMBL2177653	=	Activity	uM	10.0	CHEMBL2534	Homo sapiens	Activity	uM	10.0
	12146509	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(I)cc1)c1ccccc1		CHEMBL2177681	=	Activity	uM	10.0	CHEMBL2534	Homo sapiens	Activity	uM	10.0
	12146510	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177666	=	Activity	uM	10.0	CHEMBL2534	Homo sapiens	Activity	uM	10.0
	12146511	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Activity	uM	8.0	CHEMBL2534	Homo sapiens	Activity	uM	8.0
	12146512	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc2ccccc2c1)c1ccc2ccccc2c1		CHEMBL2181203	=	Activity	uM	7.0	CHEMBL2534	Homo sapiens	Activity	uM	7.0
	12146513	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	CCc1ccc(C(=O)CC(c2ccc(Cl)cc2)C(C(=O)O)C(=O)O)cc1		CHEMBL2177662	=	Activity	uM	6.8	CHEMBL2534	Homo sapiens	Activity	uM	6.8
	12146514	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc2ccccc2c1)c1ccccc1		CHEMBL2177652	=	Activity	uM	5.0	CHEMBL2534	Homo sapiens	Activity	uM	5.0
	12146515	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	CCc1ccc(C(=O)CC(c2ccccc2)C(C(=O)O)C(=O)O)cc1		CHEMBL2177663	=	Activity	uM	4.0	CHEMBL2534	Homo sapiens	Activity	uM	4.0
	12146516	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1cccc(Cl)c1		CHEMBL2177674	=	Activity	uM	4.0	CHEMBL2534	Homo sapiens	Activity	uM	4.0
	12146517	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	COc1ccc2cc(C(=O)CC(c3ccccc3)C(C(=O)O)C(=O)O)ccc2c1		CHEMBL2177656	=	Activity	uM	3.3	CHEMBL2534	Homo sapiens	Activity	uM	3.3
	12146518	CHEMBL2182497	Increase in thermal stability of PDK1 assessed as concentration required to increase 1.5 degC thermal stability by differential scanning fluorimetry	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	Activity	uM	3.1	CHEMBL2534	Homo sapiens	Activity	uM	3.1
	12146519	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1Cl)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177664	=	Activity	uM	2.2	CHEMBL2534	Homo sapiens	Activity	uM	2.2
	12146520	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc2ccccc2c1		CHEMBL2177655	=	Activity	uM	2.0	CHEMBL2534	Homo sapiens	Activity	uM	2.0
	12146521	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	Activity	uM	2.0	CHEMBL2534	Homo sapiens	Activity	uM	2.0
	12146522	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177669	=	Activity	uM	2.0	CHEMBL2534	Homo sapiens	Activity	uM	2.0
	12146523	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(C[C@H](c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177667	=	Activity	uM	1.8	CHEMBL2534	Homo sapiens	Activity	uM	1.8
	12146524	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Br)cc1		CHEMBL2177672	=	Activity	uM	1.4	CHEMBL2534	Homo sapiens	Activity	uM	1.4
	12146525	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	Activity	uM	1.0	CHEMBL2534	Homo sapiens	Activity	uM	1.0
	12146526	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2ccccc2c1		CHEMBL2177657	=	Activity	uM	0.9	CHEMBL2534	Homo sapiens	Activity	uM	0.9
	12146527	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(c1)[nH]c1ccccc12		CHEMBL2177686	=	Activity	uM	0.7	CHEMBL2534	Homo sapiens	Activity	uM	0.7
	12146528	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(ccc3ccccc32)c1		CHEMBL2177687	=	Activity	uM	0.6	CHEMBL2534	Homo sapiens	Activity	uM	0.6
	12146529	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc2c(ccc3ccccc32)c1)c1ccccc1		CHEMBL2177651	=	Activity	uM	0.5	CHEMBL2534	Homo sapiens	Activity	uM	0.5
	12146530	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177670	=	Activity	uM	0.4	CHEMBL2534	Homo sapiens	Activity	uM	0.4
	12146531	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177659	=	Activity	uM	0.2	CHEMBL2534	Homo sapiens	Activity	uM	0.2
	12146532	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1cccc(Cl)c1)c1ccccc1		CHEMBL2177684	>	Activity	uM	70.0	CHEMBL2534	Homo sapiens	Activity	uM	70.0
	12146533	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	CCc1ccc(C(=O)CC(CC(=O)O)c2ccccc2)cc1		CHEMBL2177677	>	Activity	uM	20.0	CHEMBL2534	Homo sapiens	Activity	uM	20.0
	12146534	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(Br)cc1)c1ccccc1		CHEMBL2177682	>	Activity	uM	20.0	CHEMBL2534	Homo sapiens	Activity	uM	20.0
	12146535	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL2177685	>	Activity	uM	20.0	CHEMBL2534	Homo sapiens	Activity	uM	20.0
	12146536	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177673	>	Activity	uM	10.0	CHEMBL2534	Homo sapiens	Activity	uM	10.0
	12146537	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(C[C@@H](c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177665	>	Activity	uM	9.0	CHEMBL2534	Homo sapiens	Activity	uM	9.0
	12146540	CHEMBL2182498	Increase in thermal stability of PDK1 by differential scanning fluorimetry relative to control	B	CC[C@H](C)[C@H](NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCNC(=N)N)[C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CS)C(=O)O		CHEMBL1213203	=	Delta Tm	degrees C	7.3	CHEMBL2534	Homo sapiens	deltaTm	degrees C	7.3
	12146541	CHEMBL2182498	Increase in thermal stability of PDK1 by differential scanning fluorimetry relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177670	=	Delta Tm	degrees C	5.2	CHEMBL2534	Homo sapiens	deltaTm	degrees C	5.2
	12146542	CHEMBL2182498	Increase in thermal stability of PDK1 by differential scanning fluorimetry relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc2c(c1)[nH]c1ccccc12		CHEMBL2177686	=	Delta Tm	degrees C	4.9	CHEMBL2534	Homo sapiens	deltaTm	degrees C	4.9
	12146543	CHEMBL2182498	Increase in thermal stability of PDK1 by differential scanning fluorimetry relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	Delta Tm	degrees C	3.9	CHEMBL2534	Homo sapiens	deltaTm	degrees C	3.9
	12146544	CHEMBL2182498	Increase in thermal stability of PDK1 by differential scanning fluorimetry relative to control	B	O=C(CC(c1ccc2ccccc2c1)C(C(=O)O)C(=O)O)c1ccc(I)cc1		CHEMBL2177659	=	Delta Tm	degrees C	2.4	CHEMBL2534	Homo sapiens	deltaTm	degrees C	2.4
	12146546	CHEMBL2182495	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 50 uM by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	Activity	%	637.0	CHEMBL2534	Homo sapiens	Activity	%	637.0
	12146547	CHEMBL2182495	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 50 uM by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177675	=	Activity	%	558.0	CHEMBL2534	Homo sapiens	Activity	%	558.0
	12146548	CHEMBL2182496	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 2 uM by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	Activity	%	305.0	CHEMBL2534	Homo sapiens	Activity	%	305.0
	12146549	CHEMBL2182495	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 50 uM by phosphor imaging analysis relative to control	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134	=	Activity	%	242.0	CHEMBL2534	Homo sapiens	Activity	%	242.0
	12146550	CHEMBL2182496	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 2 uM by phosphor imaging analysis relative to control	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(Cl)cc1		CHEMBL2177675	=	Activity	%	228.0	CHEMBL2534	Homo sapiens	Activity	%	228.0
Not Active	12146560	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(Cl)cc1		CHEMBL2177678		max activation			CHEMBL2534	Homo sapiens	max activation		
Not Active	12146561	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(O)CC(CC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1		CHEMBL2177683		max activation			CHEMBL2534	Homo sapiens	max activation		
Not Active	12146562	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1cc(-c2ccccc2)cs1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177658		max activation			CHEMBL2534	Homo sapiens	max activation		
Not Active	12146563	CHEMBL2182501	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis relative to control	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(O)cc1		CHEMBL2177661		max activation			CHEMBL2534	Homo sapiens	max activation		
Not Active	12146567	CHEMBL2182468	Activation of PDK1 in IGF-I-stimulated HEK293 cells assessed as decrease of phosphorylation of PKB T-loop at 50 uM after 2 hrs by Western blot analysis	B	CC(=O)OCOC(=O)C(C(=O)OCOC(C)=O)C(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL2177688		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146568	CHEMBL2182469	Activation of PDK1 in IGF-I-stimulated HEK293 cells assessed as decrease of phosphorylation of PKCzeta at Thr410 at 50 uM after 2 hrs by Western blot analysis	B	CC(=O)OCOC(=O)C(C(=O)OCOC(C)=O)C(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL2177688		Activity			CHEMBL2534	Homo sapiens	Activity		
Active	12146569	CHEMBL2182470	Activation of PDK1 in IGF-I-stimulated HEK293 cells assessed as decrease of phosphorylation of S6K activation loop at 50 uM after 2 hrs by Western blot analysis	B	CC(=O)OCOC(=O)C(C(=O)OCOC(C)=O)C(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccccc1		CHEMBL2177688		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146609	CHEMBL2182496	Activation of PDK1 using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ at 2 uM by phosphor imaging analysis relative to control	B	O=C(O)/C=C(/CCc1ccc(Cl)cc1)c1ccccc1		CHEMBL539134		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146610	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(Cl)cc1		CHEMBL2177678		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146611	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(O)CC(CC(=O)c1ccc(Cl)cc1)c1ccc(Cl)cc1		CHEMBL2177683		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146612	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1cc(-c2ccccc2)cs1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177658		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	12146613	CHEMBL2182500	Activation of PDK1 assessed as half maximal activation using KTFCGTPEYLAPEVRR as substrate and [gamma32P]-ATP/Mg2+ by phosphor imaging analysis	B	O=C(CC(c1ccc(Cl)cc1)C(C(=O)O)C(=O)O)c1ccc(O)cc1		CHEMBL2177661		Activity			CHEMBL2534	Homo sapiens	Activity		
	12170756	CHEMBL2209883	Inhibition of PDK1 assessed as residual activity at 1 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
	12170887	CHEMBL2213206	Inhibition of PDK1 assessed as residual activity at 10 uM	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	91.0	CHEMBL2534	Homo sapiens	Activity	%	91.0
	12172293	CHEMBL2215408	Inhibition of PDPK1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	12183839	CHEMBL2211977	Inhibition of PDPK1	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	pIC50		5.0
	12190927	CHEMBL2213810	Inhibition of PDK1 by radiometry	B	O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1C1CC1)C1CCC1		CHEMBL2207187	=	IC50	nM	580.0	CHEMBL2534	Homo sapiens	IC50	nM	580.0
	12190928	CHEMBL2213810	Inhibition of PDK1 by radiometry	B	O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)C1CCC1		CHEMBL2207181	=	IC50	nM	68.0	CHEMBL2534	Homo sapiens	IC50	nM	68.0
	12190929	CHEMBL2213810	Inhibition of PDK1 by radiometry	B	O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)C1CCCC1		CHEMBL2207180	=	IC50	nM	220.0	CHEMBL2534	Homo sapiens	IC50	nM	220.0
	12190930	CHEMBL2213810	Inhibition of PDK1 by radiometry	B	O=C(NCCCNc1nc(Nc2cccc(F)c2)ncc1Br)c1cccs1		CHEMBL2207218	=	IC50	nM	130.0	CHEMBL2534	Homo sapiens	IC50	nM	130.0
	12190931	CHEMBL2213810	Inhibition of PDK1 by radiometry	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1		CHEMBL2207217	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
	12195436	CHEMBL2209636	Inhibition of recombinant PDK1 after 1 hr by scintillation counter analysis in presence of gamma-[33P]ATP	B	CC(C)(C)Nc1c(Nc2ccnc(Nc3ccc(-c4ccncc4)cc3)n2)c(=O)c1=O		CHEMBL2205426	=	Ki	nM	71.0	CHEMBL2534	Homo sapiens	Ki	nM	71.0
	12195593	CHEMBL2212372	Inhibition of human recombinant PDK1 expressed in insect cells using Ulight-FLGFTYVAP as substrate assessed as residual activity at 1 uM after 90 mins relative to staurosporine	B	CCN(CC)CCOc1ccc(/C=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL2206008	=	Activity	%	106.9	CHEMBL2534	Homo sapiens	Activity	%	106.9
	12252098	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12252099	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	21.0	CHEMBL2534	Homo sapiens	Residual Activity	%	21.0
	12252100	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	29.0	CHEMBL2534	Homo sapiens	Residual Activity	%	29.0
	12252101	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	83.0	CHEMBL2534	Homo sapiens	Residual Activity	%	83.0
	12252102	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	103.0	CHEMBL2534	Homo sapiens	Residual Activity	%	103.0
	12252103	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	90.0	CHEMBL2534	Homo sapiens	Residual Activity	%	90.0
	12252104	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12252105	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12252106	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12252107	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	9.0	CHEMBL2534	Homo sapiens	Residual Activity	%	9.0
	12252108	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12252109	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	94.0	CHEMBL2534	Homo sapiens	Residual Activity	%	94.0
	12252110	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	39.0	CHEMBL2534	Homo sapiens	Residual Activity	%	39.0
	12252111	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12252112	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12252113	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12252114	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	87.0	CHEMBL2534	Homo sapiens	Residual Activity	%	87.0
	12252115	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12252116	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12252117	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	70.0	CHEMBL2534	Homo sapiens	Residual Activity	%	70.0
	12252118	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	39.0	CHEMBL2534	Homo sapiens	Residual Activity	%	39.0
	12252119	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	0.0	CHEMBL2534	Homo sapiens	Residual Activity	%	0.0
	12252120	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12252121	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	4.0	CHEMBL2534	Homo sapiens	Residual Activity	%	4.0
	12252122	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	45.0	CHEMBL2534	Homo sapiens	Residual Activity	%	45.0
	12252123	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12252124	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	94.0	CHEMBL2534	Homo sapiens	Residual Activity	%	94.0
	12252125	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12252126	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12252127	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	26.0	CHEMBL2534	Homo sapiens	Residual Activity	%	26.0
	12252128	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12252129	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12252130	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12252131	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	85.0	CHEMBL2534	Homo sapiens	Residual Activity	%	85.0
	12252132	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12252133	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12252134	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	17.0	CHEMBL2534	Homo sapiens	Residual Activity	%	17.0
	12252135	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12252136	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12252137	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12252138	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	31.0	CHEMBL2534	Homo sapiens	Residual Activity	%	31.0
	12252139	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	84.0	CHEMBL2534	Homo sapiens	Residual Activity	%	84.0
	12252140	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	81.0	CHEMBL2534	Homo sapiens	Residual Activity	%	81.0
	12252141	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	44.0	CHEMBL2534	Homo sapiens	Residual Activity	%	44.0
	12252142	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12252143	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12252144	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	97.0	CHEMBL2534	Homo sapiens	Residual Activity	%	97.0
	12252145	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12252146	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	65.0	CHEMBL2534	Homo sapiens	Residual Activity	%	65.0
	12252147	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	0.0	CHEMBL2534	Homo sapiens	Residual Activity	%	0.0
	12252148	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12252149	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	97.0	CHEMBL2534	Homo sapiens	Residual Activity	%	97.0
	12252150	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	19.0	CHEMBL2534	Homo sapiens	Residual Activity	%	19.0
	12252151	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12252152	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	40.0	CHEMBL2534	Homo sapiens	Residual Activity	%	40.0
	12252153	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	68.0	CHEMBL2534	Homo sapiens	Residual Activity	%	68.0
	12252154	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	85.0	CHEMBL2534	Homo sapiens	Residual Activity	%	85.0
	12252155	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	3.0	CHEMBL2534	Homo sapiens	Residual Activity	%	3.0
	12252156	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	37.0	CHEMBL2534	Homo sapiens	Residual Activity	%	37.0
	12252157	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	74.0	CHEMBL2534	Homo sapiens	Residual Activity	%	74.0
	12252158	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	87.0	CHEMBL2534	Homo sapiens	Residual Activity	%	87.0
	12252159	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12252160	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	82.0	CHEMBL2534	Homo sapiens	Residual Activity	%	82.0
	12252161	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	84.0	CHEMBL2534	Homo sapiens	Residual Activity	%	84.0
	12252162	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12252163	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12252164	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	67.0	CHEMBL2534	Homo sapiens	Residual Activity	%	67.0
	12252165	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	93.0	CHEMBL2534	Homo sapiens	Residual Activity	%	93.0
	12252166	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	40.0	CHEMBL2534	Homo sapiens	Residual Activity	%	40.0
	12252167	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12252168	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	20.0	CHEMBL2534	Homo sapiens	Residual Activity	%	20.0
	12252169	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12252170	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12252171	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12252172	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12252173	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12252174	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	94.0	CHEMBL2534	Homo sapiens	Residual Activity	%	94.0
	12252175	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	41.0	CHEMBL2534	Homo sapiens	Residual Activity	%	41.0
	12277437	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12277438	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	71.0	CHEMBL2534	Homo sapiens	Residual Activity	%	71.0
	12277439	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	93.0	CHEMBL2534	Homo sapiens	Residual Activity	%	93.0
	12277440	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12277441	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12277442	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279026	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	76.0	CHEMBL2534	Homo sapiens	Residual Activity	%	76.0
	12279027	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	97.0	CHEMBL2534	Homo sapiens	Residual Activity	%	97.0
	12279028	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279029	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279030	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12279031	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279032	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279033	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279034	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279035	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279036	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	121.0	CHEMBL2534	Homo sapiens	Residual Activity	%	121.0
	12279037	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279038	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279039	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	3.0	CHEMBL2534	Homo sapiens	Residual Activity	%	3.0
	12279040	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279041	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279042	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279043	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279044	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279045	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279046	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	79.0	CHEMBL2534	Homo sapiens	Residual Activity	%	79.0
	12279047	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	97.0	CHEMBL2534	Homo sapiens	Residual Activity	%	97.0
	12279048	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279049	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	39.0	CHEMBL2534	Homo sapiens	Residual Activity	%	39.0
	12279050	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279051	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279052	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	113.0	CHEMBL2534	Homo sapiens	Residual Activity	%	113.0
	12279053	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279054	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279055	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279056	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279057	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	117.0	CHEMBL2534	Homo sapiens	Residual Activity	%	117.0
	12279058	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279059	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279060	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	131.0	CHEMBL2534	Homo sapiens	Residual Activity	%	131.0
	12279061	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	115.0	CHEMBL2534	Homo sapiens	Residual Activity	%	115.0
	12279062	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12279063	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12279064	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279065	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279066	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	113.0	CHEMBL2534	Homo sapiens	Residual Activity	%	113.0
	12279067	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279068	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	121.0	CHEMBL2534	Homo sapiens	Residual Activity	%	121.0
	12279069	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279070	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	62.0	CHEMBL2534	Homo sapiens	Residual Activity	%	62.0
	12279071	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279072	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	31.0	CHEMBL2534	Homo sapiens	Residual Activity	%	31.0
	12279073	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12279074	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279075	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279076	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	124.0	CHEMBL2534	Homo sapiens	Residual Activity	%	124.0
	12279077	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279078	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279079	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279080	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279081	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	2.0	CHEMBL2534	Homo sapiens	Residual Activity	%	2.0
	12279082	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279083	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279084	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	120.0	CHEMBL2534	Homo sapiens	Residual Activity	%	120.0
	12279085	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279086	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279087	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279088	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279089	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279090	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	115.0	CHEMBL2534	Homo sapiens	Residual Activity	%	115.0
	12279091	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279092	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	63.0	CHEMBL2534	Homo sapiens	Residual Activity	%	63.0
	12279093	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	119.0	CHEMBL2534	Homo sapiens	Residual Activity	%	119.0
	12279094	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	113.0	CHEMBL2534	Homo sapiens	Residual Activity	%	113.0
	12279095	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279096	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279097	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	78.0	CHEMBL2534	Homo sapiens	Residual Activity	%	78.0
	12279098	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	103.0	CHEMBL2534	Homo sapiens	Residual Activity	%	103.0
	12279099	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	1.0	CHEMBL2534	Homo sapiens	Residual Activity	%	1.0
	12279100	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279101	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	68.0	CHEMBL2534	Homo sapiens	Residual Activity	%	68.0
	12279102	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	75.0	CHEMBL2534	Homo sapiens	Residual Activity	%	75.0
	12279103	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279104	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279105	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279106	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279107	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	117.0	CHEMBL2534	Homo sapiens	Residual Activity	%	117.0
	12279108	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12279109	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	53.0	CHEMBL2534	Homo sapiens	Residual Activity	%	53.0
	12279110	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279111	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12279112	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	94.0	CHEMBL2534	Homo sapiens	Residual Activity	%	94.0
	12279113	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279114	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279115	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279116	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	103.0	CHEMBL2534	Homo sapiens	Residual Activity	%	103.0
	12279117	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279118	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12279119	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL2534	Homo sapiens	Residual Activity	%	85.0
	12279120	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	56.0	CHEMBL2534	Homo sapiens	Residual Activity	%	56.0
	12279121	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-1.0	CHEMBL2534	Homo sapiens	Residual Activity	%	-1.0
	12279122	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279123	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	27.0	CHEMBL2534	Homo sapiens	Residual Activity	%	27.0
	12279124	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	45.0	CHEMBL2534	Homo sapiens	Residual Activity	%	45.0
	12279125	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279126	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	102.0	CHEMBL2534	Homo sapiens	Residual Activity	%	102.0
	12279127	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279128	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279129	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	85.0	CHEMBL2534	Homo sapiens	Residual Activity	%	85.0
	12279130	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	117.0	CHEMBL2534	Homo sapiens	Residual Activity	%	117.0
	12279131	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279132	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	17.0	CHEMBL2534	Homo sapiens	Residual Activity	%	17.0
	12279133	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279134	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279135	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279136	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	57.0	CHEMBL2534	Homo sapiens	Residual Activity	%	57.0
	12279137	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	119.0	CHEMBL2534	Homo sapiens	Residual Activity	%	119.0
	12279138	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279139	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279140	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	60.0	CHEMBL2534	Homo sapiens	Residual Activity	%	60.0
	12279141	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279142	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279143	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	56.0	CHEMBL2534	Homo sapiens	Residual Activity	%	56.0
	12279144	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	29.0	CHEMBL2534	Homo sapiens	Residual Activity	%	29.0
	12279145	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	113.0	CHEMBL2534	Homo sapiens	Residual Activity	%	113.0
	12279146	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279147	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	115.0	CHEMBL2534	Homo sapiens	Residual Activity	%	115.0
	12279148	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	70.0	CHEMBL2534	Homo sapiens	Residual Activity	%	70.0
	12279149	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	3.0	CHEMBL2534	Homo sapiens	Residual Activity	%	3.0
	12279150	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279151	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279152	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	72.0	CHEMBL2534	Homo sapiens	Residual Activity	%	72.0
	12279153	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279154	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	92.0	CHEMBL2534	Homo sapiens	Residual Activity	%	92.0
	12279155	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279156	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279157	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	20.0	CHEMBL2534	Homo sapiens	Residual Activity	%	20.0
	12279158	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	42.0	CHEMBL2534	Homo sapiens	Residual Activity	%	42.0
	12279159	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279160	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	98.0	CHEMBL2534	Homo sapiens	Residual Activity	%	98.0
	12279161	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279162	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279163	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279164	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279165	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279166	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	91.0	CHEMBL2534	Homo sapiens	Residual Activity	%	91.0
	12279167	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279168	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	92.0	CHEMBL2534	Homo sapiens	Residual Activity	%	92.0
	12279169	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279170	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	76.0	CHEMBL2534	Homo sapiens	Residual Activity	%	76.0
	12279171	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279172	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	98.0	CHEMBL2534	Homo sapiens	Residual Activity	%	98.0
	12279173	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279174	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279175	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279176	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279177	CHEMBL2219388	Millipore: Percentage of residual kinase activity of PDPK1 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	45.0	CHEMBL2534	Homo sapiens	Residual Activity	%	45.0
	12279178	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	94.0	CHEMBL2534	Homo sapiens	Residual Activity	%	94.0
	12279179	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	18.0	CHEMBL2534	Homo sapiens	Residual Activity	%	18.0
	12279180	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	87.0	CHEMBL2534	Homo sapiens	Residual Activity	%	87.0
	12279181	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279182	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	64.0	CHEMBL2534	Homo sapiens	Residual Activity	%	64.0
	12279183	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	87.0	CHEMBL2534	Homo sapiens	Residual Activity	%	87.0
	12279184	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	32.0	CHEMBL2534	Homo sapiens	Residual Activity	%	32.0
	12279185	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	92.0	CHEMBL2534	Homo sapiens	Residual Activity	%	92.0
	12279186	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279187	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	92.0	CHEMBL2534	Homo sapiens	Residual Activity	%	92.0
	12279188	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279189	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	81.0	CHEMBL2534	Homo sapiens	Residual Activity	%	81.0
	12279190	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279191	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	117.0	CHEMBL2534	Homo sapiens	Residual Activity	%	117.0
	12279192	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	88.0	CHEMBL2534	Homo sapiens	Residual Activity	%	88.0
	12279193	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	108.0	CHEMBL2534	Homo sapiens	Residual Activity	%	108.0
	12279194	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	149.0	CHEMBL2534	Homo sapiens	Residual Activity	%	149.0
	12279195	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279196	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279197	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	1.0	CHEMBL2534	Homo sapiens	Residual Activity	%	1.0
	12279198	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279199	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279200	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279201	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279202	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	103.0	CHEMBL2534	Homo sapiens	Residual Activity	%	103.0
	12279203	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	86.0	CHEMBL2534	Homo sapiens	Residual Activity	%	86.0
	12279204	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	23.0	CHEMBL2534	Homo sapiens	Residual Activity	%	23.0
	12279205	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	76.0	CHEMBL2534	Homo sapiens	Residual Activity	%	76.0
	12279206	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279207	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	8.0	CHEMBL2534	Homo sapiens	Residual Activity	%	8.0
	12279208	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279209	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279210	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	120.0	CHEMBL2534	Homo sapiens	Residual Activity	%	120.0
	12279211	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279212	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279213	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279214	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279215	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	126.0	CHEMBL2534	Homo sapiens	Residual Activity	%	126.0
	12279216	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279217	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	99.0	CHEMBL2534	Homo sapiens	Residual Activity	%	99.0
	12279218	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	138.0	CHEMBL2534	Homo sapiens	Residual Activity	%	138.0
	12279219	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	107.0	CHEMBL2534	Homo sapiens	Residual Activity	%	107.0
	12279220	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12279221	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	2.0	CHEMBL2534	Homo sapiens	Residual Activity	%	2.0
	12279222	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279223	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279224	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279225	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	60.0	CHEMBL2534	Homo sapiens	Residual Activity	%	60.0
	12279226	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	116.0	CHEMBL2534	Homo sapiens	Residual Activity	%	116.0
	12279227	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279228	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	14.0	CHEMBL2534	Homo sapiens	Residual Activity	%	14.0
	12279229	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279230	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	6.0	CHEMBL2534	Homo sapiens	Residual Activity	%	6.0
	12279231	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	95.0	CHEMBL2534	Homo sapiens	Residual Activity	%	95.0
	12279232	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279233	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	100.0	CHEMBL2534	Homo sapiens	Residual Activity	%	100.0
	12279234	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279235	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	111.0	CHEMBL2534	Homo sapiens	Residual Activity	%	111.0
	12279236	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	88.0	CHEMBL2534	Homo sapiens	Residual Activity	%	88.0
	12279237	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL2534	Homo sapiens	Residual Activity	%	101.0
	12279238	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	52.0	CHEMBL2534	Homo sapiens	Residual Activity	%	52.0
	12279239	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	1.0	CHEMBL2534	Homo sapiens	Residual Activity	%	1.0
	12279240	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279241	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	105.0	CHEMBL2534	Homo sapiens	Residual Activity	%	105.0
	12279242	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	110.0	CHEMBL2534	Homo sapiens	Residual Activity	%	110.0
	12279243	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	92.0	CHEMBL2534	Homo sapiens	Residual Activity	%	92.0
	12279244	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	96.0	CHEMBL2534	Homo sapiens	Residual Activity	%	96.0
	12279245	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279246	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL2534	Homo sapiens	Residual Activity	%	98.0
	12279247	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	120.0	CHEMBL2534	Homo sapiens	Residual Activity	%	120.0
	12279248	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	109.0	CHEMBL2534	Homo sapiens	Residual Activity	%	109.0
	12279249	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	93.0	CHEMBL2534	Homo sapiens	Residual Activity	%	93.0
	12279250	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	15.0	CHEMBL2534	Homo sapiens	Residual Activity	%	15.0
	12279251	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279252	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	114.0	CHEMBL2534	Homo sapiens	Residual Activity	%	114.0
	12279253	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	112.0	CHEMBL2534	Homo sapiens	Residual Activity	%	112.0
	12279254	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	106.0	CHEMBL2534	Homo sapiens	Residual Activity	%	106.0
	12279255	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	39.0	CHEMBL2534	Homo sapiens	Residual Activity	%	39.0
	12279256	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	104.0	CHEMBL2534	Homo sapiens	Residual Activity	%	104.0
	12279257	CHEMBL2219389	Millipore: Percentage of residual kinase activity of PDPK1 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 50 mM Tris pH 7.5, 0.1% ?-mercaptoethanol	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL2534	Homo sapiens	Residual Activity	%	0.0
	12700143	CHEMBL2342681	Inhibition of recombinant PDK1 (unknown origin) at 5 uM by FRET-based Z'-LYTE assay	B	O=C1/C(=C/c2ccccn2)CNC/C1=C\c1ccccn1		CHEMBL574646	=	Inhibition	%	54.0	CHEMBL2534	Homo sapiens	INH	%	54.0
	12705518	CHEMBL2343757	Inhibition of middle T-tagged at N terminus (MEYMPME) full length human recombinant PDK1 using Thr-308tide as substrate incubated for 10 mins prior to substrate addition measured after 40 mins by TR-FRET uHTS assay	B	CCNC(=O)O[C@@H]1CC[C@@H]2C(C(=O)Nc3ccc(N(C)C)cc3)C[C@H]1N2Cc1ccccc1		CHEMBL2332033	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	12705519	CHEMBL2343758	Inhibition of middle T-tagged at N terminus (MEYMPME) full length human recombinant PDK1 using PDKtide as substrate incubated for 10 mins prior to substrate addition measured after 40 mins by TR-FRET uHTS assay	B	CCNC(=O)O[C@@H]1CC[C@@H]2C(C(=O)Nc3ccc(N(C)C)cc3)C[C@H]1N2Cc1ccccc1		CHEMBL2332033	=	IC50	nM	5700.0	CHEMBL2534	Homo sapiens	IC50	uM	5.7
	12705520	CHEMBL2343759	Agonist activity at human N-terminal His6-tagged PDK1 amino acid residues 51 to 359 expressed in insect sf21 cells using T308tide as substrate at 313 uM incubated for 60 mins prior to substrate addition measured after 60 mins by ATP depletion assay	B	COc1ccc(CC(C(=O)O)c2ccccc2)cc1		CHEMBL83949	=	Activity	%	33.0	CHEMBL2534	Homo sapiens	Activity	%	33.0
	12705521	CHEMBL2343760	Competitive binding affinity to GST-PDK1 (unknown origin) preincubated for 1 to 10 mins by surface plasmon resonance in presence of biotin-PIFtide	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1	Outside typical range	CHEMBL550259	=	EC50	nM	133000.0	CHEMBL2534	Homo sapiens	EC50	uM	133.0
	12705522	CHEMBL2343761	Binding affinity to PDK1 (unknown origin) by isothermal titration calorimetric assay	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL550259	=	Kd	nM	18000.0	CHEMBL2534	Homo sapiens	Kd	uM	18.0
	12705523	CHEMBL2343762	Agonist activity at PDK1 (unknown origin) using T308tide as substrate assessed as concentration required to elicit 50% response in presence of [gamma-32P]ATP	B	O=C(O)CSC(CC(=O)c1ccc(Cl)cc1)c1ccccc1		CHEMBL550259	=	Activity	uM	34.0	CHEMBL2534	Homo sapiens	Activity	uM	34.0
	12705525	CHEMBL2340278	Inhibition of PDK1 (unknown origin)	B	O=P(O)(O)O[C@@H]1[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@@H]1OCc1ccccc1		CHEMBL2332032	=	IC50	nM	26.5	CHEMBL2534	Homo sapiens	IC50	nM	26.5
	12705526	CHEMBL2343756	Inhibition of PDK1 autophosphorylation at ser241 in human PC3 cells at 5 uM measured at 48 hrs	B	O=C(N[C@@H](COc1ccc2[nH]c(=O)[nH]c2c1)c1ccccc1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL1234429	=	Inhibition	%	70.0	CHEMBL2534	Homo sapiens	INH	%	70.0
	12705544	CHEMBL2340279	Inhibition of recombinant full length PDK1 (unknown origin) expressed in insect cells assessed as inhibition of Akt activation measured for 30 mins in presence of [gamma32P-ATP]	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
	12705545	CHEMBL2340278	Inhibition of PDK1 (unknown origin)	B	N#CCc1ccc(-n2cnc3cnc4ccc(C#Cc5cccnc5)cc4c32)cc1		CHEMBL272265	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
	12705546	CHEMBL2340278	Inhibition of PDK1 (unknown origin)	B	COc1cc2ncc3c(N)nc4c(C)c(N)ccc4c3c2cc1OC		CHEMBL235157	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	nM	60.0
	12705547	CHEMBL2340278	Inhibition of PDK1 (unknown origin)	B	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL228654	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
	12705548	CHEMBL2340281	Displacement of [gamma33P]ATP from human TBK1 expressed in insect sf21 cells measured for 30 mins	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1		CHEMBL2207217	=	IC50	nM	2.3	CHEMBL2534	Homo sapiens	IC50	nM	2.3
	12705549	CHEMBL2340280	Inhibition of human IKKepsilon expressed in insect sf21 cells using MBP as substrate measured for 30 mins	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1		CHEMBL2207217	=	IC50	nM	9.5	CHEMBL2534	Homo sapiens	IC50	nM	9.5
	12705550	CHEMBL2340282	Inhibition of human Aurora B expressed in insect sf21 cells using LRRLSLGLRRLSLGLRRLSLGLRRLSLG peptide as substrate measured for 30 mins	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1		CHEMBL2207217	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
	12705551	CHEMBL2340283	Displacement of [gamma33P]ATP from human PDK1 expressed in insect sf21 cells measured for 30 mins	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br)c1cccs1		CHEMBL2207217	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
	12705552	CHEMBL2340285	Inhibition of N terminal His-tagged human recombinant PDK1 using H2NARRRGVTTKTFCGT peptide as substrate assessed as substrate phosphorylation after 4 hrs by phosphorimager analysis in presence of [gamma-32P]ATP	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	IC50	nM	30.0	CHEMBL2534	Homo sapiens	IC50	nM	30.0
	12705553	CHEMBL2340284	Inhibition of recombinant PDK1 (unknown origin) using RPRAATF peptide as substrate assessed as substrate phosphorylation by scintillation counting analysis in presence of [gamma-32P]ATP	B	NC(N)=Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL2332031	=	IC50	nM	2000.0	CHEMBL2534	Homo sapiens	IC50	uM	2.0
	12705554	CHEMBL2340284	Inhibition of recombinant PDK1 (unknown origin) using RPRAATF peptide as substrate assessed as substrate phosphorylation by scintillation counting analysis in presence of [gamma-32P]ATP	B	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1650595	=	IC50	nM	5000.0	CHEMBL2534	Homo sapiens	IC50	uM	5.0
	12721803	CHEMBL2353789	Inhibition of PDPK1 (unknown origin) at 1 uM relative to control	B	CCNC(=O)Nc1nc2ccc(-c3ccccc3OC)cc2s1		CHEMBL2347710	=	Inhibition	%	67.0	CHEMBL2534	Homo sapiens	INH	%	67.0
Not Active	13349222	CHEMBL2399721	Inhibition of recombinant PDPK-1 (unknown origin) at 10 uM	B	O=C(Nc1ccc(OC(F)(F)F)cc1)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL2397148		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	13349223	CHEMBL2399721	Inhibition of recombinant PDPK-1 (unknown origin) at 10 uM	B	O=C(NC12CC3CC(CC(C3)C1)C2)N[C@H]1CC[C@H](Oc2ccc(C(=O)O)cc2)CC1		CHEMBL242459		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	13364122	CHEMBL2404357	Inhibition of PDK1-mediated Akt activation in human PC3 cells after 2 hrs by Western blotting analysis	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118	=	IC50	nM	48000.0	CHEMBL2534	Homo sapiens	IC50	uM	48.0
	13442317	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	13445452	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	97.0	CHEMBL2534	Homo sapiens	INH	%	97.0
	13448507	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	13448643	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O=C([C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1)N1CCOCC1		CHEMBL2425649	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	13451438	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	N[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425652	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	13454623	CHEMBL2429485	Competitive binding affinity to PDPK1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	13859805	CHEMBL3101310	Inhibition of PDK1 (unknown origin) at 1 uM relative to control	B	COC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)c1cc(C(=O)O)c2cc(-c3cccc(Cl)c3)ccc2n1		CHEMBL3099755	>	Inhibition	%	20.0	CHEMBL2534	Homo sapiens	INH	%	20.0
	13871789	CHEMBL3101250	Inhibition of human PDK1 assessed as residual activity at 1 uM relative to control	B	O=C1Nc2ncccc2/C1=C1/Nc2ncccc2C1=O		CHEMBL3099673	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
Not Active	13932956	CHEMBL3124151	Binding affinity to PDK1 in human SQ20B cells after 10 to 12 hrs by pull down assay	B	O=C(CCC(=O)ON1C(=O)CCC1=O)NCCNC(=O)COC(=O)NCCOCCOCCOCCOCCOCCOCCNC(=O)C1CCN(C2CCN(Cc3c(O)ccc4oc(-c5ccccc5)cc34)CC2)CC1		CHEMBL3120211		Activity			CHEMBL2534	Homo sapiens	Activity		
	14582581	CHEMBL3241645	Inhibition of human PDK1 assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	105.0	CHEMBL2534	Homo sapiens	Activity	%	105.0
	14648058	CHEMBL3265839	Inhibition of human PDK1 at 1 uM relative to control	B	CC(C)CCNc1ccc(-c2cnc3ccc(NC4CCN(C)CC4)nn23)cn1		CHEMBL2380687	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	14648059	CHEMBL3265839	Inhibition of human PDK1 at 1 uM relative to control	B	N[C@H]1CC[C@H](Nc2ccc3ncc(-c4cnc(Nc5ncccc5F)nc4)n3n2)CC1		CHEMBL3264059	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	14980854	CHEMBL3372440	Inhibition of PDK1 (unknown origin) in presence of 1 mM ATP	B	CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2)cc1		CHEMBL3355482	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	uM	100.0
	14983177	CHEMBL3385022	Inhibition of PDK1 (unknown origin) at 1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	54.0	CHEMBL2534	Homo sapiens	INH	%	54.0
	14984419	CHEMBL3384372	Inhibition of PDK1 (unknown origin) at 0.1 uM	B	CN1CCN(c2ccc(-c3cnc4[nH]c5cnc(C#N)cc5c4c3)cc2)CC1		CHEMBL3359895	=	Inhibition	%	9.0	CHEMBL2534	Homo sapiens	INH	%	9.0
	15002986	CHEMBL3362011	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	CN[C@@H]1CCc2ccccc21		CHEMBL1235698	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
	15002987	CHEMBL3362011	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)nc2[nH]ccc12		CHEMBL3311455	=	IC50	nM	1200.0	CHEMBL2534	Homo sapiens	IC50	uM	1.2
	15002988	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)nc2[nH]ccc12		CHEMBL3311455	=	Inhibition	%	90.0	CHEMBL2534	Homo sapiens	INH	%	90.0
	15002989	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	O=C(Nc1cccc(Nc2nc(-c3ccc4c(c3)OCO4)c3cc[nH]c3n2)c1)N1CCCC1		CHEMBL3311454	=	Inhibition	%	61.0	CHEMBL2534	Homo sapiens	INH	%	61.0
	15002990	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1cc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc(OC)c1OC		CHEMBL3311453	=	Inhibition	%	36.0	CHEMBL2534	Homo sapiens	INH	%	36.0
	15002991	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc1OC		CHEMBL3311452	=	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	INH	%	65.0
	15002992	CHEMBL3362011	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc1		CHEMBL3311451	=	IC50	nM	4900.0	CHEMBL2534	Homo sapiens	IC50	uM	4.9
	15002993	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1ccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc1		CHEMBL3311451	=	Inhibition	%	70.0	CHEMBL2534	Homo sapiens	INH	%	70.0
	15002994	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1cccc(-c2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)c1		CHEMBL3311450	=	Inhibition	%	48.0	CHEMBL2534	Homo sapiens	INH	%	48.0
	15002995	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	O=C(Nc1cccc(Nc2nc(-c3ccccc3)c3cc[nH]c3n2)c1)N1CCCC1		CHEMBL3311449	=	Inhibition	%	59.0	CHEMBL2534	Homo sapiens	INH	%	59.0
	15002996	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1ccc(Oc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc1		CHEMBL3311448	=	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	INH	%	65.0
	15002997	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	COc1ccc(Nc2nc(Nc3cccc(NC(=O)N4CCCC4)c3)nc3[nH]ccc23)cc1		CHEMBL3311447	=	Inhibition	%	45.0	CHEMBL2534	Homo sapiens	INH	%	45.0
	15002998	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	O=C(Nc1cccc(Nc2nc(Nc3ccccc3)c3cc[nH]c3n2)c1)N1CCCC1		CHEMBL3311446	=	Inhibition	%	46.0	CHEMBL2534	Homo sapiens	INH	%	46.0
	15002999	CHEMBL3362010	Inhibition of PDK1 (unknown origin) expressed in HEK293 cells using PDKtide as substrate at 10 uM after 10 mins by liquid scintillation counting in presence of [gamma-32P]ATP	B	O=C(Nc1cccc(Nc2nc(-c3cccc(OCc4cccnc4)c3)c3cc[nH]c3n2)c1)N1CCCC1		CHEMBL3311445	=	Inhibition	%	46.0	CHEMBL2534	Homo sapiens	INH	%	46.0
	15008075	CHEMBL3369102	Inhibition of human PDK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccc4)cc23)c1		CHEMBL3330255	=	Inhibition	%	31.0	CHEMBL2534	Homo sapiens	INH	%	31.0
	15008076	CHEMBL3369102	Inhibition of human PDK1 at 1 uM by radiometric Assay	B	COC(C(=O)Nc1ccc2[nH]nc(-c3cccc(S(N)(=O)=O)c3)c2c1)c1ccccc1		CHEMBL3330401	=	Inhibition	%	31.0	CHEMBL2534	Homo sapiens	INH	%	31.0
	15008077	CHEMBL3369102	Inhibition of human PDK1 at 1 uM by radiometric Assay	B	NS(=O)(=O)c1cccc(-c2n[nH]c3ccc(NC(=O)C(c4ccsc4)N4CCCC4)cc23)c1		CHEMBL3330410	=	Inhibition	%	34.0	CHEMBL2534	Homo sapiens	INH	%	34.0
	15018661	CHEMBL3361553	Inhibition of PDK1 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	17.9	CHEMBL2534	Homo sapiens	INH	%	17.9
	15019193	CHEMBL3364386	Inhibition of PDK1 (unknown origin) at 1 uM in presence of 100 uM ATP	B	C=CC(=O)[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C		CHEMBL3298512	=	Inhibition	%	15.0	CHEMBL2534	Homo sapiens	INH	%	15.0
	15036908	CHEMBL3381097	Inhibition of PDK1 (unknown origin)	B	Nc1nc2c3c(F)cccc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309990	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15036909	CHEMBL3381097	Inhibition of PDK1 (unknown origin)	B	Nc1ccc2c(c1)nc(Cc1ccc3c(c1)OCO3)n1nc(N)nc21		CHEMBL3309995	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15036910	CHEMBL3381097	Inhibition of PDK1 (unknown origin)	B	OCCCNc1ccc2c(c1)nc(-c1ccc3c(c1)OCO3)n1ncnc21		CHEMBL3309997	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15036911	CHEMBL3381097	Inhibition of PDK1 (unknown origin)	B	Nc1nc2c3ccc(NCCO)cc3nc(Cc3ccc4c(c3)OCO4)n2n1		CHEMBL3309998	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15036912	CHEMBL3381097	Inhibition of PDK1 (unknown origin)	B	CN1CCN(c2cc(F)c3c(c2)nc(Cc2ccc4c(c2)OCO4)n2nc(N)nc32)CC1		CHEMBL3310151	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15037318	CHEMBL3368573	Inhibition of PDPK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1OC		CHEMBL3102948	=	Inhibition	%	65.0	CHEMBL2534	Homo sapiens	INH	%	65.0
	15037319	CHEMBL3368573	Inhibition of PDPK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1cc(-c2c[nH]c3ncc(-c4cccc(N)c4)cc23)cc(OC)c1OC		CHEMBL3319457	=	Inhibition	%	100.0	CHEMBL2534	Homo sapiens	INH	%	100.0
	15037320	CHEMBL3368573	Inhibition of PDPK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4ccc(C(=O)N5CCOCC5)c(N)c4)cc23)cc1OC		CHEMBL3319467	=	Inhibition	%	31.0	CHEMBL2534	Homo sapiens	INH	%	31.0
	15037321	CHEMBL3368573	Inhibition of PDPK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2c[nH]c3ncc(-c4cc(OC)c(OC)c(OC)c4)cc23)cc1OC		CHEMBL3319468	=	Inhibition	%	76.0	CHEMBL2534	Homo sapiens	INH	%	76.0
	15037322	CHEMBL3368573	Inhibition of PDPK1 (unknown origin) at 1 uM by KINOMEscanning assay relative to control	B	COc1ccc(-c2cnc3[nH]cc(-c4ccc(OC)c(OC)c4)c3c2)cc1N		CHEMBL3319470	=	Inhibition	%	91.0	CHEMBL2534	Homo sapiens	INH	%	91.0
	15044508	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	NC(=O)Nc1ccc2[nH]c(=O)c(Nc3cccc(NC(=O)N4CCCC4)c3)cc2c1		CHEMBL3310921	=	Inhibition	%	40.0	CHEMBL2534	Homo sapiens	INH	%	40.0
	15044509	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	NC(=O)Nc1ccc2[nH]c(=O)c(Nc3cc(CC(=O)NCCN4CCCCC4)cc(NC(=O)N4CCCC4)c3)cc2c1		CHEMBL3310922	=	Inhibition	%	40.0	CHEMBL2534	Homo sapiens	INH	%	40.0
	15044510	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	O=C(Cc1ccc2[nH]c(=O)c(Nc3ccccc3)cc2c1)NCCN1CCCCC1		CHEMBL3310923	=	Inhibition	%	36.0	CHEMBL2534	Homo sapiens	INH	%	36.0
	15044511	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	CC(=O)Nc1cccc(Nc2cc3cc(NC(N)=O)ccc3[nH]c2=O)c1		CHEMBL3310924	=	Inhibition	%	20.0	CHEMBL2534	Homo sapiens	INH	%	20.0
	15044512	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	N#Cc1cccc(Nc2cc3cc(NC(=O)N4CCCC4)ccc3[nH]c2=O)c1		CHEMBL3310925	=	Inhibition	%	30.0	CHEMBL2534	Homo sapiens	INH	%	30.0
	15044513	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	COc1cccc(-c2cccc(Nc3cc4cc(NC(=O)N5CCCC5)ccc4[nH]c3=O)c2)c1		CHEMBL3310926	=	Inhibition	%	29.0	CHEMBL2534	Homo sapiens	INH	%	29.0
	15044514	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	CCOc1cccc(Nc2cc3cc(NC(=O)N4CCCC4)ccc3[nH]c2=O)c1		CHEMBL3310927	=	Inhibition	%	23.0	CHEMBL2534	Homo sapiens	INH	%	23.0
	15044515	CHEMBL3376280	Inhibition of PDK1 (unknown origin) at 10 uM using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	O=C(Nc1ccc2[nH]c(=O)c(Nc3cccc(-c4nnn[nH]4)c3)cc2c1)N1CCCC1		CHEMBL3310928	=	Inhibition	%	14.0	CHEMBL2534	Homo sapiens	INH	%	14.0
	15044516	CHEMBL3376281	Inhibition of PDK1 (unknown origin) using PDKtide substrate and [gamma-32P]ATP by scintillation counting method	B	CN[C@@H]1CCc2ccccc21		CHEMBL1235698	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
	15072481	CHEMBL3379514	Inhibition of PDK1 (unknown origin) assessed as remaining enzyme activity at 10 uM by radioactive [33P]-ATP filter binding assay	B	Cc1ccc(-c2cc(C(=O)Nc3ccnc(Cl)c3)nn2-c2ccc3ccccc3n2)cc1		CHEMBL3338802	=	Activity	%	101.0	CHEMBL2534	Homo sapiens	Activity	%	101.0
	15091075	CHEMBL3382227	Inhibition of human recombinant PDK1 expressed insect cells using Ulight-FLGFTYVAP substrate assessed as remaining enzyme activity at 1 uM after 90 mins relative to control	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Br)c(O)c(Br)c1		CHEMBL2206014	=	Activity	%	83.0	CHEMBL2534	Homo sapiens	Activity	%	83.0
	15122491	CHEMBL3367697	Inhibition of human PDK1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3ccc(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331445	=	Activity	%	78.0	CHEMBL2534	Homo sapiens	Activity	%	78.0
	15126968	CHEMBL3367697	Inhibition of human PDK1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	CCOC(=O)C1=C(C)N=c2s/c(=C\c3cc(O)c(O)c(O)c3)c(=O)n2C1c1ccc(Cl)cc1		CHEMBL3331446	=	Activity	%	69.0	CHEMBL2534	Homo sapiens	Activity	%	69.0
	15127000	CHEMBL3367697	Inhibition of human PDK1 assessed as residual activity at 10 uM by KinaseProfiler assay	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	15228438	CHEMBL3419801	Binding affinity to GST-tagged PH domain of PDK1 (unknown origin) by surface Plasmon resonance spectroscopy	B	Cc1c(O)cc2c(c1C)O[C@](C)(CCCC(C)C)CC2		CHEMBL3414669	=	Kd	nM	10200.0	CHEMBL2534	Homo sapiens	Kd	uM	10.2
	15228439	CHEMBL3419801	Binding affinity to GST-tagged PH domain of PDK1 (unknown origin) by surface Plasmon resonance spectroscopy	B	Cc1c(S(N)(=O)=O)cc2c(c1C)OC(C)(CCCC(C)C)CC2		CHEMBL3414686	=	Kd	nM	19500.0	CHEMBL2534	Homo sapiens	Kd	uM	19.5
	15228440	CHEMBL3419801	Binding affinity to GST-tagged PH domain of PDK1 (unknown origin) by surface Plasmon resonance spectroscopy	B	CC(C)CCCC1(C)CCc2cc(S(N)(=O)=O)cc(Br)c2O1		CHEMBL3414688	=	Kd	nM	11100.0	CHEMBL2534	Homo sapiens	Kd	uM	11.1
	15251810	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL443738	=	Activity	%	75.0	CHEMBL2534	Homo sapiens	Activity	%	75.0
	15251987	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427170	=	Activity	%	145.0	CHEMBL2534	Homo sapiens	Activity	%	145.0
	15252632	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427171	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	15252734	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(O)cc3s2)=N1		CHEMBL3427172	=	Activity	%	98.0	CHEMBL2534	Homo sapiens	Activity	%	98.0
	15252836	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)CS3)sc2c1		CHEMBL3427173	=	Activity	%	95.0	CHEMBL2534	Homo sapiens	Activity	%	95.0
	15253510	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)CS3)sc2c1		CHEMBL3427174	=	Activity	%	92.0	CHEMBL2534	Homo sapiens	Activity	%	92.0
	15253612	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427175	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	15253714	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COC(=O)[C@@H]1CSC(c2nc3ccc(OC)cc3s2)=N1		CHEMBL3427176	=	Activity	%	103.0	CHEMBL2534	Homo sapiens	Activity	%	103.0
	15254380	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427177	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	15254482	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	COc1ccc2nc(C3=N[C@H](C(=O)O)C(C)(C)S3)sc2c1		CHEMBL3427178	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	15254584	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@H]1C(=O)O		CHEMBL3427179	=	Activity	%	99.0	CHEMBL2534	Homo sapiens	Activity	%	99.0
	15255274	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	CC1(C)SC(c2nc3ccc(O)cc3s2)=N[C@@H]1C(=O)O		CHEMBL3427180	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	15255377	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427181	=	Activity	%	102.0	CHEMBL2534	Homo sapiens	Activity	%	102.0
	15255479	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cc(O)ccc3n2)=N1		CHEMBL3427182	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	15256211	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427183	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
	15256313	CHEMBL3428737	Inhibition of PDK1 (unknown origin) assessed as remaining activity at 100 uM by radioactive filter binding assay in presence of [33P]-ATP relative to control	B	O=C(O)[C@@H]1CSC(c2ccc3cccc(O)c3n2)=N1		CHEMBL3427184	=	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	15258367	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15258427	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15258487	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15258547	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15258607	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258667	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Thermal melting change	degrees C	-0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.5
	15258727	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15258787	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(O)Cc1ccc(O)c([N+](=O)[O-])c1		CHEMBL501822	=	Thermal melting change	degrees C	-0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.6
	15258847	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	NS(=O)(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL319467	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15258907	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Thermal melting change	degrees C	1.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.9
	15258967	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CS(=O)(=O)O.Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL1642	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259027	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259087	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15259147	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL216543	=	Thermal melting change	degrees C	0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.8
	15259207	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Thermal melting change	degrees C	0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.4
	15259267	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cn1cc(/C=C2/C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL3430785	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15259327	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B			CHEMBL3430786	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15259387	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCOc1ccc(/C=C2/SC(=O)N(CCN)C2=O)cc1		CHEMBL262615	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15259447	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1c(-c2ccc(F)cc2)c(-c2ccncc2)[nH]n1-c1ccc(Cl)cc1		CHEMBL408678	=	Thermal melting change	degrees C	-1.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.2
	15259507	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Thermal melting change	degrees C	-0.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.9
	15259567	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15259627	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1nccc(-c2c(-c3ccc(F)cc3)ncn2[C@H]2CC[C@H](O)CC2)n1		CHEMBL97162	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15259687	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15259747	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Thermal melting change	degrees C	2.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	2.9
	15259807	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCCNC(=O)Nc1ccc(Oc2ncnc3cc(OC)c(OC)cc23)cc1Cl		CHEMBL406381	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15259867	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Thermal melting change	degrees C	1.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.1
	15259927	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Thermal melting change	degrees C	-0.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.9
	15259987	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cl.NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL558969	=	Thermal melting change	degrees C	5.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	5.5
	15260047	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)c(C)c1C(=O)N1CCN(C)CC1		CHEMBL261641	=	Thermal melting change	degrees C	-0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.6
	15260107	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Thermal melting change	degrees C	1.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.0
	15260167	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15260227	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B			CHEMBL3430787	=	Thermal melting change	degrees C	3.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	3.7
	15260287	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Thermal melting change	degrees C	1.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.7
	15260347	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(c1cccnc1)c1cc2c(Nc3ccc(F)c(Cl)c3)c(C#N)cnc2cn1		CHEMBL261238	=	Thermal melting change	degrees C	1.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.2
	15260407	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15260467	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Thermal melting change	degrees C	-3.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-3.4
	15260527	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1		CHEMBL298445	=	Thermal melting change	degrees C	1.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.9
	15260587	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Thermal melting change	degrees C	1.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.6
	15260647	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B			CHEMBL3430788	=	Thermal melting change	degrees C	2.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	2.1
	15260707	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Thermal melting change	degrees C	1.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.4
	15260767	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Thermal melting change	degrees C	3.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	3.0
	15260827	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN1CCc2[nH]c(=S)c(C#N)c(-c3cccs3)c2C1		CHEMBL261211	=	Thermal melting change	degrees C	1.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.5
	15260887	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(O)c1c(F)cccc1F		CHEMBL259605	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15260947	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Thermal melting change	degrees C	6.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	6.8
	15261007	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	=	Thermal melting change	degrees C	4.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	4.0
	15261067	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN1CCC(Nc2ncc3ncnc(Nc4ccc(F)c(Cl)c4)c3n2)CC1		CHEMBL258940	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15261127	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	=	Thermal melting change	degrees C	-0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.5
	15261150	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261210	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15261270	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Brc1c(Br)c(Br)c2[nH]nnc2c1Br		CHEMBL177820	=	Thermal melting change	degrees C	-4.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-4.4
	15261330	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1cc2ncnc(Nc3cccc(Br)c3)c2cc1N		CHEMBL328216	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15261390	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Thermal melting change	degrees C	-0.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.9
	15261445	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	NC1=N/C(=C2/CCNC(=O)c3[nH]ccc32)C(=O)N1		CHEMBL255465	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15261505	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O		CHEMBL435734	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15261565	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1C=C2C(=Nc3c2c2c(c4c3=NC3=C4CCC=C3)C=NC=2)CC1		CHEMBL408953	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261625	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC.[Cl-]		CHEMBL258893	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15261698	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OC		CHEMBL29197	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15261758	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C[S+]([O-])c1ccc(CSc2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL111456	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15261818	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1cc(-c2ccc(O)cc2)oc2cc(O)cc(O)c12		CHEMBL28	=	Thermal melting change	degrees C	-1.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.9
	15261878	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12		CHEMBL44	=	Thermal melting change	degrees C	2.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	2.5
	15261934	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15261994	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)c1cc(/C=C(\C#N)C(=O)NCCCc2ccccc2)cc(C(C)C)c1O		CHEMBL261508	=	Thermal melting change	degrees C	-0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.5
	15262054	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262114	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B			CHEMBL3430782	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15262187	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)(C)n1nc(-c2cccc3ccccc23)c2c(N)ncnc21		CHEMBL264406	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262247	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)(C)n1nc(-c2ccc(Cl)cc2)c2c(N)ncnc21		CHEMBL406845	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15262307	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15262367	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(O)c1cc(NCc2cc(O)ccc2O)ccc1O		CHEMBL319620	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15262427	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	OC[C@H]1O[C@@H](n2cnc3cc(Cl)c(Cl)cc32)[C@H](O)[C@@H]1O		CHEMBL375530	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15262487	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(O)c1cc(N(Cc2ccccc2O)Cc2cc(O)ccc2O)ccc1O		CHEMBL103552	=	Thermal melting change	degrees C	0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.6
	15262547	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C\c1cc(Br)c(O)c(Br)c1		CHEMBL264949	=	Thermal melting change	degrees C	-1.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.0
	15262607	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15262667	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)c1ncnc2nc[nH]c12		CHEMBL407391	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15262727	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1ccc2c(c1)C(=O)c1cc(O)cc(O)c1C2=O		CHEMBL405992	=	Thermal melting change	degrees C	0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.3
	15262787	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1ccc2ccc(O)c(O)c2o1		CHEMBL244948	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15262847	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc(O)c2c(c1)oc(=O)c1c3cc(O)c(O)cc3oc21		CHEMBL97453	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15262907	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Thermal melting change	degrees C	4.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	4.0
	15262967	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263027	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15263087	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15263147	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#CC(C#N)=Cc1ccc(O)c(O)c1		CHEMBL76904	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15263207	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Thermal melting change	degrees C	0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.5
	15263267	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)Nc1ccccc1		CHEMBL56731	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15263327	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCOc1cc(/C=C(\C#N)C(N)=O)cc(CSc2ccccc2)c1O		CHEMBL485070	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15263423	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Thermal melting change	degrees C	-0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.6
	15263478	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C/C(O)=C(\C#N)C(=O)Nc1cc(Br)ccc1Br		CHEMBL228043	=	Thermal melting change	degrees C	-3.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-3.7
	15263538	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1c2ccccc2-c2n[nH]c3cccc1c23		CHEMBL7064	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15263598	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B			CHEMBL3430783	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15263658	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1nc2sccn2c(=O)c1CCN1CCC(=C(c2ccccc2)c2ccc(F)cc2)CC1		CHEMBL259388	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15263718	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1c2ccncc2c(C)c2c1[nH]c1ccccc12		CHEMBL123	=	Thermal melting change	degrees C	8.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	8.6
	15263732	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15263792	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1cncc2cccc(S(=O)(=O)N3CCCNC[C@@H]3C)c12		CHEMBL406821	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15263852	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15263912	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)c1ccc(CC2C(=O)Nc3ccccc32)cc1		CHEMBL1373282	=	Thermal melting change	degrees C	0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.3
	15263972	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cc2c([nH]1)CCC(Br)C2		CHEMBL408565	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15264026	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCOC(=O)c1cnc2oc3ccc(O)cc3c2c1-c1ccccc1		CHEMBL132904	=	Thermal melting change	degrees C	-0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.5
	15264086	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21.[Cl-]		CHEMBL258765	=	Thermal melting change	degrees C	-2.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-2.7
	15264146	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COC1=C2C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\C)[C@H](OC(N)=O)[C@@H](OC)/C=C\C=C(/C)C(=O)NC(=CC1=O)C2=O		CHEMBL278315	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15264206	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15264279	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C/c1cnc[nH]1		CHEMBL261692	=	Thermal melting change	degrees C	1.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.3
	15264339	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=S(=O)(c1cccc2c(Cl)cccc12)N1CCCNCC1		CHEMBL429298	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15264399	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc(/C=C/C(=O)/C=C(O)/C=C/c2ccc(O)c(OC)c2)ccc1O		CHEMBL116438	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15264459	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	NC1=NC(=O)/C(=C2\CCNC(=O)c3[nH]c(Br)cc32)N1		CHEMBL361708	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264515	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Thermal melting change	degrees C	1.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.5
	15264575	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COC(=O)[C@]1(O)C[C@@H]2O[C@@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL416056	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264635	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Thermal melting change	degrees C	0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.4
	15264695	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cl.NCCNS(=O)(=O)c1cccc2c(Cl)cccc12		CHEMBL1255867	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15264767	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1cc(C=C2C(=O)C=CC2=O)cc(C)c1O		CHEMBL437612	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15264827	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)(C)c1cc(C=C2C(=O)C=CC2=O)cc(C(C)(C)C)c1O		CHEMBL258726	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15264887	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Thermal melting change	degrees C	-1.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.3
	15264947	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)N(CCO)c1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL126254	=	Thermal melting change	degrees C	-0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.8
	15265003	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N=C(N)NCCNS(=O)(=O)c1cccc2cnccc12		CHEMBL143054	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265063	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CNC(=O)c1cc(Oc2ccc(Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL3430784	=	Thermal melting change	degrees C	1.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.1
	15265123	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15265183	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CCn1cnc2c(N)nc(N(c3cccc(Cl)c3)[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL411901	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15265256	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15265316	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc21		CHEMBL280074	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15265376	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(C)n1cnc2c(NCc3ccccc3O)nc(NCCCO)nc21		CHEMBL419931	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15265436	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15265492	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15265552	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cc1ccc(NC(=O)c2cccc(N(C)C)c2)cc1NC(=O)c1ccc(O)cc1		CHEMBL186526	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15265612	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15265672	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C[C@@H]1C[C@H]2O[C@@H]2/C=C\C=C\C(=O)Cc2c(Cl)c(O)cc(O)c2C(=O)O1		CHEMBL414883	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15265744	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15265804	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15265864	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C(O)/C=C/c1cc(CO)ccc1CO		CHEMBL407534	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15265924	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15265981	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Thermal melting change	degrees C	0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.4
	15266041	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1		CHEMBL69863	=	Thermal melting change	degrees C	-0.4	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.4
	15266101	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#C/C(=C(/N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL261237	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266161	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccc(I)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL411645	=	Thermal melting change	degrees C	-0.3	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.3
	15266233	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1CC(=O)c2[nH]c3c4[nH]c5c(c4c4cn(Br)cc4c3c2C1)CCC=C5		CHEMBL264685	=	Thermal melting change	degrees C	-1.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.0
	15266293	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Thermal melting change	degrees C	-1.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.9
	15266353	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Thermal melting change	degrees C	-0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.6
	15266413	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccccc2/C1=C\c1ccc[nH]1		CHEMBL101797	=	Thermal melting change	degrees C	0.9	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.9
	15266468	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1Nc2ccc(S(=O)(=O)O)cc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL440411	=	Thermal melting change	degrees C	0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.7
	15266528	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(=O)O/N=C1C(=C2/C(=O)Nc3cc(Br)ccc32)/Nc2ccccc2/1		CHEMBL430226	=	Thermal melting change	degrees C	0.8	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.8
	15266588	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Thermal melting change	degrees C	-0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.2
	15266648	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CC(=O)O.Cn1cc(C2=C(c3cn(CCCN)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL3430781	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266721	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12		CHEMBL50	=	Thermal melting change	degrees C	1.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	1.1
	15266781	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15266841	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Thermal melting change	degrees C	0.2	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.2
	15266901	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Thermal melting change	degrees C	0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.6
	15266956	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15267016	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CS(=O)(=O)O.Cn1cc(C2=C(c3cn(CCCSC(=N)N)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL1591531	=	Thermal melting change	degrees C	0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.1
	15267076	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Cl.Cn1cc(C2=C(c3ccc4cc5n(c4c3)CCC(CN)C5)C(=O)NC2=O)c2ccccc21		CHEMBL541401	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15267136	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN(C)CC1CCn2c(c(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc32)C1		CHEMBL372585	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267196	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	CN[C@@H]1CC2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL162	=	Thermal melting change	degrees C	-0.7	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.7
	15267209	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Thermal melting change	degrees C	0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.5
	15267269	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Thermal melting change	degrees C	-0.5	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.5
	15267329	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	COc1cc2ncnc(Nc3cccc(O)c3)c2cc1OC		CHEMBL127907	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15267389	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Thermal melting change	degrees C	-1.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-1.0
	15267504	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	O=c1sn(Cc2ccccc2)c(=S)n1Cc1ccccc1		CHEMBL24338	=	Thermal melting change	degrees C	0.0	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	0.0
	15267564	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	C=CNC#N		CHEMBL259526	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
	15267624	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	N#CC(=C(/N)Sc1ccccc1N)/C(C#N)=C(/N)Sc1ccccc1N		CHEMBL100473	=	Thermal melting change	degrees C	-0.6	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.6
	15267684	CHEMBL3430826	Delta TM value showing the stabilisation of PDK1 produced by compound binding	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Thermal melting change	degrees C	-0.1	CHEMBL2534	Homo sapiens	Thermal melting change	degrees C	-0.1
Not Active	15656213	CHEMBL3599693	Effect on PDK1 phosphorylation at Ser241 in human A549 cells at 6 uM after 3 to 24 hrs by Western blot analysis	B	CC[C@@]12CCCN3CCc4c(n(c5ccccc45)[C@H](c4ccc(O)c5c4N[C@@H]4CC[C@@]6(CC)CCCN7CC[C@@]54[C@H]76)C1)[C@H]32		CHEMBL1077259		Activity			CHEMBL2534	Homo sapiens	Activity		
	15665860	CHEMBL3602856	Inhibition of recombinant PDK1 (unknown origin) at 1 uM after 3 hrs	B	CS(=O)(=O)NCc1ccc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nn12		CHEMBL3601472	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	15685909	CHEMBL3608088	Inhibition of human PDK1	B	NC(=O)c1cc(F)cc2c1C(=O)N(C1CCN(C3CCC(F)(F)CC3)CC1)C2		CHEMBL3606021	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	15744132	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	O=P(O)(O)[C@H](NC[C@@H]1CCCc2ccccc21)c1ccc(F)cc1		CHEMBL3623846	=	EC50	nM	50000.0	CHEMBL2534	Homo sapiens	EC50	uM	50.0
	15744133	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)O)c(C)c1		CHEMBL3623844	=	EC50	nM	40000.0	CHEMBL2534	Homo sapiens	EC50	uM	40.0
	15744134	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	Cc1cccc(C)c1OCCSc1nc2ccccc2n1CC(=O)O		CHEMBL1439113	=	FC		1.6	CHEMBL2534	Homo sapiens	FC		1.6
	15744135	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	O=P(O)(O)[C@H](NC[C@@H]1CCCc2ccccc21)c1ccc(F)cc1		CHEMBL3623846	<=	FC		1.8	CHEMBL2534	Homo sapiens	FC		1.8
	15744136	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)O)c(C)c1		CHEMBL3623844	<=	FC		1.8	CHEMBL2534	Homo sapiens	FC		1.8
	15744137	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	C[C@H](CN[C@H](c1ccc(F)cc1)P(=O)(O)O)c1ccccc1	Outside typical range	CHEMBL3623853	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744138	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=P(O)(O)[C@H](NCCc1ccc(F)cc1)c1ccc(F)cc1	Outside typical range	CHEMBL3623852	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744139	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	C[C@@H](CN[C@H](c1ccccc1)P(=O)(O)O)c1ccccc1	Outside typical range	CHEMBL3623851	=	Kd	nM	150000.0	CHEMBL2534	Homo sapiens	Kd	uM	150.0
	15744140	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	C[C@@H](CN[C@H](c1ccc(F)c(F)c1)P(=O)(O)O)c1ccccc1		CHEMBL3623850	=	Kd	nM	83000.0	CHEMBL2534	Homo sapiens	Kd	uM	83.0
	15744141	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1cccc(OCCn2c(SCC(=O)O)nc3ccccc32)c1		CHEMBL1559959	=	Kd	nM	75000.0	CHEMBL2534	Homo sapiens	Kd	uM	75.0
	15744142	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)CSc1nc2ccccc2n1CCOc1ccccc1	Outside typical range	CHEMBL3623849	=	Kd	nM	120000.0	CHEMBL2534	Homo sapiens	Kd	uM	120.0
	15744143	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)Cn1c(SCc2cccc3ccccc23)nc2ccccc21	Outside typical range	CHEMBL1568528	=	Kd	nM	120000.0	CHEMBL2534	Homo sapiens	Kd	uM	120.0
	15744144	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)Cn1c(SCc2ccccc2)nc2ccccc21	Outside typical range	CHEMBL1549031	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744145	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1ccccc1OCCSc1nc2ccccc2n1CCC(=O)O		CHEMBL1382642	=	Kd	nM	74000.0	CHEMBL2534	Homo sapiens	Kd	uM	74.0
	15744146	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1cccc(OCCSc2nc3ccccc3n2CC(=O)O)c1C	Outside typical range	CHEMBL3623848	=	Kd	nM	110000.0	CHEMBL2534	Homo sapiens	Kd	uM	110.0
	15744147	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1ccccc1OCCSc1nc2ccccc2n1CC(=O)O		CHEMBL3623847	=	Kd	nM	50000.0	CHEMBL2534	Homo sapiens	Kd	uM	50.0
	15744148	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)Cn1c(SCCOc2ccccc2F)nc2ccccc21	Outside typical range	CHEMBL1310463	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744149	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	COc1ccccc1OCCSc1nc2ccccc2n1CC(=O)O	Outside typical range	CHEMBL2139600	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744150	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)Cn1c(SCCOc2ccccc2)nc2ccccc21	Outside typical range	CHEMBL1881201	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744151	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1cccc(C)c1OCCSc1nc2ccccc2n1CC(=O)O		CHEMBL1439113	=	Kd	nM	8000.0	CHEMBL2534	Homo sapiens	Kd	uM	8.0
	15744152	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=P(O)(O)[C@H](NC[C@@H]1CCCc2ccccc21)c1ccc(F)cc1		CHEMBL3623846	=	Kd	nM	39400.0	CHEMBL2534	Homo sapiens	Kd	uM	39.4
	15744153	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	O=C(O)C/C(=C/c1cccc(C(F)(F)F)c1)c1nc2ccccc2o1	Outside typical range	CHEMBL3623845	>	Kd	nM	200000.0	CHEMBL2534	Homo sapiens	Kd	uM	200.0
	15744154	CHEMBL3626032	Displacement of PIFtide from human PDK1 PIF pocket after 1 hr by fluorescence polarization assay	B	Cc1ccc(OCCSc2nc3ccccc3n2CC(=O)O)c(C)c1		CHEMBL3623844	=	Kd	nM	39100.0	CHEMBL2534	Homo sapiens	Kd	uM	39.1
	15744155	CHEMBL3626033	Activation of human PDK1 catalytic activity using PIFtide as substrate after 1 hr by phosphor imager analysis in presence of [gamma-32P]-ATP relative to control	B	Cc1cccc(C)c1OCCSc1nc2ccccc2n1CC(=O)O		CHEMBL1439113	=	EC50	nM	2000.0	CHEMBL2534	Homo sapiens	EC50	uM	2.0
	15755914	CHEMBL3631434	Inhibition of PDPK1 (unknown origin) assessed as remaining activity at 10 uM by high-throughput assay relative to control	B	O=C1c2ccccc2-c2c1oc1ccccc1c2=O		CHEMBL3629616	=	Activity	%	99.0	CHEMBL2534	Homo sapiens	Activity	%	99.0
	15756866	CHEMBL3630917	Inhibition of PDK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	8.32	CHEMBL2534	Homo sapiens	INH	%	8.32
	15757857	CHEMBL3630917	Inhibition of PDK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	7.26	CHEMBL2534	Homo sapiens	INH	%	7.26
	15758836	CHEMBL3630917	Inhibition of PDK1 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	4.43	CHEMBL2534	Homo sapiens	INH	%	4.43
234070	16291171	CHEMBL3707800	Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.	B	O=C(NC(=S)Nc1cc([N+](=O)[O-])cc(Cl)c1O)c1ccccc1		CHEMBL3596523	=	IC50	nM	66700.0	CHEMBL2534	Homo sapiens	IC50	nM	66700.0
234072	16313418	CHEMBL3707800	Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.	B	Cc1cc(C)cc(C(=O)NC(=S)Nc2c(O)cc(C)c(Cl)c2C)c1	Outside typical range	CHEMBL3693945	=	IC50	nM	106800.0	CHEMBL2534	Homo sapiens	IC50	nM	106800.0
234071	16342577	CHEMBL3707800	Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.	B	Cc1cc(C)cc(C(=O)NC(=S)Nc2cc([N+](=O)[O-])ccc2O)c1		CHEMBL3596524	=	IC50	nM	80500.0	CHEMBL2534	Homo sapiens	IC50	nM	80500.0
234073	16345586	CHEMBL3707800	Fluorescence Polarization Assay: In order to identify compounds that disrupt the interaction between PIP3 and PH domains, a high-throughput fluorescence polarization (FP)-binding assay was developed using recombinant 1-123 amino acid N-terminal fragment of human Akt1 (also referred to herein simply as Akt), encompassing the PH domain (PH123 protein), and fluorescent NBD-labeled PIP3 molecule. The amino acid sequence of human Akt1 is publicly available as, for example, GenBank Accession No. NP001014432.1 (SEQ ID NO:1), and the corresponding DNA sequence is publicly available as, for example, GenBank Accession No. NM001014432. Briefly, 5 M recombinant GST fusion proteins containing 1-123 a.a. N-terminal fragment of human Akt1 (PH 123) or 100 nM 441-551 a.a. region of human PDK1 were incubated with 15 nM TMR-labeled PIP3, PIP2, or PIP5 in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 5 mM b-ME for 15 min at room temperature in the dark.	B	Cc1cc(C)cc(C(=O)NC(=S)Nc2cc(-c3ccccc3)ccc2O)c1		CHEMBL3693949	=	IC50	nM	52300.0	CHEMBL2534	Homo sapiens	IC50	nM	52300.0
	16376470	CHEMBL3734494	Inhibition of recombinant human PDK1 using fluorescein-labeled peptide as substrate by fluorescence-electrophoretic mobility shift assay	B	Cl.NCCN1C(=O)S/C(=C\CCC2CCCCC2)C1=O		CHEMBL3732044	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	16379679	CHEMBL3739156	Inhibition of PDK1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1CN1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735816	=	Inhibition	%	-3.7	CHEMBL2534	Homo sapiens	INH	%	-3.7
	16379680	CHEMBL3739156	Inhibition of PDK1 (unknown origin) at 200 nM by electrophoretic mobility shift assay	B	COc1ccc2c(c1C(C)N1CCNCC1)O/C(=C\c1n[nH]c3ncccc13)C2=O		CHEMBL3735890	=	Inhibition	%	0.2	CHEMBL2534	Homo sapiens	INH	%	0.2
	16388221	CHEMBL3738880	Inhibition of PDK1 (unknown origin) incubated for 1 hr by Z'Lyte assay	B	CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1cccs1)C(=O)N2		CHEMBL3735078	=	IC50	nM	6810.0	CHEMBL2534	Homo sapiens	IC50	uM	6.81
	16388222	CHEMBL3738880	Inhibition of PDK1 (unknown origin) incubated for 1 hr by Z'Lyte assay	B	CS(=O)(=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3736436	=	IC50	nM	310.0	CHEMBL2534	Homo sapiens	IC50	uM	0.31
	16388245	CHEMBL3737518	Inhibition of PDK1 (unknown origin) in presence of 25 uM ATP incubated for 1 hr by Z'Lyte assay	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	IC50	nM	998.0	CHEMBL2534	Homo sapiens	IC50	nM	998.0
	16388259	CHEMBL3738880	Inhibition of PDK1 (unknown origin) incubated for 1 hr by Z'Lyte assay	B	COc1cc2c(cc1OC)CN(CC(=O)Nc1ccc3c(c1)/C(=C/c1cnc[nH]1)C(=O)N3)CC2		CHEMBL3091673	=	IC50	nM	980.0	CHEMBL2534	Homo sapiens	IC50	uM	0.98
	16413488	CHEMBL3742692	Inhibition of PDK1 (unknown origin)	B	O=C(O)C1CN(Cc2ccc(OCc3ccc(Cl)c(Cl)c3)cc2)C1		CHEMBL3741589	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16421936	CHEMBL3750419	Inhibition of PDK1 (unknown origin)	B	C[C@@H]1C[C@H](N)C[C@H](c2ccncc2NC(=O)c2ccc(F)c(-c3c(F)cccc3F)n2)C1		CHEMBL3651966	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16425404	CHEMBL3751049	Inhibition of PKD1 (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	1.6	CHEMBL2534	Homo sapiens	INH	%	1.6
	16426124	CHEMBL3750451	Inhibition of PDK1 (unknown origin) at 1 uM by direct binding assay	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	-8.0	CHEMBL2534	Homo sapiens	INH	%	-8.0
	16431952	CHEMBL3748045	Inhibition of human PDK1 using MBP substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16451557	CHEMBL3760854	Inhibition of PDK1 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	3.4	CHEMBL2534	Homo sapiens	INH	%	3.4
	16451558	CHEMBL3760855	Inhibition of PDK1 (unknown origin) by direct binding assay at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	-1.4	CHEMBL2534	Homo sapiens	INH	%	-1.4
	16474705	CHEMBL3767325	Inhibition of PDK1 (unknown origin) at 10 uM	B	CN1CCN(CCCOc2ccc(N3C(=O)/C(=C/c4ccc(Oc5ccc(F)cc5)cc4)SC3=S)cc2)CC1		CHEMBL3765499	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	16486373	CHEMBL3771607	Inhibition of human recombinant PDPK1 assessed as residual activity at 10 uM after 1 hr by qPCR analysis relative to control	B	Cc1c(Cl)cccc1NC(=O)c1sc2nc3c(cc2c1N)C(=O)CC3		CHEMBL3771285	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	16495164	CHEMBL3777743	Inhibition of N-terminal His6-tagged recombinant human PDK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	-11.0	CHEMBL2534	Homo sapiens	Activity	%	-11.0
	16496083	CHEMBL3777743	Inhibition of N-terminal His6-tagged recombinant human PDK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-3.0	CHEMBL2534	Homo sapiens	Activity	%	-3.0
Not Active	16496868	CHEMBL3776416	Inhibition of human PDK1 (52 to 556 residues) at 1 uM by radioactive [33P]-ATP filter binding assay	B	O=c1[nH]cnc2c(-n3cc(CCN4CCC(c5cccc(Cl)c5)CC4)cn3)nccc12		CHEMBL3774537		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	16507173	CHEMBL3779003	Inhibition of recombinant PDK1 (unknown origin) assessed as residual activity at 1 uM relative to control	B	CC(O)CNc1nc(NCc2ccc(-c3ccccn3)cc2)c2[nH]nc(C(C)C)c2n1		CHEMBL3774632	>=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	16508270	CHEMBL3777743	Inhibition of N-terminal His6-tagged recombinant human PDK1 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	-5.0	CHEMBL2534	Homo sapiens	Activity	%	-5.0
Not Active	16514158	CHEMBL3782379	Inhibition of partial length human PDPK1 expressed in bacterial system at 1 uM	B	Cc1cnc(N)nc1OCC(C)(C)CO		CHEMBL3780032		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	16540899	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL1614712	=	IC50	nM	8900.0	CHEMBL2534	Homo sapiens	IC50	uM	8.9
	16540900	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OC[C@@H]3CCCO3)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787614	=	IC50	nM	9400.0	CHEMBL2534	Homo sapiens	IC50	uM	9.4
	16540901	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(O)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3787112	=	IC50	nM	8200.0	CHEMBL2534	Homo sapiens	IC50	uM	8.2
	16540902	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	Nc1ncnc2c1c(-c1cccc(OCC34CCC(CC3)O4)c1)cn2[C@H]1C[C@@H](CN2CCC2)C1		CHEMBL3785500	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16540903	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cccc(OC[C@@H]5CCCO5)c4F)c4c(N)ncnc43)C2)CC1		CHEMBL3786167	=	IC50	nM	6800.0	CHEMBL2534	Homo sapiens	IC50	uM	6.8
	16540904	CHEMBL3790009	Inhibition of PDK1 (unknown origin) in presence of [gamma33P]ATP	B	CC(=O)N1CCN([C@H]2C[C@@H](n3cc(-c4cc(OC[C@@H]5CCCO5)ccc4F)c4c(N)ncnc43)C2)CC1		CHEMBL3785951	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16587039	CHEMBL3807850	Inhibition of PDK1 (unknown origin) in presence of gamma33-ATP	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16589168	CHEMBL3807602	Inhibition of PDK1 (unknown origin) at 0.5 uM by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	3.7	CHEMBL2534	Homo sapiens	INH	%	3.7
	16589625	CHEMBL3807485	Inhibition of PDK1 (unknown origin) at 10 uM by mobility shift assay	B	Cn1ncc(Cl)c1-c1cc(C(=O)NC2(c3ccc(Cl)c(Cl)c3)CCNCC2)oc1Cl		CHEMBL3805228	=	Inhibition	%	24.9	CHEMBL2534	Homo sapiens	INH	%	24.9
	16589708	CHEMBL3807896	Inhibition of PDK1 (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	5.2	CHEMBL2534	Homo sapiens	IC50	nM	5.2
	16593512	CHEMBL3812364	Inhibition of PDK1 (unknown origin) at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL2534	Homo sapiens	INH	%	40.0
	16594856	CHEMBL3812881	Inhibition of full length human PDPK1 expressed in bacterial system assessed as enzyme activity at 10 uM by KINOMEScan assay	B	O=C1C2=C(C(=O)c3c(O)ccc(O)c31)[C@@H](O)[C@@H](O)[C@@H](O)C2		CHEMBL1987813	=	Activity	%	87.0	CHEMBL2534	Homo sapiens	Activity	%	87.0
	16611817	CHEMBL3815765	Inhibition of human PDK1	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	IC50	nM	5900.0	CHEMBL2534	Homo sapiens	IC50	uM	5.9
	16612642	CHEMBL3815500	Inhibition of human PDK1 (52 to 556 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	Activity	%	-12.0	CHEMBL2534	Homo sapiens	Activity	%	-12.0
	16612643	CHEMBL3815500	Inhibition of human PDK1 (52 to 556 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	Activity	%	-54.0	CHEMBL2534	Homo sapiens	Activity	%	-54.0
	16612644	CHEMBL3815500	Inhibition of human PDK1 (52 to 556 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	Activity	%	-80.0	CHEMBL2534	Homo sapiens	Activity	%	-80.0
	16612645	CHEMBL3815500	Inhibition of human PDK1 (52 to 556 residues) assessed as enzyme activity at 1 uM using 33P ATP by radioactive filter binding assay	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Activity	%	-92.0	CHEMBL2534	Homo sapiens	Activity	%	-92.0
	16612760	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CSc1nn(C(N)=O)c(N)c1C(N)=O		CHEMBL3814512	=	IC50	nM	17000.0	CHEMBL2534	Homo sapiens	IC50	uM	17.0
	16612761	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	COc1ccc2[nH]c(-c3cc[nH]n3)nc2c1		CHEMBL3815097	=	IC50	nM	93000.0	CHEMBL2534	Homo sapiens	IC50	uM	93.0
	16612762	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Nc1nc2c3ccccc3nc(-c3ccccc3)n2n1		CHEMBL1779261	=	IC50	nM	60000.0	CHEMBL2534	Homo sapiens	IC50	uM	60.0
	16612763	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Oc1ccc(-c2n[nH]c3cc(O)ccc23)cc1		CHEMBL2042885	=	IC50	nM	6700.0	CHEMBL2534	Homo sapiens	IC50	uM	6.7
	16612764	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Nc1ncc(-c2ccccc2)cc1-c1nc2ccccc2[nH]1		CHEMBL3799935	=	IC50	nM	1100.0	CHEMBL2534	Homo sapiens	IC50	uM	1.1
	16612765	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Nc1nccc(-c2c[nH]c3ccc(Br)cc23)n1		CHEMBL44541	=	IC50	nM	12000.0	CHEMBL2534	Homo sapiens	IC50	uM	12.0
	16612766	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	=	IC50	nM	5900.0	CHEMBL2534	Homo sapiens	IC50	uM	5.9
	16612767	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	=	IC50	nM	1100.0	CHEMBL2534	Homo sapiens	IC50	uM	1.1
	16612768	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CNc1nccc(-c2cn(CCOC)c3ncccc23)n1		CHEMBL3814490	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612769	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c(C)[nH]c3ncccc23)nc(N)n1		CHEMBL3814415	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612770	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3nccc(Cl)c23)nc(N)n1		CHEMBL3814483	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612771	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Nc1ncc(Br)c(-c2c[nH]c3ncccc23)n1		CHEMBL3813955	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612772	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL3813792	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612773	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	Cc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL3814215	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612774	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814391	=	IC50	nM	1200.0	CHEMBL2534	Homo sapiens	IC50	uM	1.2
	16612775	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814350	=	IC50	nM	1800.0	CHEMBL2534	Homo sapiens	IC50	uM	1.8
	16612776	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814929	=	IC50	nM	2200.0	CHEMBL2534	Homo sapiens	IC50	uM	2.2
	16612777	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	NCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814554	=	IC50	nM	390.0	CHEMBL2534	Homo sapiens	IC50	uM	0.39
	16612778	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	NCCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3813908	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	uM	1.0
	16612779	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(Br)cc23)nc(N)n1		CHEMBL3814704	=	IC50	nM	480.0	CHEMBL2534	Homo sapiens	IC50	uM	0.48
	16612780	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)nc(N)n1		CHEMBL3813962	=	IC50	nM	3500.0	CHEMBL2534	Homo sapiens	IC50	uM	3.5
	16612781	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cccnc4)cc23)nc(N)n1		CHEMBL3814357	=	IC50	nM	500.0	CHEMBL2534	Homo sapiens	IC50	uM	0.5
	16612782	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccncc4)cc23)nc(N)n1		CHEMBL3813886	=	IC50	nM	450.0	CHEMBL2534	Homo sapiens	IC50	uM	0.45
	16612783	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccc(N)nc4)cc23)nc(N)n1		CHEMBL3814154	=	IC50	nM	170.0	CHEMBL2534	Homo sapiens	IC50	uM	0.17
	16612784	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccco4)cc23)nc(N)n1		CHEMBL3814317	=	IC50	nM	120.0	CHEMBL2534	Homo sapiens	IC50	uM	0.12
	16612785	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)nc(N)n1		CHEMBL3813865	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	uM	0.013
	16612786	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccn[nH]4)cc23)nc(N)n1		CHEMBL3814539	=	IC50	nM	260.0	CHEMBL2534	Homo sapiens	IC50	uM	0.26
	16612787	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3814785	=	IC50	nM	85.0	CHEMBL2534	Homo sapiens	IC50	uM	0.085
	16612788	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4ccnn4C)cc23)nc(N)n1		CHEMBL3813849	=	IC50	nM	2400.0	CHEMBL2534	Homo sapiens	IC50	uM	2.4
	16612789	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4c(C)nn(C)c4C)cc23)nc(N)n1		CHEMBL3814343	=	IC50	nM	2700.0	CHEMBL2534	Homo sapiens	IC50	uM	2.7
	16612790	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CCN(C)C)c4)cc23)nc(N)n1		CHEMBL3814770	=	IC50	nM	82.0	CHEMBL2534	Homo sapiens	IC50	uM	0.082
	16612791	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	IC50	nM	58.0	CHEMBL2534	Homo sapiens	IC50	uM	0.058
	16612792	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(C)C)c4)cc23)nc(N)n1		CHEMBL3813933	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	uM	0.11
	16612793	CHEMBL3815750	Inhibition of human His6-tagged PDK1 using biotinylated PDKtide as substrate after 60 mins by topcount method	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	IC50	nM	84.0	CHEMBL2534	Homo sapiens	IC50	uM	0.084
	16612794	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	Nc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL405665	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	16612795	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814340	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
Not Determined	16612796	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CNc1nccc(-c2cn(CCOC)c3ncccc23)n1		CHEMBL3814490		IC50			CHEMBL2534	Homo sapiens	IC50		
Not Determined	16612797	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c(C)[nH]c3ncccc23)nc(N)n1		CHEMBL3814415		IC50			CHEMBL2534	Homo sapiens	IC50		
Not Determined	16612798	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3nccc(Cl)c23)nc(N)n1		CHEMBL3814483		IC50			CHEMBL2534	Homo sapiens	IC50		
Not Determined	16612799	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	Nc1ncc(Br)c(-c2c[nH]c3ncccc23)n1		CHEMBL3813955		IC50			CHEMBL2534	Homo sapiens	IC50		
	16612800	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncccc23)ncn1		CHEMBL3813792	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
Not Determined	16612801	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	Cc1nccc(-c2c[nH]c3ncccc23)n1		CHEMBL3814215		IC50			CHEMBL2534	Homo sapiens	IC50		
	16612802	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814391	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612803	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814350	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612804	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814929	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612805	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	NCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3814554	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612806	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	NCCCCc1cc(-c2c[nH]c3ncccc23)nc(N)n1		CHEMBL3813908	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612807	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(Br)cc23)nc(N)n1		CHEMBL3814704	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612808	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccccc4)cc23)nc(N)n1		CHEMBL3813962	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612809	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cccnc4)cc23)nc(N)n1		CHEMBL3814357	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612810	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccncc4)cc23)nc(N)n1		CHEMBL3813886	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612811	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccc(N)nc4)cc23)nc(N)n1		CHEMBL3814154	=	IC50	nM	21000.0	CHEMBL2534	Homo sapiens	IC50	uM	21.0
	16612812	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccco4)cc23)nc(N)n1		CHEMBL3814317	=	IC50	nM	28000.0	CHEMBL2534	Homo sapiens	IC50	uM	28.0
	16612813	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cn[nH]c4)cc23)nc(N)n1		CHEMBL3813865	=	IC50	nM	5400.0	CHEMBL2534	Homo sapiens	IC50	uM	5.4
	16612814	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccn[nH]4)cc23)nc(N)n1		CHEMBL3814539	=	IC50	nM	26000.0	CHEMBL2534	Homo sapiens	IC50	uM	26.0
	16612815	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3814785	=	IC50	nM	11000.0	CHEMBL2534	Homo sapiens	IC50	uM	11.0
	16612816	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4ccnn4C)cc23)nc(N)n1		CHEMBL3813849	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612817	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4c(C)nn(C)c4C)cc23)nc(N)n1		CHEMBL3814343	>	IC50	nM	30000.0	CHEMBL2534	Homo sapiens	IC50	uM	30.0
	16612818	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CCN(C)C)c4)cc23)nc(N)n1		CHEMBL3814770	=	IC50	nM	14000.0	CHEMBL2534	Homo sapiens	IC50	uM	14.0
	16612819	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3814140	=	IC50	nM	13000.0	CHEMBL2534	Homo sapiens	IC50	uM	13.0
	16612820	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCc1cc(-c2c[nH]c3ncc(-c4cnn(CC(C)C)c4)cc23)nc(N)n1		CHEMBL3813933	=	IC50	nM	9600.0	CHEMBL2534	Homo sapiens	IC50	uM	9.6
	16612821	CHEMBL3815751	Inhibition of PDK1 in human PC3 cells assessed as reduction in AKT Thr308 phosphorylation after 45 mins	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	IC50	nM	2300.0	CHEMBL2534	Homo sapiens	IC50	uM	2.3
	16613490	CHEMBL3815764	Inhibition of human recombinant PDK1 assessed as PtdIns-3,4-P2-mediated AKT2 activation using biotin-ARRRDGGGAQPFRPRAATF as substrate after 2 hrs by scintillation proximity assay in presence of [33P] ATP	B	CC(C)(C(N)=O)C(=O)NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1Br		CHEMBL573108	=	IC50	nM	39.0	CHEMBL2534	Homo sapiens	IC50	nM	39.0
	16613491	CHEMBL3815765	Inhibition of human PDK1	B	Nc1nccc(-c2c[nH]c3cccc(O)c23)n1		CHEMBL50498	=	IC50	nM	5400.0	CHEMBL2534	Homo sapiens	IC50	uM	5.4
	16613492	CHEMBL3815766	Selectivity ratio of IC50 for PDK1-mediated AKT phosphorylation at Thr308 in human PC3 cells to IC50 for human His6-tagged PDK1	B	CCCCc1cc(-c2c[nH]c3ncc(-c4cnn(C5CCNCC5)c4)cc23)nc(N)n1		CHEMBL3815046	=	Ratio IC50		30.0	CHEMBL2534	Homo sapiens	Ratio IC50		30.0
	16614584	CHEMBL3817615	Inhibition of human PDK1 at 1 uM using MBP substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-7.0	CHEMBL2534	Homo sapiens	INH	%	-7.0
	16618098	CHEMBL3816381	Inhibition of full length recombinant human His-tagged PDK1 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	16618099	CHEMBL3817336	Inhibition of full length recombinant human His-tagged PDK1 (direct) expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	16627552	CHEMBL3820352	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	Cc1cc(-c2cnn3c(NCC4CCOCC4)nc(Oc4ccccc4)nc23)ccc1C(=O)NC1CC1		CHEMBL3819210	=	Inhibition	%	-6.0	CHEMBL2534	Homo sapiens	INH	%	-6.0
	16627553	CHEMBL3820352	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52-end residues) expressed in baculovirus infected Sf21 cells at 1 uM by radiometric assay relative to control	B	O=C(N[C@@H](c1ccccn1)C1CC1)c1ccc2[nH]nc(-c3ccc(N4C5CCC4CC(O)C5)cc3)c2c1		CHEMBL3818239	=	Inhibition	%	40.0	CHEMBL2534	Homo sapiens	INH	%	40.0
	16628526	CHEMBL3820642	Inhibition of PDPK1 (unknown origin) at 1 uM	B	O=C(Nc1cc(Nc2c(Cl)cnc3c2OCO3)ccn1)C1CC1		CHEMBL3818173	<	Inhibition	%	80.0	CHEMBL2534	Homo sapiens	INH	%	80.0
	16641975	CHEMBL3826032	Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C/c1ncc[nH]1		CHEMBL3823622	=	IC50	nM	1520.0	CHEMBL2534	Homo sapiens	IC50	nM	1520.0
	16641976	CHEMBL3826032	Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C/c1cnc[nH]1		CHEMBL3823844	=	IC50	nM	416.0	CHEMBL2534	Homo sapiens	IC50	nM	416.0
	16641977	CHEMBL3826032	Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	IC50	nM	112.0	CHEMBL2534	Homo sapiens	IC50	nM	112.0
	16641978	CHEMBL3826032	Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)CC(=O)N2		CHEMBL3822974	=	IC50	nM	6680.0	CHEMBL2534	Homo sapiens	IC50	nM	6680.0
	16641979	CHEMBL3826032	Inhibition of PDK1 (unknown origin) by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2/C1=C/c1cnc[nH]1		CHEMBL3824264	=	IC50	nM	512.0	CHEMBL2534	Homo sapiens	IC50	nM	512.0
	16641980	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C/c1ncc[nH]1		CHEMBL3823622	=	Inhibition	%	74.0	CHEMBL2534	Homo sapiens	INH	%	74.0
Not Determined	16641981	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	Cn1ccnc1/C=C1/C(=O)Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc21		CHEMBL3823757		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	16641982	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C\c1ccc(F)cc1		CHEMBL3823307	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641983	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C/c1cccs1		CHEMBL3823151	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641984	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)cc2/C1=C/c1cnc[nH]1		CHEMBL3823844	=	Inhibition	%	95.0	CHEMBL2534	Homo sapiens	INH	%	95.0
	16641985	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Cc2cc(NC(=O)[C@H](NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c3ccccc3)ccc2N1		CHEMBL3823733	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641986	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C\c1ccc(F)cc1)C(=O)N2		CHEMBL3823249	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641987	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cccs1)C(=O)N2		CHEMBL3822461	=	Inhibition	%	19.0	CHEMBL2534	Homo sapiens	INH	%	19.0
	16641988	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	87.0	CHEMBL2534	Homo sapiens	INH	%	87.0
	16641989	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)CC(=O)N2		CHEMBL3822974	=	Inhibition	%	57.0	CHEMBL2534	Homo sapiens	INH	%	57.0
	16641990	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	Cn1ccnc1/C=C1/C(=O)Nc2ccc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc21		CHEMBL3823062	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641991	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2/C1=C\c1ccc(F)cc1		CHEMBL3823732	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641992	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2/C1=C/c1cccs1		CHEMBL3824168	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	16641993	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Nc2ccc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2/C1=C/c1cnc[nH]1		CHEMBL3824264	=	Inhibition	%	64.0	CHEMBL2534	Homo sapiens	INH	%	64.0
	16641994	CHEMBL3826033	Inhibition of PDK1 (unknown origin) at 10 uM by FRET-based Z-lyte assay	B	O=C1Cc2cc(NC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)ccc2N1		CHEMBL3824110	<	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
Active	16642638	CHEMBL3826570	Inhibition of PDK1-mediated cell migration in human U87MG cells at 10 uM treated for 72 hrs measured at 6 to 24 hrs by scratch wound assay	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
tde	16642646	CHEMBL3826577	Inhibition of PDK1 in human GSC cells assessed as reduction in AKT phosphorylation at Thr308 residue at 10 uM by ELISA relative to control	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	16642647	CHEMBL3826780	Inhibition of PDK1 in human U87MG cells cells assessed as reduction in AKT phosphorylation at Thr308 residue at 10 uM measured at 120 mins by ELISA relative to control	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	19.6	CHEMBL2534	Homo sapiens	INH	%	19.6
	16642648	CHEMBL3826781	Inhibition of PDK1 in human GSC cells assessed as reduction in AKT phosphorylation at Thr308 residue at 10 uM measured at 120 mins by ELISA relative to control	B	O=C(CNC(=O)c1cccn(Cc2ccc(F)c(F)c2)c1=O)Nc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL3824119	=	Inhibition	%	80.4	CHEMBL2534	Homo sapiens	INH	%	80.4
	16642650	CHEMBL3826783	Inhibition of PDK1 (unknown origin)	B	O=P(O)(O)OC[C@@H]1[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H]1OCc1ccccc1		CHEMBL3823242	=	IC50	nM	26.5	CHEMBL2534	Homo sapiens	IC50	nM	26.5
	16642651	CHEMBL3826783	Inhibition of PDK1 (unknown origin)	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	IC50	nM	2.5	CHEMBL2534	Homo sapiens	IC50	nM	2.5
	16642652	CHEMBL3826784	Inhibition of PDK1 (unknown origin) using AKT(Thr-308)-tide substrate	B	O=C(CC(c1ccccc1)C(C(=O)O)C(=O)O)c1ccc(C(F)(F)F)cc1		CHEMBL2177668	=	AC50	nM	2000.0	CHEMBL2534	Homo sapiens	AC50	uM	2.0
	16654174	CHEMBL3830961	Inhibition of human PDK1 (52 to 556 residues) assessed as remaining enzyme activity at 50 uM after 30 mins by 33P-ATP filter-binding assay	B	Cc1cc(=O)c2c(O)cc(O)c([C@H]3CCN(C)C[C@H]3O)c2o1		CHEMBL1077604	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
191780	17602078	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL4113701	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
191781	17602079	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)C(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3950250	=	IC50	nM	185.0	CHEMBL2534	Homo sapiens	IC50	nM	185.0
222016	17610924	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	IC50	nM	143.0	CHEMBL2534	Homo sapiens	IC50	nM	143.0
222017	17610925	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	IC50	nM	159.0	CHEMBL2534	Homo sapiens	IC50	nM	159.0
222018	17610926	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1		CHEMBL3659971	=	IC50	nM	283.0	CHEMBL2534	Homo sapiens	IC50	nM	283.0
222019	17610927	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659972	=	IC50	nM	304.0	CHEMBL2534	Homo sapiens	IC50	nM	304.0
222020	17610928	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	CC1CCN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CC1		CHEMBL3659973	=	IC50	nM	780.0	CHEMBL2534	Homo sapiens	IC50	nM	780.0
222021	17610929	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659974	=	IC50	nM	1500.0	CHEMBL2534	Homo sapiens	IC50	nM	1500.0
222022	17610930	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1		CHEMBL3659975	=	IC50	nM	1740.0	CHEMBL2534	Homo sapiens	IC50	nM	1740.0
222023	17610931	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659976	=	IC50	nM	1940.0	CHEMBL2534	Homo sapiens	IC50	nM	1940.0
222024	17610932	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659977	=	IC50	nM	3750.0	CHEMBL2534	Homo sapiens	IC50	nM	3750.0
222025	17610933	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1cccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c12)C1CC1(F)F		CHEMBL3659978	=	IC50	nM	4400.0	CHEMBL2534	Homo sapiens	IC50	nM	4400.0
222026	17610934	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	Brc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1		CHEMBL3659979	=	IC50	nM	10900.0	CHEMBL2534	Homo sapiens	IC50	nM	10900.0
222027	17610935	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CC1		CHEMBL3659980	=	IC50	nM	11600.0	CHEMBL2534	Homo sapiens	IC50	nM	11600.0
222028	17610936	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)c1cccc(F)c1		CHEMBL3659981	=	IC50	nM	21100.0	CHEMBL2534	Homo sapiens	IC50	nM	21100.0
222029	17610937	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	CS(=O)(=O)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659982	=	IC50	nM	23700.0	CHEMBL2534	Homo sapiens	IC50	nM	23700.0
222030	17610938	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	FC(F)(F)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659983	=	IC50	nM	55700.0	CHEMBL2534	Homo sapiens	IC50	nM	55700.0
222031	17610939	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	[C-]#[N+]C(C)(C)c1ccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)cc1		CHEMBL3659984	=	IC50	nM	58500.0	CHEMBL2534	Homo sapiens	IC50	nM	58500.0
222032	17610940	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)Nc1ccc(F)cc1F		CHEMBL3659985	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222033	17610941	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	CN1CCC(C)(C(=O)Nc2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)CC1		CHEMBL3659986	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222034	17610942	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CCCC1		CHEMBL3659987	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222035	17610943	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCN(c2ccncc2)CC1		CHEMBL3659988	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222036	17610944	CHEMBL3705101	Activity Assay: The primary assay for compound inhibitory activity was the ATP depletion assay using the PDKtide substrate purchase from Millipore Corporation.	B	O=C(Nc1ccc2c(-c3nc4ccc(N5CCOCC5)cc4[nH]3)n[nH]c2c1)C1CC1(F)F		CHEMBL3659989	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222037	17610945	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	nM	80.0
222038	17610946	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	IC50	nM	94.0	CHEMBL2534	Homo sapiens	IC50	nM	94.0
222039	17610947	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1		CHEMBL3659971	=	IC50	nM	229.0	CHEMBL2534	Homo sapiens	IC50	nM	229.0
222040	17610948	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659972	=	IC50	nM	265.0	CHEMBL2534	Homo sapiens	IC50	nM	265.0
222041	17610949	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659974	=	IC50	nM	410.0	CHEMBL2534	Homo sapiens	IC50	nM	410.0
222042	17610950	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1		CHEMBL3659975	=	IC50	nM	1230.0	CHEMBL2534	Homo sapiens	IC50	nM	1230.0
222043	17610951	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659976	=	IC50	nM	280.0	CHEMBL2534	Homo sapiens	IC50	nM	280.0
222044	17610952	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659977	=	IC50	nM	1220.0	CHEMBL2534	Homo sapiens	IC50	nM	1220.0
222045	17610953	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1cccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c12)C1CC1(F)F		CHEMBL3659978	=	IC50	nM	385.0	CHEMBL2534	Homo sapiens	IC50	nM	385.0
222046	17610954	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CC1		CHEMBL3659980	=	IC50	nM	920.0	CHEMBL2534	Homo sapiens	IC50	nM	920.0
222047	17610955	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)c1cccc(F)c1		CHEMBL3659981	=	IC50	nM	8790.0	CHEMBL2534	Homo sapiens	IC50	nM	8790.0
222048	17610956	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	CS(=O)(=O)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659982	=	IC50	nM	15300.0	CHEMBL2534	Homo sapiens	IC50	nM	15300.0
222049	17610957	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	FC(F)(F)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659983	=	IC50	nM	30300.0	CHEMBL2534	Homo sapiens	IC50	nM	30300.0
222050	17610958	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	[C-]#[N+]C(C)(C)c1ccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)cc1		CHEMBL3659984	=	IC50	nM	5170.0	CHEMBL2534	Homo sapiens	IC50	nM	5170.0
222051	17610959	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)Nc1ccc(F)cc1F		CHEMBL3659985	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222052	17610960	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	CN1CCC(C)(C(=O)Nc2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)CC1		CHEMBL3659986	=	IC50	nM	12400.0	CHEMBL2534	Homo sapiens	IC50	nM	12400.0
222053	17610961	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CCCC1		CHEMBL3659987	=	IC50	nM	53900.0	CHEMBL2534	Homo sapiens	IC50	nM	53900.0
222054	17610962	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCN(c2ccncc2)CC1		CHEMBL3659988	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
222055	17610963	CHEMBL3705102	Binding Assay: The secondary assay was a time resolved-FRET LanthaScreen Kinase Binding Assay. (Invitrogen Corporation, Carlsbad, Calif.). This assay evaluates the ability of the test compound to compete with a fluorescently-labeled tracer molecule to bind in the ATP pocket of a kinase.	B	O=C(Nc1ccc2c(-c3nc4ccc(N5CCOCC5)cc4[nH]3)n[nH]c2c1)C1CC1(F)F		CHEMBL3659989	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	nM	100000.0
223819	17612380	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640546	=	IC50	nM	103.0	CHEMBL2534	Homo sapiens	IC50	nM	103.0
223820	17612381	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640543	=	IC50	nM	37.0	CHEMBL2534	Homo sapiens	IC50	nM	37.0
223821	17612382	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)c(C)c12		CHEMBL3640541	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223822	17612383	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(O)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640548	=	IC50	nM	311.0	CHEMBL2534	Homo sapiens	IC50	nM	311.0
223823	17612384	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Nc1ncnc2cc(Cl)c(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640547	=	IC50	nM	229.0	CHEMBL2534	Homo sapiens	IC50	nM	229.0
223824	17612385	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3c(C)n(C)n(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640544	=	IC50	nM	68.0	CHEMBL2534	Homo sapiens	IC50	nM	68.0
223825	17612386	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCOc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3922103	=	IC50	nM	94.0	CHEMBL2534	Homo sapiens	IC50	nM	94.0
223826	17612387	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640546	=	IC50	nM	103.0	CHEMBL2534	Homo sapiens	IC50	nM	103.0
223827	17612388	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(CCO)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640540	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223828	17612389	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1c(C#CCNC(=O)c2cncn(Cc3ccc(F)c(F)c3)c2=O)ccc2ncc(NCCCN(C)C)nc12		CHEMBL3640542	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
223829	17612390	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCN(C)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3640545	=	IC50	nM	88.0	CHEMBL2534	Homo sapiens	IC50	nM	88.0
223830	17612391	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCNc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689184	=	IC50	nM	35.0	CHEMBL2534	Homo sapiens	IC50	nM	35.0
223831	17612392	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCN(C)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689185	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
223832	17612393	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689186	=	IC50	nM	27.0	CHEMBL2534	Homo sapiens	IC50	nM	27.0
223833	17612394	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689187	=	IC50	nM	68.0	CHEMBL2534	Homo sapiens	IC50	nM	68.0
223834	17612395	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)C1		CHEMBL3689188	=	IC50	nM	33.0	CHEMBL2534	Homo sapiens	IC50	nM	33.0
223835	17612396	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689189	=	IC50	nM	95.0	CHEMBL2534	Homo sapiens	IC50	nM	95.0
223836	17612397	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCSc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689190	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
223837	17612398	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689191	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223838	17612399	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689191	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223839	17612400	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)C1		CHEMBL3689192	=	IC50	nM	149.0	CHEMBL2534	Homo sapiens	IC50	nM	149.0
223840	17612401	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689193	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
223841	17612402	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(C4CC4)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689194	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223842	17612403	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCN(c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689195	=	IC50	nM	117.0	CHEMBL2534	Homo sapiens	IC50	nM	117.0
223843	17612404	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CC(C)(C)CNc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689196	=	IC50	nM	42.0	CHEMBL2534	Homo sapiens	IC50	nM	42.0
223844	17612405	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCCCC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689197	=	IC50	nM	588.0	CHEMBL2534	Homo sapiens	IC50	nM	588.0
223845	17612406	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCNCC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689198	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223846	17612407	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(N(C)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689199	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
223847	17612408	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CC(N4CCCC4)C3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689200	=	IC50	nM	41.0	CHEMBL2534	Homo sapiens	IC50	nM	41.0
223848	17612409	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	C[C@H](c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(NC4CCN(C)CC4)nc3c2)c1=O		CHEMBL3689201	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223849	17612410	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689202	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223850	17612411	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](CO)c5ccccc5)c4=O)cc3n2)CC1		CHEMBL3689203	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223851	17612412	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	N[C@H]1CC[C@@H](Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689204	=	IC50	nM	40.0	CHEMBL2534	Homo sapiens	IC50	nM	40.0
223852	17612413	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	N[C@H]1CC[C@H](Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689205	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223853	17612414	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)Nc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689206	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
223854	17612415	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCN(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689207	=	IC50	nM	87.0	CHEMBL2534	Homo sapiens	IC50	nM	87.0
223855	17612416	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689208	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223856	17612417	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Oc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689209	=	IC50	nM	56.0	CHEMBL2534	Homo sapiens	IC50	nM	56.0
223857	17612418	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](O)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3639880	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
223858	17612419	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCOCC4)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689210	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223859	17612420	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689211	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223860	17612421	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCN(CC5CC5)CC4)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689212	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223861	17612422	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)[C@H]1CC[C@H](Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689213	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223862	17612423	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	NC1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)C1		CHEMBL3689214	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
223863	17612424	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CC[C@@H](Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)[C@@H](F)C1		CHEMBL3689215	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223864	17612425	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689216	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
223865	17612426	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CC[C@H](Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)[C@H](F)C1		CHEMBL3689217	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223866	17612427	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689218	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223867	17612428	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689219	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
223868	17612429	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689220	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
223869	17612430	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689221	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223870	17612431	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689222	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223871	17612432	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4ccnn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689223	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223872	17612433	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(C4COC4)CC3)nc2c1)c1ccnn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689224	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223873	17612434	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](CO)c5cccc(F)c5)c4=O)cc3n2)CC1		CHEMBL3689225	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223874	17612435	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(C4COC4)CC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689226	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223875	17612436	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(C4COC4)CC3)nc2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689227	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
223876	17612437	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	C[C@@H](c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3ncc(NC4CCN(C5COC5)CC4)nc3c2)c1=O		CHEMBL3689228	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223877	17612438	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCOCC4)CC3)nc2c1)c1cccn([C@H](CO)c2ccccc2)c1=O		CHEMBL3689229	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223878	17612439	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCOCC4)CC3)nc2c1)c1ccnn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689230	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
223879	17612440	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCN(CC5CC5)CC4)CC3)nc2c1)c1cccn([C@H](CO)c2cccc(F)c2)c1=O		CHEMBL3689231	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223880	17612441	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCN(CC5CC5)CC4)CC3)nc2c1)c1ccnn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689232	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223881	17612442	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(NC3CCN(C4COC4)CC3)nc2c1)c1cccn([C@H](CO)c2cccc(F)c2)c1=O		CHEMBL3689233	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223882	17612443	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCOCC4)CC3)nc2c1)c1cccn([C@H](CO)c2cccc(F)c2)c1=O		CHEMBL3689234	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223883	17612444	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(N[C@H]3CC[C@H](N4CCN(CC5CC5)CC4)CC3)nc2c1)c1cccn([C@H](CO)c2ccccc2)c1=O		CHEMBL3689235	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
223884	17612445	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(CC3CCNCC3)nc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689236	=	IC50	nM	654.0	CHEMBL2534	Homo sapiens	IC50	nM	654.0
223885	17612446	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Cc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3n2)CC1		CHEMBL3689237	=	IC50	nM	940.0	CHEMBL2534	Homo sapiens	IC50	nM	940.0
223886	17612447	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)=Cc1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL3689238	=	IC50	nM	233.0	CHEMBL2534	Homo sapiens	IC50	nM	233.0
223887	17612448	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2n1		CHEMBL4113701	=	IC50	nM	64.0	CHEMBL2534	Homo sapiens	IC50	nM	64.0
223888	17612449	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689239	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
223889	17612450	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689240	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223890	17612451	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689241	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223891	17612452	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689242	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223892	17612453	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689243	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
223893	17612454	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689244	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
223894	17612455	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](CO)c5cccc(F)c5)c4=O)cc3c2)CC1		CHEMBL3689245	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223895	17612456	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689246	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223896	17612457	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCC(Nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3689247	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
223897	17612458	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1c(C#CCNC(=O)c2cncn(Cc3ccc(F)c(F)c3)c2=O)ccc2ncc(-c3ccccc3)cc12		CHEMBL3689248	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	nM	80.0
223898	17612459	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncccc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689249	=	IC50	nM	132.0	CHEMBL2534	Homo sapiens	IC50	nM	132.0
223899	17612460	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(-c3ccccc3)cc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689250	=	IC50	nM	66.0	CHEMBL2534	Homo sapiens	IC50	nM	66.0
223900	17612461	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)c(C)c2c1		CHEMBL3689251	=	IC50	nM	119.0	CHEMBL2534	Homo sapiens	IC50	nM	119.0
223901	17612462	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1c(C#CCNC(=O)c2cncn(Cc3ccc(F)c(F)c3)c2=O)ccc2ncc(C(=O)O)cc12		CHEMBL3689252	=	IC50	nM	62.0	CHEMBL2534	Homo sapiens	IC50	nM	62.0
223902	17612463	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)c(C)c2c1		CHEMBL3689253	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
223904	17612465	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(O)cc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689255	=	IC50	nM	86.0	CHEMBL2534	Homo sapiens	IC50	nM	86.0
223905	17612466	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(OC3CCNCC3)cc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689256	=	IC50	nM	23.0	CHEMBL2534	Homo sapiens	IC50	nM	23.0
223906	17612467	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689257	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
223907	17612468	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCN(C)c1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689258	=	IC50	nM	23.0	CHEMBL2534	Homo sapiens	IC50	nM	23.0
223908	17612469	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)c1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689259	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	nM	110.0
223909	17612470	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689260	=	IC50	nM	38.0	CHEMBL2534	Homo sapiens	IC50	nM	38.0
223910	17612471	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689261	=	IC50	nM	128.0	CHEMBL2534	Homo sapiens	IC50	nM	128.0
223911	17612472	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689262	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
223912	17612473	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689263	=	IC50	nM	55.0	CHEMBL2534	Homo sapiens	IC50	nM	55.0
223913	17612474	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCOc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689264	=	IC50	nM	33.0	CHEMBL2534	Homo sapiens	IC50	nM	33.0
223914	17612475	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)Oc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689265	=	IC50	nM	74.0	CHEMBL2534	Homo sapiens	IC50	nM	74.0
223915	17612476	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)Oc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689266	=	IC50	nM	38.0	CHEMBL2534	Homo sapiens	IC50	nM	38.0
223916	17612477	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689267	=	IC50	nM	25.0	CHEMBL2534	Homo sapiens	IC50	nM	25.0
223917	17612478	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCOc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689268	=	IC50	nM	36.0	CHEMBL2534	Homo sapiens	IC50	nM	36.0
223918	17612479	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCN(CCCOc2ccnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3689269	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
223919	17612480	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCCC(COc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689270	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223920	17612481	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CC(C)(C)COc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689271	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
223921	17612482	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CC(C)(C)COc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689272	=	IC50	nM	33.0	CHEMBL2534	Homo sapiens	IC50	nM	33.0
223922	17612483	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CC(O)COc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689273	=	IC50	nM	71.0	CHEMBL2534	Homo sapiens	IC50	nM	71.0
223923	17612484	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CC(O)COc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689274	=	IC50	nM	47.0	CHEMBL2534	Homo sapiens	IC50	nM	47.0
223924	17612485	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Oc2ccnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689275	=	IC50	nM	119.0	CHEMBL2534	Homo sapiens	IC50	nM	119.0
223925	17612486	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Oc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689276	=	IC50	nM	212.0	CHEMBL2534	Homo sapiens	IC50	nM	212.0
223926	17612487	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCCCO3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689277	=	IC50	nM	116.0	CHEMBL2534	Homo sapiens	IC50	nM	116.0
223927	17612488	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCCCO3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689278	=	IC50	nM	166.0	CHEMBL2534	Homo sapiens	IC50	nM	166.0
223928	17612489	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COC(C)CCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689279	=	IC50	nM	137.0	CHEMBL2534	Homo sapiens	IC50	nM	137.0
223929	17612490	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Oc2ccnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3689280	=	IC50	nM	29.0	CHEMBL2534	Homo sapiens	IC50	nM	29.0
223930	17612491	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(Oc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3689281	=	IC50	nM	71.0	CHEMBL2534	Homo sapiens	IC50	nM	71.0
223931	17612492	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OC3CCNCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689282	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
223932	17612493	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OC3CCNCC3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689283	=	IC50	nM	23.0	CHEMBL2534	Homo sapiens	IC50	nM	23.0
223933	17612494	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(NC3CC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689284	=	IC50	nM	780.0	CHEMBL2534	Homo sapiens	IC50	nM	780.0
223934	17612495	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(NC3CC3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689285	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
223935	17612496	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCNc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689286	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
223936	17612497	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCNc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689287	=	IC50	nM	853.0	CHEMBL2534	Homo sapiens	IC50	nM	853.0
223937	17612498	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCNc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689288	=	IC50	nM	554.0	CHEMBL2534	Homo sapiens	IC50	nM	554.0
223938	17612499	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCNc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689289	=	IC50	nM	656.0	CHEMBL2534	Homo sapiens	IC50	nM	656.0
223939	17612500	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCCO3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689290	=	IC50	nM	156.0	CHEMBL2534	Homo sapiens	IC50	nM	156.0
223940	17612501	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCNC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689291	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223941	17612502	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCCNC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689292	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223942	17612503	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OCCCN(C)C)c3c2)c1=O		CHEMBL3689293	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223943	17612504	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ccnc2ccc(C#CCNC(=O)c3cccn(C(CO)c4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689294	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223944	17612505	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@@H]4CCN(C)C4)c3c2)c1=O		CHEMBL3689295	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223945	17612506	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4cc(F)c(F)c(F)c4)c3=O)cc12		CHEMBL3689296	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223946	17612507	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCCOc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689297	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
223947	17612508	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCOC3)c2c1)c1cccn(C(CO)c2ccc(F)c(F)c2)c1=O		CHEMBL3689298	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
223948	17612509	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCOc1ccnc2ccc(C#CCNC(=O)c3ccnn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689299	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
223949	17612510	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCOCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689300	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
223950	17612511	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(N)CCOc1ccnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689301	=	IC50	nM	32.0	CHEMBL2534	Homo sapiens	IC50	nM	32.0
223951	17612512	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCCOC3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689302	=	IC50	nM	46.0	CHEMBL2534	Homo sapiens	IC50	nM	46.0
223952	17612513	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CC[C@H](COc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5cc(F)c(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689303	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223953	17612514	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(c1ccc(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@H]4CCN(C)C4)c3c2)c1=O		CHEMBL3689304	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223954	17612515	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@H]4CCN(C)C4)c3c2)c1=O		CHEMBL3689305	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223955	17612516	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CC[C@@H](COc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5cc(F)c(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689306	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
223956	17612517	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)CCCOc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689307	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
223957	17612518	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)(C)COc1ccnc2ccc(C#CCNC(=O)c3cccn(C(CO)c4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3689308	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	nM	60.0
223958	17612519	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCOc1ccnc2ccc(C#CCNC(=O)c3cccn(C(CO)c4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3639881	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
223959	17612520	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OCC3CCOCC3)c2c1)c1cccn(C(CO)c2ccc(F)c(F)c2)c1=O		CHEMBL3689309	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
223960	17612521	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC[C@@H](COc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5cc(F)c(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689310	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223961	17612522	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@@H]4CCCN(C)C4)c3c2)c1=O		CHEMBL3689311	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223962	17612523	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OC[C@@H]3CCCN(CCN4CCOCC4)C3)c2c1)c1cccn(Cc2cc(F)c(F)c(F)c2)c1=O		CHEMBL3689312	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223963	17612524	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	C[C@@H](c1cc(F)c(F)c(F)c1)n1cccc(C(=O)NCC#Cc2ccc3nccc(OC[C@@H]4CCCN(CCN5CCOCC5)C4)c3c2)c1=O		CHEMBL3689313	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
223964	17612525	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC[C@@H](COc2ccnc3ccc(C#CCNC(=O)c4cccn(C(CO)c5cc(F)c(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689314	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
223965	17612526	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)N1CCC[C@@H](COc2ccnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3689315	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
223966	17612527	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(OC[C@@H]3CCCNC3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3689316	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
223967	17612528	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCNc1c([N+](=O)[O-])cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640435	=	IC50	nM	86.0	CHEMBL2534	Homo sapiens	IC50	nM	86.0
223968	17612529	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1c([N+](=O)[O-])cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640436	=	IC50	nM	98.0	CHEMBL2534	Homo sapiens	IC50	nM	98.0
223969	17612530	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)Nc1c([N+](=O)[O-])cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640437	=	IC50	nM	116.0	CHEMBL2534	Homo sapiens	IC50	nM	116.0
223970	17612531	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640438	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
223971	17612532	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CC(Nc2ncnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3640439	=	IC50	nM	171.0	CHEMBL2534	Homo sapiens	IC50	nM	171.0
223972	17612533	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(CCc1ccccc1)c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640440	=	IC50	nM	134.0	CHEMBL2534	Homo sapiens	IC50	nM	134.0
223973	17612534	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640441	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
223974	17612535	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(Cc1ccccc1)c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640442	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
223975	17612536	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCCc3ccco3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640443	=	IC50	nM	98.0	CHEMBL2534	Homo sapiens	IC50	nM	98.0
223976	17612537	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCCc3ccccn3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640444	=	IC50	nM	105.0	CHEMBL2534	Homo sapiens	IC50	nM	105.0
223977	17612538	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ccc(CCNc2ncnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)cc1OC		CHEMBL3640445	=	IC50	nM	91.0	CHEMBL2534	Homo sapiens	IC50	nM	91.0
223978	17612539	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(N3CCNCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640446	=	IC50	nM	443.0	CHEMBL2534	Homo sapiens	IC50	nM	443.0
223979	17612540	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640447	=	IC50	nM	229.0	CHEMBL2534	Homo sapiens	IC50	nM	229.0
223980	17612541	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCCCn3ccnc3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640448	=	IC50	nM	135.0	CHEMBL2534	Homo sapiens	IC50	nM	135.0
223981	17612542	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCCc3cccs3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640449	=	IC50	nM	161.0	CHEMBL2534	Homo sapiens	IC50	nM	161.0
223982	17612543	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCC(O)c3ccccc3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640450	=	IC50	nM	184.0	CHEMBL2534	Homo sapiens	IC50	nM	184.0
223983	17612544	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCCNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640451	=	IC50	nM	158.0	CHEMBL2534	Homo sapiens	IC50	nM	158.0
223984	17612545	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(CNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12)c1ccccc1		CHEMBL3640452	=	IC50	nM	445.0	CHEMBL2534	Homo sapiens	IC50	nM	445.0
223985	17612546	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(CNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12)c1ccccc1		CHEMBL3640453	=	IC50	nM	218.0	CHEMBL2534	Homo sapiens	IC50	nM	218.0
223986	17612547	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	NC(=O)[C@@H](Cc1ccccc1)Nc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640454	=	IC50	nM	488.0	CHEMBL2534	Homo sapiens	IC50	nM	488.0
223987	17612548	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ccc(CCNc2ncnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc23)cc1		CHEMBL3640455	=	IC50	nM	41.0	CHEMBL2534	Homo sapiens	IC50	nM	41.0
223988	17612549	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12)C(C)(C)C		CHEMBL3640456	=	IC50	nM	500.0	CHEMBL2534	Homo sapiens	IC50	nM	500.0
223989	17612550	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12)C1CC1		CHEMBL3640457	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
223990	17612551	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NC3CCOCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640458	=	IC50	nM	515.0	CHEMBL2534	Homo sapiens	IC50	nM	515.0
223991	17612552	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12)C1CCCCC1		CHEMBL3640459	=	IC50	nM	371.0	CHEMBL2534	Homo sapiens	IC50	nM	371.0
223992	17612553	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NC3CCN(Cc4ccccc4)CC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640460	=	IC50	nM	142.0	CHEMBL2534	Homo sapiens	IC50	nM	142.0
223993	17612554	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NC3CCN(CCO)CC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640461	=	IC50	nM	77.0	CHEMBL2534	Homo sapiens	IC50	nM	77.0
223994	17612555	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC1CN(C)CCC1Nc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640462	=	IC50	nM	126.0	CHEMBL2534	Homo sapiens	IC50	nM	126.0
223995	17612556	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccsc4)c3=O)cc12		CHEMBL3640463	=	IC50	nM	199.0	CHEMBL2534	Homo sapiens	IC50	nM	199.0
223996	17612557	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(N3CCCC3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640464	=	IC50	nM	52.0	CHEMBL2534	Homo sapiens	IC50	nM	52.0
223997	17612558	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNCCCN(C)c1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640465	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	nM	110.0
223998	17612559	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCCN(c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3640466	=	IC50	nM	156.0	CHEMBL2534	Homo sapiens	IC50	nM	156.0
223999	17612560	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(=O)N[C@@H]1CCN(c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3640467	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
224000	17612561	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(N3CC[C@H](O)C3)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640468	=	IC50	nM	114.0	CHEMBL2534	Homo sapiens	IC50	nM	114.0
224001	17612562	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)(CO)CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640469	=	IC50	nM	124.0	CHEMBL2534	Homo sapiens	IC50	nM	124.0
224002	17612563	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	NC(=O)CCNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640470	=	IC50	nM	79.0	CHEMBL2534	Homo sapiens	IC50	nM	79.0
224003	17612564	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(CCCO)c1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640471	=	IC50	nM	59.0	CHEMBL2534	Homo sapiens	IC50	nM	59.0
224004	17612565	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	NC(=O)CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640472	=	IC50	nM	59.0	CHEMBL2534	Homo sapiens	IC50	nM	59.0
224005	17612566	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC1(CNc2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)COC1		CHEMBL3640473	=	IC50	nM	468.0	CHEMBL2534	Homo sapiens	IC50	nM	468.0
224006	17612567	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(NCC(O)CO)c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640474	=	IC50	nM	44.0	CHEMBL2534	Homo sapiens	IC50	nM	44.0
224007	17612568	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(CNc2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3640475	=	IC50	nM	97.0	CHEMBL2534	Homo sapiens	IC50	nM	97.0
224008	17612569	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCCC1CCNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640476	=	IC50	nM	137.0	CHEMBL2534	Homo sapiens	IC50	nM	137.0
224009	17612570	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)C1CCN(c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3640477	=	IC50	nM	74.0	CHEMBL2534	Homo sapiens	IC50	nM	74.0
224010	17612571	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC1(O)CCN(c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)CC1		CHEMBL3640478	=	IC50	nM	61.0	CHEMBL2534	Homo sapiens	IC50	nM	61.0
224011	17612572	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)c1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccn[nH]4)c3=O)cc12		CHEMBL3640479	=	IC50	nM	697.0	CHEMBL2534	Homo sapiens	IC50	nM	697.0
224012	17612573	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1ncnc2ccc(C#CCNC(=O)c3cc(Cl)nn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640480	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
224013	17612574	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(Cc1cnn(-c2ccc(F)cc2)c1)c1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640481	=	IC50	nM	40.0	CHEMBL2534	Homo sapiens	IC50	nM	40.0
224014	17612575	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1cccc(CN(C)c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)c1		CHEMBL3640482	=	IC50	nM	63.0	CHEMBL2534	Homo sapiens	IC50	nM	63.0
224015	17612576	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(Cc1cccc2ncccc12)c1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640483	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
224016	17612577	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCC(CN(C)c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)C1		CHEMBL3640484	=	IC50	nM	117.0	CHEMBL2534	Homo sapiens	IC50	nM	117.0
224017	17612578	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(c1ccccc1)c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640485	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
224018	17612579	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1ncnc2ccc(C#CCNC(=O)c3c(C)n(CCO)n(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640486	=	IC50	nM	50.0	CHEMBL2534	Homo sapiens	IC50	nM	50.0
224019	17612580	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)C(=O)CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640487	=	IC50	nM	182.0	CHEMBL2534	Homo sapiens	IC50	nM	182.0
224020	17612581	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cccn(Cc4ccoc4)c3=O)cc12		CHEMBL3640488	=	IC50	nM	770.0	CHEMBL2534	Homo sapiens	IC50	nM	770.0
224021	17612582	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COc1ccc(CN(C)c2ncnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc23)cc1		CHEMBL3640489	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
224022	17612583	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccccc4F)c3=O)cc12		CHEMBL3640490	=	IC50	nM	486.0	CHEMBL2534	Homo sapiens	IC50	nM	486.0
224023	17612584	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1ncnc2ccc(C#CCNC(=O)c3cccn(C(C)c4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640491	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
224024	17612585	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1ncnc2ccc(C#CCNC(=O)c3cccn([C@@H](C)c4ccccc4)c3=O)cc12		CHEMBL3640492	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	nM	60.0
224025	17612586	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1ncnc2ccc(C#CCNC(=O)c3cccn([C@H](CO)c4ccccc4)c3=O)cc12		CHEMBL3640493	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
224026	17612587	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cc(NCCN(C)C)nn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640494	=	IC50	nM	357.0	CHEMBL2534	Homo sapiens	IC50	nM	357.0
224027	17612588	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cc(Cl)nn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640495	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
224028	17612589	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cc(OC)nn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640496	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
224029	17612590	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cccn([C@@H](C)c4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640497	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
224030	17612591	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CONc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640498	=	IC50	nM	57.0	CHEMBL2534	Homo sapiens	IC50	nM	57.0
224031	17612592	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CON(C)c1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640499	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
224032	17612593	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1ncnc2ccc(C#CCNC(=O)c3cccn([C@H](CO)c4ccccc4)c3=O)cc12		CHEMBL3640500	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
224033	17612594	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(-c3cn[nH]c3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640501	=	IC50	nM	57.0	CHEMBL2534	Homo sapiens	IC50	nM	57.0
224034	17612595	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(-c3ccccc3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3639393	=	IC50	nM	58.0	CHEMBL2534	Homo sapiens	IC50	nM	58.0
224035	17612596	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1ncnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640502	=	IC50	nM	98.0	CHEMBL2534	Homo sapiens	IC50	nM	98.0
224036	17612597	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncnc(C3=CCNCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640503	=	IC50	nM	96.0	CHEMBL2534	Homo sapiens	IC50	nM	96.0
224037	17612598	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640504	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	nM	20.0
224038	17612599	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)c(C)c2c1		CHEMBL3689253	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
224039	17612600	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1c(C#CCNC(=O)c2cncn(Cc3ccc(F)c(F)c3)c2=O)ccc2ncc(C(=O)N(C)C)cc12		CHEMBL3689254	=	IC50	nM	185.0	CHEMBL2534	Homo sapiens	IC50	nM	185.0
224040	17612601	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)C(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640505	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
224041	17612602	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640506	=	IC50	nM	45.0	CHEMBL2534	Homo sapiens	IC50	nM	45.0
224042	17612603	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NC1CC1)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640507	=	IC50	nM	31.0	CHEMBL2534	Homo sapiens	IC50	nM	31.0
224043	17612604	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(NC(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3640508	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
224044	17612605	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640506	=	IC50	nM	45.0	CHEMBL2534	Homo sapiens	IC50	nM	45.0
224045	17612606	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCNC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640509	=	IC50	nM	31.0	CHEMBL2534	Homo sapiens	IC50	nM	31.0
224046	17612607	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)NC(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640510	=	IC50	nM	53.0	CHEMBL2534	Homo sapiens	IC50	nM	53.0
224047	17612608	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN1CCN(C(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3640511	=	IC50	nM	402.0	CHEMBL2534	Homo sapiens	IC50	nM	402.0
224048	17612609	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)CCCN(C)C(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640512	=	IC50	nM	201.0	CHEMBL2534	Homo sapiens	IC50	nM	201.0
224049	17612610	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCCC(NC(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)C1		CHEMBL3640513	=	IC50	nM	64.0	CHEMBL2534	Homo sapiens	IC50	nM	64.0
224050	17612611	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CC(NC(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)C1		CHEMBL3640514	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	nM	20.0
224051	17612612	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(C(=O)N3CCOCC3)cc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640515	=	IC50	nM	531.0	CHEMBL2534	Homo sapiens	IC50	nM	531.0
224052	17612613	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2ncc(C(=O)N3CCNCC3)cc2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640516	=	IC50	nM	286.0	CHEMBL2534	Homo sapiens	IC50	nM	286.0
224053	17612614	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCN(C(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3640517	=	IC50	nM	405.0	CHEMBL2534	Homo sapiens	IC50	nM	405.0
224054	17612615	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	COCCN1CCN(C(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)CC1		CHEMBL3640518	=	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
224055	17612616	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)C(=O)c1cnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc2c1		CHEMBL3640519	=	IC50	nM	355.0	CHEMBL2534	Homo sapiens	IC50	nM	355.0
224056	17612617	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN1CCC(NC(=O)c2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2)C1		CHEMBL3640520	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
224057	17612618	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(-c3cc[nH]c3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640521	=	IC50	nM	19.0	CHEMBL2534	Homo sapiens	IC50	nM	19.0
224058	17612619	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(-c3cn[nH]c3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640522	=	IC50	nM	35.0	CHEMBL2534	Homo sapiens	IC50	nM	35.0
224059	17612620	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(C3=CCNCC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640523	=	IC50	nM	86.0	CHEMBL2534	Homo sapiens	IC50	nM	86.0
224060	17612621	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	O=C(NCC#Cc1ccc2nccc(C3=CCCNC3)c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3640524	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
224061	17612622	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640525	=	IC50	nM	56.0	CHEMBL2534	Homo sapiens	IC50	nM	56.0
224062	17612623	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	Cc1n[nH]cc1-c1ccnc2ccc(C#CCNC(=O)c3cncn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640526	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
224063	17612624	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(C)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640527	=	IC50	nM	27.0	CHEMBL2534	Homo sapiens	IC50	nM	27.0
224064	17612625	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12)C1CCCCC1		CHEMBL3640528	=	IC50	nM	544.0	CHEMBL2534	Homo sapiens	IC50	nM	544.0
224065	17612626	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	N#Cc1cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2c1NCCc1ccccc1		CHEMBL3640529	=	IC50	nM	607.0	CHEMBL2534	Homo sapiens	IC50	nM	607.0
224066	17612627	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	N#Cc1cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2c1NCC1CCCCC1		CHEMBL3640530	=	IC50	nM	1055.0	CHEMBL2534	Homo sapiens	IC50	nM	1055.0
224067	17612628	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(Cc1ccccc1)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640531	=	IC50	nM	184.0	CHEMBL2534	Homo sapiens	IC50	nM	184.0
224068	17612629	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(CC1CCCCC1)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640532	=	IC50	nM	683.0	CHEMBL2534	Homo sapiens	IC50	nM	683.0
224069	17612630	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(CC)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640533	=	IC50	nM	276.0	CHEMBL2534	Homo sapiens	IC50	nM	276.0
224070	17612631	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)N(C)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640534	=	IC50	nM	148.0	CHEMBL2534	Homo sapiens	IC50	nM	148.0
224071	17612632	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	N#Cc1cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc2c1NCc1ccccc1		CHEMBL3640535	=	IC50	nM	871.0	CHEMBL2534	Homo sapiens	IC50	nM	871.0
224072	17612633	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CCN(C)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640536	=	IC50	nM	77.0	CHEMBL2534	Homo sapiens	IC50	nM	77.0
224073	17612634	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CC(C)Nc1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640537	=	IC50	nM	147.0	CHEMBL2534	Homo sapiens	IC50	nM	147.0
224074	17612635	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CNc1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640538	=	IC50	nM	46.0	CHEMBL2534	Homo sapiens	IC50	nM	46.0
224075	17612636	CHEMBL3705125	Kinase Assay: The activity of the compounds according to the invention on the kinase PDK1 which inhibits the signal transduction pathway is determined in an in vitro kinase assay with recombinantly prepared protein.	B	CN(CCc1ccccc1)c1c(C#N)cnc2ccc(C#CCNC(=O)c3cccn(Cc4ccc(F)c(F)c4)c3=O)cc12		CHEMBL3640539	=	IC50	nM	414.0	CHEMBL2534	Homo sapiens	IC50	nM	414.0
243128	17626623	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)Nc4ccccc4Cl)c3)ncnc12		CHEMBL3670422	=	IC50	nM	4800.0	CHEMBL2534	Homo sapiens	IC50	nM	4800.0
243129	17626624	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	COc1cccc(NC(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)c1		CHEMBL3670433	=	IC50	nM	6300.0	CHEMBL2534	Homo sapiens	IC50	nM	6300.0
243130	17626625	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccccc4)c3)ncnc12		CHEMBL3670475	=	IC50	nM	1900.0	CHEMBL2534	Homo sapiens	IC50	nM	1900.0
243131	17626626	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(OCCN2CCOCC2)cc2c(NCc3ccc(C(F)(F)F)cc3)ncnc12		CHEMBL3670501	=	IC50	nM	3500.0	CHEMBL2534	Homo sapiens	IC50	nM	3500.0
243132	17626627	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCCc3c[nH]c4ccccc34)ncnc12		CHEMBL3675452	=	IC50	nM	79000.0	CHEMBL2534	Homo sapiens	IC50	nM	79000.0
243133	17626628	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680394	=	IC50	nM	77000.0	CHEMBL2534	Homo sapiens	IC50	nM	77000.0
243134	17626629	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cccc(F)c3F)ncnc12		CHEMBL3680461	=	IC50	nM	87000.0	CHEMBL2534	Homo sapiens	IC50	nM	87000.0
243135	17626630	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(N5CCCCC5)c4)c3)ncnc12		CHEMBL3680464	=	IC50	nM	83000.0	CHEMBL2534	Homo sapiens	IC50	nM	83000.0
243136	17626631	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cc(F)cc(F)c1		CHEMBL3680465	=	IC50	nM	61000.0	CHEMBL2534	Homo sapiens	IC50	nM	61000.0
243137	17626632	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CS(=O)(=O)c1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1		CHEMBL3680481	=	IC50	nM	97000.0	CHEMBL2534	Homo sapiens	IC50	nM	97000.0
243138	17626633	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CCN(C[C@@H](Nc1ccccc(C(N)=O)cncn1)C1C=CC=CC1)C(C)C		CHEMBL3680482	=	IC50	nM	95000.0	CHEMBL2534	Homo sapiens	IC50	nM	95000.0
243139	17626634	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NC(Cn3ccnc3)c3ccccc3)ncnc12		CHEMBL3680484	=	IC50	nM	89000.0	CHEMBL2534	Homo sapiens	IC50	nM	89000.0
243140	17626635	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC(F)(F)F)cc2)c1		CHEMBL3680491	=	IC50	nM	86000.0	CHEMBL2534	Homo sapiens	IC50	nM	86000.0
243141	17626636	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CN1CCN(c2ccc(C(=O)Nc3cccc(CNc4nncc5c(C(N)=O)cccc45)c3)cc2C(F)(F)F)CC1		CHEMBL3680492	=	IC50	nM	82000.0	CHEMBL2534	Homo sapiens	IC50	nM	82000.0
243142	17626637	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cccc(NC(=O)c4ccnc(NCCO)c4)c3)ncnc12		CHEMBL3680497	=	IC50	nM	96000.0	CHEMBL2534	Homo sapiens	IC50	nM	96000.0
243143	17626638	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	COCCC(Nc1ncnc2c(C(N)=O)cccc12)c1cccc(NC(=O)c2ccc(OC)cc2)c1		CHEMBL3680499	=	IC50	nM	96000.0	CHEMBL2534	Homo sapiens	IC50	nM	96000.0
243144	17626639	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CN(C[C@@H](Nc1ncnc2c1=CCCC=2C(N)=O)c1ccccc1)C1CC1		CHEMBL3680501	=	IC50	nM	74000.0	CHEMBL2534	Homo sapiens	IC50	nM	74000.0
243145	17626640	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	COc1ccc(C(=O)Nc2cccc(CNc3ncnc4c(C(N)=O)cccc34)c2)cc1C(F)(F)F		CHEMBL3680532	=	IC50	nM	87000.0	CHEMBL2534	Homo sapiens	IC50	nM	87000.0
243146	17626641	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc2c(NCc3cc(F)c(F)c(F)c3)ncnc12	Outside typical range	CHEMBL3680537	=	IC50	nM	102000.0	CHEMBL2534	Homo sapiens	IC50	nM	102000.0
243147	17626642	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2ccsc2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685311	=	IC50	nM	44.0	CHEMBL2534	Homo sapiens	IC50	nM	44.0
243148	17626643	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)C1=c2ncnc(N[C@H]3CCCNC3)c2=CC(c2cccs2)C1		CHEMBL3923286	=	IC50	nM	60.0	CHEMBL2534	Homo sapiens	IC50	nM	60.0
243149	17626644	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	COc1ccc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)cc1		CHEMBL3685312	=	IC50	nM	62.0	CHEMBL2534	Homo sapiens	IC50	nM	62.0
243150	17626645	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	Cn1cc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)cn1		CHEMBL3685313	=	IC50	nM	94.0	CHEMBL2534	Homo sapiens	IC50	nM	94.0
243151	17626646	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	COc1ccc2cc(-c3cc(C(N)=O)c4ncnc(N[C@H]5CCCNC5)c4c3)ccc2c1		CHEMBL3685314	=	IC50	nM	98.0	CHEMBL2534	Homo sapiens	IC50	nM	98.0
243152	17626647	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2ccc(OC(F)(F)F)cc2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685315	=	IC50	nM	100.0	CHEMBL2534	Homo sapiens	IC50	nM	100.0
243153	17626648	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2ccc(C(F)(F)F)cc2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685316	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	nM	110.0
243154	17626649	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CC(C)n1cc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)cn1		CHEMBL3685317	=	IC50	nM	160.0	CHEMBL2534	Homo sapiens	IC50	nM	160.0
243155	17626650	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(C2=CCC(C(N)=O)C=C2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685318	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
243156	17626651	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	N#Cc1ccc(-c2ccc3ncnc(NC4CCCNC4)c3c2)cc1		CHEMBL3685319	=	IC50	nM	340.0	CHEMBL2534	Homo sapiens	IC50	nM	340.0
243157	17626652	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cccc(-c2cc(C(N)=O)c3ncnc(N[C@H]4CCCNC4)c3c2)c1		CHEMBL3685320	=	IC50	nM	390.0	CHEMBL2534	Homo sapiens	IC50	nM	390.0
243158	17626653	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2ccccc2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685321	=	IC50	nM	510.0	CHEMBL2534	Homo sapiens	IC50	nM	510.0
243159	17626654	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2ccc(Cl)c(Cl)c2)cc2c(NC3CCCNC3)ncnc12		CHEMBL3685322	=	IC50	nM	520.0	CHEMBL2534	Homo sapiens	IC50	nM	520.0
243160	17626655	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(-c2cnoc2)cc2c(NC3CCCNC3)ncnc12		CHEMBL3685323	=	IC50	nM	610.0	CHEMBL2534	Homo sapiens	IC50	nM	610.0
243161	17626656	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CC(Nc1ncnc2c(C(N)=O)cc(-c3cnn(C)c3)cc12)c1cccc(F)c1		CHEMBL3685324	=	IC50	nM	750.0	CHEMBL2534	Homo sapiens	IC50	nM	750.0
243162	17626657	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	NC(=O)c1cc(/C=C/c2ccccc2)cc2c(N[C@H]3CCCNC3)ncnc12		CHEMBL3685325	=	IC50	nM	790.0	CHEMBL2534	Homo sapiens	IC50	nM	790.0
243163	17626658	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	Cn1cc(-c2cc(C(N)=O)c3ncnc(NCc4cccc(F)c4)c3c2)cn1		CHEMBL3685326	=	IC50	nM	800.0	CHEMBL2534	Homo sapiens	IC50	nM	800.0
243164	17626659	CHEMBL3706328	Enzyme Assay: The kinase assay is performed as 384-well Flashplate assay (PerkinElmer LAS Germany GmbH). 3.4 nM His6-PDK1(Delta 1-50) (PDK1 that has a His-tag consisting of six histidines and lacks the first fifty amino acids), 400 nM PDKtide (Biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as the substrate, and 4 M ATP (spiked with 0.25 Ci 33P-ATP/well) are incubated in a total volume of 50 l (50 mM TRIS, 10 mM Mg-acetate, 0.1% Mercaptoethanol, 0.02 Brij35, 0.1% BSA, pH 7.5) with or without test compound (5-10 concentrations) for 60 Min at 30 C. The reaction is stopped with 25 l 200 mM EDTA. After 30 Min at room temperature the liquid is removed and each well washed thrice with 100 ml 0.9% sodium chloride solution. Nonspecific reaction is determined in presence of 100 nM of the high affinity protein kinase inhibitor Staurosporine. Radioactivity is measured in a Topcount (PerkinElmer LAS Germany GmbH).	B	CCC(Nc1ncnc2c(C(N)=O)cc(-c3cnn(C)c3)cc12)c1cccc(F)c1		CHEMBL3685327	=	IC50	nM	1100.0	CHEMBL2534	Homo sapiens	IC50	nM	1100.0
243170	17626665	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652558	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
243171	17626666	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C(C)(C)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652559	=	IC50	nM	65.0	CHEMBL2534	Homo sapiens	IC50	nM	65.0
243172	17626667	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652560	=	IC50	nM	59.5	CHEMBL2534	Homo sapiens	IC50	nM	59.5
243173	17626668	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652561	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
243174	17626669	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	COc1ccc(N(C[C@H](O)CO)c2cc(-c3c[nH]c4ncc(-c5cnn(C)c5)cc34)nc(N)n2)cc1		CHEMBL3652562	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
243175	17626670	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652563	=	IC50	nM	130.0	CHEMBL2534	Homo sapiens	IC50	nM	130.0
243176	17626671	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccc(Cl)cc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652564	=	IC50	nM	870.0	CHEMBL2534	Homo sapiens	IC50	nM	870.0
243177	17626672	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1cccc(Cl)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652565	=	IC50	nM	51.0	CHEMBL2534	Homo sapiens	IC50	nM	51.0
243178	17626673	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1F		CHEMBL3652566	=	IC50	nM	9.7	CHEMBL2534	Homo sapiens	IC50	nM	9.7
243179	17626674	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652567	=	IC50	nM	7.6	CHEMBL2534	Homo sapiens	IC50	nM	7.6
243180	17626675	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652568	=	IC50	nM	16.5	CHEMBL2534	Homo sapiens	IC50	nM	16.5
243181	17626676	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652569	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
243182	17626677	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CCN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652570	=	IC50	nM	46.0	CHEMBL2534	Homo sapiens	IC50	nM	46.0
243183	17626678	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CCN(Cc1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652571	=	IC50	nM	51.0	CHEMBL2534	Homo sapiens	IC50	nM	51.0
243184	17626679	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652572	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
243185	17626680	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652573	=	IC50	nM	4.7	CHEMBL2534	Homo sapiens	IC50	nM	4.7
243186	17626681	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652574	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
243187	17626682	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652575	=	IC50	nM	5900.0	CHEMBL2534	Homo sapiens	IC50	nM	5900.0
243188	17626683	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(C)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652576	=	IC50	nM	30.0	CHEMBL2534	Homo sapiens	IC50	nM	30.0
243189	17626684	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1nncs1		CHEMBL3652577	=	IC50	nM	155.0	CHEMBL2534	Homo sapiens	IC50	nM	155.0
243190	17626685	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	COCC(O)CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652578	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
243191	17626686	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CC(O)CO)c5cccc(C#N)c5)nc(N)n4)c3c2)cn1		CHEMBL3652579	=	IC50	nM	90.0	CHEMBL2534	Homo sapiens	IC50	nM	90.0
243192	17626687	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(=O)O)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3639514	=	IC50	nM	4.8	CHEMBL2534	Homo sapiens	IC50	nM	4.8
243193	17626688	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	COC(=O)CN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652580	=	IC50	nM	69.0	CHEMBL2534	Homo sapiens	IC50	nM	69.0
243194	17626689	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccc(F)cc5F)nc(N)n4)c3c2)cn1		CHEMBL3652581	=	IC50	nM	6.5	CHEMBL2534	Homo sapiens	IC50	nM	6.5
243195	17626690	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5F)nc(N)n4)c3c2)cn1		CHEMBL3652582	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
243196	17626691	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCOc6ccccc65)nc(N)n4)c3c2)cn1		CHEMBL3652583	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
243197	17626692	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCN5CCOCC5)c5cccc(F)c5)nc(N)n4)c3c2)cn1		CHEMBL3652584	=	IC50	nM	89.0	CHEMBL2534	Homo sapiens	IC50	nM	89.0
243198	17626693	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	COCCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652585	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
243199	17626694	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC#N)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652586	=	IC50	nM	7.9	CHEMBL2534	Homo sapiens	IC50	nM	7.9
243200	17626695	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)ncn1		CHEMBL3652587	=	IC50	nM	190.0	CHEMBL2534	Homo sapiens	IC50	nM	190.0
243201	17626696	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCCN)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652588	=	IC50	nM	8.7	CHEMBL2534	Homo sapiens	IC50	nM	8.7
243202	17626697	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(N)=O)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652589	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
243203	17626698	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6F)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652590	=	IC50	nM	45.5	CHEMBL2534	Homo sapiens	IC50	nM	45.5
243204	17626699	CHEMBL3705571	Inhibition Assay: The compound inhibits the target protein in the enzymatic PDK1 inhibition assay.	B	CC(=O)NCCCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652591	=	IC50	nM	22.0	CHEMBL2534	Homo sapiens	IC50	nM	22.0
252333	17635507	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	Cc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL118	=	IC50	nM	48000.0	CHEMBL2534	Homo sapiens	IC50	nM	48000.0
252334	17635508	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(CCBr)cc2)cc1		CHEMBL3661089	=	IC50	nM	42000.0	CHEMBL2534	Homo sapiens	IC50	nM	42000.0
252335	17635509	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(CCCBr)cc2)cc1		CHEMBL3661090	=	IC50	nM	38000.0	CHEMBL2534	Homo sapiens	IC50	nM	38000.0
252336	17635510	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	[N-]=[N+]=NCCc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL3661091	=	IC50	nM	32000.0	CHEMBL2534	Homo sapiens	IC50	nM	32000.0
252337	17635511	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	[N-]=[N+]=NCCCc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL3661092	=	IC50	nM	34000.0	CHEMBL2534	Homo sapiens	IC50	nM	34000.0
252338	17635512	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	CCCCc1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL3661093	=	IC50	nM	20000.0	CHEMBL2534	Homo sapiens	IC50	nM	20000.0
252339	17635513	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	CC(C)(C)c1ccc(-c2cc(C(F)(F)F)nn2-c2ccc(S(N)(=O)=O)cc2)cc1		CHEMBL3639599	=	IC50	nM	34000.0	CHEMBL2534	Homo sapiens	IC50	nM	34000.0
252340	17635514	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3ccccc3c2)cc1		CHEMBL3342105	=	IC50	nM	24000.0	CHEMBL2534	Homo sapiens	IC50	nM	24000.0
252341	17635515	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2c[nH]c3ccccc23)cc1		CHEMBL261143	=	IC50	nM	65000.0	CHEMBL2534	Homo sapiens	IC50	nM	65000.0
252342	17635516	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccccc3)cc2)cc1		CHEMBL3661094	=	IC50	nM	21000.0	CHEMBL2534	Homo sapiens	IC50	nM	21000.0
252343	17635517	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(Cl)cc3)cc2)cc1		CHEMBL1652453	=	IC50	nM	22000.0	CHEMBL2534	Homo sapiens	IC50	nM	22000.0
252344	17635518	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cc(Cl)cc(Cl)c3)cc2)cc1		CHEMBL3661095	=	IC50	nM	18000.0	CHEMBL2534	Homo sapiens	IC50	nM	18000.0
252345	17635519	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cccc(Cl)c3Cl)cc2)cc1		CHEMBL3661096	=	IC50	nM	23000.0	CHEMBL2534	Homo sapiens	IC50	nM	23000.0
252346	17635520	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3cc(Cl)c(Cl)cc3Cl)cc2)cc1		CHEMBL1652454	=	IC50	nM	9000.0	CHEMBL2534	Homo sapiens	IC50	nM	9000.0
252347	17635521	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	Cc1ccc(-c2ccc(-c3cc(C(F)(F)F)nn3-c3ccc(S(N)(=O)=O)cc3)cc2)cc1		CHEMBL3661097	=	IC50	nM	15000.0	CHEMBL2534	Homo sapiens	IC50	nM	15000.0
252348	17635522	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(C(F)(F)F)cc3)cc2)cc1		CHEMBL3665653	=	IC50	nM	18000.0	CHEMBL2534	Homo sapiens	IC50	nM	18000.0
252349	17635523	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(-c3ccc(CBr)cc3)cc2)cc1		CHEMBL3665654	=	IC50	nM	20000.0	CHEMBL2534	Homo sapiens	IC50	nM	20000.0
252350	17635524	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	Cc1cc(C)cc(-c2ccc(-c3cc(C(F)(F)F)nn3-c3ccc(S(N)(=O)=O)cc3)cc2)c1		CHEMBL3665655	=	IC50	nM	17000.0	CHEMBL2534	Homo sapiens	IC50	nM	17000.0
252351	17635525	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	CCCCc1ccc(-c2ccc(-c3cc(C(F)(F)F)nn3-c3ccc(S(N)(=O)=O)cc3)cc2)cc1		CHEMBL3665656	=	IC50	nM	32000.0	CHEMBL2534	Homo sapiens	IC50	nM	32000.0
252352	17635526	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	CC(C)(C)c1ccc(-c2ccc(-c3cc(C(F)(F)F)nn3-c3ccc(S(N)(=O)=O)cc3)cc2)cc1		CHEMBL3665657	=	IC50	nM	32000.0	CHEMBL2534	Homo sapiens	IC50	nM	32000.0
252353	17635527	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc(Cc3ccccc3)cc2)cc1		CHEMBL3665658	=	IC50	nM	15000.0	CHEMBL2534	Homo sapiens	IC50	nM	15000.0
252354	17635528	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(c2)Cc2ccccc2-3)cc1		CHEMBL3665659	=	IC50	nM	16000.0	CHEMBL2534	Homo sapiens	IC50	nM	16000.0
252355	17635529	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2c3ccccc3cc3ccccc23)cc1		CHEMBL3665660	=	IC50	nM	12000.0	CHEMBL2534	Homo sapiens	IC50	nM	12000.0
252356	17635530	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1830598	=	IC50	nM	9000.0	CHEMBL2534	Homo sapiens	IC50	nM	9000.0
252357	17635531	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NS(=O)(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2cc3ccccc3c3ccccc23)cc1		CHEMBL3665661	=	IC50	nM	42000.0	CHEMBL2534	Homo sapiens	IC50	nM	42000.0
252358	17635532	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NC(=O)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665662	=	IC50	nM	12000.0	CHEMBL2534	Homo sapiens	IC50	nM	12000.0
252359	17635533	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	N#Cc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665663	=	IC50	nM	45000.0	CHEMBL2534	Homo sapiens	IC50	nM	45000.0
252360	17635534	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	N=C(NO)c1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665664	=	IC50	nM	40000.0	CHEMBL2534	Homo sapiens	IC50	nM	40000.0
252361	17635535	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	FC(F)(F)c1cc(-c2ccc3c(ccc4ccccc43)c2)n(-c2ccc(-c3nnn[nH]3)cc2)n1		CHEMBL3665665	=	IC50	nM	52000.0	CHEMBL2534	Homo sapiens	IC50	nM	52000.0
252362	17635536	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	O=NCc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665666	=	IC50	nM	25000.0	CHEMBL2534	Homo sapiens	IC50	nM	25000.0
252363	17635537	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	N=NCc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665667	=	IC50	nM	16000.0	CHEMBL2534	Homo sapiens	IC50	nM	16000.0
252364	17635538	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	N#CCc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665668	=	IC50	nM	42000.0	CHEMBL2534	Homo sapiens	IC50	nM	42000.0
252365	17635539	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	N[N+](=O)CCc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3974336	=	IC50	nM	15000.0	CHEMBL2534	Homo sapiens	IC50	nM	15000.0
252366	17635540	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	FC(F)(F)c1cc(-c2ccc3c(ccc4ccccc43)c2)n(-c2ccc(Cc3nnn[nH]3)cc2)n1		CHEMBL3665669	=	IC50	nM	45000.0	CHEMBL2534	Homo sapiens	IC50	nM	45000.0
252367	17635541	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NCC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL1650595	=	IC50	nM	5000.0	CHEMBL2534	Homo sapiens	IC50	nM	5000.0
252368	17635542	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NC(N)=Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL2332031	=	IC50	nM	2000.0	CHEMBL2534	Homo sapiens	IC50	nM	2000.0
252369	17635543	CHEMBL3705073	In Vitro Kinase Assay: PDK-1 kinase activity This in vitro assay was performed using a PDK-1 kinase assay kit (Upstate, Lake Placid, N.Y.) according to the vendor's instructions. This cell-free assay is based on the ability of recombinant PDK-1, in the presence of DMSO vehicle or the test agent, to activate its downstream kinase serum- and glucocorticoid-regulated kinase (SGK.) which, in turn, phosphorylates the Akt/SGK-specific peptide substrate RPRAATF with [-32]-ATP. The [32P]-phosphorylated peptide substrate was then separated from the residual [-32P]-ATP using PS1 phosphocellulose paper and quantitated by a scintillation counter after three washes with 0.75% phosphoric acid.	B	NC(=O)Nc1ccc(-n2nc(C(F)(F)F)cc2-c2ccc3c(ccc4ccccc43)c2)cc1		CHEMBL3665670	=	IC50	nM	40000.0	CHEMBL2534	Homo sapiens	IC50	nM	40000.0
274719	17657019	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3nc[nH]c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644680	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274720	17657020	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(CCO)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644681	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
274721	17657021	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCC4)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644682	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
274722	17657022	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(CCCO)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644683	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274723	17657023	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)CCn1cnc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3644684	=	IC50	nM	50.0	CHEMBL2534	Homo sapiens	IC50	nM	50.0
274724	17657024	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CC[C@@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cncn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644685	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
274725	17657025	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CC[C@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cncn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644686	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
274726	17657026	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)CCCn1cnc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3644687	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
274727	17657027	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CCC[C@@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cncn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644688	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
274728	17657028	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5cncn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644689	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274729	17657029	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CC(C)N1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5cncn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644690	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
274730	17657030	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn([C@H]4CCCNC4)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644691	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
274731	17657031	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCNC4)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644692	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
274732	17657032	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCNCC4)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644693	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
274733	17657033	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn([C@H]4CCNC4)c3c2c1)c1cncn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644694	=	IC50	nM	28.0	CHEMBL2534	Homo sapiens	IC50	nM	28.0
274734	17657034	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1cc(C(=O)NCC#Cc2ccc3ncc4nc(C)n(C(C)C)c4c3c2)c(=O)n([C@H](C)c2ccc(F)c(F)c2)n1		CHEMBL3644695	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274735	17657035	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccccc5)c4=O)cc3c2n1C(C)C		CHEMBL3644696	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
274736	17657036	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644697	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274737	17657037	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cc(Cl)nn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644698	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274738	17657038	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCOc1cc(C(=O)NCC#Cc2ccc3ncc4nc(C)n(C(C)C)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1		CHEMBL3644699	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
274739	17657039	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](CO)c5cccc(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644700	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274740	17657040	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644701	=	IC50	nM	55.0	CHEMBL2534	Homo sapiens	IC50	nM	55.0
274741	17657041	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](C)C5CCCCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644702	=	IC50	nM	507.0	CHEMBL2534	Homo sapiens	IC50	nM	507.0
274742	17657042	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@H](CO)c5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644703	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274743	17657043	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644704	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274744	17657044	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1cc(C(=O)NCC#Cc2ccc3ncc4nc(C)n(C(C)C)c4c3c2)c(=O)n([C@@H](C)c2ccc(F)c(F)c2)n1		CHEMBL3644705	=	IC50	nM	70.0	CHEMBL2534	Homo sapiens	IC50	nM	70.0
274745	17657045	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCc1c(C(=O)NCC#Cc2ccc3ncc4nc(C)n(C(C)C)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1C		CHEMBL3644706	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274746	17657046	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644704	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274747	17657047	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)C5CCCCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644707	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
274748	17657048	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4c(C)n(C)n(C(C)c5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644708	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274749	17657049	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4c(C)n(C)n(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644709	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274750	17657050	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644710	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274751	17657051	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5CCCCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644711	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
274752	17657052	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	COc1cc(C(=O)NCC#Cc2ccc3ncc4nc(C)n(C(C)C)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1		CHEMBL3644712	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274753	17657053	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644704	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274754	17657054	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5ccccc5)c4=O)cc3c2n1C(C)C		CHEMBL3644713	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274755	17657055	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CN)c5ccccc5)c4=O)cc3c2n1C(C)C		CHEMBL3644714	=	IC50	nM	16.0	CHEMBL2534	Homo sapiens	IC50	nM	16.0
274756	17657056	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5C[C@@H]6CC[C@H]5C6)c4=O)cc3c2n1C(C)C		CHEMBL3644715	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
274757	17657057	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5CCOCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644716	=	IC50	nM	590.0	CHEMBL2534	Homo sapiens	IC50	nM	590.0
274758	17657058	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5CCCCO5)c4=O)cc3c2n1C(C)C		CHEMBL3644717	=	IC50	nM	1015.0	CHEMBL2534	Homo sapiens	IC50	nM	1015.0
274759	17657059	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5CCCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644718	=	IC50	nM	27.0	CHEMBL2534	Homo sapiens	IC50	nM	27.0
274760	17657060	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5(O)CCCCC5)c4=O)cc3c2n1C(C)C		CHEMBL3644719	=	IC50	nM	1096.0	CHEMBL2534	Homo sapiens	IC50	nM	1096.0
274761	17657061	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(C[C@H]5CCCC[C@H]5O)c4=O)cc3c2n1C(C)C		CHEMBL3644720	=	IC50	nM	221.0	CHEMBL2534	Homo sapiens	IC50	nM	221.0
274762	17657062	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(CC5CCCOC5)c4=O)cc3c2n1C(C)C		CHEMBL3644721	=	IC50	nM	202.0	CHEMBL2534	Homo sapiens	IC50	nM	202.0
274763	17657063	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CN)c5ccc(F)c(F)c5)c4=O)cc3c2n1C(C)C		CHEMBL3644722	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274764	17657064	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCN(C(C)C)CC1		CHEMBL3644723	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
274765	17657065	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCN(C(C)C)CC1		CHEMBL3644724	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
274766	17657066	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCN1CCC(n2c(C)nc3cnc4ccc(C#CCNC(=O)c5cc(C)nn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644725	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
274767	17657067	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCN(C)CC1		CHEMBL3644726	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
274768	17657068	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CC(C)N1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5cccn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644727	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
274769	17657069	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCNC4)c3c2c1)c1cccn([C@H](CO)c2ccccc2)c1=O		CHEMBL3644728	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
274770	17657070	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CC(C)N1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5cccn([C@@H](C)c6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644729	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274771	17657071	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1cc(C(=O)NCC#Cc2ccc3ncc4ncn([C@H]5CC[C@@H](N(C)C)CC5)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1		CHEMBL3644730	=	IC50	nM	15.0	CHEMBL2534	Homo sapiens	IC50	nM	15.0
274772	17657072	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4ccnn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCN(C(C)C)CC1		CHEMBL3644731	=	IC50	nM	21.0	CHEMBL2534	Homo sapiens	IC50	nM	21.0
274773	17657073	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1[C@H]1CC[C@@H](N(C)C)CC1		CHEMBL3644732	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274774	17657074	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCN(C)CC1		CHEMBL3644733	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274775	17657075	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cc(Cl)nn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1CCc1ccccc1		CHEMBL3644734	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
274776	17657076	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCNCC4)c3c2c1)c1cccn([C@H](CO)c2ccccc2)c1=O		CHEMBL3644735	=	IC50	nM	2007.0	CHEMBL2534	Homo sapiens	IC50	nM	2007.0
274777	17657077	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3nc[nH]c3c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644736	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
274778	17657078	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)CCn1cnc2cnc3ccc(C#CCNC(=O)c4cccn(Cc5ccccc5)c4=O)cc3c21		CHEMBL3644737	=	IC50	nM	277.0	CHEMBL2534	Homo sapiens	IC50	nM	277.0
274779	17657079	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(CCO)c3c2c1)c1cccn(Cc2ccc(F)c(F)c2)c1=O		CHEMBL3644738	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
274780	17657080	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(CCO)c3c2c1)c1cccn(Cc2ccccc2)c1=O		CHEMBL3644739	=	IC50	nM	68.0	CHEMBL2534	Homo sapiens	IC50	nM	68.0
274781	17657081	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1CCN(C)C		CHEMBL3644740	=	IC50	nM	53.0	CHEMBL2534	Homo sapiens	IC50	nM	53.0
274782	17657082	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5cc(Cl)nn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644741	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274783	17657083	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CC[C@@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cccn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644742	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	nM	20.0
274784	17657084	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CC[C@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cc(Cl)nn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644743	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
274785	17657085	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cc(Cl)nn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1[C@H]1CCCN(C)C1		CHEMBL3644744	=	IC50	nM	111.0	CHEMBL2534	Homo sapiens	IC50	nM	111.0
274786	17657086	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN1CCC[C@@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cc(Cl)nn(Cc6ccc(F)c(F)c6)c5=O)cc4c32)C1		CHEMBL3644745	=	IC50	nM	787.0	CHEMBL2534	Homo sapiens	IC50	nM	787.0
274787	17657087	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1c(C(=O)NCC#Cc2ccc3ncc4ncn(C5CCN(C(C)C)CC5)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1C		CHEMBL3644746	=	IC50	nM	45.0	CHEMBL2534	Homo sapiens	IC50	nM	45.0
274788	17657088	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCN1CCC(n2cnc3cnc4ccc(C#CCNC(=O)c5c(C)n(C)n(Cc6ccc(F)c(F)c6)c5=O)cc4c32)CC1		CHEMBL3644747	=	IC50	nM	32.0	CHEMBL2534	Homo sapiens	IC50	nM	32.0
274789	17657089	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4c(C)n(C)n(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCOCC1		CHEMBL3644748	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274790	17657090	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	O=C(NCC#Cc1ccc2ncc3ncn(C4CCOC4)c3c2c1)c1cccn([C@@H](CO)c2cccc(F)c2)c1=O		CHEMBL3644749	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
274791	17657091	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](C)c5ccc(F)c(F)c5)c4=O)cc3c2n1[C@H]1CC[C@H](N(C)C)CC1		CHEMBL3644750	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274792	17657092	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5cccc(F)c5)c4=O)cc3c2n1[C@H]1CC[C@H](N(C)C)CC1		CHEMBL3644751	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
274793	17657093	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cccn([C@@H](CO)c5cccc(F)c5)c4=O)cc3c2n1[C@H]1CC[C@@H](N(C)C)CC1		CHEMBL3644752	=	IC50	nM	4.0	CHEMBL2534	Homo sapiens	IC50	nM	4.0
274794	17657094	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)[C@H]1CC[C@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cccn([C@@H](CO)c6cccc(F)c6)c5=O)cc4c32)CC1		CHEMBL3644753	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274795	17657095	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)[C@H]1CC[C@@H](n2cnc3cnc4ccc(C#CCNC(=O)c5cccn([C@@H](CO)c6cccc(F)c6)c5=O)cc4c32)CC1		CHEMBL3644754	=	IC50	nM	3.0	CHEMBL2534	Homo sapiens	IC50	nM	3.0
274796	17657096	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C1CCCOC1		CHEMBL3644755	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274797	17657097	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	NC[C@@H](c1ccccc1)n1cccc(C(=O)NCC#Cc2ccc3ncc4ncn(C5CCOC5)c4c3c2)c1=O		CHEMBL3644756	=	IC50	nM	681.0	CHEMBL2534	Homo sapiens	IC50	nM	681.0
274798	17657098	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cn1cnc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3644757	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274799	17657099	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCn1cnc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3644758	=	IC50	nM	1.0	CHEMBL2534	Homo sapiens	IC50	nM	1.0
274800	17657100	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CC(C)n1cnc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3639436	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274801	17657101	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCn1c(C)nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3644759	=	IC50	nM	2.0	CHEMBL2534	Homo sapiens	IC50	nM	2.0
274802	17657102	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3644760	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
274803	17657103	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCOc1cc(C(=O)NCC#Cc2ccc3ncc4ncn(C(C)C)c4c3c2)c(=O)n(Cc2ccc(F)c(F)c2)n1		CHEMBL3644761	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
274804	17657104	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCOc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3644762	=	IC50	nM	33.0	CHEMBL2534	Homo sapiens	IC50	nM	33.0
274805	17657105	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cn1c(-c2ccccc2)nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3647294	=	IC50	nM	72.0	CHEMBL2534	Homo sapiens	IC50	nM	72.0
274806	17657106	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CCc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647295	=	IC50	nM	8.0	CHEMBL2534	Homo sapiens	IC50	nM	8.0
274807	17657107	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	COc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647296	=	IC50	nM	18.0	CHEMBL2534	Homo sapiens	IC50	nM	18.0
274808	17657108	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	COCCc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647290	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
274809	17657109	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cn1c(CF)nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3647291	=	IC50	nM	19.0	CHEMBL2534	Homo sapiens	IC50	nM	19.0
274810	17657110	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	COCc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647297	=	IC50	nM	41.0	CHEMBL2534	Homo sapiens	IC50	nM	41.0
274811	17657111	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)Cc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647292	=	IC50	nM	79.0	CHEMBL2534	Homo sapiens	IC50	nM	79.0
274812	17657112	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)CCCc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647298	=	IC50	nM	6.0	CHEMBL2534	Homo sapiens	IC50	nM	6.0
274813	17657113	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	CN(C)CCc1nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c2n1C		CHEMBL3647299	=	IC50	nM	22.0	CHEMBL2534	Homo sapiens	IC50	nM	22.0
274814	17657114	CHEMBL3705594	Kinase Assay: Recombinant human PDK1 enzyme (aa 52-556) linked at its N-terminal end to His6 is isolated from baculovirus-infected insect cells. Purified enzyme may be obtained for example from the University of Dundee, Scotland. The following components are combined in a well of a 96-well round-based dish (Greiner bio-one, No. 650101):  1. 15 uL of compound to be tested in varying concentrations (e.g. starting at 10 uM, and diluted in steps of 1:5) in APT buffer (50 mM Tris/Cl pH7.5; 0.05% beta -mercaptoethanol; 10 mM Mg-acetate; 0.0166% Tween 20; 3.33% DMSO)  2. 15 uL His6-PDK1 (aa 52-556) 3.33 ng/well) and PDKtide (KTFCGTPEYLAPEVRRE PRILSEEEQEMFRDFDYIADWC), synthesised by Pepceuticals Limited, Nottingham, United Kingdom; 25 uM final concentration); His6-PDK1 and PDKtide are together diluted accordingly in assay buffer (50 mM tris pH 7.5, 0.05% beta -mercaptoethanol, 10 mM Mg-acetate); PDKtide is present in this mixture as an 83.3 uM solution.	B	Cn1c(CCO)nc2cnc3ccc(C#CCNC(=O)c4cncn(Cc5ccc(F)c(F)c5)c4=O)cc3c21		CHEMBL3647293	=	IC50	nM	14.0	CHEMBL2534	Homo sapiens	IC50	nM	14.0
358627	17734290	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652558	=	IC50	nM	34.0	CHEMBL2534	Homo sapiens	IC50	nM	34.0
358628	17734291	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C(C)(C)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652559	=	IC50	nM	65.0	CHEMBL2534	Homo sapiens	IC50	nM	65.0
358629	17734292	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652560	=	IC50	nM	59.5	CHEMBL2534	Homo sapiens	IC50	nM	59.5
358630	17734293	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652561	=	IC50	nM	13.0	CHEMBL2534	Homo sapiens	IC50	nM	13.0
358631	17734294	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	COc1ccc(N(C[C@H](O)CO)c2cc(-c3c[nH]c4ncc(-c5cnn(C)c5)cc34)nc(N)n2)cc1		CHEMBL3652562	=	IC50	nM	24.0	CHEMBL2534	Homo sapiens	IC50	nM	24.0
358632	17734295	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652563	=	IC50	nM	130.0	CHEMBL2534	Homo sapiens	IC50	nM	130.0
358633	17734296	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccc(Cl)cc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652564	=	IC50	nM	870.0	CHEMBL2534	Homo sapiens	IC50	nM	870.0
358634	17734297	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1cccc(Cl)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652565	=	IC50	nM	51.0	CHEMBL2534	Homo sapiens	IC50	nM	51.0
358635	17734298	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1F		CHEMBL3652566	=	IC50	nM	9.7	CHEMBL2534	Homo sapiens	IC50	nM	9.7
358636	17734299	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652567	=	IC50	nM	7.6	CHEMBL2534	Homo sapiens	IC50	nM	7.6
358637	17734300	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652568	=	IC50	nM	16.5	CHEMBL2534	Homo sapiens	IC50	nM	16.5
358638	17734301	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652569	=	IC50	nM	12.0	CHEMBL2534	Homo sapiens	IC50	nM	12.0
358639	17734302	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CCN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652570	=	IC50	nM	46.0	CHEMBL2534	Homo sapiens	IC50	nM	46.0
358640	17734303	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CCN(Cc1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652571	=	IC50	nM	51.0	CHEMBL2534	Homo sapiens	IC50	nM	51.0
358641	17734304	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652572	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
358642	17734305	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652573	=	IC50	nM	4.7	CHEMBL2534	Homo sapiens	IC50	nM	4.7
358643	17734306	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652574	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
358644	17734307	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652575	=	IC50	nM	5900.0	CHEMBL2534	Homo sapiens	IC50	nM	5900.0
358645	17734308	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(C)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652576	=	IC50	nM	30.0	CHEMBL2534	Homo sapiens	IC50	nM	30.0
358646	17734309	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1nncs1		CHEMBL3652577	=	IC50	nM	155.0	CHEMBL2534	Homo sapiens	IC50	nM	155.0
358647	17734310	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	COCC(O)CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652578	=	IC50	nM	11.0	CHEMBL2534	Homo sapiens	IC50	nM	11.0
358648	17734311	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CC(O)CO)c5cccc(C#N)c5)nc(N)n4)c3c2)cn1		CHEMBL3652579	=	IC50	nM	90.0	CHEMBL2534	Homo sapiens	IC50	nM	90.0
358649	17734312	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(=O)O)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3639514	=	IC50	nM	4.8	CHEMBL2534	Homo sapiens	IC50	nM	4.8
358650	17734313	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CCC(=O)CN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3976393	=	IC50	nM	69.0	CHEMBL2534	Homo sapiens	IC50	nM	69.0
358651	17734314	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccc(F)cc5F)nc(N)n4)c3c2)cn1		CHEMBL3652581	=	IC50	nM	6.5	CHEMBL2534	Homo sapiens	IC50	nM	6.5
358652	17734315	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5F)nc(N)n4)c3c2)cn1		CHEMBL3652582	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
358653	17734316	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCOc6ccccc65)nc(N)n4)c3c2)cn1		CHEMBL3652583	=	IC50	nM	5.0	CHEMBL2534	Homo sapiens	IC50	nM	5.0
358654	17734317	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCN5CCOCC5)c5cccc(F)c5)nc(N)n4)c3c2)cn1		CHEMBL3652584	=	IC50	nM	89.0	CHEMBL2534	Homo sapiens	IC50	nM	89.0
358655	17734318	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	COCCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652585	=	IC50	nM	7.0	CHEMBL2534	Homo sapiens	IC50	nM	7.0
358656	17734319	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC#N)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652586	=	IC50	nM	7.9	CHEMBL2534	Homo sapiens	IC50	nM	7.9
358657	17734320	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)ncn1		CHEMBL3652587	=	IC50	nM	190.0	CHEMBL2534	Homo sapiens	IC50	nM	190.0
358658	17734321	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCCN)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652588	=	IC50	nM	8.7	CHEMBL2534	Homo sapiens	IC50	nM	8.7
358659	17734322	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(N)=O)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652589	=	IC50	nM	17.0	CHEMBL2534	Homo sapiens	IC50	nM	17.0
358660	17734323	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6F)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652590	=	IC50	nM	45.5	CHEMBL2534	Homo sapiens	IC50	nM	45.5
358661	17734324	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CC(=O)NCCCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652591	=	IC50	nM	22.0	CHEMBL2534	Homo sapiens	IC50	nM	22.0
358662	17734325	CHEMBL3887863	PDK1 Enzymatic Assay: The experimental batches are carried out in a flashplate system with 384 wells/microtitration plate.In each case, the PDK1 sample His6-PDK1(1-50)(3.4 nM) (His6 disclosed as SEQ ID NO: 2), the PDK1 substrate biotin-bA-bAKTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (SEQ ID NO: 3) (400 nM), 4 uM ATP (with 0.2 uCi of 33P-ATP/well) and the test substance in 50 ul of conventional experimental solution per well are incubated at 30 C. for 60 min. The test substances are employed in corresponding concentrations (if desired in a dilution series). The control is carried out without test substance. The reaction is stopped using standard methods and washed. The activity of the kinase is measured via the incorporated radioactivity in top count. In order to determine the non-specific kinase reaction (blank value), the experimental batches are carried out in the presence of 100 nM staurosporine.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(C(C)(O)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3969929	=	IC50	nM	54.0	CHEMBL2534	Homo sapiens	IC50	nM	54.0
358663	17734326	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652558	=	IC50	nM	280.0	CHEMBL2534	Homo sapiens	IC50	nM	280.0
358664	17734327	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C(C)(C)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652559	=	IC50	nM	140.0	CHEMBL2534	Homo sapiens	IC50	nM	140.0
358665	17734328	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652560	=	IC50	nM	110.0	CHEMBL2534	Homo sapiens	IC50	nM	110.0
358666	17734329	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652561	=	IC50	nM	250.0	CHEMBL2534	Homo sapiens	IC50	nM	250.0
358667	17734330	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	COc1ccc(N(C[C@H](O)CO)c2cc(-c3c[nH]c4ncc(-c5cnn(C)c5)cc34)nc(N)n2)cc1		CHEMBL3652562	=	IC50	nM	6800.0	CHEMBL2534	Homo sapiens	IC50	nM	6800.0
358668	17734331	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652563	=	IC50	nM	625.0	CHEMBL2534	Homo sapiens	IC50	nM	625.0
358669	17734332	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccc(Cl)cc6)CCCC5)nc(N)n4)c3c2)cn1		CHEMBL3652564	=	IC50	nM	1400.0	CHEMBL2534	Homo sapiens	IC50	nM	1400.0
358670	17734333	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1cccc(Cl)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652565	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	nM	200.0
358671	17734334	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1F		CHEMBL3652566	=	IC50	nM	27.0	CHEMBL2534	Homo sapiens	IC50	nM	27.0
358672	17734335	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652567	=	IC50	nM	26.0	CHEMBL2534	Homo sapiens	IC50	nM	26.0
358673	17734336	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652568	=	IC50	nM	800.0	CHEMBL2534	Homo sapiens	IC50	nM	800.0
358674	17734337	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652569	=	IC50	nM	690.0	CHEMBL2534	Homo sapiens	IC50	nM	690.0
358675	17734338	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CCN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652570	=	IC50	nM	120.0	CHEMBL2534	Homo sapiens	IC50	nM	120.0
358676	17734339	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CCN(Cc1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652571	=	IC50	nM	530.0	CHEMBL2534	Homo sapiens	IC50	nM	530.0
358677	17734340	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652572	=	IC50	nM	2100.0	CHEMBL2534	Homo sapiens	IC50	nM	2100.0
358678	17734341	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652573	=	IC50	nM	2.6	CHEMBL2534	Homo sapiens	IC50	nM	2.6
358679	17734342	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652574	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358680	17734343	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N5CCc6cc(F)ccc65)nc(N)n4)c3c2)cn1		CHEMBL3652575	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358681	17734344	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(N(C)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3652576	=	IC50	nM	400.0	CHEMBL2534	Homo sapiens	IC50	nM	400.0
358682	17734345	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1nncs1		CHEMBL3652577	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358683	17734346	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	COCC(O)CN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652578	=	IC50	nM	520.0	CHEMBL2534	Homo sapiens	IC50	nM	520.0
358684	17734347	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CC(O)CO)c5cccc(C#N)c5)nc(N)n4)c3c2)cn1		CHEMBL3652579	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358685	17734348	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(=O)O)c5ccccc5Cl)nc(N)n4)c3c2)cn1		CHEMBL3639514	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358686	17734349	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CCC(=O)CN(c1ccc(Cl)cc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3976393	=	IC50	nM	470.0	CHEMBL2534	Homo sapiens	IC50	nM	470.0
358687	17734350	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccc(F)cc5F)nc(N)n4)c3c2)cn1		CHEMBL3652581	=	IC50	nM	35.0	CHEMBL2534	Homo sapiens	IC50	nM	35.0
358688	17734351	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCO)c5ccccc5F)nc(N)n4)c3c2)cn1		CHEMBL3652582	=	IC50	nM	23.0	CHEMBL2534	Homo sapiens	IC50	nM	23.0
358689	17734352	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N5CCOc6ccccc65)nc(N)n4)c3c2)cn1		CHEMBL3652583	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
358690	17734353	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCN5CCOCC5)c5cccc(F)c5)nc(N)n4)c3c2)cn1		CHEMBL3652584	=	IC50	nM	9700.0	CHEMBL2534	Homo sapiens	IC50	nM	9700.0
358691	17734354	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	COCCN(c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1)c1ccccc1Cl		CHEMBL3652585	=	IC50	nM	25.5	CHEMBL2534	Homo sapiens	IC50	nM	25.5
358692	17734355	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC#N)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652586	=	IC50	nM	7.1	CHEMBL2534	Homo sapiens	IC50	nM	7.1
358693	17734356	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CN(c1cccc(F)c1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)ncn1		CHEMBL3652587	=	IC50	nM	660.0	CHEMBL2534	Homo sapiens	IC50	nM	660.0
358694	17734357	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCCN)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652588	=	IC50	nM	6800.0	CHEMBL2534	Homo sapiens	IC50	nM	6800.0
358695	17734358	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(N(CCC(N)=O)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3652589	=	IC50	nM	23000.0	CHEMBL2534	Homo sapiens	IC50	nM	23000.0
358696	17734359	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	Cn1cc(-c2cnc3[nH]cc(-c4cc(C5(c6ccccc6F)CC5)nc(N)n4)c3c2)cn1		CHEMBL3652590	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	nM	20.0
358697	17734360	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CC(=O)NCCCN(c1ccccc1)c1cc(-c2c[nH]c3ncc(-c4cnn(C)c4)cc23)nc(N)n1		CHEMBL3652591	=	IC50	nM	430.0	CHEMBL2534	Homo sapiens	IC50	nM	430.0
358698	17734361	CHEMBL3887864	Luminex Assay: The cellular assay for the determination of the PDK1 kinase activity is carried out as a Luminex assay in the 96-well format. PC3 cells are sown at 20,000 cells per well in 100 ul of medium (45% of RPMI1460/45% of Ham's F12/10% of FCS) and incubated on the following day for 30 min with a serial dilution of the test substance (7 concentrations) under serum-free conditions. The cells are subsequently lysed using 90 ul of lysis buffer (20 mM tris/HCl pH 8.0, 150 mM NaCl, 1% of NP40, 10% of glycerol, 1% of phosphatase inhibitor I, 1% of phosphatase inhibitor II, 0.1% of protease inhibitor cocktail III, 0.01% of benzonase) per well, and the lysates are separated off from insoluble cell constituents by means of centrifugation through a 96-well filter plate (0.65 um). The lysates are incubated overnight at 4 C. with shaking with Luminex beads to which an anti-total PKB antibody is coupled. The detection is carried out on the following day by addition of a phospho-T308-PKB antibody and a species-specific peroxidase-labelled secondary antibody.	B	CC(C)n1cc(-c2cnc3[nH]cc(-c4cc(C(C)(O)c5ccccc5)nc(N)n4)c3c2)cn1		CHEMBL3969929	=	IC50	nM	492.0	CHEMBL2534	Homo sapiens	IC50	nM	492.0
390670	17762780	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(Cl)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL603852	=	Kd	nM	1740.0	CHEMBL2534	Homo sapiens	Kd	nM	1740.0
390671	17762781	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL595581	=	Kd	nM	2600.0	CHEMBL2534	Homo sapiens	Kd	nM	2600.0
390672	17762782	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(C(C)(C)C)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL594411	=	Kd	nM	1700.0	CHEMBL2534	Homo sapiens	Kd	nM	1700.0
390673	17762783	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(N)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL594412	=	Kd	nM	2200.0	CHEMBL2534	Homo sapiens	Kd	nM	2200.0
390674	17762784	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(O)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL595347	=	Kd	nM	2400.0	CHEMBL2534	Homo sapiens	Kd	nM	2400.0
390675	17762785	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(Cl)cc2)C(O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL3923074	=	Kd	nM	1450.0	CHEMBL2534	Homo sapiens	Kd	nM	1450.0
390692	17762802	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(Cl)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL603852	=	Kd	nM	31280.0	CHEMBL2534	Homo sapiens	Kd	nM	31280.0
390693	17762803	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccccc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL595581	=	Kd	nM	170.0	CHEMBL2534	Homo sapiens	Kd	nM	170.0
390694	17762804	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(C(C)(C)C)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL594411	=	Kd	nM	3570.0	CHEMBL2534	Homo sapiens	Kd	nM	3570.0
390695	17762805	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(O)cc2)C(=O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL595347	=	Kd	nM	420.0	CHEMBL2534	Homo sapiens	Kd	nM	420.0
390696	17762806	CHEMBL3888337	Silico Screening Assay: KT1 PH domain small molecule inhibitors were identified using the crystal structure of the AKT1 PH domain bound by PtdIns(1,3,4,5)P4 as descried in Thomas C C, Deak M, Alessi D R, van Aalten D M, High-resolution structure of the pleckstrin homology domain of protein kinase b/AKT bound to phosphatidylinositol (3,4,5)-trisphosphate, Curr Biol 12:1256 (2002), which is hereby incorporated by reference in its entirety, using a pharmacophore query search of the National Cancer Institute database. The high-resolution crystal structure of the isolated PH domain of human AKT1 in complex Ins(1,3,4,5)P4 was utilized to define a pharmacophore pocket for screening using Unity in Sybyl (version 7.2; Tripos Inc., St Louis, Mo.). The pharmacophore pocket included all the residues of the AKT1 crystal structure within 5  of the Ins(1,3,4,5)P4 binding site, i.e., Lys14, Arg15, Gly16, Gtu17, Tyr18, Ile19, Lys20, Thr21, Arg23, Pro24, Arg25, Lys39, Pro51, Leu52, Asn53, Asn54, Phe55, Gln79, ile84, Glu85, Arg86 and Phe88, and attributes to various atoms on the ligand and/or protein binding site were assigned. The defined pharmacophore pocket was then used to search virtual chemical databases and candidate compounds were identified. Various docking orientations were analyzed on the basis of FlexX scores, G-score, and X-score.	B	CC1=NN(C(=O)c2ccc(Cl)cc2)C(O)C1/N=N/c1ccc(S(=O)(=O)Nc2ncccn2)cc1		CHEMBL3923074	=	Kd	nM	980.0	CHEMBL2534	Homo sapiens	Kd	nM	980.0
412040	17776755	CHEMBL3888683	Mobility Shift Assay: Agents: 1-fold kinase buffer without MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 2 mM DTT. 1-fold kinase buffer with MnCl2: 50 mM HEPES, pH 7.5, 0.0015% Brij-35, 10 mM MgCl2, 10 mM MnCl2, 2 mM DTT. Termination solution: 100 mM HEPES, pH 7.5, 0.0015% Brij-35, 0.2% Coating Reagent#3, 50 mM EDTA. 2.5-fold kinase solution: The kinase was added to the 1-fold kinase buffer to form a 2.5-fold kinase solution. 2.5-fold substrate solution: FAM fluorescence-labelled polypeptide and ATP were added to the 1-fold kinase buffer to form a 2.5-fold substrate solution. Compounds: The final test concentration of the compound was 10 M at maximum. Firstly, a 50-fold concentration (i.e. 500 M) was prepared with 100% DMSO. The compound was diluted with 100% DMSO by 5 folds at 5 concentrations (successively 500 M, 100 M, 20 M, 4 M, and 0.8 M). After diluting with 1-fold kinase buffer by 10 folds, 5 l of the samples were transferred to a 384-well reaction plate. Two negative control wells and two positive control wells were set at each line respectively. Replication was made in a 96-well plate in five concentrations of 5-fold compound. 10% DMSO was added to the positive control well, and 5 l of EDTA (250 mM) was added to the negative control well. Procedure: To the 384-well reaction plate was added 5-fold compound dissolved in 10% DMSO at 5 l/well. To the 384-well reaction plate was added 2.5-fold kinase solution at 10 l/well. The plate was incubated at room temperature for 10 mins. To the 384-well reaction plate was added 2.5-fold substrate solution at 10 l/well. The plate was incubated at 28 C. for a certain period. 25 l termination solution was added to terminate the reaction.	B	Nc1ccc(-c2ccc3ncc4c(=O)[nH]c(=O)n(-c5cccc(C(F)(F)F)c5)c4c3n2)cn1		CHEMBL3903725	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
	17964935	CHEMBL3995044	Inhibition of full length human PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by KINOMEscan assay relative to control	B	CNc1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)on3)c(C)c2)ncn1		CHEMBL4060295	=	Activity	%	92.0	CHEMBL2534	Homo sapiens	Activity	%	92.0
	18083253	CHEMBL4018027	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3cc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL2087474	=	Inhibition	%	5.0	CHEMBL2534	Homo sapiens	INH	%	5.0
Not Active	18083254	CHEMBL4018027	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CCN(S(=O)(=O)C2CC2)C4)cn1		CHEMBL4098032		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18083255	CHEMBL4018027	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCc2c(nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn23)C1		CHEMBL4068727		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18083256	CHEMBL4018027	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	Nc1ncc(-c2cn3c4c(nc3c(N3CCOCC3)n2)CN(c2ccc(F)cc2)CC4)cn1		CHEMBL4088855	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	18105934	CHEMBL4022700	Inhibition of human PDK1 using unactivated AKT substrate in presence of COPC, DOPS and PIP3 activators after 1 hr by scintillation counting method	B	Nc1nc(NCCNc2ncc(-c3ncc[nH]3)c(-c3ccc(Cl)cc3Cl)n2)ccc1[N+](=O)[O-]		CHEMBL1080901	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	18105935	CHEMBL4022700	Inhibition of human PDK1 using unactivated AKT substrate in presence of COPC, DOPS and PIP3 activators after 1 hr by scintillation counting method	B	Cc1c[nH]c(-c2cnc(NCCNc3ccc(C#N)cn3)nc2-c2ccc(Cl)cc2Cl)n1		CHEMBL412142	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	18114767	CHEMBL4025297	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	90.0	CHEMBL2534	Homo sapiens	Activity	%	90.0
	18203821	CHEMBL4044108	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	67.0	CHEMBL2534	Homo sapiens	Activity	%	67.0
	18218055	CHEMBL4047107	Inhibition of PDK1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2c(N=Cc3ccc4ccccc4c3)c(C#N)c3n2CCC3)cc1		CHEMBL4079032	=	Inhibition	%	27.0	CHEMBL2534	Homo sapiens	INH	%	27.0
	18218056	CHEMBL4047107	Inhibition of PDK1 (unknown origin) at 10 uM using [33P]-ATP after 20 to 40 mins by scintillation counting method	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Inhibition	%	34.0	CHEMBL2534	Homo sapiens	INH	%	34.0
	18232158	CHEMBL4050348	Inhibition of human PDK1 assessed as residual activity at 1 uM in presence of [33P]ATP by filter binding assay relative to control	B	NCCCC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)CCCCCCCCOc1nc2cc(C(=O)O)ccc2c2cnccc12)C(=O)O		CHEMBL4077554	=	Activity	%	84.0	CHEMBL2534	Homo sapiens	Activity	%	84.0
	18250440	CHEMBL4054257	Inhibition of recombinant human PDK1 using Ulight-FLGFTYVAP as substrate at 100 uM after 90 mins in presence of ATP relative to control	B	CCCCCCCCCCCCCCC(=O)NC1CCN(C(=O)C2Sc3ccccc3N(CC)C2=O)CC1		CHEMBL4081419	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	18253489	CHEMBL4055028	Inhibition of wild-type human full length PDK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	82.0	CHEMBL2534	Homo sapiens	Activity	%	82.0
	18253490	CHEMBL4055028	Inhibition of wild-type human full length PDK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	18282122	CHEMBL4120077	Inhibition of recombinant full length His-tagged human PDK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	3.3	CHEMBL2534	Homo sapiens	INH	%	3.3
	18282441	CHEMBL4120077	Inhibition of recombinant full length His-tagged human PDK1 expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	-2.7	CHEMBL2534	Homo sapiens	INH	%	-2.7
	18423268	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	COc1ccc(F)cc1-c1cc(C(F)(F)F)cc(S(=O)(=O)NCCc2cccc(F)c2)c1		CHEMBL4165578	=	Inhibition	%	40.5	CHEMBL2534	Homo sapiens	INH	%	40.5
	18423269	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	COc1cc(-c2cc(C(F)(F)F)cc(S(=O)(=O)NCCc3cccc(F)c3)c2)ccc1F		CHEMBL4173505	=	Inhibition	%	27.6	CHEMBL2534	Homo sapiens	INH	%	27.6
	18423270	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccc(S(=O)(=O)N3CCCC3)c2)cc(C(F)(F)F)c1		CHEMBL4174135	=	Inhibition	%	5.7	CHEMBL2534	Homo sapiens	INH	%	5.7
	18423271	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=Cc1ccc(-c2cc(C(F)(F)F)cc(S(=O)(=O)NCCc3cccc(F)c3)c2)s1		CHEMBL4166224	=	Inhibition	%	5.2	CHEMBL2534	Homo sapiens	INH	%	5.2
	18423272	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(F)nc2)cc(C(F)(F)F)c1		CHEMBL4170711	=	Inhibition	%	10.3	CHEMBL2534	Homo sapiens	INH	%	10.3
	18423273	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(COc3cccc(C(F)(F)F)c3)cc2)cc(C(F)(F)F)c1		CHEMBL4162777	=	Inhibition	%	50.8	CHEMBL2534	Homo sapiens	INH	%	50.8
	18423274	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	COCCc1ccc(OCc2ccc(-c3cc(C(F)(F)F)cc(S(=O)(=O)NCCc4cccc(F)c4)c3)cc2)cc1		CHEMBL4162362	=	Inhibition	%	42.8	CHEMBL2534	Homo sapiens	INH	%	42.8
	18423275	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccc3c2Sc2ccccc2S3)cc(C(F)(F)F)c1		CHEMBL4173044	=	Inhibition	%	35.0	CHEMBL2534	Homo sapiens	INH	%	35.0
	18423276	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(COc3cccc4ccccc34)cc2)cc(C(F)(F)F)c1		CHEMBL4177505	=	Inhibition	%	35.6	CHEMBL2534	Homo sapiens	INH	%	35.6
	18423277	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cccc3c2oc2ccccc23)cc(C(F)(F)F)c1		CHEMBL4169644	=	Inhibition	%	2.4	CHEMBL2534	Homo sapiens	INH	%	2.4
	18423278	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccccc2COc2cccc(C(F)(F)F)c2)cc(C(F)(F)F)c1		CHEMBL4169245	=	Inhibition	%	52.7	CHEMBL2534	Homo sapiens	INH	%	52.7
	18423279	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2ccc(-c3cccs3)s2)cc(C(F)(F)F)c1		CHEMBL4161318	=	Inhibition	%	40.3	CHEMBL2534	Homo sapiens	INH	%	40.3
	18423280	CHEMBL4154424	Inhibition of recombinant human N-terminal His6-fused pdk1 expressed in Sf9 insect cells at 10 uM using tetra (LRRWSLG) as substrate after 60 mins in presence of [gamma-33P]-ATP by microplate scintillation counting method relative to control	B	O=S(=O)(NCCc1cccc(F)c1)c1cc(-c2cc3ccccc3[nH]2)cc(C(F)(F)F)c1		CHEMBL4173450	=	Inhibition	%	52.2	CHEMBL2534	Homo sapiens	INH	%	52.2
	18440363	CHEMBL4157187	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	72.0	CHEMBL2534	Homo sapiens	Activity	%	72.0
	18443304	CHEMBL4157951	Inhibition of human PKD1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	117.0	CHEMBL2534	Homo sapiens	Activity	%	117.0
	18443319	CHEMBL4157948	Inhibition of human PDK1 assessed as enzyme residual activity at 100 nM by radiometric filter binding assay relative to control	B	NCCCC[C@@H](NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)[C@@H](CC(=O)O)NC(=O)CCCCCNC(=O)CCC(=O)Nc1ncc(-c2ccc(C(=O)O)cc2)s1)C(=O)O		CHEMBL4177303	=	Activity	%	111.0	CHEMBL2534	Homo sapiens	Activity	%	111.0
	18449829	CHEMBL4178066	Inhibition of human PDK1 (52 to 556 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	118.0	CHEMBL2534	Homo sapiens	Activity	%	118.0
	18449942	CHEMBL4178176	Inhibition of human PKD1 (2 to 912 residues) assessed as residual activity at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Activity	%	9.0	CHEMBL2534	Homo sapiens	Activity	%	9.0
	18449944	CHEMBL4178178	Inhibition of human PKD1 (2 to 912 residues) at 500 nM in presence of 33P-ATP by filter binding assay relative to control	B	Cc1cccc(-c2nc(N)sc2-c2ccc3ncccc3n2)c1		CHEMBL4209540	=	Inhibition	%	91.0	CHEMBL2534	Homo sapiens	INH	%	91.0
	18457606	CHEMBL4179657	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4212439	<	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	18457607	CHEMBL4179657	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)cn3n2)CC1		CHEMBL4217392	<	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	18457608	CHEMBL4179657	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2cn3nc(-c4cnc(N)nc4)nc(N4CCOCC4)c3n2)CC1		CHEMBL4208064	<	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	18457609	CHEMBL4179657	Inhibition of recombinant human N-terminal His6-tagged PDK1 (M1 to M460 residues) expressed in Sf9 insect cells at 1 uM using LRRWSLG as substrate by filter binding method relative to control	B	CS(=O)(=O)N1CCN(Cc2nc3c(N4CCOCC4)nc(-c4cnc(N)nc4)c(Cl)n3n2)CC1		CHEMBL4205584	<	Inhibition	%	25.0	CHEMBL2534	Homo sapiens	INH	%	25.0
	18462186	CHEMBL4180873	Inhibition of recombinant human full length His6-tagged PDK1 (52 to 556 residues) expressed in Sf21 insect cells assessed as residual activity at 1 uM after 30 mins in presence of [gamma-33P]ATP relative to control	B	CC(C)=CCC/C(C)=C/Cn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@H]3CC[C@H](N)CC3)nc21		CHEMBL4203120	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
	18463779	CHEMBL4181195	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52 to end residues) expressed in baculovirus Sf21 insect cells at 10 uM by filter binding radioactive ATP transferase assay relative to control	B	C=C(C)n1c(=O)n(C(C)=O)c2cc(Br)cnc21		CHEMBL4212680	=	Inhibition	%	-1.0	CHEMBL2534	Homo sapiens	INH	%	-1.0
	18484319	CHEMBL4185966	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	18484803	CHEMBL4185966	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	18489547	CHEMBL4187288	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	Fc1cc(F)cc(-n2cnc3c(NCc4nc5c(F)c(F)ccc5[nH]4)nc(N4CCOCC4)nc32)c1		CHEMBL4207079	=	Activity	%	71.0	CHEMBL2534	Homo sapiens	Activity	%	71.0
	18507984	CHEMBL4191104	Inhibition of recombinant human PDK1 (52 to end residues) at 1 uM using KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC (PDKtide) as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	-6.0	CHEMBL2534	Homo sapiens	INH	%	-6.0
	18568218	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	Clc1n[nH]c2cccc(Br)c12		CHEMBL4225389	=	IC50	nM	163600.0	CHEMBL2534	Homo sapiens	IC50	uM	163.6
	18568219	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	Nc1n[nH]c2cccc(I)c12		CHEMBL4226486	=	IC50	nM	29000.0	CHEMBL2534	Homo sapiens	IC50	uM	29.0
	18568220	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	Nc1n[nH]c2cc(Br)ccc12		CHEMBL501406	=	IC50	nM	82400.0	CHEMBL2534	Homo sapiens	IC50	uM	82.4
	18568221	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	CS(=O)(=O)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659982	=	IC50	nM	15300.0	CHEMBL2534	Homo sapiens	IC50	uM	15.3
	18568222	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	FC(F)(F)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL3659983	=	IC50	nM	30300.0	CHEMBL2534	Homo sapiens	IC50	uM	30.3
	18568223	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	CC(C)(C#N)c1cccc(-c2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)c1		CHEMBL4228611	=	IC50	nM	5200.0	CHEMBL2534	Homo sapiens	IC50	uM	5.2
Not Active	18568224	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)Nc1ccc(F)cc1F		CHEMBL3659985		IC50			CHEMBL2534	Homo sapiens	IC50		
	18568225	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CCCC1		CHEMBL3659987	=	IC50	nM	53900.0	CHEMBL2534	Homo sapiens	IC50	uM	53.9
	18568226	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)NC1CC1		CHEMBL3659980	=	IC50	nM	900.0	CHEMBL2534	Homo sapiens	IC50	uM	0.9
	18568227	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)c1cccc(F)c1		CHEMBL3659981	=	IC50	nM	8800.0	CHEMBL2534	Homo sapiens	IC50	uM	8.8
	18568228	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	CN1CCC(C)(C(=O)Nc2ccc3[nH]nc(-c4nc5ccccc5[nH]4)c3c2)CC1		CHEMBL3659986	=	IC50	nM	12400.0	CHEMBL2534	Homo sapiens	IC50	uM	12.4
	18568229	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659976	=	IC50	nM	300.0	CHEMBL2534	Homo sapiens	IC50	uM	0.3
	18568230	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659974	=	IC50	nM	400.0	CHEMBL2534	Homo sapiens	IC50	uM	0.4
Not Active	18568231	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CCN(c2ccncc2)CC1		CHEMBL3659988		IC50			CHEMBL2534	Homo sapiens	IC50		
	18568232	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1)C1CC1		CHEMBL3659975	=	IC50	nM	1200.0	CHEMBL2534	Homo sapiens	IC50	uM	1.2
	18568233	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(CN5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659977	=	IC50	nM	1200.0	CHEMBL2534	Homo sapiens	IC50	uM	1.2
	18568234	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CCC(F)(F)CC1		CHEMBL3659972	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	uM	0.2
	18568235	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1		CHEMBL3659971	=	IC50	nM	200.0	CHEMBL2534	Homo sapiens	IC50	uM	0.2
	18568236	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	CC1CCN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CC1		CHEMBL3659973	=	IC50	nM	800.0	CHEMBL2534	Homo sapiens	IC50	uM	0.8
	18568237	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1cccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c12)C1CC1(F)F		CHEMBL3659978	=	IC50	nM	400.0	CHEMBL2534	Homo sapiens	IC50	uM	0.4
Not Active	18568238	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2c(-c3nc4ccc(N5CCOCC5)cc4[nH]3)n[nH]c2c1)C1CC1(F)F		CHEMBL3659989		IC50			CHEMBL2534	Homo sapiens	IC50		
	18568239	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	Brc1ccc2[nH]nc(-c3nc4ccccc4[nH]3)c2c1		CHEMBL3659979	=	IC50	nM	10900.0	CHEMBL2534	Homo sapiens	IC50	uM	10.9
	18568240	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	Nc1n[nH]c2ccc(Br)cc12		CHEMBL465091	=	IC50	nM	101900.0	CHEMBL2534	Homo sapiens	IC50	uM	101.9
	18568241	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	uM	0.08
	18568242	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	IC50	nM	90.0	CHEMBL2534	Homo sapiens	IC50	uM	0.09
	18568243	CHEMBL4220018	Inhibition of PDK1 (unknown origin) after 1 hr in presence of Ser/Thr-07 by fluorometric assay	B	C/C(=C1/C(=O)Nc2ccc(NC(N)=O)cc21)c1ccc[nH]1		CHEMBL228654	=	IC50	nM	9.0	CHEMBL2534	Homo sapiens	IC50	nM	9.0
	18568255	CHEMBL4220027	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as reduction in AKT phosphorylation at Thr308 residue at 100 nM after 24 hrs by Meso Scale Discovery assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
	18568256	CHEMBL4220028	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as reduction in ribosomal p70S6 protein phosphorylation after 2 hrs by in-cell Western blotting analysis	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	EC50	nM	75.6	CHEMBL2534	Homo sapiens	EC50	nM	75.6
	18568257	CHEMBL4220028	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as reduction in ribosomal p70S6 protein phosphorylation after 2 hrs by in-cell Western blotting analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	EC50	nM	76.7	CHEMBL2534	Homo sapiens	EC50	nM	76.7
Dose-dependent effect	18568258	CHEMBL4220029	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as reduction in AKT phosphorylation at Thr308 residue after 24 hrs by Meso Scale Discovery assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568386	CHEMBL4220102	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568387	CHEMBL4220103	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568388	CHEMBL4220104	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568389	CHEMBL4220105	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568390	CHEMBL4220106	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568391	CHEMBL4220107	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568392	CHEMBL4220108	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568393	CHEMBL4220109	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568394	CHEMBL4220017	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568395	CHEMBL4220110	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568396	CHEMBL4220111	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568397	CHEMBL4220112	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568398	CHEMBL4220113	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568399	CHEMBL4220114	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568400	CHEMBL4220115	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568401	CHEMBL4220116	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568402	CHEMBL4220117	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568403	CHEMBL4220118	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568404	CHEMBL4220119	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as downregulation of DUSP6 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568405	CHEMBL4220120	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as downregulation of FOSL1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568406	CHEMBL4220121	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as downregulation of DUSP4 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568407	CHEMBL4220122	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568408	CHEMBL4220123	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568409	CHEMBL4220124	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568410	CHEMBL4220125	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568411	CHEMBL4220126	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568412	CHEMBL4220127	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568413	CHEMBL4220128	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568414	CHEMBL4220129	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568415	CHEMBL4220130	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568416	CHEMBL4220131	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568417	CHEMBL4220132	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568418	CHEMBL4220133	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568419	CHEMBL4220134	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568420	CHEMBL4220135	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568421	CHEMBL4220136	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568422	CHEMBL4220137	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568423	CHEMBL4220138	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568424	CHEMBL4220139	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568425	CHEMBL4220140	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as decrease in DUSP6 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568426	CHEMBL4220141	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as decrease in FOSL1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568427	CHEMBL4220142	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as decrease in DUSP4 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568428	CHEMBL4220143	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568429	CHEMBL4220144	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568430	CHEMBL4220145	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568431	CHEMBL4220146	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568432	CHEMBL4220147	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568433	CHEMBL4220148	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568434	CHEMBL4220149	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as downregulation of PDK1 mRNA expression level at 0.01 to 1 uM by RT-qPCR method	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568435	CHEMBL4220150	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568436	CHEMBL4220151	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human KATO III cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568437	CHEMBL4220152	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MV4-11 cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568438	CHEMBL4220153	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human HCT116 cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568439	CHEMBL4220154	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human Capan1 cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568440	CHEMBL4220155	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human SW480 cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18568441	CHEMBL4220156	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human MOLT4 cells assessed as decrease in PDK1 protein level at 0.01 to 1 uM by Western blot analysis	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18568453	CHEMBL4220165	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 1000 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	0.0	CHEMBL2534	Homo sapiens	Activity	%	0.0
	18568454	CHEMBL4220165	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 1000 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	0.0	CHEMBL2534	Homo sapiens	Activity	%	0.0
	18568455	CHEMBL4220166	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 300 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	5.0	CHEMBL2534	Homo sapiens	Activity	%	5.0
	18568456	CHEMBL4220166	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 300 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	5.0	CHEMBL2534	Homo sapiens	Activity	%	5.0
	18568457	CHEMBL4220167	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 100 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	33.0	CHEMBL2534	Homo sapiens	Activity	%	33.0
	18568458	CHEMBL4220167	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 100 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	28.0	CHEMBL2534	Homo sapiens	Activity	%	28.0
	18568459	CHEMBL4220168	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 30 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	77.0	CHEMBL2534	Homo sapiens	Activity	%	77.0
	18568460	CHEMBL4220168	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 30 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	73.0	CHEMBL2534	Homo sapiens	Activity	%	73.0
	18568461	CHEMBL4220169	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 10 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	81.0	CHEMBL2534	Homo sapiens	Activity	%	81.0
	18568462	CHEMBL4220169	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 10 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	78.0	CHEMBL2534	Homo sapiens	Activity	%	78.0
	18568463	CHEMBL4220170	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 3 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	Activity	%	95.0	CHEMBL2534	Homo sapiens	Activity	%	95.0
	18568464	CHEMBL4220170	Inhibition of PDK1 mediated PI3K/Akt/mTOR pathway activation in human AN3CA cells assessed as ribosomal p70S6 protein phosphorylation at 3 nM after 2 hrs by in-cell Western blotting analysis (Rvb = 100%)	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	Activity	%	81.0	CHEMBL2534	Homo sapiens	Activity	%	81.0
	18568467	CHEMBL4220172	Inhibition of PDK1 (unknown origin) by TR-FRET assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990	=	IC50	nM	80.0	CHEMBL2534	Homo sapiens	IC50	nM	80.0
	18568468	CHEMBL4220172	Inhibition of PDK1 (unknown origin) by TR-FRET assay	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991	=	IC50	nM	94.0	CHEMBL2534	Homo sapiens	IC50	nM	94.0
Active	18568469	CHEMBL4220173	Inhibition of PDK1 (unknown origin) by luminescence-based activity assay	B	O=C(Nc1ccc2[nH]nc(-c3nc4ccc(N5CCOCC5)cc4[nH]3)c2c1)C1CC1(F)F		CHEMBL3659990		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18568470	CHEMBL4220173	Inhibition of PDK1 (unknown origin) by luminescence-based activity assay	B	CC1CN(c2ccc3nc(-c4n[nH]c5ccc(NC(=O)C6CC6(F)F)cc45)[nH]c3c2)CCO1		CHEMBL3659991		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18653449	CHEMBL4230179	Inhibition of PDK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	4.0	CHEMBL2534	Homo sapiens	INH	%	4.0
	18653450	CHEMBL4230179	Inhibition of PDK1 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	5.0	CHEMBL2534	Homo sapiens	INH	%	5.0
	18655369	CHEMBL4230866	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	18663943	CHEMBL4232927	Inhibition of full length human PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 5 uM by KINOMEscan assay relative to control	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	18664040	CHEMBL4233024	Binding affinity to full length human PDPK1 (M1 to Q556 residues) expressed in bacterial expression system by KINOMEscan assay	B	CC(C)CN(C(=O)c1cccnc1)c1c2ccccc2c(=O)n2c1[nH]c1ccccc12		CHEMBL4247704	>=	Kd	nM	5000.0	CHEMBL2534	Homo sapiens	Kd	uM	5.0
	18665430	CHEMBL4233378	Inhibition of PDK1 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
	18665473	CHEMBL4233378	Inhibition of PDK1 (unknown origin)	B	O=C(Cc1cccc(OCCCC2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4251324	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	nM	10000.0
	18668768	CHEMBL4234421	Inhibition of wild type PDK1 (unknown origin)	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	IC50	nM	750.0	CHEMBL2534	Homo sapiens	IC50	nM	750.0
	18694015	CHEMBL4253468	Inhibition of recombinant human full length His-tagged PDK1 expressed in baculovirus expression system at 0.1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	-3.0	CHEMBL2534	Homo sapiens	INH	%	-3.0
	18694097	CHEMBL4253550	Inhibition of recombinant human full length His-tagged PDK1 expressed in baculovirus expression system at 1 uM by Z'-Lyte assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	4.0	CHEMBL2534	Homo sapiens	INH	%	4.0
	18697670	CHEMBL4254343	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCNc1cc(-c2ccc(NC(=O)Nc3cccc(Cl)c3)cc2C(F)(F)F)ccn1		CHEMBL4281348	=	Activity	%	63.0	CHEMBL2534	Homo sapiens	Activity	%	63.0
	18702469	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4278211	=	Inhibition	%	-6.0	CHEMBL2534	Homo sapiens	INH	%	-6.0
	18702569	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4282644	=	Inhibition	%	7.0	CHEMBL2534	Homo sapiens	INH	%	7.0
	18702614	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1ccc(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4287097	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	18702666	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(N)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4283739	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	18702709	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(C(N)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4294318	=	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	18702752	CHEMBL4255138	Inhibition of recombinant human full length His-tagged PDPK1 expressed in baculovirus expression system at 1 uM relative to control	B	COc1cc(C)c(S(C)(=O)=O)cc1C(=O)Nc1cccc(-c2nncn2C(C)C)n1		CHEMBL4289040	=	Inhibition	%	11.0	CHEMBL2534	Homo sapiens	INH	%	11.0
	18706760	CHEMBL4256126	Inhibition of PDK1 (unknown origin) at 50 ug/ml by mobility shift assay relative to control	B	CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(=O)O		CHEMBL12850	=	Inhibition	%	46.1	CHEMBL2534	Homo sapiens	INH	%	46.1
	18706782	CHEMBL4256139	Inhibition of PDK1 (unknown origin) by mobility shift assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	10.0	CHEMBL2534	Homo sapiens	IC50	nM	10.0
	18725404	CHEMBL4259101	Inhibition of PDK1 (unknown origin)	B	CC(=O)n1nc(C)c(-c2ccc(Cl)c(Cl)c2)c1N		CHEMBL4276946	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	uM	100.0
	18726764	CHEMBL4259288	Inhibition of PDK1 (unknown origin) at 10 uM	B	Oc1ccc(C2=NN(c3ccc(Cl)cc3)C(c3ccc(Cl)cc3)C2)cc1O		CHEMBL4283413	=	Inhibition	%	1.0	CHEMBL2534	Homo sapiens	INH	%	1.0
Not Active	18728877	CHEMBL4259707	Inhibition of PDK1 (unknown origin) at 1 uM after 40 mins by scintillation counting method relative to control	B	O=C(N1CCN(c2ncnc3[nH]nc(Cl)c23)CC1)C1(c2ccc(Cl)c(Cl)c2)CCNCC1		CHEMBL4285143		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18751189	CHEMBL4263898	Inhibition of PDK1 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	2.0	CHEMBL2534	Homo sapiens	INH	%	2.0
	18752118	CHEMBL4264455	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL2534	Homo sapiens	Activity	%	92.0
	18761553	CHEMBL4266604	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	4.0	CHEMBL2534	Homo sapiens	INH	%	4.0
	18761558	CHEMBL4266610	Inhibition of recombinant human N-terminal GST-tagged PDK1 (468 to 1203 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CN(C)[C@H]1CC[C@H](Nc2ncnc3[nH]cc([C@H]4CC[C@H](C(N)=O)CC4)c23)CC1		CHEMBL4279192	=	Inhibition	%	-2.0	CHEMBL2534	Homo sapiens	INH	%	-2.0
	18761824	CHEMBL4266604	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	7.0	CHEMBL2534	Homo sapiens	INH	%	7.0
	18761829	CHEMBL4266610	Inhibition of recombinant human N-terminal GST-tagged PDK1 (468 to 1203 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C(C)C)c34)CC2)CC1		CHEMBL4278882	=	Inhibition	%	-8.0	CHEMBL2534	Homo sapiens	INH	%	-8.0
	18761987	CHEMBL4266604	Inhibition of recombinant human N-terminal His6-tagged PDK1 (52 to end residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1	Outside typical range	CHEMBL4290222	=	Inhibition	%	-14.0	CHEMBL2534	Homo sapiens	INH	%	-14.0
	18761992	CHEMBL4266610	Inhibition of recombinant human N-terminal GST-tagged PDK1 (468 to 1203 residues) expressed in baculovirus infected Sf21 insect cells at 1 uM relative to control	B	CC(=O)N1CCN([C@H]2CC[C@H](Nc3ncnn4ccc(C5CCOCC5)c34)CC2)CC1		CHEMBL4290222	=	Inhibition	%	10.0	CHEMBL2534	Homo sapiens	INH	%	10.0
	18764406	CHEMBL4267054	Inhibition of human PDK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)cc3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4288103	<	Inhibition	%	70.0	CHEMBL2534	Homo sapiens	INH	%	70.0
	18764407	CHEMBL4267054	Inhibition of human PDK1 at 100 nM	B	CN1CCC(c2nc(-c3cccc(S(C)(=O)=O)c3)c(-c3ccnc(Nc4ccc(N5CCNCC5)cc4)n3)s2)CC1		CHEMBL4286880	<	Inhibition	%	70.0	CHEMBL2534	Homo sapiens	INH	%	70.0
	18764408	CHEMBL4267054	Inhibition of human PDK1 at 100 nM	B	CN1CCC(c2nc(-c3ccc(F)c(NS(C)(=O)=O)c3)c(-c3ccnc(NCC4CC4)n3)s2)CC1		CHEMBL4286841	<	Inhibition	%	70.0	CHEMBL2534	Homo sapiens	INH	%	70.0
	18782853	CHEMBL4270719	Inhibition of PDK1 (unknown origin) assessed as residual enzyme activity at 1 uM relative to untreated control	B	Cc1cccc(-c2nn3c(c2-c2ccc(O)cc2)C(C)C(C)(C)C3)n1		CHEMBL4277021	>	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
Dose-dependent effect	18787174	CHEMBL4271946	Inhibition of PDK1 (unknown origin) assessed as reduction in PDC phosphorylation	B	O=C(c1ccc(-c2ccc(O)cc2)cc1)C(Cl)Cl		CHEMBL4291759		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18787175	CHEMBL4271947	Binding affinity to PDK1 (unknown origin)	B	O=C(c1ccc(-c2ccc(O)cc2)cc1)C(Cl)Cl		CHEMBL4291759	=	Kd	nM	13400.0	CHEMBL2534	Homo sapiens	Kd	uM	13.4
Not Active	18787196	CHEMBL4271985	Inhibition of PDK1 in human NCI-H1650 cells assessed as reduction in PDC phosphorylation at 1 uM after 12 hrs by Western blot analysis	B	O=C(c1ccc(-c2ccc(O)c([N+](=O)[O-])c2)cc1)C(Cl)Cl		CHEMBL4289177		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787197	CHEMBL4271988	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring increase in oxygen consumption rates at 5 uM incubated for 4 hrs measured for 16 mins	B	O=C(c1ccc(-c2ccc(O)c([N+](=O)[O-])c2)cc1)C(Cl)Cl		CHEMBL4289177		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787198	CHEMBL4271990	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring reduction in lactate formation at 5 uM after 4 hrs	B	O=C(c1ccc(-c2ccc(O)c([N+](=O)[O-])c2)cc1)C(Cl)Cl		CHEMBL4289177		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787205	CHEMBL4271946	Inhibition of PDK1 (unknown origin) assessed as reduction in PDC phosphorylation	B	O=C(CC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4278526		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787218	CHEMBL4271946	Inhibition of PDK1 (unknown origin) assessed as reduction in PDC phosphorylation	B	O=C(CCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4278133		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787231	CHEMBL4271946	Inhibition of PDK1 (unknown origin) assessed as reduction in PDC phosphorylation	B	O=C(CCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4286048		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787244	CHEMBL4271946	Inhibition of PDK1 (unknown origin) assessed as reduction in PDC phosphorylation	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Dose-dependent effect	18787274	CHEMBL4271984	Inhibition of PDK1 in human NCI-H1650 cells assessed as reduction in PDC phosphorylation after 12 hrs by Western blot analysis	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787275	CHEMBL4271986	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring decrease in extracellular acidification rates at 1 to 5 uM incubated for 4 hrs measured for 16 mins	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787276	CHEMBL4271987	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring increase in oxygen consumption rates at 1 to 5 uM incubated for 4 hrs measured for 16 mins	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787277	CHEMBL4271989	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring reduction in lactate formation at 2 to 5 uM after 4 hrs	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	18787278	CHEMBL4271991	Inhibition of PDK1 in human NCI-H1650 cells assessed as switch of pyruvate metabolism from lactate production to OXPHOS in mitochondria by measuring increase in ROS production at high concentration after 4 hrs by DCFH-DA dye based assay	B	O=C(CCCCC[P+](c1ccccc1)(c1ccccc1)c1ccccc1)Oc1ccc(-c2ccc(C(=O)C(Cl)Cl)cc2)cc1[N+](=O)[O-].[Br-]		CHEMBL4293270		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18787316	CHEMBL4271985	Inhibition of PDK1 in human NCI-H1650 cells assessed as reduction in PDC phosphorylation at 1 uM after 12 hrs by Western blot analysis	B	O=C(c1ccccc1)C(Cl)Cl		CHEMBL3560171		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	18847284	CHEMBL4304936	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	O=C(Nc1ccc2[nH]nc(-c3ccc4[nH]ccc4c3)c2c1)c1c(Cl)cccc1Cl		CHEMBL4517719		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	18858119	CHEMBL4307965	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	18892940	CHEMBL4314906	Inhibition of recombinant human PDK1 (52 to end residues) assessed as residual activity at 10 uM using PDKtide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	91.0	CHEMBL2534	Homo sapiens	Activity	%	91.0
	18895037	CHEMBL4315519	Inhibition of recombinant human N-terminal His-tagged full length PDK1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC(C)C/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccc(Br)cc1)CCC2		CHEMBL4592358	=	Activity	%	28.0	CHEMBL2534	Homo sapiens	Activity	%	28.0
	18895056	CHEMBL4315519	Inhibition of recombinant human N-terminal His-tagged full length PDK1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CC/C=N/c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4527978	=	Activity	%	-15.0	CHEMBL2534	Homo sapiens	Activity	%	-15.0
	18895075	CHEMBL4315519	Inhibition of recombinant human N-terminal His-tagged full length PDK1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	CCC1SCC(=O)N1c1c(C#N)c2n(c1C(=O)Nc1ccccc1)CCC2		CHEMBL4471323	=	Activity	%	-11.0	CHEMBL2534	Homo sapiens	Activity	%	-11.0
	18895094	CHEMBL4315519	Inhibition of recombinant human N-terminal His-tagged full length PDK1 expressed in baculovirus infected Sf9 insect cells assessed as enzyme activity incubated for 15 mins by [gamma-33]ATP based scintillation counting method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	=	Activity	%	34.0	CHEMBL2534	Homo sapiens	Activity	%	34.0
	18919488	CHEMBL4322844	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PDPK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	8.0	CHEMBL2534	Homo sapiens	Kd	nM	8.0
	18919676	CHEMBL4322844	Binding affinity to recombinant full-length N-terminal His-FLAG-GST-tagged PDPK1 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	8.0	CHEMBL2534	Homo sapiens	Kd	nM	8.0
	18958641	CHEMBL4333550	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	84.0	CHEMBL2534	Homo sapiens	Activity	%	84.0
	18964570	CHEMBL4335226	Inhibition of recombinant human PDK1 (52 to end residues) assessed as residual activity at 1 uM using PDKtide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	18964571	CHEMBL4335226	Inhibition of recombinant human PDK1 (52 to end residues) assessed as residual activity at 1 uM using PDKtide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	87.0	CHEMBL2534	Homo sapiens	Activity	%	87.0
	18972039	CHEMBL4337049	Inhibition of recombinant human PDK1 (52 to end residues) assessed as residual activity at 10 uM using PDKtide as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	80.0	CHEMBL2534	Homo sapiens	Activity	%	80.0
	18989196	CHEMBL4340728	Inhibition of recombinant human N-terminal His6-fused PDK1 (M1 to M460 residues) expressed in Sf9 insect cells using tetra(LRRWSLG) peptide as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method	B	CN(CCc1ccc(-c2ccccc2)cc1)Cc1cn(C)c2ccc(C(=O)Nc3ccc(F)cc3)cc12		CHEMBL4446681	=	IC50	nM	11000.0	CHEMBL2534	Homo sapiens	IC50	uM	11.0
	19021542	CHEMBL4347764	Inhibition of recombinant human PDK1 at 20 nM using Ulight-FLGFTYVAP as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	5.0	CHEMBL2534	Homo sapiens	INH	%	5.0
	19021543	CHEMBL4347765	Inhibition of recombinant human PDK1 at 200 nM using Ulight-FLGFTYVAP as substrate measured after 90 mins by LANCE method relative to control	B	O=C(CCCCCn1cc(Nc2ncc(Cl)c(Nc3ccc(Cl)cc3)n2)cn1)NO		CHEMBL4526274	=	Inhibition	%	15.0	CHEMBL2534	Homo sapiens	INH	%	15.0
Not Active	19040097	CHEMBL4352001	Inhibition of recombinant human PDK1 (52 to end residues) at 10 uM using PDKtide as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Active	19041230	CHEMBL4352491	Inhibition of human PDK1 at 10 uM using MBP as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	19059743	CHEMBL4358044	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	93.0	CHEMBL2534	Homo sapiens	Activity	%	93.0
	19090308	CHEMBL4365882	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	87.0	CHEMBL2534	Homo sapiens	Activity	%	87.0
	19092061	CHEMBL4366535	Inhibition of human PDK1/PDPk1 at 100 nM using [KTFCGTPEYLAPEVRREPRILSEEEQEMFRDFDYIADWC as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-3.45	CHEMBL2534	Homo sapiens	INH	%	-3.45
	19147984	CHEMBL4379288	Inhibition of recombinant human PDK1 (52 to end residues) using KTFCGTPEYLAPE as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL2534	Homo sapiens	IC50	uM	10.0
	19159571	CHEMBL4382675	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	94.0	CHEMBL2534	Homo sapiens	Activity	%	94.0
	19181109	CHEMBL4387320	Inhibition of recombinant human His-tagged PDK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	1.0	CHEMBL2534	Homo sapiens	INH	%	1.0
	19181334	CHEMBL4387320	Inhibition of recombinant human His-tagged PDK1 expressed in baculovirus expression system at 0.1 uM using serine/threonine-7 peptide as substrate incubated for 60 mins by Z'-LYTE assay relative to control	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	8.5	CHEMBL2534	Homo sapiens	INH	%	8.5
	19191436	CHEMBL4389394	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	41.0	CHEMBL2534	Homo sapiens	INH	%	41.0
	19192057	CHEMBL4389871	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	34.0	CHEMBL2534	Homo sapiens	INH	%	34.0
	19200313	CHEMBL4391497	Binding affinity to wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	41.0	CHEMBL2534	Homo sapiens	Activity	%	41.0
	19225482	CHEMBL4395902	Inhibition of human recombinant PDK1 at 1 uM using Ulight-FLGFTYVAP as substrate measured after 90 mins in presence of ATP by LANCE assay relative to control	B	CCc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(=O)C3CC3)c2)[nH]1		CHEMBL4536012	=	Inhibition	%	-5.07	CHEMBL2534	Homo sapiens	INH	%	-5.07
	19256343	CHEMBL4402906	Displacement of fluorescent PIFtide from PDK1 (50 to 359 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by fluorescence polarization competitive binding assay	B	O=S(=O)(Nc1nc2ccc(Cl)cc2s1)c1csc2ccccc12		CHEMBL4592040	=	Kd	nM	1500.0	CHEMBL2534	Homo sapiens	Kd	uM	1.5
	19260482	CHEMBL4403985	Inhibition of PDK1 in human BT474c cells assessed as reduction in AKT phosphorylation at T208 residue	B	Cc1cc2ncnn2cc1Nc1ncc2c(n1)n(C1CCOCC1)c(=O)n2C		CHEMBL4439259	>	IC50	nM	8300.0	CHEMBL2534	Homo sapiens	IC50	uM	8.3
	19266557	CHEMBL4405507	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL2534	Homo sapiens	INH	%	50.0
Not Active	19334863	CHEMBL4419260	Binding affinity to PDPK1 PH-domain (unknown origin) at 0.01 to 50 uM by SPR spectroscopy	B	CC(=O)Nc1cccc(-n2nnc(SCC(=O)c3cc(-c4ccccc4)no3)n2)c1		CHEMBL4588492		Activity			CHEMBL2534	Homo sapiens	Activity		
Not Active	19334864	CHEMBL4419260	Binding affinity to PDPK1 PH-domain (unknown origin) at 0.01 to 50 uM by SPR spectroscopy	B	CCOC(=O)Cc1nn(Cc2nc(-c3ccc(C)cc3)cs2)c(=O)c2ccccc12		CHEMBL1422005		Activity			CHEMBL2534	Homo sapiens	Activity		
	19371148	CHEMBL4424900	Inhibition of human N-terminal His6-tagged PDK1 (52 to end residues) expressed in baculovirus infected Sf21 insect cells using PDKtide as substrate	A	COc1cc(C2CN(C(=O)c3cc(COC[C@@H](O)CO)ccn3)C2)ccc1OCc1ccc(C2CC2)cc1		CHEMBL4474690	>	IC50	nM	1000.0	CHEMBL2534	Homo sapiens	IC50	nM	1000.0
	19411439	CHEMBL4427726	Inhibition of PDK1 (unknown origin) by direct binding assay	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	>=	IC50	nM	5000.0	CHEMBL2534	Homo sapiens	IC50	uM	5.0
	19411495	CHEMBL4427670	Inhibition of PDK1 (unknown origin) at 1 uM by direct binding assay relative to control	B	Cc1cnc(-c2cc(Cl)ccc2F)cc1-n1c(=O)n(CC(N)=O)c2cnccc21		CHEMBL4564126	<=	Inhibition	%	16.0	CHEMBL2534	Homo sapiens	INH	%	16.0
	19476614	CHEMBL4479762	Inhibition of full-length recombinant human His-tagged PDK1 expressed in baculovirus expression system by Z'-LYTE assay	B	O=C(NCC(F)(F)F)c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)cs1		CHEMBL4569508	=	IC50	nM	130.0	CHEMBL2534	Homo sapiens	IC50	nM	130.0
	19476714	CHEMBL4479762	Inhibition of full-length recombinant human His-tagged PDK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)NCC(F)(F)F)c4)cnn3c2)cn1		CHEMBL4550702	=	IC50	nM	53.0	CHEMBL2534	Homo sapiens	IC50	nM	53.0
	19476814	CHEMBL4479762	Inhibition of full-length recombinant human His-tagged PDK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cn1cc(-c2cnc3c(-c4csc(C(=O)N[C@@H]5CCCC[C@@H]5N)c4)cnn3c2)cn1		CHEMBL4568087	=	IC50	nM	20.0	CHEMBL2534	Homo sapiens	IC50	nM	20.0
	19476914	CHEMBL4479762	Inhibition of full-length recombinant human His-tagged PDK1 expressed in baculovirus expression system by Z'-LYTE assay	B	Cc1sc(C(=O)N[C@@H]2[C@H](N)CCCC2(F)F)cc1-c1cnn2cc(Cl)cnc12		CHEMBL4552628	=	IC50	nM	330.0	CHEMBL2534	Homo sapiens	IC50	nM	330.0
	20600622	CHEMBL4603574	Inhibition of full length recombinant His-tagged human PDK1 expressed in baculovirus expression system using Ser/Thr 07 as substrate after 1 hr in presence of ATP by Z'LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL2534	Homo sapiens	IC50	uM	100.0
	22820540	CHEMBL4716272	Inhibition of human PDK1 assessed as residual activity at 1 uM relative to control	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	=	Activity	%	107.0	CHEMBL2534	Homo sapiens	Activity	%	107.0
	22820541	CHEMBL4716272	Inhibition of human PDK1 assessed as residual activity at 1 uM relative to control	B	COc1cc2c(cc1Nc1ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n1)CCNC2		CHEMBL4782674	=	Activity	%	34.0	CHEMBL2534	Homo sapiens	Activity	%	34.0
Not Active	22889544	CHEMBL4729063	Inhibition of wild-type human full length PDPK1 (M1 to Q556 residues) expressed in bacterial expression system at 1 uM by Kinomescan method	B	COc1cc(OCc2ccnc(Nc3cnn(C)c3)n2)cc2sc(N[C@H]3CCCC[C@@H]3O)nc12		CHEMBL4748740		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
Not Active	22936054	CHEMBL4739751	Inhibition of human PDK1 at 1 uM using substrate peptide by off-chip mobility shift assay	B	CC(=O)c1ccc(C(N)=O)cc1Oc1ccc(OCCOC2CCOCC2)cc1		CHEMBL4749965		Inhibition	%		CHEMBL2534	Homo sapiens	INH		
	22952947	CHEMBL4766884	Inhibition of recombinant human PDK1 (52 to end residues) assessed as residual activity at 10 uM using PDKtide as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	89.0	CHEMBL2534	Homo sapiens	Activity	%	89.0
	23120854	CHEMBL4804459	Inhibition of PDK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	IC50	nM	17500.0	CHEMBL2534	Homo sapiens	IC50	uM	17.5
	23120855	CHEMBL4804459	Inhibition of PDK1 in human NCI-H929 cells by mass spectroscopic analysis	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	IC50	nM	5900.0	CHEMBL2534	Homo sapiens	IC50	uM	5.9
	23120856	CHEMBL4804459	Inhibition of PDK1 in human NCI-H929 cells by mass spectroscopic analysis	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	IC50	nM	28100.0	CHEMBL2534	Homo sapiens	IC50	uM	28.1
	23121892	CHEMBL4804641	Inhibition of PDK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc3ncsc23)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4855542	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	23121893	CHEMBL4804641	Inhibition of PDK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	CN(C1CC1)S(=O)(=O)c1ccc(-c2cnc(N)c(-c3ccc4c(c3)CCNC4=O)c2)c(F)c1		CHEMBL4860979	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	23121894	CHEMBL4804641	Inhibition of PDK1 in human NCI-H929 cells at 10 uM by mass spectroscopic analysis relative to control	B	Nc1ncc(-c2cccc([N+](=O)[O-])c2F)cc1-c1ccc2c(c1)CCNC2=O		CHEMBL4859660	=	Inhibition	%	0.0	CHEMBL2534	Homo sapiens	INH	%	0.0
	23122728	CHEMBL4805079	Inhibition of human PDPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	86.0	CHEMBL2534	Homo sapiens	Activity	%	86.0
	23123423	CHEMBL4805667	Inhibition of human PDPK1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	97.0	CHEMBL2534	Homo sapiens	Activity	%	97.0
	23123880	CHEMBL4806124	Inhibition of DNA-tagged human PDPK1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	23124936	CHEMBL4806684	Inhibition of human PDPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	100.0	CHEMBL2534	Homo sapiens	Activity	%	100.0
	23124937	CHEMBL4806684	Inhibition of human PDPK1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	96.0	CHEMBL2534	Homo sapiens	Activity	%	96.0
	23290605	CHEMBL4839414	Inhibition of human PDPK1 at 1 uM by KINOMEscan assay relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	=	Inhibition	%	80.0	CHEMBL2534	Homo sapiens	INH	%	80.0
	23290616	CHEMBL4839425	Inhibition of human PDPK1 by KINOMEscan assay relative to control	B	CSc1ccc(NC2=C(c3ccccc3Cl)C(=O)NC2=O)cc1		CHEMBL156563	>	Kd	nM	10000.0	CHEMBL2534	Homo sapiens	Kd	nM	10000.0
Not Active	23317564	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	87.0	CHEMBL2534	Homo sapiens	% Control	%	87.0
Not Active	23318032	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23318698	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	87.0	CHEMBL2534	Homo sapiens	% Control	%	87.0
Not Active	23319182	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	96.0	CHEMBL2534	Homo sapiens	% Control	%	96.0
Not Active	23319819	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23320294	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	77.3	CHEMBL2534	Homo sapiens	% Control	%	77.3
Not Active	23320972	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	89.0	CHEMBL2534	Homo sapiens	% Control	%	89.0
Not Active	23321440	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	99.0	CHEMBL2534	Homo sapiens	% Control	%	99.0
Not Active	23322070	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23322538	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23323227	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23323695	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23324549	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	98.2	CHEMBL2534	Homo sapiens	% Control	%	98.2
Not Active	23325184	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	74.0	CHEMBL2534	Homo sapiens	% Control	%	74.0
Not Active	23325652	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	80.0	CHEMBL2534	Homo sapiens	% Control	%	80.0
Not Active	23326299	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	95.0	CHEMBL2534	Homo sapiens	% Control	%	95.0
Not Active	23326767	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	85.0	CHEMBL2534	Homo sapiens	% Control	%	85.0
Not Active	23327467	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	91.0	CHEMBL2534	Homo sapiens	% Control	%	91.0
Not Active	23327935	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	92.0	CHEMBL2534	Homo sapiens	% Control	%	92.0
Not Active	23328522	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	73.0	CHEMBL2534	Homo sapiens	% Control	%	73.0
Not Active	23328990	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	94.0	CHEMBL2534	Homo sapiens	% Control	%	94.0
Not Active	23329936	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	85.0	CHEMBL2534	Homo sapiens	% Control	%	85.0
Not Active	23330404	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	93.0	CHEMBL2534	Homo sapiens	% Control	%	93.0
Not Active	23331160	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	94.0	CHEMBL2534	Homo sapiens	% Control	%	94.0
Not Active	23331628	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	95.0	CHEMBL2534	Homo sapiens	% Control	%	95.0
Not Active	23332215	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23332681	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	92.0	CHEMBL2534	Homo sapiens	% Control	%	92.0
Not Active	23333399	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	93.4	CHEMBL2534	Homo sapiens	% Control	%	93.4
Not Active	23334038	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	92.0	CHEMBL2534	Homo sapiens	% Control	%	92.0
Not Active	23334506	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23335485	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23335953	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	61.0	CHEMBL2534	Homo sapiens	% Control	%	61.0
Not Active	23336580	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	96.0	CHEMBL2534	Homo sapiens	% Control	%	96.0
Not Active	23337048	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23338129	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	99.0	CHEMBL2534	Homo sapiens	% Control	%	99.0
Not Active	23338597	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	82.0	CHEMBL2534	Homo sapiens	% Control	%	82.0
Not Active	23339209	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23339677	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23340314	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23340782	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23341439	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23341907	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	94.0	CHEMBL2534	Homo sapiens	% Control	%	94.0
Not Active	23342523	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	90.0	CHEMBL2534	Homo sapiens	% Control	%	90.0
Not Active	23342991	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23343621	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	92.0	CHEMBL2534	Homo sapiens	% Control	%	92.0
Not Active	23344089	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23344727	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	87.0	CHEMBL2534	Homo sapiens	% Control	%	87.0
Not Active	23345300	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	99.0	CHEMBL2534	Homo sapiens	% Control	%	99.0
Not Active	23345768	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	92.0	CHEMBL2534	Homo sapiens	% Control	%	92.0
Not Active	23346345	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	86.5	CHEMBL2534	Homo sapiens	% Control	%	86.5
Not Active	23346813	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	95.5	CHEMBL2534	Homo sapiens	% Control	%	95.5
Not Active	23347415	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23347905	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	86.3	CHEMBL2534	Homo sapiens	% Control	%	86.3
Not Active	23348484	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23348952	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23349539	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23350157	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	93.0	CHEMBL2534	Homo sapiens	% Control	%	93.0
Not Active	23350625	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23351230	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23351698	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23352722	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	78.0	CHEMBL2534	Homo sapiens	% Control	%	78.0
Not Active	23353190	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23354072	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23354540	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23355272	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	90.0	CHEMBL2534	Homo sapiens	% Control	%	90.0
Not Active	23355740	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23356376	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
Not Active	23356844	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	94.0	CHEMBL2534	Homo sapiens	% Control	%	94.0
Not Active	23357453	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23358100	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	85.0	CHEMBL2534	Homo sapiens	% Control	%	85.0
Not Active	23358568	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
Not Active	23359154	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	87.8	CHEMBL2534	Homo sapiens	% Control	%	87.8
Not Active	23359752	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23360220	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23360805	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23361273	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	98.0	CHEMBL2534	Homo sapiens	% Control	%	98.0
Not Active	23361846	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23362382	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23362850	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	82.0	CHEMBL2534	Homo sapiens	% Control	%	82.0
Not Active	23364492	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	72.0	CHEMBL2534	Homo sapiens	% Control	%	72.0
Not Active	23364960	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	70.0	CHEMBL2534	Homo sapiens	% Control	%	70.0
Not Active	23365699	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23366242	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23366832	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23367300	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23368178	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
Not Active	23368646	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	88.0	CHEMBL2534	Homo sapiens	% Control	%	88.0
Not Active	23369245	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	76.0	CHEMBL2534	Homo sapiens	% Control	%	76.0
Not Active	23369713	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23370681	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	86.0	CHEMBL2534	Homo sapiens	% Control	%	86.0
Not Active	23371149	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	77.0	CHEMBL2534	Homo sapiens	% Control	%	77.0
Not Active	23371958	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23372426	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	99.0	CHEMBL2534	Homo sapiens	% Control	%	99.0
	23372842	CHEMBL4884807	PDK1(PDP1LGA1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
	23373251	CHEMBL4885098	PDK1(PDP1LGA1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
	23373608	CHEMBL4885385	PDK1(PDP1LGA1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL2534	Homo sapiens	pIC50		6.0
Not Active	23375853	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23376321	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
Not Active	23376898	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23377366	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
Not Active	23378226	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	88.0	CHEMBL2534	Homo sapiens	% Control	%	88.0
Not Active	23378694	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	85.0	CHEMBL2534	Homo sapiens	% Control	%	85.0
Not Active	23379861	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23380329	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	81.0	CHEMBL2534	Homo sapiens	% Control	%	81.0
Not Active	23381023	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23381671	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23382139	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23382763	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	81.0	CHEMBL2534	Homo sapiens	% Control	%	81.0
Not Active	23383231	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	54.0	CHEMBL2534	Homo sapiens	% Control	%	54.0
Not Active	23385146	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL2534	Homo sapiens	% Control	%	100.0
Not Active	23385613	CHEMBL4879870	KinomeScan assay: inhibition of PDPK1	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	97.0	CHEMBL2534	Homo sapiens	% Control	%	97.0
